0001099800-24-000086.txt : 20241106 0001099800-24-000086.hdr.sgml : 20241106 20241106162018 ACCESSION NUMBER: 0001099800-24-000086 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 108 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 241431333 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 10-Q 1 ew-20240930.htm 10-Q ew-20240930
000109980012/312024Q3falsehttp://fasb.org/us-gaap/2024#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2024#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://www.edwards.com/20240930#AccruedAndOtherLiabilitiesCurrenthttp://www.edwards.com/20240930#AccruedAndOtherLiabilitiesCurrent151xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesew:employeexbrli:pureiso4217:EURew:lawsuitew:agreement00010998002024-01-012024-09-3000010998002024-10-3100010998002024-09-3000010998002023-12-3100010998002024-07-012024-09-3000010998002023-07-012023-09-3000010998002023-01-012023-09-3000010998002022-12-3100010998002023-09-300001099800us-gaap:CommonStockMember2023-12-310001099800us-gaap:TreasuryStockCommonMember2023-12-310001099800us-gaap:AdditionalPaidInCapitalMember2023-12-310001099800us-gaap:RetainedEarningsMember2023-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001099800us-gaap:ParentMember2023-12-310001099800us-gaap:NoncontrollingInterestMember2023-12-310001099800us-gaap:RetainedEarningsMember2024-01-012024-03-310001099800us-gaap:ParentMember2024-01-012024-03-310001099800us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100010998002024-01-012024-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001099800us-gaap:CommonStockMember2024-01-012024-03-310001099800us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001099800us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001099800us-gaap:CommonStockMember2024-03-310001099800us-gaap:TreasuryStockCommonMember2024-03-310001099800us-gaap:AdditionalPaidInCapitalMember2024-03-310001099800us-gaap:RetainedEarningsMember2024-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001099800us-gaap:ParentMember2024-03-310001099800us-gaap:NoncontrollingInterestMember2024-03-3100010998002024-03-310001099800us-gaap:RetainedEarningsMember2024-04-012024-06-300001099800us-gaap:ParentMember2024-04-012024-06-300001099800us-gaap:NoncontrollingInterestMember2024-04-012024-06-3000010998002024-04-012024-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001099800us-gaap:CommonStockMember2024-04-012024-06-300001099800us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001099800us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001099800us-gaap:CommonStockMember2024-06-300001099800us-gaap:TreasuryStockCommonMember2024-06-300001099800us-gaap:AdditionalPaidInCapitalMember2024-06-300001099800us-gaap:RetainedEarningsMember2024-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001099800us-gaap:ParentMember2024-06-300001099800us-gaap:NoncontrollingInterestMember2024-06-3000010998002024-06-300001099800us-gaap:RetainedEarningsMember2024-07-012024-09-300001099800us-gaap:ParentMember2024-07-012024-09-300001099800us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001099800us-gaap:CommonStockMember2024-07-012024-09-300001099800us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001099800us-gaap:TreasuryStockCommonMember2024-07-012024-09-300001099800us-gaap:CommonStockMember2024-09-300001099800us-gaap:TreasuryStockCommonMember2024-09-300001099800us-gaap:AdditionalPaidInCapitalMember2024-09-300001099800us-gaap:RetainedEarningsMember2024-09-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001099800us-gaap:ParentMember2024-09-300001099800us-gaap:NoncontrollingInterestMember2024-09-300001099800us-gaap:CommonStockMember2022-12-310001099800us-gaap:TreasuryStockCommonMember2022-12-310001099800us-gaap:AdditionalPaidInCapitalMember2022-12-310001099800us-gaap:RetainedEarningsMember2022-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001099800us-gaap:ParentMember2022-12-310001099800us-gaap:NoncontrollingInterestMember2022-12-310001099800us-gaap:RetainedEarningsMember2023-01-012023-03-310001099800us-gaap:ParentMember2023-01-012023-03-3100010998002023-01-012023-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001099800us-gaap:CommonStockMember2023-01-012023-03-310001099800us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001099800us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001099800us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001099800us-gaap:CommonStockMember2023-03-310001099800us-gaap:TreasuryStockCommonMember2023-03-310001099800us-gaap:AdditionalPaidInCapitalMember2023-03-310001099800us-gaap:RetainedEarningsMember2023-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001099800us-gaap:ParentMember2023-03-310001099800us-gaap:NoncontrollingInterestMember2023-03-3100010998002023-03-310001099800us-gaap:RetainedEarningsMember2023-04-012023-06-300001099800us-gaap:ParentMember2023-04-012023-06-300001099800us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000010998002023-04-012023-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001099800us-gaap:CommonStockMember2023-04-012023-06-300001099800us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001099800us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001099800us-gaap:CommonStockMember2023-06-300001099800us-gaap:TreasuryStockCommonMember2023-06-300001099800us-gaap:AdditionalPaidInCapitalMember2023-06-300001099800us-gaap:RetainedEarningsMember2023-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001099800us-gaap:ParentMember2023-06-300001099800us-gaap:NoncontrollingInterestMember2023-06-3000010998002023-06-300001099800us-gaap:RetainedEarningsMember2023-07-012023-09-300001099800us-gaap:ParentMember2023-07-012023-09-300001099800us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001099800us-gaap:CommonStockMember2023-07-012023-09-300001099800us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001099800us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001099800us-gaap:CommonStockMember2023-09-300001099800us-gaap:TreasuryStockCommonMember2023-09-300001099800us-gaap:AdditionalPaidInCapitalMember2023-09-300001099800us-gaap:RetainedEarningsMember2023-09-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001099800us-gaap:ParentMember2023-09-300001099800us-gaap:NoncontrollingInterestMember2023-09-300001099800us-gaap:SegmentDiscontinuedOperationsMember2024-01-012024-09-300001099800us-gaap:SegmentDiscontinuedOperationsMember2023-01-012023-09-300001099800us-gaap:SegmentContinuingOperationsMember2024-09-300001099800us-gaap:SegmentContinuingOperationsMember2023-12-310001099800us-gaap:SegmentDiscontinuedOperationsMember2024-09-300001099800us-gaap:SegmentDiscontinuedOperationsMember2023-12-3100010998002023-04-122023-04-120001099800ew:MedtronicIncMember2023-04-122023-04-120001099800ew:MedtronicIncMember2023-03-012023-03-310001099800ew:MedtronicIncMember2023-04-300001099800ew:MedtronicIncMember2023-04-012023-04-3000010998002024-09-012024-09-300001099800us-gaap:EmployeeSeveranceMember2024-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-06-030001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-09-032024-09-030001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-06-032024-06-030001099800ew:BectonDickinsonAndCompanyMember2024-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-07-012024-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-01-012024-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2023-07-012023-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2023-01-012023-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2024-09-300001099800us-gaap:DiscontinuedOperationsHeldforsaleMemberew:CriticalCareMember2023-12-310001099800us-gaap:BankTimeDepositsMember2024-09-300001099800us-gaap:BankTimeDepositsMember2023-12-310001099800us-gaap:CommercialPaperMember2024-09-300001099800us-gaap:CommercialPaperMember2023-12-310001099800us-gaap:USTreasuryAndGovernmentMember2024-09-300001099800us-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:AssetBackedSecuritiesMember2024-09-300001099800us-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:CorporateDebtSecuritiesMember2024-09-300001099800us-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:MunicipalBondsMember2024-09-300001099800us-gaap:MunicipalBondsMember2023-12-310001099800ew:NewMarketsTaxCreditMemberus-gaap:LimitedLiabilityCompanyMember2024-09-300001099800us-gaap:LimitedLiabilityCompanyMember2024-01-012024-09-300001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-09-300001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2022-06-012022-06-300001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2024-09-300001099800us-gaap:SubsequentEventMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-10-012024-10-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2019-01-012019-12-310001099800ew:MedicalDeviceCompanyApril2021InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-04-300001099800ew:MedicalDeviceCompanyApril2021InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300001099800ew:MedicalDeviceCompanyApril2021InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310001099800ew:MedicalDeviceCompanyMarch2023InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-310001099800ew:MedicalDeviceCompanyMarch2023InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-012024-09-300001099800ew:MedicalDeviceCompanyMarch2023InvestmentMemberew:ConvertiblePromissoryNoteMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-310001099800ew:MedicalDeviceCompanyMarch2023InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300001099800ew:MedicalDeviceCompanyMarch2023InvestmentMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310001099800ew:EndotronixIncMember2024-08-182024-08-180001099800ew:EndotronixIncMember2024-08-180001099800ew:EndotronixIncMember2024-08-192024-08-190001099800ew:EndotronixIncMember2024-07-012024-09-300001099800ew:EndotronixIncMember2024-08-190001099800ew:EndotronixIncMember2024-09-300001099800ew:EndotronixIncMember2024-01-012024-09-300001099800ew:EndotronixIncMemberus-gaap:InProcessResearchAndDevelopmentMember2024-08-190001099800ew:EndotronixIncMemberus-gaap:DevelopedTechnologyRightsMember2024-08-190001099800ew:EndotronixIncMemberus-gaap:DevelopedTechnologyRightsMemberus-gaap:MeasurementInputDiscountRateMember2024-08-190001099800ew:EndotronixIncMemberus-gaap:InProcessResearchAndDevelopmentMemberus-gaap:MeasurementInputDiscountRateMember2024-08-190001099800ew:JCMedicalInc.Member2024-07-222024-07-220001099800ew:JCMedicalInc.Member2024-07-220001099800ew:JCMedicalInc.Member2024-01-012024-09-300001099800ew:JCMedicalInc.Memberus-gaap:InProcessResearchAndDevelopmentMember2024-07-220001099800ew:JCMedicalInc.Memberus-gaap:InProcessResearchAndDevelopmentMemberus-gaap:MeasurementInputDiscountRateMember2024-07-220001099800ew:JCMedicalInc.Member2024-08-190001099800us-gaap:FairValueInputsLevel2Member2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:BankTimeDepositsMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:BankTimeDepositsMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:BankTimeDepositsMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:BankTimeDepositsMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2024-09-300001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2024-09-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2024-09-300001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-12-310001099800us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2023-12-310001099800us-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2024-09-300001099800us-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2024-09-300001099800us-gaap:MeasurementInputDiscountRateMembersrt:WeightedAverageMember2024-09-300001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMembersrt:MinimumMember2024-09-300001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMembersrt:MaximumMember2024-09-300001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMembersrt:WeightedAverageMember2024-09-300001099800ew:MeasurementInputRevenueVolatilityMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800ew:ContingentConsiderationLiabilityMember2024-01-012024-09-300001099800us-gaap:OtherLiabilitiesMember2024-01-012024-09-300001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-012024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-01-012024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-012024-09-300001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-01-012023-09-300001099800us-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001099800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001099800us-gaap:ForeignExchangeContractMember2024-09-300001099800us-gaap:CurrencySwapMember2024-09-300001099800us-gaap:ForeignExchangeContractMember2023-12-310001099800us-gaap:CurrencySwapMember2023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2024-07-012024-09-300001099800us-gaap:InterestIncomeMemberus-gaap:ForeignExchangeContractMember2024-07-012024-09-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2024-07-012024-09-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2024-01-012024-09-300001099800us-gaap:InterestIncomeMemberus-gaap:ForeignExchangeContractMember2024-01-012024-09-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2024-07-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2024-01-012024-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:InterestIncomeMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:InterestIncomeMember2024-01-012024-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-09-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001099800us-gaap:InterestIncomeMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001099800us-gaap:InterestIncomeMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2023-07-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMember2023-01-012023-09-300001099800us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:InterestIncomeMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:InterestIncomeMember2023-01-012023-09-300001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-09-300001099800us-gaap:CostOfSalesMember2024-07-012024-09-300001099800us-gaap:CostOfSalesMember2023-07-012023-09-300001099800us-gaap:CostOfSalesMember2024-01-012024-09-300001099800us-gaap:CostOfSalesMember2023-01-012023-09-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-09-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001099800us-gaap:CommonStockMemberew:LongTermStockIncentiveCompensationProgramMember2024-05-072024-05-070001099800us-gaap:CommonStockMemberew:LongTermStockIncentiveCompensationProgramMember2024-05-070001099800us-gaap:RestrictedStockUnitsRSUMemberew:LongTermStockIncentiveCompensationProgramMember2024-05-072024-05-070001099800us-gaap:RestrictedStockUnitsRSUMemberew:LongTermStockIncentiveCompensationProgramMember2024-05-070001099800us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001099800ew:MarketBasedRestrictedStockUnitsMember2024-01-012024-09-300001099800ew:MarketBasedRestrictedStockUnitsMembersrt:MinimumMember2024-01-012024-09-300001099800ew:MarketBasedRestrictedStockUnitsMembersrt:MaximumMember2024-01-012024-09-300001099800ew:MarketBasedRestrictedStockUnitsMember2023-01-012023-09-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2024-07-012024-09-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-07-012023-09-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2024-01-012024-09-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-01-012023-09-300001099800us-gaap:EmployeeStockMember2024-07-012024-09-300001099800us-gaap:EmployeeStockMember2023-07-012023-09-300001099800us-gaap:EmployeeStockMember2024-01-012024-09-300001099800us-gaap:EmployeeStockMember2023-01-012023-09-300001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-280001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-012023-02-280001099800ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member2023-03-012023-03-310001099800ew:InitialDeliveryOfSharesSettledApril2024Member2024-04-300001099800ew:InitialDeliveryOfSharesSettledApril2024Member2024-04-012024-04-300001099800ew:April2024StockRepurchaseProgramSharesSoldInMay2024Member2024-05-012024-05-310001099800ew:InitialDeliveryOfSharesSettledApril2024Member2024-08-310001099800ew:InitialDeliveryOfSharesSettledApril2024Member2024-08-012024-08-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-04-012024-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-04-012024-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-07-012024-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-07-012024-09-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-04-012023-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-012023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001099800us-gaap:StockCompensationPlanMember2024-07-012024-09-300001099800us-gaap:StockCompensationPlanMember2023-07-012023-09-300001099800us-gaap:StockCompensationPlanMember2024-01-012024-09-300001099800us-gaap:StockCompensationPlanMember2023-01-012023-09-300001099800us-gaap:TreasuryStockCommonMember2024-01-012024-09-3000010998002020-12-3100010998002021-01-012021-12-3100010998002022-11-012022-11-3000010998002024-03-012024-03-310001099800us-gaap:IsraelTaxAuthorityMember2024-01-012024-03-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2024-07-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2023-07-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2024-01-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2023-01-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2024-07-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2023-07-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2024-01-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2023-01-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2024-07-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2023-07-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2024-01-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2023-01-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2024-07-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2023-07-012023-09-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2024-01-012024-09-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2023-01-012023-09-300001099800us-gaap:OperatingSegmentsMember2024-07-012024-09-300001099800us-gaap:OperatingSegmentsMember2023-07-012023-09-300001099800us-gaap:OperatingSegmentsMember2024-01-012024-09-300001099800us-gaap:OperatingSegmentsMember2023-01-012023-09-300001099800us-gaap:MaterialReconcilingItemsMember2024-07-012024-09-300001099800us-gaap:MaterialReconcilingItemsMember2023-07-012023-09-300001099800us-gaap:MaterialReconcilingItemsMember2024-01-012024-09-300001099800us-gaap:MaterialReconcilingItemsMember2023-01-012023-09-300001099800us-gaap:CorporateNonSegmentMember2024-07-012024-09-300001099800us-gaap:CorporateNonSegmentMember2023-07-012023-09-300001099800us-gaap:CorporateNonSegmentMember2024-01-012024-09-300001099800us-gaap:CorporateNonSegmentMember2023-01-012023-09-300001099800country:US2024-07-012024-09-300001099800country:US2023-07-012023-09-300001099800country:US2024-01-012024-09-300001099800country:US2023-01-012023-09-300001099800srt:EuropeMember2024-07-012024-09-300001099800srt:EuropeMember2023-07-012023-09-300001099800srt:EuropeMember2024-01-012024-09-300001099800srt:EuropeMember2023-01-012023-09-300001099800country:JP2024-07-012024-09-300001099800country:JP2023-07-012023-09-300001099800country:JP2024-01-012024-09-300001099800country:JP2023-01-012023-09-300001099800ew:RestOfWorldMember2024-07-012024-09-300001099800ew:RestOfWorldMember2023-07-012023-09-300001099800ew:RestOfWorldMember2024-01-012024-09-300001099800ew:RestOfWorldMember2023-01-012023-09-300001099800ew:TranscatheterAorticValveReplacementMember2024-07-012024-09-300001099800ew:TranscatheterAorticValveReplacementMember2023-07-012023-09-300001099800ew:TranscatheterAorticValveReplacementMember2024-01-012024-09-300001099800ew:TranscatheterAorticValveReplacementMember2023-01-012023-09-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2024-07-012024-09-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2023-07-012023-09-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2024-01-012024-09-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2023-01-012023-09-300001099800ew:SurgicalHeartValveTherapyMember2024-07-012024-09-300001099800ew:SurgicalHeartValveTherapyMember2023-07-012023-09-300001099800ew:SurgicalHeartValveTherapyMember2024-01-012024-09-300001099800ew:SurgicalHeartValveTherapyMember2023-01-012023-09-300001099800ew:InnovalveBioMedicalLimitedMemberus-gaap:SubsequentEventMember2024-10-012024-10-310001099800ew:InnovalveBioMedicalLimitedMemberus-gaap:SubsequentEventMember2024-10-310001099800ew:InnovalveBioMedicalLimitedMember2024-07-012024-07-310001099800ew:InnovalveBioMedicalLimitedMember2024-07-310001099800ew:ScottB.UllemMember2024-01-012024-09-300001099800ew:ScottB.UllemMember2024-07-012024-09-300001099800ew:ScottB.UllemMember2024-09-300001099800ew:BernardJ.ZovighianMember2024-01-012024-09-300001099800ew:BernardJ.ZovighianMember2024-07-012024-09-300001099800ew:BernardJ.ZovighianMember2024-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2024
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
            For the transition period from                                    to            
Commission file number 1-15525
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
36-4316614
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

One Edwards Way
Irvine, California 92614
(Address of principal executive offices and zip code)

(949) 250-2500
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $1.00 per shareEWNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ☒
The number of shares outstanding of the registrant's common stock, $1.00 par value, as of October 31, 2024 was 589.8 million.



EDWARDS LIFESCIENCES CORPORATION
FORM 10-Q
For the quarterly period ended September 30, 2024

TABLE OF CONTENTS



NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Statements other than statements of historical or current fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these safe harbor provisions. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negatives thereof. Statements regarding past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negatives thereof. These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report. These risks and uncertainties include, but are not limited to: our ability to complete or realize the anticipated benefits of the sale of our critical care product group; our ability to develop new products and avoid manufacturing and quality issues; risks related to our recent pending acquisitions, including our ability to close the transactions in a timely manner or at all; clinical trial or commercial results or new product approvals and therapy adoption; the impact of domestic and global conditions; competition in the markets in which we operate; our reliance on vendors, suppliers, and other third parties; damage, failure or interruption of our information technology systems; the impact of public health crises; consolidation in the healthcare industry; our ability to protect our intellectual property; our compliance with applicable regulations; our exposure to product liability claims; use of our products in unapproved circumstances; changes to reimbursement for our products; the impact of currency exchange rates; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; changes to tax laws; unexpected impacts or expenses of litigation or internal or government investigations; and other risks detailed under “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2023, as amended in this report, and as such risks and uncertainties may be further amended, supplemented or superseded from time to time by our subsequent reports on Forms 10-Q and 8-K we file with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.

Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.



Part I. Financial Information

Item 1.    Financial Statements
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
(in millions, except par value; unaudited)
 September 30, 2024December 31, 2023
ASSETS  
Current assets  
Cash and cash equivalents$3,676.4 $1,132.3 
Short-term investments (Note 6)769.7 500.5 
Accounts receivable, net of allowances of $12.6 and $8.2, respectively
716.0 771.5 
Other receivables95.5 56.6 
Inventories (Note 2)1,104.2 903.5 
Prepaid expenses114.9 128.8 
Other current assets231.0 224.9 
Current assets of discontinued operations (Note 5)20.0 317.6 
Total current assets6,727.7 4,035.7 
Long-term investments (Note 6)319.6 583.9 
Property, plant, and equipment, net1,675.7 1,591.0 
Operating lease right-of-use assets 104.4 84.4 
Goodwill 1,605.3 1,145.1 
Other intangible assets, net956.1 399.4 
Deferred income taxes888.4 749.4 
Other assets (Note 2)683.5 463.2 
Non-current assets of discontinued operations (Note 5)10.5 311.1 
Total assets$12,971.2 $9,363.2 
LIABILITIES AND STOCKHOLDERS' EQUITY  
Current liabilities  
Accounts payable$172.8 $186.6 
Accrued and other liabilities (Note 2)1,745.3 856.4 
Operating lease liabilities24.2 22.9 
Current liabilities of discontinued operations (Note 5)1.8 129.5 
Total current liabilities1,944.1 1,195.4 
Long-term debt 597.5 597.0 
Taxes payable1.1 80.6 
Operating lease liabilities 85.0 65.2 
Uncertain tax positions345.6 335.0 
Litigation settlement accrual63.9 94.2 
Other liabilities322.6 251.3 
Non-current liabilities of discontinued operations (Note 5)— 25.1 
Total liabilities3,359.8 2,643.8 
Commitments and contingencies (Note 13)
Stockholders' equity  
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding          
— — 
Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively
654.3 650.5 
Additional paid-in capital2,452.1 2,274.4 
Retained earnings12,781.4 8,992.4 
Accumulated other comprehensive loss (Note 14)(252.5)(242.8)
Treasury stock, at cost, 64.5 and 49.4 shares, respectively
(6,089.7)(5,024.5)
Total Edwards Lifesciences Corporation stockholders' equity9,545.6 6,650.0 
Noncontrolling interest65.8 69.4 
Total stockholders' equity9,611.4 6,719.4 
Total liabilities and equity$12,971.2 $9,363.2 
The accompanying notes are an integral part of these consolidated condensed financial statements.
1

EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(in millions, except per share information; unaudited)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net sales$1,354.4 $1,243.4 $4,053.7 $3,743.6 
Cost of sales262.9 250.6 825.3 727.4 
Gross profit1,091.5 992.8 3,228.4 3,016.2 
Selling, general, and administrative expenses421.4 381.9 1,297.3 1,165.9 
Research and development expenses253.4 242.8 781.9 720.8 
Intellectual property agreement and certain litigation expenses (Note 3)
10.8 2.2 27.8 193.6 
Change in fair value of contingent consideration liabilities (Note 9)— — — (26.2)
Restructuring expenses (Note 4)32.9 — 32.9 — 
Other operating expenses, net22.4 — 22.4 — 
Operating income, net350.6 365.9 1,066.1 962.1 
Interest income, net(24.3)(15.1)(56.3)(32.8)
Other non-operating income, net(27.9)(6.6)(35.6)(10.3)
Income from continuing operations before provision for income taxes402.8 387.6 1,158.0 1,005.2 
Provision for income taxes40.7 52.7 107.0 118.3 
Net income from continuing operations362.1 334.9 1,051.0 886.9 
Income from discontinued operations, net of tax2,707.3 48.8 2,734.4 142.8 
Net income3,069.4 383.7 3,785.4 1,029.7 
Net loss attributable to noncontrolling interest(1.4)(1.2)(3.6)(2.8)
Net income attributable to Edwards Lifesciences Corporation$3,070.8 $384.9 $3,789.0 $1,032.5 
Share information (Note 15)
    
Earnings per share:    
Basic
Continuing operations$0.61 $0.55 $1.76 $1.47 
Discontinued operations$4.53 $0.08 $4.55 $0.23 
Basic earnings per share$5.14 $0.63 $6.31 $1.70 
Diluted
Continuing operations$0.61 $0.55 $1.75 $1.46 
Discontinued operations$4.52 $0.08 $4.54 $0.23 
Diluted earnings per share$5.13 $0.63 $6.29 $1.69 
Weighted-average number of common shares outstanding:    
Basic597.2 607.0 600.3 607.2 
Diluted598.1 609.5 602.2 610.2 
The accompanying notes are an integral part of these consolidated condensed financial statements.
2

EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(in millions; unaudited)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net income$3,069.4 $383.7 $3,785.4 $1,029.7 
Other comprehensive (loss) income, net of tax (Note 14):
Foreign currency translation adjustments4.3 (23.4)(20.8)(31.1)
Unrealized (loss) gain on hedges
(42.7)18.2 (8.9)6.3 
Unrealized pension credits
— — 0.2 0.1 
Unrealized gain on available-for-sale investments
6.1 10.6 19.8 29.5 
Other comprehensive (loss) income, net of tax
(32.3)5.4 (9.7)4.8 
Comprehensive income3,037.1 389.1 3,775.7 1,034.5 
Comprehensive loss attributable to noncontrolling interest
(1.4)(1.2)(3.6)(2.8)
Comprehensive income attributable to Edwards Lifesciences Corporation$3,038.5 $390.3 $3,779.3 $1,037.3 
The accompanying notes are an integral part of these consolidated condensed financial statements.
3

EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(in millions; unaudited)
 Nine Months Ended
September 30,
 20242023
Cash flows from operating activities  
Net income$3,785.4 $1,029.7 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization112.6 108.2 
Non-cash operating lease cost21.6 20.7 
Stock-based compensation (Note 11)130.6 108.9 
Gain on sale of business (Note 5)(3,337.4)— 
Change in fair value of contingent consideration liabilities (Note 9)— (26.2)
Deferred income taxes(224.9)(180.7)
Gain on remeasurement of previously held interest upon acquisition (Note 8)(24.6)— 
Other2.7 8.8 
Changes in operating assets and liabilities:  
Accounts and other receivables, net15.3 (123.0)
Inventories(204.9)(189.7)
Accounts payable and accrued liabilities92.6 112.6 
Income taxes301.8 106.3 
Prepaid expenses and other current assets27.4 (63.7)
Intellectual property agreement accrual(24.3)(26.0)
Long-term prepaid royalties (Note 3)6.2 (111.9)
Other(10.3)(14.8)
Net cash provided by operating activities669.8 759.2 
Cash flows from investing activities  
Capital expenditures(202.6)(164.7)
Purchases of held-to-maturity investments (Note 6)(36.3)(23.5)
Proceeds from held-to-maturity investments (Note 6)50.4 91.5 
Purchases of available-for-sale investments (Note 6)(518.8)(8.4)
Proceeds from available-for-sale investments (Note 6)539.1 486.9 
Investments in intangible assets(25.4)(13.3)
Proceeds from sale of business3,927.4 — 
Business combination, net of cash(763.6)(141.2)
Payment for acquisition options (Note 7)(16.2)(15.0)
Issuances of notes receivable(28.0)(47.5)
Other(36.4)(5.1)
Net cash provided by investing activities2,889.6 159.7 
Cash flows from financing activities  
Purchases of treasury stock(1,059.3)(431.2)
Equity forward contract related to accelerated share repurchase agreement (Note 12)(100.0)— 
Proceeds from stock plans150.9 136.7 
Other(3.2)(3.3)
Net cash used in financing activities(1,011.6)(297.8)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash(12.4)20.2 
Net increase in cash, cash equivalents, and restricted cash2,535.4 641.3 
Cash, cash equivalents, and restricted cash at beginning of period1,148.0 772.6 
Cash, cash equivalents, and restricted cash at end of period (Note 2)$3,683.4 $1,413.9 
The accompanying notes are an integral part of these consolidated condensed financial statements.
4

EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions; unaudited)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Edwards Lifesciences Corporation Stockholders' EquityNoncontrolling InterestTotal Stockholders' Equity
Balance at December 31, 2023650.5 $650.5 49.4 $(5,024.5)$2,274.4 $8,992.4 $(242.8)$6,650.0 $69.4 $6,719.4 
Net income     351.9  351.9 (0.9)351.0 
Other comprehensive gain, net of tax      9.5 9.5 9.5 
Common stock issued under stock plans1.3 1.3   60.8   62.1 62.1 
Stock-based compensation expense    44.6   44.6 44.6 
Purchases of treasury stock  — (0.2)  (0.2)(0.2)
Balance at March 31, 2024
651.8 $651.8 49.4 $(5,024.7)$2,379.8 $9,344.3 $(233.3)$7,117.9 $68.5 $7,186.4 
Net income366.3 366.3 (1.3)365.0 
Other comprehensive gain, net of tax13.1 13.1 13.1 
Common stock issued under equity plans
1.7 1.7 52.6 54.3 54.3 
Stock-based compensation expense43.9 43.9 43.9 
Purchases of treasury stock1.8 (158.1)(158.1)(158.1)
Balance at June 30, 2024
653.5 $653.5 51.2 $(5,182.8)$2,476.3 $9,710.6 $(220.2)$7,437.4 $67.2 $7,504.6 
Net income3,070.8 3,070.8 (1.4)3,069.4 
Other comprehensive loss, net of tax(32.3)(32.3)(32.3)
Common stock issued under equity plans
0.8 0.8 33.7 34.5 34.5 
Stock-based compensation expense42.1 42.1 42.1 
Purchases of treasury stock13.3 (906.9)(100.0)(1,006.9)(1,006.9)
Balance at September 30, 2024
654.3 $654.3 64.5 $(6,089.7)$2,452.1 $12,781.4 $(252.5)$9,545.6 $65.8 $9,611.4 
The accompanying notes are an integral part of these consolidated condensed financial statements.

5

EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions; unaudited)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Edwards Lifesciences, Inc. Stockholders' EquityNoncontrolling InterestTotal Stockholders' Equity
Balance at December 31, 2022646.3 $646.3 38.0 $(4,144.0)$1,969.3 $7,590.0 $(254.9)$5,806.7 $— $5,806.7 
Net income     340.5  340.5 — 340.5 
Other comprehensive loss, net of tax      (0.5)(0.5)(0.5)
Common stock issued under stock plans0.8 0.8   41.1   41.9 41.9 
Stock-based compensation expense    38.9   38.9 38.9 
Purchases of treasury stock  3.1 (249.5)  (249.5)(249.5)
Changes to noncontrolling interest84.0 84.0 
Balance at March 31, 2023
647.1 $647.1 41.1 $(4,393.5)$2,049.3 $7,930.5 $(255.4)$5,978.0 $84.0 $6,062.0 
Net income307.1 307.1 (1.6)305.5 
Other comprehensive loss, net of tax(0.1)(0.1)(0.1)
Common stock issued under equity plans
2.0 2.0 58.8 60.8 60.8 
Stock-based compensation expense37.4 37.4 37.4 
Purchases of treasury stock0.1 (7.5)(7.5)(7.5)
Changes to noncontrolling interest(11.6)(11.6)
Balance at June 30, 2023
649.1 $649.1 41.2 $(4,401.0)$2,145.5 $8,237.6 $(255.5)$6,375.7 $70.8 $6,446.5 
Net income384.9 384.9 (1.2)383.7 
Other comprehensive loss, net of tax5.4 5.4 5.4 
Common stock issued under equity plans
0.8 0.8 33.2 34.0 34.0 
Stock-based compensation expense32.6 32.6 32.6 
Purchases of treasury stock2.2 (175.1)(175.1)(175.1)
Balance at September 30, 2023
649.9 $649.9 43.4 $(4,576.1)$2,211.3 $8,622.5 $(250.1)$6,657.5 $69.6 $6,727.1 
The accompanying notes are an integral part of these consolidated condensed financial statements.
6


1.     BASIS OF PRESENTATION

The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.

The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

On September 3, 2024, the Company sold its Critical Care product group ("Critical Care"). The historical results of Critical Care are reflected as discontinued operations in the Company's consolidated condensed financial statements for all periods presented. In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the historical results of a small non-core product group that the Company plans to sell are also included in discontinued operations. Unless otherwise indicated, the information in the notes to the consolidated condensed financial statements refer only to Edwards Lifesciences' continuing operations. For more information, see Note 5.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.

Recently Adopted Accounting Standards

In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

New Accounting Standards Not Yet Adopted

In November 2024, the FASB issued an amendment to the accounting guidance on income statement presentation to require disclosure, in the notes to the financial statements, of disaggregated information about certain costs and expenses, including purchases of inventory, employee compensation, and depreciation and amortization included in each relevant expense caption within continuing operations. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.

In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay
7

to allow the legal process to proceed. The Company is currently evaluating the disclosure impact the guidance will have on its consolidated financial statements.

In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.

2.     OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions
(in millions)

Components of selected captions in the consolidated condensed balance sheets consisted of the following:
September 30,
2024		December 31, 2023
Inventories
Raw materials$248.8 $196.3 
Work in process244.4 195.8 
Finished products611.0 511.4 
$1,104.2 $903.5 

At September 30, 2024 and December 31, 2023, $187.8 million and $164.6 million, respectively, of the Company's finished products inventories were held on consignment.

8

September 30,
2024		December 31, 2023
Other assets
Tax receivable (Note 16)$293.7 $— 
Notes and other receivables132.9 155.1 
Acquisition options117.5 161.3 
Long-term prepaid royalties103.7 109.9 
Fair value of derivatives21.8 23.4 
Other long-term assets13.9 13.5 
$683.5 $463.2 
Accrued and other liabilities 
Employee compensation and withholdings$312.1 $316.4 
Taxes payable (Note 5)715.1 52.7 
Property, payroll, and other taxes83.7 53.8 
Research and development accruals79.0 71.6 
Accrued rebates140.0 123.5 
Fair value of derivatives24.3 15.2 
Accrued marketing expenses14.5 13.7 
Legal and insurance29.5 28.9 
Litigation settlement75.1 69.1 
Accrued relocation costs16.2 16.9 
Accrued professional services62.2 8.5 
Accrued realignment reserves39.6 6.4 
Unfavorable contract liability66.0 — 
Other accrued liabilities88.0 79.7 
$1,745.3 $856.4 

Supplemental Cash Flow Information
(in millions)
Nine Months Ended
September 30,
20242023
Cash paid during the year for:
Income taxes (a) (Note 16)
$633.8 $219.1 
Amounts included in the measurement of operating lease liabilities$21.0 $19.1 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$38.9 $19.9 
Capital expenditures accruals$22.9 $32.5 
______________________________________
(a)     Includes cash paid for income taxes from discontinued operations of $29.7 million and $22.7 million for the nine months ended September 30, 2024 and 2023, respectively.
9


Cash, Cash Equivalents, and Restricted Cash
(in millions)
September 30,
2024		December 31, 2023
Continuing operations
Cash and cash equivalents$3,676.4 $1,132.3 
Restricted cash included in other current assets3.2 3.3 
Restricted cash included in other assets0.9 0.7 
Total$3,680.5 $1,136.3 
Discontinued operations
Cash and cash equivalents$2.9 $11.7 
Total$2.9 $11.7 
Total cash, cash equivalents, and restricted cash$3,683.4 $1,148.0 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.

3.    INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES

On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalties tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in Intellectual Property Agreement and Certain Litigation Expenses in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in Intellectual Property Agreement and Certain Litigation Expenses in April 2023 related to products currently in development.

4.    RESTRUCTURING EXPENSES

In September 2024, the Company recorded an expense of $32.9 million related primarily to severance expenses associated with a global workforce realignment impacting approximately 360 employees. As of September 30, 2024, the Company's remaining severance obligations of $30.6 million are expected to be substantially paid within the next 12 months.

5.    DISCONTINUED OPERATIONS

On June 3, 2024, the Company entered into a definitive agreement to sell its Critical Care product group ("Critical Care") to Becton, Dickinson and Company ("BD"). In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the Company has committed to a plan to sell a non-core product group, with the sale expected to occur within the next 12 months.

Critical Care and the aforementioned non-core product group (collectively, the "discontinued product groups") were historically reported in each of the Company's segments (United States, Europe, Japan, and Rest of World).

The Company concluded that the Critical Care product group met the criteria to be classified as held-for-sale in June 2024 and that the non-core product group met the criteria to be classified as held-for-sale in September 2024. The Company determined that, when considered together, the conditions for discontinued operations presentation had been met with respect to the discontinued product groups. A component of an entity is reported in discontinued operations after meeting the criteria for held-for-sale classification if the disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial results. The Company analyzed the quantitative and qualitative factors relevant to the discontinued product groups, including their significance to the Company’s overall net income and total assets, and determined that those
10

conditions for discontinued operations presentation had been met. As such, the historical financial condition and results of the discontinued product groups have been reflected as discontinued operations in the Company's consolidated condensed financial statements. The assets and liabilities associated with discontinued product groups are classified as assets and liabilities of discontinued operations in the Company's consolidated condensed balance sheets. Prior period amounts have been adjusted to reflect the discontinued operations presentation.

On September 3, 2024, Critical Care was sold for $4.2 billion, which is subject to a further working capital adjustment, resulting in a gain of $3.3 billion which was included in Income from Discontinued Operations, net of tax.

In connection with the sale of Critical Care, the Company entered into a Transition Services Agreement ("TSA") to provide certain support services for up to 36 months from the closing date of the sale (with certain extension rights as provided therein). These support services may be in the areas of accounting, information technology, human resources, quality assurance, regulatory affairs, customer support, and global supply chain, among others. In connection with the TSA, the Company recognized an unfavorable contract liability of $115.1 million, which will be recognized over the TSA term.

In addition, Edwards and BD entered into other agreements to provide a framework for the ongoing activities between the Company and BD after the sale and until the end of the TSA including, but not limited to, interim operating model agreements to support the commercial operations until full transfer of all regulatory licenses to BD and completion of services under the TSA agreement, a manufacturing and supply agreement, and a quality agreement. Under these agreements, the Company will continue to provide certain services to BD during the term of these agreements including serving as an undisclosed selling and purchasing agent for the Critical Care business on behalf of BD for a period of up to 36 months.

As of September 30, 2024, the Company had a receivable of approximately $24.6 million from BD related to the services under the agreements. The Company recorded income from the TSA of $7.6 million during the three and nine months ended September 30, 2024, which is recorded in Other Operating Expenses, net on the Company's consolidated condensed statements of operations.

Details of Income from Discontinued Operations are as follows (in millions):

 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net sales$177.2 $237.5 $708.4 $727.1 
Cost of sales65.4 99.8 265.1 295.5 
Gross profit111.8 137.7 443.3 431.6 
Selling, general, and administrative expenses40.9 57.7 163.2 178.7 
Research and development expenses21.4 27.5 81.3 81.0 
Separation costs81.5 — 202.5 — 
Operating (loss) income, net(32.0)52.5 (3.7)171.9 
Other non-operating (income) expense, net(3,338.9)0.8 (3,337.5)0.7 
Income from discontinued operations before provision for income taxes3,306.9 51.7 3,333.8 171.2 
Provision for income taxes from discontinued operations599.6 2.9 599.4 28.4 
Net income from discontinued operations2,707.3 48.8 2,734.4 142.8 

Separation costs related primarily to consulting, legal, tax, and other professional advisory services associated with the sale of Critical Care.

11

Details of assets and liabilities of discontinued operations are as follows (in millions):

 September 30,
2024		December 31,
2023
Cash and cash equivalents$2.9 $11.7 
Accounts receivable, net of allowances— 3.6 
Other receivables— 5.2 
Inventories17.1 264.7 
Prepaid expenses— 18.0 
Other current assets— 14.4 
Total current assets of discontinued operations$20.0 $317.6 
Property, plant, and equipment, net3.1 158.4 
Operating lease right-of-use assets — 9.6 
Goodwill 7.4 108.4 
Other intangible assets, net— 29.0 
Deferred income taxes— 5.2 
Other assets— 0.5 
Total non-current assets of discontinued operations$10.5 $311.1 
Accounts payable$— $14.8 
Accrued and other liabilities1.8 112.7 
Operating lease liabilities— 2.0 
Total current liabilities of discontinued operations$1.8 $129.5 
Operating lease liabilities — 7.8 
Uncertain tax positions— 4.3 
Other liabilities— 13.0 
Total non-current liabilities of discontinued operations$— $25.1 

Cash flows attributable to the Company's discontinued operations are included in the Company's consolidated condensed statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following (in millions):

 Nine Months Ended
September 30,
 20242023
Depreciation and amortization12.1 16.2 
Stock-based compensation16.7 11.6 
Inventory write off17.0 13.2 
Capital expenditures16.4 21.0 

12

6.     INVESTMENTS

Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):
 September 30, 2024December 31, 2023
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$50.5 $— $— $50.5 $64.5 $— $— $64.5 
Available-for-sale
Bank time deposits$17.6 $— $— $17.6 $— $— $— $— 
Commercial paper112.9 — — 112.9 — — — — 
U.S. government and agency securities185.2 0.1 (1.2)184.1 72.7 0.1 (2.8)70.0 
Asset-backed securities80.2 — (1.6)78.6 192.1 — (7.8)184.3 
Corporate debt securities502.2 0.1 (4.0)498.3 658.5 — (16.7)641.8 
Municipal securities2.8 — (0.1)2.7 2.8 — (0.2)2.6 
Total$900.9 $0.2 $(6.9)$894.2 $926.1 $0.1 $(27.5)$898.7 
The cost and fair value of investments in debt securities, by contractual maturity, as of September 30, 2024, were as follows:
Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$50.5 $50.5 $721.1 $719.2 
Due after 1 year through 5 years— — 81.4 79.2 
Instruments not due at a single maturity date (a)
— — 98.4 95.8 
$50.5 $50.5 $900.9 $894.2 
_______________________________________
(a)     Consists of mortgage-backed and asset-backed securities.
Actual maturities may differ from the contractual maturities due to call or prepayment rights.
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024 and December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

September 30, 2024
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$— $— $34.0 $(1.2)$34.0 $(1.2)
Asset-backed securities3.6 (0.1)65.3 (1.5)68.9 (1.6)
Corporate debt securities— — 193.0 (4.0)193.0 (4.0)
Municipal securities— — 2.7 (0.1)2.7 (0.1)
$3.6 $(0.1)$295.0 $(6.8)$298.6 $(6.9)
13

December 31, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)

The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of September 30, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in Long-term Investments on the consolidated condensed balance sheets, and are as follows:
 September 30,
2024		December 31,
2023
 (in millions)
Equity method investments  
Carrying value of equity method investments$32.3 $33.6 
Equity securities  
Carrying value of marketable equity securities7.4 — 
Carrying value of non-marketable equity securities104.9 87.6 
Total investments in unconsolidated entities$144.6 $121.2 

The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

Marketable equity securities consist of investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $0.5 million and a downward adjustment of $2.4 million during the nine months ended September 30, 2024 based on observable price changes. As of September 30, 2024, the Company had recorded cumulative upward adjustments of $9.3 million based on observable price changes, and cumulative downward adjustments of $5.5 million due to impairments and observable price changes.

During the three and nine months ended September 30, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material.

14

7.     INVESTMENTS IN VARIABLE INTEREST ENTITIES

The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

Consolidated VIEs

In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. The total assets and liabilities of the Company's consolidated VIE was $258.1 million and $26.7 million, respectively, as of September 30, 2024, and were $272.1 million and $31.5 million, respectively, as of December 31, 2023. The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company.

Unconsolidated VIEs

Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $42.5 million had been advanced as of September 30, 2024. The remaining $5.0 million was advanced in October 2024. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The option and the note receivable are included in Other Assets on the consolidated balance sheets.

In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee"). The secured promissory note provides for borrowings up to $45.0 million. At both September 30, 2024 and December 31, 2023, the Company had advanced $30.0 million under the promissory note (included in Other Assets). As of September 30, 2024 and December 31, 2023, the Company had invested $42.8 million and $39.3 million, respectively, in the Investee's preferred equity securities (included in Long-term Investments) and had paid $20.9 million and $13.1 million, respectively, for an option to acquire the Investee (included in Other Assets). Pursuant to the agreements, the Company may be required to invest up to an additional $3.0 million in the Investee's preferred equity securities and up to an additional $6.6 million for the option to acquire the Investee.

In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option
to acquire that medical device company, of which $30.0 million had been paid as of September 30, 2024. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. In addition, as of September 30, 2024 and December 31, 2023, the Company had invested $3.5 million and $3.3 million, respectively, in the medical device company's preferred equity securities. The option and the note are included in Other Assets on the consolidated balance sheets, and the equity investment is included in Long-term Investments. In July 2024, the Company exercised its option to acquire the medical device company and the transaction closed in October 2024. For more information, see Note 18.

In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 6.

8.     BUSINESS COMBINATIONS

Endotronix, Inc.

On August 19, 2024, the Company acquired all the remaining outstanding shares of Endotronix, Inc. ("Endotronix"). Endotronix is a developer of an implantable sensor for management of heart failure patients. The acquisition was completed primarily to expand the Company's structural heart portfolio into a new therapeutic area to address the large unmet needs of patients suffering from heart failure.

15

Prior to the acquisition date, the Company had previously paid $60.0 million for an option to acquire Endotronix, which was historically recorded in Other Assets using the measurement alternative for fair value, and had an existing preferred stock investment in Endotronix of $10.0 million, which represented an ownership interest in Endotronix of approximately 7% (collectively, the "previously held equity interest"). In July 2024, the Company exercised its option to acquire the remaining equity interest in Endotronix which was accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations." Accordingly, the Company allocated the purchase price of the acquired company to the net tangible assets and intangible assets acquired based upon their preliminary estimated fair values. The Company remeasured the previously held equity interest to its fair value, as of the date of acquisition. The Company considered multiple factors in determining the fair value of the previously held equity interest, including, (i) the price negotiated with the selling shareholders for the remaining 93% interest in Endotronix and (ii) an income approach valuation model. As a result of the remeasurement of the previously held equity interest, the Company recognized a gain of $24.6 million in Other income, net in the third quarter of 2024.

The purchase consideration for the acquisition of Endotronix was $798.8 million, which consisted of cash consideration of $649.1 million (net of cash acquired of $1.2 million), the fair value of the Company's previously held equity interest of $94.6 million, and the settlement of pre-existing relationships of $53.1 million. In addition, the Company agreed to pay an additional $2.0 million in a pre-specified milestone-driven payment that is dependent on the receipt of CE Mark approval for the CorPASS before June 30, 2025. The Company recognized a $2.0 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payment will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations.
In connection with the acquisition of Endotronix, the Company placed $35.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement and for purchase price adjustments. Acquisition-related costs of $5.6 million were recorded in Selling, General, and Administrative Expenses during the nine months ended September 30, 2024.

The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

Cash consideration paid at closing$650.3 
Settlement of pre-existing relationships53.1 
Fair value of previously held equity interest94.6 
Fair value of contingent consideration2.0 
Total purchase price800.0 
Less: cash acquired(1.2)
Total purchase price, net of cash acquired$798.8 
Current assets$7.7 
Property and equipment, net12.6 
Goodwill412.0 
In-process research and development69.0 
Developed technology385.0 
Operating lease right-of-use assets9.9 
Other assets0.7 
Liabilities assumed(26.3)
Deferred tax liabilities(70.6)
Net assets acquired800.0 
Less: cash acquired(1.2)
Total purchase price, net of cash acquired$798.8 

The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.

16

Goodwill includes Endotronix's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. The fair value of the developed technology was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the developed technology was 15.5%. The fair value of the IPR&D was also determined using the income approach. IPR&D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The discount rate used to determine the fair value of the IPR&D was 18.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $47.1 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2027 and in Japan and Europe in 2028. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life.

The results of operations for Endotronix have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of Endotronix are not material in relation to the consolidated financial statements of Edwards Lifesciences.

JC Medical, Inc.

On July 22, 2024, the Company acquired all the outstanding shares of JC Medical, Inc. ("JC Medical") for purchase consideration of $116.3 million, net of cash acquired. In addition, the Company agreed to pay up to an additional $200.0 million in pre-specified milestone-driven payments over the next 12 years. The Company recognized a $1.8 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations.

The Company placed $12.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement. Any funds remaining 15 months after the acquisition date will be disbursed to JC Medical's former shareholders. Acquisition-related costs of $1.6 million were recorded in Selling, General, and Administrative Expenses during the nine months ended September 30, 2024.

JC Medical, Inc. is a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart disease. The acquisition was completed primarily to expand the Company's TAVR portfolio to enable the treatment of patients with aortic regurgitation. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill.

17

The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

Cash consideration paid at closing$114.8 
Fair value of contingent consideration1.8 
Total purchase price116.6 
Less: cash acquired(0.3)
Total purchase price, net of cash acquired$116.3 
Current assets$0.3 
Property and equipment, net0.3 
Goodwill46.9 
In-process research and development86.6 
Current liabilities assumed(1.0)
Deferred tax liabilities(16.5)
Net assets acquired116.6 
Less: cash acquired(0.3)
Total purchase price, net of cash acquired$116.3 

The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.

Goodwill includes JC Medical's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. IPR&D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The fair value of the IPR&D was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the IPR&D was 15.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $55.8 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2028 and Europe in 2029. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life.

The results of operations for JC Medical have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of JC Medical are not material in relation to the consolidated financial statements of Edwards Lifesciences.

9.     FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.
Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3—Unobservable inputs that are not corroborated by market data.

18

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of September 30, 2024, the fair value of the notes payable, based on Level 2 inputs, was $600.0 million.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
September 30, 2024Level 1Level 2Level 3Total
Assets    
Cash equivalents$2,287.8 $852.3 $— $3,140.1 
Available-for-sale investments:
Bank time deposits
— 17.6 — 17.6 
Corporate debt securities
— 498.3 — 498.3 
Asset-backed securities
— 78.6 — 78.6 
United States government and agency securities49.3 134.8 — 184.1 
Commercial paper
— 112.9 — 112.9 
Municipal securities
— 2.7 — 2.7 
Equity investments in unconsolidated entities7.5 — — 7.5 
Investments held for deferred compensation plans143.9 — — 143.9 
Derivatives— 27.6 — 27.6 
$2,488.5 $1,724.8 $— $4,213.3 
Liabilities    
Derivatives$— $24.3 $— $24.3 
Contingent consideration liabilities— — 3.8 3.8 
Other— — 5.0 5.0 
$— $24.3 $8.8 $33.1 
December 31, 2023    
Assets    
Cash equivalents$579.2 $— $— $579.2 
Available-for-sale investments:
Corporate debt securities
— 641.8 — 641.8 
Asset-backed securities
— 184.3 — 184.3 
United States government and agency securities— 70.0 — 70.0 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans125.8 — — 125.8 
Derivatives— 39.5 — 39.5 
$705.0 $938.2 $— $1,643.2 
Liabilities    
Derivatives$— $15.2 $— $15.2 
Other— — 10.3 10.3 
$— $15.2 $10.3 $25.5 

19

Cash Equivalents and Available-for-sale Investments

Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, commercial paper, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures. All derivative instruments are recognized on the balance sheet at their fair value, which was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates. The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows
(ranging from 0.0% to 11.7%; with a weighted average of 5.6%), (2) the probability of milestone achievement (ranging from 60% to 100%; with a weighted average of 80.9%), (3) the projected payment dates (ranging from 2025 to 2032; with a weighted average of 2029), and (4) the volatility of future revenue (27%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.

The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):
 Contingent ConsiderationOtherTotal
Balance at December 31, 2023
$— $10.3 $10.3 
Additions3.8 — 3.8 
Payments— — — 
Changes in fair value— (5.3)(5.3)
Balance at September 30, 2024$3.8 $5.0 $8.8 
Contingent ConsiderationOtherTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)(3.7)(29.9)
Balance at September 30, 2023$— $10.3 $10.3 


20

10.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 September 30,
2024		December 31, 2023
 (in millions)
Foreign currency forward exchange contracts$2,219.8 $1,460.3 
Cross-currency swap contracts300.0 300.0 

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately one year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions).

All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings and offsets the loss or gain on the underlying hedged item. The Company reports in Accumulated Other Comprehensive Loss the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in Accumulated Other Comprehensive Loss as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

21

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
  Fair Value
Derivatives designated as hedging instrumentsBalance Sheet
Location		September 30,
2024		December 31, 2023
Assets   
Foreign currency contractsOther current assets$5.8 $16.1 
Cross-currency swap contractsOther assets$21.8 $23.4 
Liabilities   
Foreign currency contractsAccrued and other liabilities$21.2 $15.2 
Derivatives not designated as hedging instruments    
Liabilities
Foreign currency contractsAccrued and other liabilities$3.1 $— 

The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
    Gross Amounts
Not Offset in
the Consolidated
Balance Sheet		 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		 
  Net Amounts
Presented in the
Consolidated
Balance Sheet
September 30, 2024Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative assets      
Foreign currency contracts$5.8 $— $5.8 $(3.8)$— $2.0 
Cross-currency swap contracts$21.8 $— $21.8 $— $— $21.8 
Derivative liabilities      
Foreign currency contracts$24.3 $— $24.3 $(3.8)$— $20.5 
December 31, 2023      
Derivative assets      
Foreign currency contracts$16.1 $— $16.1 $(9.4)$— $6.7 
Cross-currency swap contracts$23.4 $— $23.4 $— $— $23.4 
Derivative liabilities   
Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
 Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative
(Effective Portion)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 
2024202320242023
Cash flow hedges
Foreign currency contracts$(40.9)$33.5 $17.0 $60.4 
Net investment hedges
Cross-currency swap contracts$(8.7)$3.8 $(1.6)$(5.2)

The cross-currency swap contracts have an expiration date of June 15, 2028. At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.

22

The following tables present the effect of derivative instruments on the consolidated condensed statements of operations (in millions):
 Location and Amount of Gain or (Loss) Recognized in Income
 Three Months Ended
September 30, 2024		Nine Months Ended
September 30, 2024
 Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
Total amounts presented in the consolidated condensed statements of operations$(262.9)$24.3 $27.9 $(825.3)$56.3 $35.6 
The effects of fair value hedges:
Foreign currency contracts:
Hedged items$— $— $— $— $— $(4.0)
Derivatives designated as hedging instruments$— $— $— $— $— $4.0 
Amount excluded from effectiveness testing (amortized)$— $— $— $— $— $0.8 
The effects of cash flow hedges:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$17.0 $— $— $31.9 $— $— 
The effects of net investment hedges:
Cross currency swap contracts:
Amount excluded from effectiveness testing$— $1.6 $— $— $5.1 $— 
The effects of non-designated hedges:
Foreign currency contracts$— $— $(29.6)$— $— $3.7 
 Location and Amount of Gain or (Loss) Recognized in Income
 Three Months Ended
September 30, 2023		Nine Months Ended
September 30, 2023
 Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
Total amounts presented in the consolidated condensed statements of operations$(250.6)$15.1 $6.6 $(727.4)$32.8 $10.3 
The effects of fair value hedges:
Foreign currency contracts:
Hedged items$— $— $(3.6)$— $— $(12.5)
Derivatives designated as hedging instruments$— $— $3.6 $— $— $12.5 
Amount excluded from effectiveness testing (amortized)$— $— $1.2 $— $— $3.6 
The effects of cash flow hedges:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$9.3 $— $— $53.0 $— $— 
The effects of net investment hedges:
Cross currency swap contracts:
Amount excluded from effectiveness testing$— $1.7 $— $— $5.2 $— 
The effects of non-designated hedges:
Foreign currency contracts$— $— $14.6 $— $— $19.1 

The Company expects that during the next twelve months it will reclassify to earnings a $4.1 million gain currently recorded in Accumulated Other Comprehensive Loss.

23

11.    STOCK-BASED COMPENSATION

Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2024 and 2023 was as follows (in millions):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Cost of sales$6.1 $4.7 $20.8 $16.3 
Selling, general, and administrative expenses20.4 17.2 62.4 57.3 
Research and development expenses8.7 7.2 28.3 23.7 
Total stock-based compensation expense35.2 29.1 111.5 97.3 
Income tax benefit(6.0)(4.7)(17.5)(14.5)
Total stock-based compensation expense, net of tax$29.2 $24.4 $94.0 $82.8 

At September 30, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $289.7 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 33 months.

On May 7, 2024, the Company’s stockholders approved the amendment and restatement of the Company’s Long-term Stock Incentive Compensation Program (the “Long-term Stock Program”) to (1) increase the total number of shares of the Company’s common stock available for issuance under the Long-term Stock Program by 6.9 million shares to a new total share limit of 334.5 million shares, (2) increase the total number of shares of the Company’s common stock available for issuance as restricted stock and restricted stock unit awards under the Long-term Stock Program by 2.0 million shares to a new limit on the total number of shares available for these types of awards of 35.6 million shares, and (3) extend the term within which new awards may be granted under the Long-term Stock Program through February 21, 2034.

During the nine months ended September 30, 2024, the Company granted 1.5 million stock options at a weighted-average
exercise price per share of $85.94, and 1.9 million restricted stock units at a weighted-average grant-date fair value per share of $85.09. During the nine months ended September 30, 2024, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $97.66. The market-based restricted stock units granted during the nine months ended September 30, 2024 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.

Fair Value Disclosures

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2024 and 2023 included a risk-free interest rate of 4.5% and 3.6%, respectively, and an expected volatility rate of 32.4% and 32.6%, respectively.

The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 Option Awards
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Risk-free interest rate4.2 %4.3 %4.5%3.4%
Expected dividend yieldNoneNoneNoneNone
Expected volatility31.0 %32.7 %30.9%32.8%
Expected term (years)5.55.25.35.1
Fair value, per option$32.15 $31.16 $31.30 $31.02 
24

The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 ESPP
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Risk-free interest rate5.3 %5.3 %5.2%4.6%
Expected dividend yieldNoneNoneNoneNone
Expected volatility29.5 %34.8 %33.5%31.5%
Expected term (years)0.60.60.60.6
Fair value, per share$16.51 $18.53 $25.01$19.03 

12.    ACCELERATED SHARE REPURCHASE

During 2024 and 2023, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
April 2024$150.0 1.4 $85.95 80 %May 20241.7 $86.72 
August 2024$500.0 5.8 $68.93 80 %(a)
______________________________________
(a)     The ASR agreement has a scheduled settlement date of December 27, 2024. At the conclusion of the ASR agreement, the Company may receive additional shares or may be required to pay additional cash or shares (at our election).

The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in Additional Paid-in Capital and subsequently, upon settlement, will be transferred to Treasury Stock on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.

13.    COMMITMENTS AND CONTINGENCIES

In 2021, the Company initiated an internal review and investigation into whether certain business activities in Japan and other markets violated provisions of the Foreign Corrupt Practices Act (“FCPA”). The Company voluntarily notified the SEC and the United States Department of Justice (“DOJ”) about the matter and thereafter provided status updates. In September 2024, the Company received a letter from the SEC Staff stating that the SEC is not recommending an enforcement action.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (“Edwards”) in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company is vigorously defending itself in this litigation.

The European Commission (the “Commission”) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is cooperating with the Commission and believes its business practices support healthy competition. The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.

25

On October 14, 2024, a purported stockholder of the Company filed a putative securities class action complaint against the Company and certain of the Company’s executive officers in the United States District Court for the Central District of California, captioned Patel v. Edwards Lifesciences Corporation, et al., No. 24-cv-02221. The complaint alleges violations of various securities laws based on alleged false or misleading statements regarding the Company’s business prospects. The complaint seeks damages, interest, costs and other fees. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to defend against the lawsuit vigorously.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the “Lawsuits”). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.

26

14.    ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables summarize the activity for each component of Accumulated Other Comprehensive Loss (in millions):
 Foreign
Currency
Translation
Adjustments
Unrealized Gain (Loss) on Hedges

Unrealized Loss on Available-for-sale Investments
Unrealized
Pension
Costs
Total
Accumulated
Other
Comprehensive
Loss
December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
Other comprehensive (loss) income before reclassifications
(23.3)43.4 7.0 0.4 27.5 
Amounts reclassified from accumulated other comprehensive loss(1.7)(7.2)2.5 — (6.4)
Deferred income tax expense
(1.1)(9.3)(1.1)(0.1)(11.6)
March 31, 2024$(240.6)$27.6 $(16.4)$(3.9)$(233.3)
Other comprehensive income (loss) before reclassifications
3.4 21.8 4.2 (0.1)29.3 
Amounts reclassified from accumulated other comprehensive loss(1.8)(12.5)1.0 — (13.3)
Deferred income tax (expense) benefit
(0.6)(2.4)0.1 — (2.9)
June 30, 2024$(239.6)$34.5 $(11.1)$(4.0)$(220.2)
Other comprehensive income (loss) before reclassifications
3.8 (41.0)6.8 — (30.4)
Amounts reclassified from accumulated other comprehensive loss(1.6)(17.0)(0.8)(19.4)
Deferred income tax benefit
2.1 15.3 0.1 — 17.5 
September 30, 2024$(235.3)$(8.2)$(5.0)$(4.0)$(252.5)

 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Credits		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
Other comprehensive income (loss) before reclassifications
4.9 6.7 9.0 (0.1)20.5 
Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
Deferred income tax benefit
0.6 5.9 — — 6.5 
March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
Other comprehensive (loss) income before reclassifications
(11.3)33.5 2.1 0.2 24.5 
Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
Deferred income tax benefit (expense)
1.6 (3.0)— — (1.4)
June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)
Other comprehensive (loss) income before reclassifications
(20.7)38.6 9.4 — 27.3 
Amounts reclassified from accumulated other comprehensive loss(1.7)(14.1)1.2 — (14.6)
Deferred income tax (expense) benefit
(1.0)(6.3)— — (7.3)
September 30, 2023$(249.9)$30.1 $(36.1)$5.8 $(250.1)

27

The following table provides information about amounts reclassified from Accumulated Other Comprehensive Loss (in millions):
 Three Months Ended
September 30,		Nine Months Ended
September 30,		 
 Affected Line on Consolidated Condensed
Statements of Operations
Details about Accumulated Other
Comprehensive Loss Components
2024202320242023
Foreign currency translation adjustments$1.6 $1.7 $5.1 $5.2 Other non-operating income, net
(0.5)(0.5)(1.3)(1.3)Provision for income taxes
$1.1 $1.2 $3.8 $3.9 Net of tax
Gain (Loss) on hedges
$17.0 $9.3 $31.9 $53.0 Cost of sales
— 4.8 4.8 16.1 Other non-operating income, net
17.0 14.1 36.7 69.1 Total before tax
(4.2)(2.9)(8.9)(14.8)Provision for income taxes
$12.8 $11.2 $27.8 $54.3 Net of tax
Loss on available-for-sale investments
$0.8 $(1.2)$(2.7)$(9.0)Interest income, net
(0.2)0.4 0.7 2.3 Provision for income taxes
$0.6 $(0.8)$(2.0)$(6.7)Net of tax

15.    EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

28

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net Income for Earnings Per Share Calculations:
Income from continuing operations, net of tax$362.1 $334.9 $1,051.0 $886.9 
Net loss attributable to noncontrolling interests(1.4)(1.2)(3.6)(2.8)
Income from continuing operations attributable to Edwards Lifesciences Corporation363.5 336.1 1,054.6 889.7 
Income from discontinued operations2,707.3 48.8 2,734.4 142.8 
Net income attributable to Edwards Lifesciences Corporation$3,070.8 $384.9 $3,789.0 $1,032.5 
Weighted Average Shares:
Basic weighted-average shares outstanding597.2 607.0 600.3 607.2 
Dilutive effect of stock plans0.9 2.5 1.9 3.0 
Dilutive weighted-average shares outstanding598.1 609.5 602.2 610.2 
Earnings per Share:
Basic:
Continuing operations$0.61 $0.55 $1.76 $1.47 
Discontinued operations4.53 0.08 4.55 0.23 
Basic earnings per share$5.14 $0.63 $6.31 $1.70 
Diluted:
Continuing operations$0.61 $0.55 $1.75 $1.46 
Discontinued operations4.52 0.08 4.54 0.23 
Diluted earnings per share$5.13 $0.63 $6.29 $1.69 

Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 10.4 million and 6.5 million common shares for the three months ended September 30, 2024 and 2023, respectively, and 7.8 million and 6.1 million shares for the nine months ended September 30, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive. Additionally, 1.9 million shares that would have been received if the ASR agreement discussed in Note 12 was settled as of September 30, 2024 were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

16.    INCOME TAXES

The Company's effective income tax rates attributable to continuing operations were 10.1% and 13.6% for the three months ended September 30, 2024 and 2023, respectively and 9.2% and 11.8% for the nine months ended September 30, 2024 and 2023, respectively. The decrease in the effective rate between the nine months ended September 30, 2024 and 2023 is primarily due to an increase in tax benefits from foreign earnings taxed at lower rates and favorable global income tax audit settlements. In addition, the effective rates for the nine months ended September 30, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. The effective rates include a tax benefit from employee share-based compensation attributable to continuing operations of $0.6 million and $1.8 million for the three months ended September 30, 2024 and 2023, respectively, and $10.1 million and $12.8 million for the nine months ended September 30, 2024 and 2023, respectively.

The Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each taxing authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect
29

potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

As of September 30, 2024 and December 31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $656.5 million and $583.9 million, respectively. The Company estimates that these liabilities would be reduced by $326.1 million and $250.7 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $330.4 million and $333.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.

The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The APA renewal between Singapore and Japan covering tax years 2020 through 2026 is pending.

The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years. The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.

During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for the 2015 through 2017 period of approximately $250 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.

The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2024 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $75 million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. In March 2024, the Company made an additional deposit with the IRS of $305 million to further mitigate interest on potential tax liabilities and interest thereon while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.

Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2024 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September 30, 2024. The Company has considered this information, as well as information regarding the NOD and other proceedings described above in its evaluation
30

of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.

During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (“ITA”) wherein the ITA claimed that the Company owes approximately $110 million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative proceedings including a formal appeal of the assessment that was filed during the third quarter of 2024. If necessary, the Company will defend that position through judicial proceedings. There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.

17.    SEGMENT INFORMATION

Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Segment Net Sales    
United States$804.6 $735.9 $2,393.1 $2,203.6 
Europe315.1 282.7 968.4 878.0 
Japan85.8 84.9 265.6 251.5 
Rest of World153.2 136.1 440.9 399.0 
Total segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
Segment Operating Income    
United States$551.2 $498.4 $1,619.2 $1,510.2 
Europe177.3 156.1 540.3 489.2 
Japan54.4 53.7 159.8 158.5 
Rest of World67.2 59.5 184.7 170.6 
Total segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
31

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net Sales Reconciliation    
Segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
Foreign currency(4.3)3.8 (14.3)11.5 
Consolidated net sales$1,354.4 $1,243.4 $4,053.7 $3,743.6 
Pre-tax Income Reconciliation    
Segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
Unallocated amounts:    
Corporate items(468.7)(410.1)(1,396.5)(1,259.4)
Restructuring expenses (Note 4)(32.9)— (32.9)— 
Intellectual property agreement and certain litigation expenses
(10.8)(2.2)(27.8)(193.6)
Change in fair value of contingent consideration liabilities— — — 26.2 
Foreign currency12.9 10.5 19.3 60.4 
Consolidated operating income350.6 365.9 1,066.1 962.1 
Non-operating income52.2 21.7 91.9 43.1 
Consolidated pre-tax income$402.8 $387.6 $1,158.0 $1,005.2 

Enterprise-wide Information
(in millions)

The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net Sales by Geographic Region    
United States$804.6 $735.9 $2,393.1 $2,203.6 
Europe319.8 286.5 978.0 877.7 
Japan81.4 85.8 253.9 266.4 
Rest of World148.6 135.2 428.7 395.9 
$1,354.4 $1,243.4 $4,053.7 $3,743.6 
Net Sales by Major Product Group    
Transcatheter Aortic Valve Replacement$1,023.3 $960.9 $3,069.8 $2,900.4 
Transcatheter Mitral and Tricuspid Therapies91.1 52.4 247.0 141.6 
Surgical Structural Heart240.0 230.1 736.9 701.6 
$1,354.4 $1,243.4 $4,053.7 $3,743.6 

18.    SUBSEQUENT EVENTS

In October 2024, the Company acquired all the remaining outstanding shares of Innovalve Bio Medical Limited ("Innovalve") for an aggregate cash purchase price of $300.0 million, subject to certain adjustments, plus an additional $25.0 million upon achievement of a certain regulatory milestone. Innovalve is a developer of a transcatheter mitral valve replacement system.

Prior to the acquisition date, the Company had previously paid $30.0 million for an option to acquire Innovalve, which the Company exercised in July 2024, and had an existing preferred stock investment in Innovalve of $3.5 million, which represented approximately a 4% interest in Innovalve (collectively, the "previously held interest"). The acquisition of the remaining equity interest in Innovalve is expected to be accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations."
32

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations        
Overview

The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws, and should be read in conjunction with the disclosures we make concerning risks and other factors that may affect our business and operating results. See “Note Regarding Forward-Looking Statements” preceding Part I, Item 1 in this Quarterly Report on Form 10-Q.

We are the global leader in patient-focused medical innovations for structural heart disease. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease. We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), and Surgical Structural Heart ("Surgical").

On June 3, 2024, we entered into a definitive agreement to sell our Critical Care product group ("Critical Care") to Becton, Dickinson and Company in an all cash-transaction for $4.2 billion, subject to certain customary adjustments as set forth in the agreement. We completed the sale of Critical Care on September 3, 2024. We believe that the sale will enable us to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies. In addition, as a next step in our disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, we have committed to a plan to sell a non-core product group, with the sale expected to occur within the next 12 months. We analyzed the quantitative and qualitative factors relevant to the divestiture of Critical Care and the aforementioned non-core product group (collectively, the "discontinued product groups"), including its significance to our overall net income and total assets, and determined that, when considered together, the conditions for discontinued operations presentation with respect to the discontinued product groups had been met. As such, the historical financial condition and results of the discontinued product groups have been reflected as discontinued operations in our consolidated condensed financial statements, including a $3.3 billion pre-tax gain on the sale of Critical Care. Prior period amounts have been adjusted to reflect the discontinued operations presentation. Our discussion and analysis of our results of operations is reflective of our continuing operations. See Note 5 to the Consolidated Condensed Financial Statements for further information.

Financial Highlights
23612362
Our net sales for the first nine months of 2024 were $4.1 billion, representing an increase of $310.1 million compared to the first nine months of 2023, driven primarily by sales of our TAVR and TMTT products.

Our gross profit increased in the nine months ended September 30, 2024, driven by our sales growth. Gross profit as a percentage of sales decreased primarily due to foreign currency rate fluctuations. The increase in our diluted earnings per share
33

in the nine months ended September 30, 2024 was driven by a one-time after-tax charge of $138.7 million in the nine months ended September 30, 2023 related to an intellectual property agreement.
Healthcare Environment, Opportunities, and Challenges

The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and innovations, and we are committed to defending our intellectual property in support of those developments. Our vision for growth is to treat patients with both valvular and non-valvular structural heart disease, such as heart failure, which is a natural progression of the disease for many patients suffering from aortic stenosis and mitral and tricuspid regurgitation.

We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.

New Accounting Standards

Information on new accounting standards is included in Note 1 to the Consolidated Condensed Financial Statements.

Results of Operations

Net Sales by Region
(dollars in millions)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 Percent ChangePercent Change
 20242023Change20242023Change
United States$804.6 $735.9 $68.7 9.3 %$2,393.1 $2,203.6 $189.5 8.6 %
Europe319.8 286.5 33.3 11.6 %978.0 877.7 100.3 11.4 %
Japan81.4 85.8 (4.4)(5.1)%253.9 266.4 (12.5)(4.7)%
Rest of World148.6 135.2 13.4 10.1 %428.7 395.9 32.8 8.3 %
Outside of the United States549.8 507.5 42.3 8.4 %1,660.6 1,540.0 120.6 7.8 %
Total net sales$1,354.4 $1,243.4 $111.0 8.9 %$4,053.7 $3,743.6 $310.1 8.3 %

Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations. The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities.

Net Sales by Product Group
(dollars in millions)
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 Percent ChangePercent Change
 20242023Change20242023Change
Transcatheter Aortic Valve Replacement$1,023.3 $960.9 $62.4 6.5 %$3,069.8 $2,900.4 $169.4 5.8 %
Transcatheter Mitral and Tricuspid Therapies91.1 52.4 38.7 73.4 %247.0 141.6 105.4 74.4 %
Surgical Structural Heart240.0 230.1 9.9 4.3 %736.9 701.6 35.3 5.0 %
Total net sales$1,354.4 $1,243.4 $111.0 8.9 %$4,053.7 $3,743.6 $310.1 8.3 %

34

Transcatheter Aortic Valve Replacement Sales
565
Net sales of TAVR products increased for the three and nine months ended September 30, 2024 driven by:

•higher sales of the Edwards SAPIEN platform in 2024, primarily the Edwards SAPIEN 3 Ultra RESILIA valve in the United States and Japan, and the Edwards SAPIEN 3 Ultra valve in Europe;

partially offset by:

•foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $5.9 million and $18.4 million for the three and nine months ended September 30, 2024, respectively, primarily due to the weakening of the Japanese yen against the United States dollar.

While our global competitive position and pricing remained stable during the first nine months of 2024, we experienced some regional sales pressure and a reduction in procedures with certain hospital centers in the United States related to a variety of factors including, but not limited to, resources and priorities.

In January 2024, we completed patient treatment in our PROGRESS pivotal trial, studying the treatment of moderate aortic stenosis patients, and we received CE Mark approval for the Edwards SAPIEN 3 Ultra RESILIA valve in Europe. In September 2024, we received CE mark for the Edwards SAPIEN 3 transcatheter pulmonary valve system with Alterra adaptive prestent for use in the management of patients with severe pulmonary regurgitation.

35

Transcatheter Mitral and Tricuspid Therapies Sales
1741
Net sales of TMTT products increased for the three and nine months ended September 30, 2024 primarily due to higher sales of our PASCAL transcatheter edge-to-edge repair ("TEER") system and our continued launch of the EVOQUE tricuspid valve replacement system in the United States and Europe.


36


Surgical Structural Heart Sales
2308
Net sales of Surgical products increased for the three and nine months ended September 30, 2024 primarily due to higher sales of the INSPIRIS RESILIA aortic valve in the United States and Europe, the KONECT RESILIA tissue valved conduit in the United States, and the MITRIS RESILIA valve in the United States and Europe.
We have completed enrollment in the United States and Canada of patients in our MOMENTIS clinical study to demonstrate the durability of RESILIA tissue in the mitral position.

37

Gross Profit
2780
Gross profit as a percentage of net sales increased for the three months ended September 30, 2024 driven by a 0.3 percentage point impact from foreign currency rate fluctuations, including the settlement of foreign currency hedging contracts, and timing of variable expenses. Gross profit as a percentage of net sales decreased for the nine months ended September 30, 2024 driven by a 0.8 percentage point impact from foreign currency rate fluctuations, including the settlement of foreign currency hedging contracts.

Selling, General, and Administrative ("SG&A") Expenses
3210
SG&A expenses increased for the three and nine months ended September 30, 2024 primarily due to higher field-based personnel-related costs in support of our growth strategy initiatives, primarily in the United States and Europe, and costs associated with our recent business combinations. Foreign currency exchange rate fluctuations decreased expenses by $2.9 million and $8.6 million for the three and nine months ended September 30, 2024, respectively, primarily due to the strengthening of United States dollar against the Japanese yen.
38


Research and Development ("R&D") Expenses
3647
R&D expenses increased for the three and nine months ended September 30, 2024 primarily due to continued investments in our aortic transcatheter valve innovations, including increased clinical trial activity.

Intellectual Property Agreement and Certain Litigation Expenses

We incurred certain litigation expenses related to intellectual property litigation and tax litigation of $10.8 million and $2.2 million during the three months ended September 30, 2024 and 2023, respectively, and $27.8 million and $17.6 million during the nine months ended September 30, 2024 and 2023, respectively. Also, on April 12, 2023, we entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") and recorded a $37.0 million charge in March 2023 and a $139.0 million charge in April 2023. For more information, see Note 3 to the Consolidated Condensed Financial Statements.
Change in Fair Value of Contingent Consideration Liabilities

The change in fair value of contingent consideration liabilities resulted in a gain of $26.2 million during the nine months ended September 30, 2023. The gain in 2023 was primarily due to changes in projected probabilities of milestone achievement. For further information, see Note 9 to the Consolidated Condensed Financial Statements.

Provision for Income Taxes

The provision for income taxes consists of provisions for federal, state, and foreign income taxes. We operate in an international environment with significant operations in various locations outside the United States which have statutory tax rates typically lower than the United States tax rate. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates.

Our effective income tax rate attributable to continuing operations was 10.1% and 13.6% for the three months ended September 30, 2024 and 2023, respectively, and 9.2% and 11.8% for the nine months ended September 30, 2024 and 2023, respectively. The decrease in the effective rate between the nine months ended September 30, 2024 and 2023 was primarily due to an increase in tax benefits from foreign earnings taxed at lower rates and favorable global income tax audit settlements. In addition, the effective rates for the nine months ended September 30, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation.

The Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of our tax filings. During these audits, we may receive proposed audit adjustments that could be material. An adverse outcome in these audits could have a material effect on our results of operations and financial condition. We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a taxing authority at any time. While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may
39

result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. We believe that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.

We executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The APA renewal between Singapore and Japan covering tax years 2020 through 2026 is pending.

The audits of our United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years. The audits of our material state, local, and foreign income tax matters have been concluded for years through 2015.

During 2021, we received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to our United States taxable income, which could result in additional tax expense for the 2015 through 2017 period of approximately $250 million and represented a departure from a transfer pricing method we had previously agreed upon with the IRS. We have disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when we and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing our 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of our filing position is $269.3 million before consideration of interest and a repatriation tax
offset.

We plan to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. We believe the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to our facts and, accordingly, have not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on our consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2024 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, we made a partial deposit with the IRS of $75 million in November 2022 to prevent the further accrual of interest on that portion of any additional tax we may ultimately be found to owe. In March 2024, we made an additional deposit with the IRS of $305 million to further mitigate interest on potential tax liabilities and interest thereon while we prepare to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.

Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2024 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September 30, 2024. We have considered this information, as well as information regarding the NOD and other proceedings described above, in our evaluation of our uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to our consolidated financial statements. Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.

40

During the first quarter of 2024, we received a notice of assessment from the Israel Tax Authority (“ITA”) wherein the ITA claimed that we owe approximately $110 million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. We maintain that we did not transfer intellectual property outside of Israel and intend to vigorously defend that position through administrative proceedings including a formal appeal of the assessment that was filed during the third quarter of 2024. If necessary, we will defend that position through judicial proceedings. There can be no assurance that this matter will be resolved in our favor and an adverse outcome could have a material effect on our consolidated financial statements.

Additionally, many countries are implementing some or all the Organization for Economic Co-operation and Development's Base Erosion and Profit Shifting Pillar Two rules ("Pillar Two") that impose a global minimum tax of 15%. Under Pillar Two, a company is required to determine a combined effective tax rate for all entities located in a jurisdiction. If the jurisdictional effective tax rate is less than 15%, a top-up tax will be due to bring the jurisdictional effective tax rate up to 15%. We are continuing to monitor the implementation of Pillar Two by individual countries and the potential effects of Pillar Two on our effective tax rate. We do not expect Pillar Two to have a material impact on our consolidated financial statements in 2024. The provisions effective in 2025 may have a material impact on our consolidated financial statements in 2025 and future years, depending on future legislation, regulatory guidance, and business events.

Liquidity and Capital Resources

Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.

As of September 30, 2024, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $4.1 billion and $333.9 million, respectively.

We have a Five-year Credit Agreement (the "Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. We may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year, subject to agreement of the lenders. As of September 30, 2024, no amounts were outstanding under the Credit Agreement.

In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028. We may redeem the 2018 Notes, in whole or in part, at any time and from time to time at specified redemption prices. As of September 30, 2024, we have not elected to redeem any of the 2018 Notes. As of September 30, 2024, the carrying value of the 2018 Notes was $597.5 million.

From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors. We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During the nine months ended September 30, 2024, under the Board authorized repurchase program, we repurchased a total of 15.0 million shares at an aggregate cost of $1.2 billion, including pursuant to a $500 million accelerated share repurchase agreement (see Note 12 to the Consolidated Condensed Financial Statements). As of September 30, 2024, we had remaining authority to purchase $1.4 billion of our common stock under the share repurchase program.

In July 2024, we entered into agreements and plans of mergers to acquire multiple medical device companies for a total aggregate cash purchase price of $1.5 billion, subject to certain adjustments. Two of these transactions closed in the third quarter of 2024, and upon closing we paid $763.6 million, and a third closed in October 2024. These agreements include up to an additional $670.0 million of potential payments upon achievement of certain regulatory, performance, and sales milestones. For more information, see Notes 8 and 18 to the Consolidated Condensed Financial Statements.

In June 2024, we entered into a definitive agreement to sell our Critical Care product group ("Critical Care") to Becton, Dickinson and Company in an all cash-transaction for $4.2 billion, subject to certain customary adjustments as set forth in the agreement. We completed the sale of Critical Care in early September 2024.

On April 12, 2023, we entered into the Intellectual Property Agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS, we paid Medtronic a one-time, lump sum payment of
41

$300.0 million and are paying annual royalties that are tied to net sales of certain Edwards products. For more information, see Note 3 to the Consolidated Condensed Financial Statements.

We have purchased options to acquire and have agreed to provide promissory notes to various entities. These arrangements could result in additional cash outlays in the future should we decide to exercise the options or should the entities
draw on the promissory notes.

At September 30, 2024, there had been no material changes in our cash requirements from known contractual and other obligations, including commitments for capital expenditures, as disclosed in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the year ended December 31, 2023.

Consolidated Cash Flows - For the nine months ended September 30, 2024 and 2023:
4062 4066 4069
Net cash flows provided by operating activities of $669.8 million for the nine months ended September 30, 2024 decreased $89.4 million over the same period last year primarily due to tax payments of $633.8 million for the nine months ended September 30, 2024, which included a $305.1 million tax deposit we made to mitigate interest on potential tax liabilities we are contesting through the judicial process (see Note 16 to the Consolidated Condensed Financial Statements). The nine months ended September 30, 2023 included $219.1 million of tax payments and a $300.0 million payment under an intellectual property agreement.

Net cash provided by investing activities of $2.9 billion for the nine months ended September 30, 2024 consisted primarily of the sale of our Critical Care product group for proceeds of 3.9 billion, partially offset by capital expenditures of $202.6 million and net purchases of investments of $2.3 million

Net cash provided by investing activities of $159.7 million for the nine months ended September 30, 2023 consisted primarily of net proceeds from investments of $541.1 million, partially offset by a payment of $141.2 million to acquire a majority interest in another company and capital expenditures of $164.7 million.

Net cash used in financing activities of $1.0 billion for the nine months ended September 30, 2024 consisted primarily of purchases of treasury stock of 1.2 billion, partially offset by proceeds from stock plans of $150.9 million.

Net cash used in financing activities of $297.8 million for the nine months ended September 30, 2023 consisted primarily of purchases of treasury stock of $431.2 million, partially offset by proceeds from stock plans of $136.7 million.

Critical Accounting Policies and Estimates

The consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated condensed financial statements and sales and expenses during the periods reported. Actual results could differ from those estimates. Information with respect to our critical accounting policies and estimates which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained on pages 38-40 in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes from the information discussed therein.

42

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk, Foreign Currency Risk, Credit Risk, and Concentrations of Risk

For a complete discussion of our exposure to interest rate risk, foreign currency risk, credit risk, and concentrations of risk, refer to Item 7A Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no material changes from the information discussed therein.

Investment Risk

We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments. As of September 30, 2024, we had $944.7 million of investments in debt securities, of which $175.0 million were long-term. In addition, we had $144.6 million of investments in equity instruments of public and private companies. Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, a decline in the investments' value may occur, resulting in unrealized or realized losses. See Note 6 to the Consolidated Condensed Financial Statements for additional information.

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures.    Our management, including the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2024. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of September 30, 2024 that our disclosure controls and procedures are designed at a reasonable assurance level and effective in providing reasonable assurance that the information we are required to disclose in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting. There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
43

Part II. Other Information
Item 1.    Legal Proceedings

Please see Part I, Item 1, Note 11 of the “Consolidated Condensed Financial Statements” of this Quarterly Report on Form 10-Q for a description of our legal proceedings, which is incorporated by reference herein.

Item 1A.    Risk Factors

A description of the risk factors associated with our business is contained in the “Risk Factors” section of our Annual Report on Form 10-K for our fiscal year ended December 31, 2023 and of our Quarterly Report on Form 10-Q for our quarter ended June 30, 2024. There have been no material changes to our Risk Factors as previously reported.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities
PeriodTotal Number
 of Shares  
Purchased		Average
Price Paid
per Share		Total Number of 
Shares 
Purchased as Part of Publicly Announced Plans or Programs		Approximate 
Dollar Value of 
Shares that
May Yet Be 
Purchased
Under the Plans
or Programs
(in millions) (a) (b)
July 1, 2024 through July 31, 2024444,999 $62.91 444,999 $870.5 
August 1, 2024 through August 31, 20246,741,892 66.81 6,741,892 1,919.9 
September 1, 2024 through September 30, 20246,108,421 68.99 6,108,421 1,398.5 
Total13,295,312 67.68 13,295,312 
(a)    In December 2023, the Board of Directors approved a stock repurchase program providing for up to $1.0 billion of repurchases of our common stock. In August 2024, the Board of Directors approved an additional $1.5 billion of repurchases under this program. Repurchases under the program may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions. The repurchase program does not have an expiration date.
(b)    In August 2024, we entered into a $500.0 million accelerated share repurchase ("ASR") agreement and received, on September 5, 2024, an initial delivery of 5.8 million shares of our common stock, representing approximately 80 percent of the total contract value. At the conclusion of the ASR agreement, we may receive additional shares or may be required to pay additional cash or shares (at our election). The final settlement is based on the volume-weighted average price over the term of the agreement, less a discount. The ASR has a scheduled termination date of December 27, 2024. Shares purchased pursuant to the ASR agreement are presented in the table above in the periods in which they were received.


Item 5.    Other Information

Rule 10b5-1 Trading Plans

During the third quarter of 2024, following is a list of activity by any executive officer or director with respect to a 10b5-1 trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (each, a "Plan"):

On August 19, 2024, Scott B. Ullem, Corporate Vice President, Chief Financial Officer, entered into a Plan providing for the potential sale of 56,250 shares of the Company’s stock commencing December 9, 2024. Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.

In addition, on September 23, 2024, Bernard J. Zovighian, Chief Executive Officer and Director, terminated a Plan that had provided for the potential sale of 25,147 shares of the Company’s stock commencing May 20, 2024. Following the termination date, no remaining shares can be sold pursuant to the Plan.



44

Item 6.    Exhibits

The exhibits listed in the Exhibit Index below are filed, furnished, or incorporated by reference as part of this report on Form 10-Q.

Exhibit No.Description
3.1 
3.2 
3.3 
3.4 
31.1 
31.2 
32 
101.INS
XBRL Inline Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________________________________________
* Represents management contract or compensatory plan
45

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 EDWARDS LIFESCIENCES CORPORATION
 (Registrant)
Date: November 6, 2024By:/s/ SCOTT B. ULLEM
Scott B. Ullem
Corporate Vice President, Chief Financial Officer
(Principal Financial Officer; Duly Authorized Officer)
Date: November 6, 2024By:/s/ ANDREW M. DAHL
Andrew M. Dahl
Senior Vice President, Corporate Controller
(Principal Accounting Officer)

46
 EX-31.1 2 ex-31110xqq32024.htm EX-31.1 Document

Exhibit 31.1
EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION
I, Bernard J. Zovighian, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Edwards Lifesciences Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:November 6, 2024By:/s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
Chief Executive Officer


 EX-31.2 3 ex-31210xqq32024.htm EX-31.2 Document

Exhibit 31.2

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION
I, Scott B. Ullem, certify that:
1.  I have reviewed this quarterly report on Form 10-Q of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:November 6, 2024By:/s/ SCOTT B. ULLEM
Scott B. Ullem
Corporate Vice President, Chief Financial Officer


 EX-32 4 ex-3210xqq32024.htm EX-32 Document


Exhibit 32
EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Edwards Lifesciences Corporation (the "Company") on Form 10-Q for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Bernard J. Zovighian, Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 6, 2024/s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
Chief Executive Officer
November 6, 2024/s/ SCOTT B. ULLEM
Scott B. Ullem
Corporate Vice President, Chief Financial Officer


 EX-101.SCH 5 ew-20240930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - RESTRUCTURING EXPENSES link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - ACCELERATED SHARE REPURCHASE link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 9952171 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 9952172 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 9952173 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 9952174 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - RESTRUCTURING EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - ACCELERATED SHARE REPURCHASE (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - EARNINGS PER SHARE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ew-20240930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 ew-20240930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 ew-20240930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Cover [Abstract] Cover [Abstract] Net increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect In-process research and development In Process Research and Development [Member] Discount Rate Measurement Input, Discount Rate [Member] Restructuring and related cost, expected number of positions eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Accrued relocation costs Accrued Relocation Costs, Current Accrued Relocation Costs, Current Hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Trading Symbol Trading Symbol Investment percentage (in percent) Equity Method Investment, Ownership Percentage Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Gross Amounts Derivative Asset, Subject to Master Netting Arrangement, before Offset Non-NEOs Non-NEOs [Member] Income tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Schedule of Accelerated Share Repurchases Accelerated Share Repurchases [Table Text Block]  Option Awards Employee and Nonemployee Stock Options [Member] An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Disposal Group Name [Domain] Disposal Group Name [Domain] Number of APAs renewed Number Of Advance Pricing Agreements Renewed Number Of Advance Pricing Agreements Renewed Cross-currency swap contracts Cross-currency swap contracts Currency Swap [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Net income from continuing operations Income from continuing operations, net of tax Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Hedging Relationship [Domain] Hedging Relationship [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Unrealized gain on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Net investment hedges Net Investment Hedging [Member] Foreign currency contracts Derivative, Gain (Loss) on Derivative, Net Investment, Name [Domain] Investment, Name [Domain] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Interest income, net Interest income, net Interest income, net Interest Income (Expense), Operating Shares expected to be granted as percentage of target (as a percent) Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Plan Name [Domain] Plan Name [Domain] United States UNITED STATES Inventories Inventory, Net [Abstract] Dilutive effect of stock plans (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Cash and cash equivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Other assets (Note 2) Other assets, noncurrent Other Assets, Noncurrent INVESTMENTS IN VARIABLE INTEREST ENTITIES Variable Interest Entity Disclosure [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Payments for legal settlements Payments for Legal Settlements Operating segments Operating Segments [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Deferred income taxes Disposal Group, Including Discontinued Operation, Deferred Tax Assets Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Prepaid expenses Prepaid Expense, Current Contingent consideration liability, term Business Combination, Contingent Consideration, Liability, Term Business Combination, Contingent Consideration, Liability, Term Allocation of stock-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Restructuring Type [Axis] Restructuring Type [Axis] Measurement Frequency [Axis] Measurement Frequency [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Proceeds from sale of business Proceeds from Divestiture of Businesses Use of Estimates Use of Estimates, Policy [Policy Text Block] Depreciation and amortization Disposal Group, Including Discontinued Operation, Depreciation And Amortization, Noncash Disposal Group, Including Discontinued Operation, Depreciation And Amortization, Noncash Transition services agreement period Disposal Groups, Including Discontinued Operations, Transition Services Agreement, Period Disposal Groups, Including Discontinued Operations, Transition Services Agreement, Period Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Adjustment to Compensation, Amount Adjustment to Compensation Amount Probability of Milestone Achievement Measurement Input, Probability Of Milestone Achievement [Member] Measurement Input, Probability Of Milestone Achievement [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Accrued and other liabilities Payables and Accruals [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Disposal Group Classification [Axis] Disposal Group Classification [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Other non-operating (income) expense, net Disposal Group, Including Discontinued Operation, Other Non-Operating Expense (Income), Net Disposal Group, Including Discontinued Operation, Other Non-Operating Expense (Income), Net Tax benefit from employee share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Anti-dilutive securities excluded from the computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Purchases of held-to-maturity investments (Note 6) Payments to Acquire Held-to-Maturity Securities Accrued marketing expenses Accrued Marketing Costs, Current Option to acquire investment amount Option To Acquire Investment, Amount Option To Acquire Investment, Amount Non-current assets of discontinued operations (Note 5) Total non-current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Noncurrent Goodwill Goodwill Amount Paid Share Repurchase Program, Authorized, Amount Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Rest of World Rest of World Segment [Member] Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World). Foreign currency forward exchange contracts Foreign Exchange Forward [Member] In-process research and development, expected costs Business Combination, In-process Research and Development, Expected Costs Business Combination, In-process Research and Development, Expected Costs Other Proceeds from (Payments for) Other Financing Activities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive income attributable to Edwards Lifesciences Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Taxes payable (Note 5) Accrued Income Taxes, Current Derivative assets Offsetting Derivative Assets [Abstract] Municipal securities Municipal securities Municipal securities Municipal Bonds [Member] Capital expenditures Disposal Group, Including Discontinued Operation, Capital Expenditures Disposal Group, Including Discontinued Operation, Capital Expenditures Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral And Tricuspid Therapies [Member] Transcatheter Mitral And Tricuspid Therapies [Member] Award Type [Axis] Award Type [Axis] Corporate debt securities Corporate debt securities Corporate debt securities Corporate Debt Securities [Member] Schedule of Enterprise-Wide Information Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Basic: Earnings Per Share, Basic [Abstract] Amount excluded from effectiveness testing (amortized) Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax Work in process Inventory, Work in Process, Net of Reserves Property, plant, and equipment, net Property, Plant and Equipment, Net Gain on remeasurement of previously held interest upon acquisition (Note 8) Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net Total liabilities Liabilities Liabilities Noncontrolling interest Equity, Attributable to Noncontrolling Interest Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Continuing Operations Continuing Operations [Member] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Expiration Date Trading Arrangement Expiration Date Schedule of Investments in Unconsolidated Affiliates Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Other assets Other Assets [Abstract] Operating lease liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Subsequent Event [Line Items] Subsequent Event [Line Items] Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Fair Value Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development expenses Research and Development Expense [Member] Endotronix, Inc Endotronix, Inc [Member] Endotronix, Inc Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Diluted (in shares) Dilutive weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted JC Medical, Inc JC Medical, Inc. [Member] JC Medical, Inc. Other non-operating income, net Other Nonoperating Income (Expense) [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] AOCI Attributable to Parent, Net of Tax AOCI Attributable to Parent, Net of Tax [Roll Forward] Total Edwards Lifesciences Corporation stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Net sales Disposal Group, Including Discontinued Operation, Revenue Litigation Case [Axis] Litigation Case [Axis] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Initial Delivery of Shares Settled April 2024 Initial Delivery Of Shares Settled April 2024 [Member] Initial Delivery Of Shares Settled April 2024 Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Selling, general, and administrative expenses Selling, General and Administrative Expense Downward price adjustment, annual amount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount Cost of sales Cost of Sales [Member] Value of Shares as % of Contract Value Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement. New total shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Document Fiscal Period Focus Document Fiscal Period Focus Acquisition-related costs Business Combination, Acquisition Related Costs Litigation settlement Estimated Litigation Liability, Current All Executive Categories All Executive Categories [Member] Unrealized Loss on Available-for-sale Investments Loss on available-for-sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Number of lawsuits that if settled could have a material adverse impact on net income or cash flows Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Changes to noncontrolling interest Noncontrolling Interest, Period Increase (Decrease) ASSETS Assets [Abstract] Other comprehensive (loss) income, net of tax Other Comprehensive Income (Loss), Net of Tax Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income Schedule of Segment Reporting Information, by Segment [Table Text Block] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Subsequent Event [Table] Subsequent Event [Table] Maximum Maximum [Member] Available-for-sale Debt Securities, Available-for-Sale [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities Offsetting Liabilities [Table Text Block] Schedule of Weighted-Average Assumptions for Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss Statistical Measurement [Axis] Statistical Measurement [Axis] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income from continuing operations before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Fair value of previously held equity interest Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value Name Outstanding Recovery, Individual Name Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Research and development expenses Disposal Group, Including Discontinued Operation, Research And Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expense Award Timing Predetermined Award Timing Predetermined [Flag] Becton, Dickinson and Company Becton, Dickinson And Company [Member] Becton, Dickinson And Company Europe Europe Segment [Member] Represents the Europe reportable segment of the entity. Subsequent Event Type [Domain] Subsequent Event Type [Domain] Investment, Name [Axis] Investment, Name [Axis] Restricted cash included in other assets Restricted Cash, Noncurrent Market Based Restricted Stock Units Market Based Restricted Stock Units [Member] Market Based Restricted Stock Units Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Counterparty Name [Domain] Counterparty Name [Domain] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Surgical Structural Heart Surgical Heart Valve Therapy [Member] This element represents the surgical heart valve therapy product line. Foreign currency Gain (Loss), Foreign Currency Transaction, before Tax Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Asset-backed securities Asset-Backed Securities [Member] Net income Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Measurement input Business Combination, Assets Acquired, Measurement Input Business Combination, Assets Acquired, Measurement Input Provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Segment Operating Income Pre-tax Income Reconciliation Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Notional Amount Derivative liability, fair value Derivative, Notional Amount Derivatives Fair value of derivative assets Net Amounts Presented in the Consolidated Balance Sheet Derivative Asset Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Net sales Total segment net sales Revenue from Contract with Customer, Excluding Assessed Tax Investments in intangible assets Payments to Acquire Intangible Assets Maximum additional option to acquire investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Business Acquisition [Line Items] Business Acquisition [Line Items] All Adjustments to Compensation All Adjustments to Compensation [Member] Employee compensation and withholdings Employee-related Liabilities, Current Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Restructuring expenses (Note 4) Restructuring charges Restructuring expenses (Note 4) Restructuring Charges Affected Line on Consolidated Condensed Statements of Operations Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Unrealized Gain (Loss) on Hedges Gain (Loss) on hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Held-to-Maturity Debt Securities, Held-to-Maturity, Maturity [Abstract] Entity Address, State or Province Entity Address, State or Province Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current assets of discontinued operations (Note 5) Total current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Consideration Disposal Group, Including Discontinued Operation, Consideration Financial Instruments [Domain] Financial Instruments [Domain] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Estimate of additional tax owed Income Tax Examination, Estimate of Possible Loss Offsetting Assets [Line Items] Offsetting Assets [Line Items] Other Other Liabilities, Fair Value Disclosure Restatement Determination Date Restatement Determination Date Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Accrued and other liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Israel Tax Authority Israel Tax Authority [Member] EARNINGS PER SHARE Earnings Per Share [Text Block] Discontinued Operations Discontinued Operations [Member] Subsequent Event Subsequent Event [Member] Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Amortization of unfavorable contract liability Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Amortization Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Amortization PEO PEO [Member] Name Trading Arrangement, Individual Name Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Acquisition options Acquisition Options, Noncurrent Acquisition Options, Noncurrent Disposal Group Name [Axis] Disposal Group Name [Axis] Treasury stock, at cost, 64.5 and 49.4 shares, respectively Treasury Stock, Common, Value Total before tax Total segment operating income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Gross profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Local Phone Number Local Phone Number Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Additional deposit Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Changes due to currency rate movements and expenses expected to occur, maximum term Maximum Length of Time, Foreign Currency Cash Flow Hedge PEO Total Compensation Amount PEO Total Compensation Amount Interest income, net Interest Income [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Gross Amounts Derivative Liability, Subject to Master Netting Arrangement, before Offset Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Common Stock Common Stock [Member] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract] Cash Collateral Received Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Changes in Fair Value of Contingent Consideration and Other Liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Finished products inventories held on consignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Segment Reporting [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Schedule of Components of Selected Captions in the Consolidated Balance Sheets Schedule of Inventory, Current [Table Text Block] Foreign Currency Translation Adjustments Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Discontinued Operations and Disposal Groups [Abstract] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount ACCELERATED SHARE REPURCHASE Equity [Text Block] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Financial Instrument [Axis] Financial Instrument [Axis] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Property, payroll, and other taxes Accrual for Property Payroll and Other Taxes Other than Income Taxes Current Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Measurement Basis [Axis] Measurement Basis [Axis] Title Trading Arrangement, Individual Title Consolidated Entities [Axis] Consolidated Entities [Axis] Liability for income taxes associated with uncertain tax positions Unrecognized Tax Benefits Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest City Area Code City Area Code Current liabilities Liabilities, Current [Abstract] Contingent consideration liabilities Fair value of contingent consideration Business Combination, Contingent Consideration, Liability Disposal Group Classification [Domain] Disposal Group Classification [Domain] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Share information (Note 15) Share Information [Abstract] Held-to-maturity Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract] Purchases of treasury stock Payments for Repurchase of Common Stock Financial Instruments Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Long-term debt Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Settlement of pre-existing relationships Business Combination, Settlement Of Pre-Existing Relationships Business Combination, Settlement Of Pre-Existing Relationships Subsequent Event Type [Axis] Subsequent Event Type [Axis] Earnings per share: Earnings Per Share [Abstract] Equity [Abstract] Equity [Abstract] Net loss attributable to noncontrolling interest Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Raw materials Inventory, Raw Materials, Net of Reserves Retained earnings Retained Earnings (Accumulated Deficit) Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Total purchase price, net of cash acquired Total purchase price, net of cash acquired Business Combination, Consideration Transferred, Net Of Cash Acquired Business Combination, Consideration Transferred, Net Of Cash Acquired Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value Legal and insurance Accrued Litigation And Insurance Reserves Accrued Litigation And Insurance Reserves Cash flow gain to be reclassified in the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Due in 1 year or less Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Inventories Increase (Decrease) in Inventories Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Underlying Securities Award Underlying Securities Amount Maximum secured promissory note Equity Securities, FV-NI, Maximum Secured Promissory Note Equity Securities, FV-NI, Maximum Secured Promissory Note INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Amendment Flag Amendment Flag Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Subsequent Events [Abstract] Subsequent Events [Abstract] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Medical Device Company, March 2023 Investment Medical Device Company, March 2023 Investment [Member] Medical Device Company, March 2023 Investment Revenue Volatility Measurement Input, Revenue Volatility [Member] Measurement Input, Revenue Volatility Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Zip Code Entity Address, Postal Zip Code Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share April 2024 Stock Repurchase Program Shares Sold in May 2024 April 2024 Stock Repurchase Program Shares Sold In May 2024 [Member] April 2024 Stock Repurchase Program Shares Sold In May 2024 Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other Payments for (Proceeds from) Other Investing Activities Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Excluding Deferred Tax Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Excluding Deferred Tax Liabilities Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] February 2023 Stock Repurchase Program Shares Sold in March 2023 February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member] February 2023 Stock Repurchase Program Shares Sold In March 2023 Stock Compensation Plan Share-Based Payment Arrangement [Member] Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member]  ESPP Employee Stock [Member] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Proceeds from stock plans Proceeds from Stock Plans Less: cash acquired Cash Acquired from Acquisition Loans receivables, maximum lending amount Loans Receivables, Maximum Lending Capacity Loans Receivables, Maximum Lending Capacity Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Assets Derivative Asset [Abstract] Derivatives designated as hedging instruments Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Percentage of previously held interest Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage Net of tax Net Income (Loss) Available to Common Stockholders, Basic Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Weighted-average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Total assets Assets Assets Cost of sales Cost of sales Cost of sales Cost of Goods and Services Sold Capital expenditures Payments to Acquire Property, Plant, and Equipment Other liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and contingencies (Note 13) Commitments and Contingencies Termination Date Trading Arrangement Termination Date Fair value of financial instruments measured on a recurring basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net Amount Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Contingent Consideration Contingent Consideration Liability [Member] Contingent Consideration Liability Schedule of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Cash Collateral Received Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Net Income (Loss) Attributable to Parent Other operating expenses, net Other Operating Income (Expense), Net Trading Arrangement: Trading Arrangement [Axis] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets Offsetting Assets [Table Text Block] Gross Unrealized Gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Variable Interest Entities [Abstract] Investments in Variable Interest Entities Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Entity File Number Entity File Number Accrued and other liabilities (Note 2) Total accrued and other liabilities Accrued And Other Liabilities, Current Accrued And Other Liabilities, Current Consolidated Entities [Domain] Consolidated Entities [Domain] Noncontrolling Interest Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Other comprehensive (loss) income before reclassifications OCI, before Reclassifications, before Tax, Attributable to Parent Weighted Average Shares: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Name Forgone Recovery, Individual Name Deferred income taxes Increase (Decrease) in Deferred Income Taxes Other Other Noncash Income (Expense) Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Goodwill Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Rest of World Rest of World [Member] Represents the geographic areas of the world other than the United States, Europe and Japan. Financial instruments Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Proceeds from held-to-maturity investments (Note 6) Proceeds from Sale and Maturity of Held-to-Maturity Securities Adjustment to Compensation: Adjustment to Compensation [Axis] Provision for income taxes from discontinued operations Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period Net loss attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Liabilities Derivative Liability [Abstract] Document Quarterly Report Document Quarterly Report Amount of gain (loss) reclassified from accumulated other comprehensive loss into income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Litigation Case [Domain] Litigation Case [Domain] Accumulated other comprehensive loss (Note 14) Accumulated Other Comprehensive Income (Loss), Net of Tax Fair Value Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract] Term for continued services Disposal Group, Including Discontinued Operations, Term For Continued Services Disposal Group, Including Discontinued Operations, Term For Continued Services Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Notes and other receivables Other Receivable, after Allowance for Credit Loss, Noncurrent Related Party [Axis] Related and Nonrelated Parties [Axis] Basic (in shares) Basic weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Gross unrealized losses, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Business combination, escrow deposit Business Combination, Escrow Deposit Business Combination, Escrow Deposit Total stockholders' equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Unfavorable contract liability Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Current Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Current Accrued professional services Accrued Professional Fees, Current Name Awards Close in Time to MNPI Disclosures, Individual Name Initial Delivery of Shares Settled February 2023 Initial Delivery Of Shares Settled February 2023 [Member] Initial Delivery Of Shares Settled February 2023 Prepaid expenses Disposal Group, Including Discontinued Operation, Prepaid Expense, Current Disposal Group, Including Discontinued Operation, Prepaid Expense, Current Gross unrealized losses, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Investment option to acquire Equity Securities, FV-NI, Option To Acquire Investment Equity Securities, FV-NI, Option To Acquire Investment Entity Filer Category Entity Filer Category Loss Contingencies [Line Items] Loss Contingencies [Line Items] Fair value of derivatives Derivative Asset, Noncurrent Accrued realignment reserves Restructuring Reserve, Current Business combination, net of cash Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Derivatives designated as hedging instruments Derivatives, Fair Value [Line Items] Net amounts that would favorably affect effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Operating (loss) income, net Disposal Group, Including Discontinued Operation, Operating Income (Loss) Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Derivative Financial Instruments Derivative [Line Items] Carrying value of equity method investments Equity Method Investments Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Derivative [Table] Derivative [Table] Income Tax Contingency [Table] Income Tax Contingency [Table] Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Restructuring and Related Activities [Abstract] Total stock-based compensation expense, net of tax Share-Based Payment Arrangement, Expense, after Tax Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Other Performance Measure, Amount Other Performance Measure, Amount INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES Legal Matters and Contingencies [Text Block] Common stock, shares outstanding (in shares) Common stock, beginning balance (in shares) Common stock, ending balance (in shares) Common Stock, Shares, Outstanding Other receivables Other Receivables, Net, Current Operating lease liabilities Operating Lease, Liability, Noncurrent Cash flow hedges Cash Flow Hedging [Member] Equity securities Investments, All Other Investments [Abstract] Escrow deposit, holding period Business Combination, Escrow Deposit, Holding Period Business Combination, Escrow Deposit, Holding Period Entity Tax Identification Number Entity Tax Identification Number Purchases of treasury stock (in shares) Shares Received (in shares) Treasury Stock, Shares, Acquired Selling, general, and administrative expenses Selling, General and Administrative Expenses [Member] Treasury Stock Treasury Stock, Common [Member] Other assets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Tax receivable (Note 16) Income Taxes Receivable Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Fair Value Fair Value Available-for-sale investments: Debt Securities, Available-for-Sale Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Corporate items Costs and Expenses Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Diluted: Earnings Per Share, Diluted [Abstract] Non-cash investing and financing transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Developed technology Developed Technology Rights [Member] Geographical [Axis] Geographical [Axis] Gain on sale of business (Note 5) Gain (Loss) on Disposition of Business Intellectual property agreement accrual Increase (Decrease) In Legal Settlement Accrual Increase (Decrease) In Legal Settlement Accrual Weighted Average Weighted Average [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Other Other Liabilities [Member] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Stock-based compensation Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Noncash Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Noncash Maximum additional required investment Equity Securities, FV-NI, Maximum Additional Required Equity Securities, FV-NI, Maximum Additional Required Initial delivery, price per share (in dollars per share) Accelerated Share Repurchases, Initial Price Paid Per Share Fair value, total Debt Securities, Available-for-Sale, Unrealized Loss Position Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period (Note 2) Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Carrying value of non-marketable equity securities Equity Securities, FV-NI, Current Total remaining unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Current assets Assets, Current [Abstract] Consolidation Items [Axis] Consolidation Items [Axis] Income from continuing operations attributable to Edwards Lifesciences Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Treasury stock (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Prepaid royalty asset Prepaid Royalties Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Security Exchange Name Security Exchange Name Amount Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Member] Other long-term assets Other Assets, Miscellaneous, Noncurrent Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development expenses Research and Development Expense Schedule of Investments in Debt Securities Unrealized Gain (Loss) on Investments [Table Text Block] Deferred income tax expense (benefit) Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Common stock, shares issued (in shares) Common Stock, Shares, Issued Income taxes Increase (Decrease) in Income Taxes Payable Financing receivable Financing Receivable, before Allowance for Credit Loss Gross unrealized losses, total Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Derivatives Fair value of derivative liabilities Net Amounts Presented in the Consolidated Balance Sheet Derivative Liability Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accounts receivable Accounts Receivable, after Allowance for Credit Loss Europe Europe [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Payments to acquire businesses Payments to Acquire Businesses, Net of Cash Acquired Remaining financing receivable Financing Receivable, Advancement On Loans Financing Receivable, Advancement On Loans Other comprehensive (loss) income, net of tax (Note 14): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Schedule of Supplemental Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Other receivables Disposal Group, Including Discontinued Operation, Other Receivables, Current Disposal Group, Including Discontinued Operation, Other Receivables, Current Property, plant, and equipment, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Other comprehensive gain (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Fair Value on a Recurring Basis Fair Value, Recurring [Member] Accounts receivable, net of allowances of $12.6 and $8.2, respectively Accounts Receivable, after Allowance for Credit Loss, Current Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Enterprise-Wide Information Revenues from External Customers and Long-Lived Assets [Line Items] Fair value, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Current liabilities of discontinued operations (Note 5) Total current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Restricted cash included in other current assets Restricted Cash, Current Commercial paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Total investments in unconsolidated entities Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Separation costs Disposal Group, Including Discontinued Operation, Other Nonrecurring (Income) Expense Disposal Group, Including Discontinued Operation, Other Nonrecurring (Income) Expense Litigation settlement accrual Estimated Litigation Liability, Noncurrent Inventory write off Disposal Group, Including Discontinued Operation, Inventory Write-Down Disposal Group, Including Discontinued Operation, Inventory Write-Down Investments held for deferred compensation plans Deferred Compensation Plan Assets Limited Liability Company Limited Liability Company [Member] Total Edwards Lifesciences Corporation Stockholders' Equity Parent [Member] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate New Markets Tax Credit New Markets Tax Credit [Member] New Markets Tax Credit Accounting Policies [Abstract] Accounting Policies [Abstract] Segment Net Sales Net Sales Reconciliation Revenues [Abstract] BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Short-term investments (Note 6) Short-Term Investments PEO Name PEO Name Award Type [Domain] Award Type [Domain] Accounts receivable, net of allowances Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Common stock issued under stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Discontinued Operations, Held-for-Sale Discontinued Operations, Held-for-Sale [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Deferred income taxes Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Other intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent Due in 1 year or less Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year Class of Stock [Line Items] Class of Stock [Line Items] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Non-cash operating lease cost Operating Lease, Right-of-Use Asset, Periodic Reduction Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Type of Restructuring [Domain] Type of Restructuring [Domain] Investments taken period Equity Method Investments, Investment Period Equity Method Investments, Investment Period United States United States Segment [Member] Represents the United States reportable segment of the entity. Operating Activities [Axis] Operating Activities [Axis] Income taxes Income Taxes Paid Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Employee Severance Employee Severance [Member] RESTRUCTURING EXPENSES Restructuring and Related Activities Disclosure [Text Block] Contingent consideration liability measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Unrealized Pension Credits (Costs) Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Japan Japan Segment [Member] Represents the Japan reportable segment of the entity. Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Corporate items Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Other liabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Cash paid during the year for: Supplemental Cash Flow Information [Abstract] Carrying value of marketable equity securities Equity investments in unconsolidated entities Equity Securities, FV-NI Additional tax sought in excess of filing position Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income Derivative Instruments, Gain (Loss) [Table Text Block] Non-operating income Nonoperating Income (Expense) Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement [Member] Transcatheter Aortic Valve Replacement [Member] Effective income tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Operating income, net Consolidated operating income Operating Income (Loss) Equity method investments Equity Method Investment, Financial Statement, Reported Amounts [Abstract] Total liabilities and equity Liabilities and Equity SUBSEQUENT EVENTS Subsequent Events [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Hedging Designation [Axis] Hedging Designation [Axis] Fair value of derivatives Derivative Liability, Current DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Income from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] BASIS OF PRESENTATION Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Right-of-use assets obtained in exchange for new lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Measurement Input Type [Axis] Measurement Input Type [Axis] Individual: Individual [Axis] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Medical Device Company, April 2021 Investment Medical Device Company, April 2021 Investment [Member] Medical Device Company, April 2021 Investment Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Operating lease liabilities Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent Inventories (Note 2) Total inventories Inventory, Net Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Product and Service [Axis] Product and Service [Axis] Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Intellectual property agreement term Intellectual Property Agreement Term Intellectual Property Agreement Term Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Total purchase price Business Combination, Consideration Transferred Threshold of disclosing material environmental legal proceedings Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure Fair value beginning balance Fair value ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Accounts and other receivables, net Increase (Decrease) in Accounts and Other Receivables Minimum Minimum [Member] Notes payable fair value disclosure Notes Payable, Fair Value Disclosure Adoption Date Trading Arrangement Adoption Date Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Exercise Price Award Exercise Price Arrangement Duration Trading Arrangement Duration Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Net income from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Schedule of Variable Interest Entities [Table] Variable Interest Entity [Table] Fair value, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Medical Device Company Medical Device Company [Member] Medical Device Company Payment for acquisition options (Note 7) Payment for acquisition options Other Payments to Acquire Businesses Long-term investments (Note 6) Long-Term Investments Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Long-term prepaid royalties (Note 3) Increase (Decrease) in Prepaid Royalties Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Financial Instruments Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Medtronic Inc Medtronic Inc [Member] Medtronic Inc All Individuals All Individuals [Member] Investee drew additional amount Equity Securities, FV-NI Promissory Note Outstanding Equity Securities, FV-NI Promissory Note Outstanding Gross Unrealized Losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Other non-operating income, net Other non-operating income, net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Bernard J. Zovighian [Member] Bernard J. Zovighian Equity interest in acquire, excluding initial acquisition, percentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Excluding Initial Acquisition, Percentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Excluding Initial Acquisition, Percentage Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Assets Assets, Fair Value Disclosure [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Related Party [Domain] Related and Nonrelated Parties [Domain] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Liability Class [Axis] Liability Class [Axis] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Net Amount Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Unrealized pension credits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Proceeds from available-for-sale investments (Note 6) Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Measure: Measure [Axis] Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract] Common stock issued under stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Entity Emerging Growth Company Entity Emerging Growth Company Liabilities Liabilities, Fair Value Disclosure Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of sales Disposal Group, Including Discontinued Operation, Costs of Goods Sold Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Schedule of Accrued and Other Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Other current assets Disposal Group, Including Discontinued Operation, Other Assets, Current Japan JAPAN Additional tax expense Income Tax Assessment, Estimate Of Additional Tax Expense Income Tax Assessment, Estimate Of Additional Tax Expense Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Change in fair value of contingent consideration liabilities (Note 9) Change in fair value of contingent consideration liabilities Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Statement [Table] Statement [Table] Taxes payable Taxes Payable Measurement Frequency [Domain] Measurement Frequency [Domain] Counterparty Name [Axis] Counterparty Name [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Net Income for Earnings Per Share Calculations: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Increase in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Restructuring and related cost, expected cost remaining Restructuring and Related Cost, Expected Cost Remaining Level 1 Fair Value, Inputs, Level 1 [Member] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Available-for-Sale Available-for-Sale Securities, Debt Maturities [Abstract] Accrued rebates Accrued Rebates Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates. Fair value, per option/share (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Carrying value of non-marketable equity securities Equity Securities without Readily Determinable Fair Value, Amount Scott B. Ullem [Member] Scott B. Ullem Bank time deposits Bank Time Deposits [Member] INCOME TAXES Income Tax Disclosure [Text Block] Uncertain tax positions Liability for Uncertainty in Income Taxes, Noncurrent Current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Decrease in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Final settlement per share price (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Long Term Stock Incentive Compensation Program Long Term Stock Incentive Compensation Program [Member] Long Term Stock Incentive Compensation Program Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years Entity Registrant Name Entity Registrant Name Cash consideration paid at closing Payments to Acquire Businesses, Gross Derivative liabilities Offsetting Derivative Liabilities [Abstract] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Gross profit Gross Profit Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Fair Value as of Grant Date Award Grant Date Fair Value Operating lease liabilities Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current Level 2 Fair Value, Inputs, Level 2 [Member] Offsetting Assets [Table] Offsetting Assets [Table] Stockholders' equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Geographical [Domain] Geographical [Domain] Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract] Derivative Fair Value of Derivative Asset Gross Amounts Not Offset Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Consolidation Consolidation, Policy [Policy Text Block] Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Restatement Determination Date: Restatement Determination Date [Axis] Innovalve Bio Medical Limited Innovalve Bio Medical Limited [Member] Innovalve Bio Medical Limited Title of 12(b) Security Title of 12(b) Security Research and development accruals Research And Development Accruals Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials. Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively Common Stock, Value, Issued Amount excluded from effectiveness testing Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Performance period (years) Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding           Preferred Stock, Value, Issued Basic earnings per share (in dollars per share) Earnings Per Share, Basic Amounts included in the measurement of operating lease liabilities Operating Lease, Payments Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Current liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Capital expenditures accruals Capital Expenditures Incurred but Not yet Paid Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Total current liabilities Liabilities, Current Additional contingent consideration Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Restricted stock units granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Critical Care Critical Care [Member] This element represents the critical care product line. U.S. government and agency securities U.S. government and agency securities United States government and agency securities US Treasury and Government [Member] Unallocated amounts: Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Fair Value Fair Value Debt Securities, Held-to-Maturity, Fair Value Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Equity forward contract related to accelerated share repurchase agreement (Note 12) Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement Operating Activities [Domain] Operating Activities [Domain] STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Non-current liabilities of discontinued operations (Note 5) Total non-current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Total stock-based compensation expense Share-Based Payment Arrangement, Expense DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Weighted average exercise price of options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Step acquisition, equity interest in acquire, remeasurement gain Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain Loss Contingencies [Table] Loss Contingencies [Table] Business Acquisition [Axis] Business Acquisition [Axis] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Liabilities Liabilities, Fair Value Disclosure [Abstract] Unrealized (loss) gain on hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Document Fiscal Year Focus Document Fiscal Year Focus Selling, general, and administrative expenses Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expense Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expense Purchases of treasury stock Treasury Stock, Value, Acquired, Cost Method Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Assets Assets, Fair Value Disclosure Other accrued liabilities Other Accrued Liabilities, Current Document Period End Date Document Period End Date Finished products Inventory, Finished Goods, Net of Reserves Unfavorable contract liability Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability Insider Trading Arrangements [Line Items] OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Issuances of notes receivable Payments to Acquire Receivables Reconciling items Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] Uncertain tax positions Disposal Group, Including Discontinued Operation, Uncertain Tax Positions, Noncurrent Disposal Group, Including Discontinued Operation, Uncertain Tax Positions, Noncurrent Operating lease right-of-use assets Disposal Group, Including Discontinued Operation, Operating Lease Right Of Use Asset, Noncurrent Disposal Group, Including Discontinued Operation, Operating Lease Right Of Use Asset, Noncurrent Foreign currency contracts Foreign Exchange Contract [Member] Document Transition Report Document Transition Report Upward price adjustments Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Intellectual property agreement and certain litigation expenses (Note 3) Intellectual property litigation expense Intellectual property agreement and certain litigation expenses Litigation Settlement, Fee Expense Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Long-term prepaid royalties Prepaid Expense Income from discontinued operations before provision for income taxes Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Convertible Promissory Note Convertible Promissory Note [Member] Convertible Promissory Note Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Purchases of available-for-sale investments (Note 6) Payments to Acquire Debt Securities, Available-for-Sale Company Selected Measure Name Company Selected Measure Name EX-101.PRE 9 ew-20240930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 ew-20240930_g1.jpg begin 644 ew-20240930_g1.jpg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end GRAPHIC 11 ew-20240930_g10.jpg begin 644 ew-20240930_g10.jpg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
  •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ew-20240930_g11.jpg begin 644 ew-20240930_g11.jpg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

    :]!H \%_X=U? _\ Z&[QW_X5\]'_ [J^!__ $-WCO\ M\*^>O>J* /!?^'=7P/\ ^AN\=_\ A7SUZG\(_A/X;^#'@]?!/A6_U.YM$N'F M$FK7[7,VY\9&]N<<<#M73T4 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4453\ M0Z?J&K:!?:5I.LR:==7-G+%;:A%&KO:R,A"RJK<,5)# '@XYH \.\:_\%3O^ M"<7PX^.1_9K\>?MK_#C2?'"7@LY_#U]XH@CEM[DG MY6+;(9VMXFEN+B>0(D2*,L[,>%4 $DG@ 5\$?\%/_P#@G%_P M3G^&?_!(?XM^$-:_9Z\*6-AX6^&^I7VB>(6TB%M8_MN.W=K2[^VE?/GO9KLQ MAG9RT[S,K[A(P/S=_P %(-=_:.^"G_!$?]D7]@KXK>(=3MO&7QH\3^"/AY\1 M99;EUNX].EA5[NSDE!W>9\EO;2'/SKYH)(8Y /T_^#?[9_[*G[0GB:3P=\%? MCWX;\1ZFMBU]!9Z;J 9KRS5PAN[;.!=6X,8! M6-1Q@5]EZK^Q-^SAXU^-'B/X_?%CX7:#XV\1:]8VNFVEYXLT:"_&DZ5#$ +" MU$RL(H7F:XN'V@&1[@[BP2,* =A\%OCE\&_VC?AW8_%OX"?%#0O&/AG4@WV' M7?#NIQW=M*5.&7?&2 RGAE.&4@@@$8I_QE^,_P *?V>?ACK'QG^-_C[3/"_A M70+87&L:[J]R(K>UC+*@+,>Y9E4 9+,P !) KX%_X(>?LW:1^S_^V7^VVGP# MT\Z7\#9OBYINF^ M$M25L;;6;6RD.NK:Q_=2..YGBMOD^4?9A'QY.!Y;_P ' M!VIZK^V=_P $V_CQ\8K+4KB+X3_":*WLO!@MYF6/Q;XE75K6TO=38@_O;*R5 MY[2 \: M>-?B5\5_@KX8\<^(O'UX3X@U?QAX?MK^1K)(E@M]/C\Y&\JUBA15$2X5G:65 M@7E)TU.'39],EU1/\ 1[^8 PV4 MLG^KANI RE+=V65]R[5.X9_-G_@FYJ.O_P#!./\ X)<_MN_M"?!>>=?AIX;^ M*'CW5/V>[*[E:>W^Q64;6UO/ 7SOM7NX0@.3N^SNYR7);TS]CS]F;PMXX_X- MCV\ >,[?^T+WXB_ W6O%NOZO>L9;F\UK48;C4UU&61LM)<).\,BR,2084Y^4 M4 ?H5\6?B_\ "KX#?#[4OBQ\:_B+HOA/PSH\(EU/7O$&I1VEI;*2%&^20A02 MQ"@9RS$ D@5Q'[+O[>'[&W[:UIJ-W^RC^TGX2\=G2"O]JVV@:LDMQ9AB0K2 MPG$B*Q!"L5"L00"<&OF/_@E1;>%O^"J__!,O]F;]IC]KC38?&MUX>T.^^T:- MXBMDN[+4MYBD!6:Y1+6Y9"X*A[V20 .J%>"^)/['?PY^'W_ <; M_ 7XA_L>>!--\)7<7PE\3:I\>;7PO9)9VEUI#1FSTI[B*(+&TLM\[ $C!+G6@S:39:_JR17%TBG#2)",N8P M>"^W:#P3FO2/ /C_ ,"_%3P7IGQ&^&7C'3/$/A_6K-+K2-;T6^CN;2]@<962 M*6,E74]B"17@?[:6I?\ !-K]DGX<^/?VEOVV=+\&0Z?XILO*\2WGBZQBO[O6 MH8H%BCTVVAE#/*@4?+:Q#9OEDD*AI)'/F7_!NS\*/ /PB_X)3> M)^&OQ?TO MQAI.L7VIZU!)HFIFZM='^UWDDW]EH[?,'MPPCE# 'SA*<[\0^(=5MK"PL+:2XOKZ]G6 M*&WA12SR2.Q"HBJ"2Q( )-6:K:QH^D>(=)N=!U_2K:^L;V!X+RRO(%EBGB8 M%61T8$,I!(((((- 'YG^(?\ @L]_P2;_ &L?C1!J_P :_P!MSP-I7PR^'7B0 M7/A;PKJ%Y(9?%>M6LG[K5[M A LK>1=UI W,LJBZ< 1VU0_\%C=4T3_@H3_P M3J^&W_!1#]CC3-6\6Z3\$OC5IOQ!TMK?2Y(YM?T?2[J6WOYK2&0"1HP0TRLR MJ7CM69059"WZ ?\ #)_[+/\ T;5\/_\ PC;'_P"-5VFA:!H7A;1[?P[X9T6T MT[3[.(16EC86RPPP(.BHB *H]@,4 ?FW_P %T[;PC_P4J^"_P"_86_9Q\7:= MXKNOC-\4M&\074^BW2W$=IX-M(IIKW69"A.R!?,@16; DDD"+E_EKU;_ (** M?\%=OV4/V<_B?;_L67_[7?A7X>^-=8L//\4>*M2NU<^#M-8#]XD>UQ)J4JM_ MHT+J4C!^T3 HL<5Q]9^ /@I\&OA1?:GJGPM^$OAGPUHW?L_>)_^"#-.G MO5\*_:&\A+R:XF:,S7TTL\TX/F&61XIY7=6PS?%/_!8G_@GU_P %'?V9?^". M_P 1[#QW_P %>&\:_#/PCX8TFQ/PQM?V>?#NB6]U9QZA90P6Z75H?-MUC/EN M"G)\K:>&-?LGX&^$OPK^&!NF^&GPS\/^'3>A/MIT+1H+3[1LW;-_E(N_;N;& M)?#'AKQGH=QX9\8>'K'5M-NU"W6GZE:)/!, P8!XW!5L$ \CJ : M /&/^"<7PQ^/_P *?V3/#/A_]H[]IV7XKZU6'B"7P=9:(;.PDM8/)L? M(L_DD$6&_?-\[[_FZ"O=:9;V]O:6Z6MK D442!(XXU"JB@8 ' ':GT %? MO[?7_!7G]A[0_C+J7[ ?B/\ ;7\,_#R2&U"_%?Q8=6*76E6DF0VDV#1!BNHS M+N5Y1C['&2^?/:)1]]5P^J?LQ_LV:YJ=QK6M?L]>![R\O)WGN[NZ\)VWCS2-5\/:;\)Y M/#-MJ'AW3I8=%T&2[M)X-.MED=5$C(8?,*1A]B(-Y4N@;Q;]G']J_1/A1_P; MAW_@SQ]G2_B5\//AEJGPMU#P!.0=63Q9#%-I=CI8MUR[SW#FV>-4#%XYE<9' M-?I5X(^&GPY^&=E-IWPW\ :)X?M[F427$&B:5#:)*X&-S+$JACCC)YQ52Z^" MGP:O?B3#\9;WX2>&)O&%O!Y-OXKET&W;4HHL;=BW13S57'& V,<4 ?!WP#^- M?P7_ .#?O_@CM\$_@S^U5XST;3/&HT3[-IOA>_U=+N7US)?743RX;RK6V MFNW\^Y"LJ(F561WCCDUOV,?^"E__ 2YTCQY'X>\%_MF^'_BS\<_C/XJLHO$ M5QX2T^>6YU2\.(HH+>,KBTTRQ@W[$=\1PQRR.TD\LCR_;WCCX._"/XFW,%[\ M2?A9X<\0S6L92UEUS0[>[:%2*/!?P.\'Z1 MJ=J6^RZCI?AFUMYX=RE&VR1QAERK,IP>02.] '%WW[;7["'C#QGXT_9\\0_M M*_#BXUOPHCVOCGPGK?B&T22SC:,%UGAG8!H]C8_9@TW] MGGP9\>?%?POT>;1_A1\0_CWJ^O?!_1C"T4 T/RH(4O+>-@"EM,\;^1P-]O%! M(,JZD_7/B3]E_P#9H\9>/A\5O%_[._@75?%*E"OB74O"5G/J * !#]H>(R?* M /FX XKNJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** -** "BBB@ HHHH __V0$! end GRAPHIC 13 ew-20240930_g2.jpg begin 644 ew-20240930_g2.jpg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ew-20240930_g3.jpg begin 644 ew-20240930_g3.jpg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end GRAPHIC 15 ew-20240930_g4.jpg begin 644 ew-20240930_g4.jpg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ew-20240930_g5.jpg begin 644 ew-20240930_g5.jpg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end GRAPHIC 17 ew-20240930_g6.jpg begin 644 ew-20240930_g6.jpg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end GRAPHIC 18 ew-20240930_g7.jpg begin 644 ew-20240930_g7.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M.@/T P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKVS@U"SEL+I6,4\3 M1R!7*DJPP<%2".#U!R*EHH _)G]@CX6K\9O^"TG[:7[._P 3OB_\5]5\%_#V M;PW-X+\/GXT>)8(-(-[:O-<+%Y-^AVLYX4DA0 % Q7VY^S%^RCX,^#_ .T5 MXG^+OP0^/7CC6O"6HZ,^@:WX-\6?$76-?MM,UJSN\M/:G4KB=H69'DBE57"@ MQ1[1]_'P=^Q=^S5\)OVCO^"__P"WII_Q4M=?ECTL^$'L_P"P?&FJZ,P,FG8; M;+(LCLSDHI8L+]!_9?^/GA_QO=> ] M3CT_Q8F@W)E6PGD\SRP6P%D1_*E"R1ED8Q. Q*G'C7_!2O\ X*Q_"']@'Q]\ M)_@QK%U)-XG^)?Q#T;3)C_9D\]OI&C27B"]O)FC4C?Y"RI%$"9&=@X1EC:OI M_P *?#'X:^ ]5U/7? WP\T/1K[6FA;6;S2=)AMI;\PQ^7"9GC4&78GR+N)VK MP,#BO@K_ (+IA_^BWH X;_ (*'^,/A?J?_ 5]_P""?_[1 M_A'XD:D/#?BC4?'5UJMUJ?B"]BTL6]CHD7EW'V6ZD$-GY:RW!:18XRP8LY. M:^XOV7?^"B?[$O[:GBCQ#X*_9;_:.\/>,M7\*[&UW3M-DD6:"-SA9E65%,L) M. )H]T9W+\WS#/R'_P %>?"?ACQO_P %A?\ @G;X:\8^'[/5=.F\5^/GFL=0 MMEFAD:/2K"1"R,"&VNBL,CJHJ[XNM+70_P#@ZA\)WND6Z6TNM?L97:ZL\*A3 M=^7XADV&3'WR!&@!.3A%'110!]9?'G_@H-^Q]^S-J.I:9\:?C/;Z6VAK"WB. M:VTF]OH-"68 Q'4)K2&6/3PZLK*;AH]RD,,CFO5?"?BWPMX]\+Z=XW\#^)+' M6-&U>RBO-*U;2[M)[:\MY%#QS12(2LB,I!#*2"""*_+G_@BUX5OOV[?V*_BM MX&\>?MC>/M&\4WGQ5\::7\;/ ^E:?X:?RKN^U"ZW>9]NTBXNMLEJZ1!GE91Y M+1IM6((GV[_P35_9I^!G['7[(NA_LQ?LW?%/Q-XP\'^"]6U;3=.U?Q9?0W-V MDR:C"-TAN3/$-J87RRF3M- 'F'[9'_!83X$_LI?MW_!W]B36=5D M2_\ &5_J=WXYU232+F6WT;3+?1;RY@17C0^9_C) MXX^$?PH_X.+_ (9_'K6_BM'K/45T_P#9IUB^L4O;995@N8]3F,?LZ?\ M%#_V)/VLO GB;XF_ #]I3PSKVA^"YS%XNOVNFLQHQ"LVZZ6Y6-H$(1R)' 1M MCX)VMCD8?^"Q/_!,&Y3P]+9?ML^!KF/Q;XPE\+^&IK746ECU+4XS"'CB=%*O M&IN( ;C/DYE4>9DU\^?L@6=IH?\ P<@_M*9H9M4T>&Y, M,EC/"UFT?F*WEF!I)6C*XV-*[+@NQ(!]L_'K_@H#^R#^S)?ZEIOQI^,D&EOH M<4,OB.2TTB]OXM#CF ,3ZA+:0RI8*X(96N#&&4[ADZ'XLF^,GC33?C-X&TK3O#3^7<7E].N9!?Z1<7.R2 MU*0J7D91]G:--JQ;%X/X^?#KX&?\$[-8_80_9"^$O[5OCJV^!VA?'/QCINH> M/M;%DAU"\O(P7MV6(I(0RO#O0 _37X&?MS?LK? MM'?$36_@_P#";XLPW/C#PY:I=:WX0U?2[O2M6M;=\;;AK*^AAG,)+*/-"%,N MHS\PSZK=W=K86LM]?7,<,$,;2332N%2- ,EF)X &237R+XA_P""='P5T+_@ MH)\)OVZ_C!^U_P#%'7?B=HMK?>%?!5GJ9T*VM-7@ELKZ>6SN(=.TBW>=$B-U M."SJ$:,'/0'VW]MWQ5\"?!7['7Q1\1_M03W,?PZA\ ZJGC<632+/)IDEK)'< M1Q&(AQ*\;LB;2&W,N"#S0!S/A7_@II^PUXS\7^&/!>@_'VS:;QOJ,EAX'U2[ MTF^MM*\2W2':8=.U*:!;._?=P%@FD+'A-(]*N]3O/#MUKT0N+"SMK=KF>XNP"1:1K"K/NG* @'&:_+#_ (*$V?Q" MO/\ @F[^Q?XL\/>#=!\ _"BS^/GPT/PN\!"6;5-*_"NGZE&OPO\87 BOK1)4\VWC> M6!RK @M'*?,0G[K@,,$ T ?8_P"RC^WY^QQ^W&OB _LH?'_0_&DGA6[2V\0V M^FF1)K%WW>67BF1'V/L?;( 4;8VUCM.,7]IC]KG]BW2K+Q5\"OC/\:KW3UL; M")?&]SX8EU:/_A&8)P&C?4-2TM<:.&7#![B: &,Y)*$Y^4/!3WG@W_@Y;^.N MI^"=#26^O?V0=.U.:QA7']HWT.I0Q0E\?>?8B1@]=O%:'_!LIXI\,?'[_@D9 M:^-/&EY;^(/%?C+QWXLNOB]/>JLDNH:Q-O"WPS^./Q]\,>&_$OC;5[33/"?AN_U-?[0U6YN9Q;PB&V7 M,K(TS!#)M\M2?F85\=?\&JA7_AQ_\*54]-5\2 ^W_$]OJSO^#C3PIX9\7VW[ M&VB>*=!M-0M+_P#;;\$V-[;7<"R)/;3"[66%@1\R. RG@CK0!]9?!'_ (*6 M?L&_M)?'+5OV;/@3^U)X4\4>-M%MI+B]T+2KUG9XHVV2202%1%=*C'#&%W"] M\5QGA*X_X)P^,/\ @JEKGQ'\#_';3M8_:%T;X33Z)XC\.:5XODN8]+T&WU&% MY3:O!O^"CFAZ-X6_X+J_\ !.O4_#>E6]A/.GQ) MTV62TA6/=9Q:%;>5!\H'[M/.EVKT&\X'-2Z)96EO_P '6>LR06T:-+O&%W^VIX#FTOP-J%M8 M>)=0T[5Q=Q07=PDSQ6T30!Q=3%;>=C%!YCJ(G+!=IKU;X&_M&_ O]I7X.:;^ MT%\"?BEI'B;P7JUM)/8^(M.N0;=DC9EDW%L&-D9&5U<*R%2& (-?!O\ P21\ M#>##_P %?O\ @H'XO;PKI[:K9?$/PY!9ZBUHAFMXKC3II)TCOA#]J3]@?]F;]N?\ 9;\%?&/XV_\ !1;XK:O\-O".H:=X^\%>(_#Z^%;, M6TL$+?99[>6RT%93E9MJPIRSE%"EPH'WD0&!5AD'J#0!\[:I_P %;/\ @FMI M7A3Q5XY?]LWP/=:1X+U2'3?$.HZ7JGVR**\ECDE2VB, ?[5+Y<,KE(/,95B< ML %.(_%W_!73_@FMX&^ _A[]IGQ'^V)X0C\%>*Q,?#VKVUS)46 ?:2,_-'_!'+P;X2B_X*??M_^)X_#5C_ &E#\8].@AO_ +*A MFBBFLY)9D5\957D"LP!PQ52 M.= E4:?'\^E1+;>78GCFW7SIB(ON RN0/F.0#]$/#/QO^#OC'X/VO[07AGXH M:#=^!KS1/[8M_%R:I$-.-AY?F&Y,Y8(L80$EF("@'.,&O/\ P'_P4/\ V-?B M/\2=%^$7AOXVVL7B#Q/;/<>$K+6=*O=-3Q'"@#-)ILUY#%%J*A2&S;-*-OS= M.:_$/0/BKXH\#_\ !J/^R]'J=Q._@?5?VBK?3/BDS$M'_P (TOB76+F6*;_I MBT\%LI!X.0N,-7Z&?\'1'@^PU;_@DKJ_Q;\)N\/C/X?>.?"^N?#35-+XO+75 M7U:UM$:U9/FWF*YE("]=H/84 ?7/CK_@H#^Q)\,_C#+^S_X]_:E\$Z7XRM=) MN]4U'P_ M-?\ @X;_ &09/B[X/TN]U9?@1XANM2M[BT26*._@5I5=0003%.S.A_A;#+@@ M&NC^ MC9Z+_P<[_':+2;9+==7_9GT"]U-85VBYN$OH84E?'WG$:A 3S@8H [ MW]@G_@JE^SM_P5-O?BQ\*;35=8TRUM?B7J7AKP?IT":GI&I7VDV>FV$DMV]Q M!Y,W$BHLDI3<55IW 3_\ !N/\>+ZZ\'::]QX@L?B2FMW#62&2]6);U8A( MV,N$'W0?NY)&"30!^JOCC]HKX)?#KX9:=\8_%/Q'T]?#>LFT70=2L6:\_M=[ MH VL=E';AY+R28,#''"KLX.5!%9WP1_:Q^ ?[1/B;Q)X(^$WC>6]UWP-^ O\ @HU^Q9\2?B[I/P)\+_'6R'BK MQ#9/>>%],U73;S3QX@MT&YIM.ENH8XM13;EMUL\@*@L"1S7SW_P<>_$?6OA? M_P $R[_Q$FHW]EX;D^(WA2W^(%[ID"22PZ"VKVYNL+(CHP".2^D MEA6S\F6PT-);A+AW@18HV)E9HPN6VT >R^(?^"H7_!/+PMK_ (Q\,:U^V'X# M2]^']@EWXSC@UV.9=)5YO(2*5X]RB=I2$%N"9BQ "9(KL_V7?VN/V;?VU/A> MOQG_ &6?B]I/C3PT;Z6RDU+2G<>1,-L) M7."0?!/!OQ$^(G[.W@'_ (*Z^,?@ 9M-U?0/&%SJ6C-I@*-I]S/IDS7%]&%^ M[(@+3[O[T8)Z4 ?37_!:W]LO]C_QK_P3D^.G@2R^/>J0ZKH_A;6+32M;\,W> MKV>F#Q%;VLIBTR35;,)92W'F@1FQEG8M)A&B+X%>V?\ !//XJ_#KX,_\$B/V M=?B#\5?&=AH6CVOP&\%1RW^HSA%:631[*.*)!UDED=E1(U!=W954%B ?F?5= M'^$'B#_@TUGM/ .GZ==Z$/V0FNBD2*Z?VG%I'G7,C=O/6_25W/43*QZBO(O% M'Q6E\$^%/^"1/A+QI\8M5\!^!=>^&*+=>*=-CL'6TU__ (0_3;;22XU"VN+8 M,S7ES$C/$Q4SLRE"NX 'Z=_ 7]M_]EK]ICQOK_PO^#OQ8@OO%?A6..3Q%X2U M/3;O2]6T^)\;)9+&^BAN%B.Y<2;-F6 SDBN9_:=_:Y_8NTS3/%OP*^,GQKO= M/6PT^-/&UUX8EU:/_A&8I@&C?4-2TQ<:.&7#!KB: -&%O!6A:J=$M[+Q! MA?W9L[F#3-)MW ME5,RS*[2*%D2$%B2B-YK_P &SOB?PM\?/^"/MGXQ\97L'B'Q5XR\:^+;GXO7 M%Z%DEU'6+G4[@R&Z!ZN]D]GD-_ 4'3% &C_P:UZGJ6M?\$2OA5K&LZA/=W=U MJWB:6ZNKJ5I))I&\0:@6=F8DLQ)))/))J3_@X"_:ZU_]E?X??!+3?$_C;Q-X M.^$OCGXQ66C?&CQMX0GG@O[#1!$\IMDN+?\ ?6RSE#YDD)$WEPR+&SA6ZDA(8Y$HC5YD91N4P,P*E5- 'S3X\_8)^$WC'PI\*?VC/ M^"9WQQ\4:;I%K\4O"&LZSI_@SXFW^H>'O&>@1:Y9O>K<0R74L#M'")9_.0"1 MO):-RRN0/KGXR?M!?"#X Z?8WWQ5\8II\FJW#P:/IMM9SWM_J4J(7>.UL[9) M+BY94!=A%&Q506. ,U^-'[;/["_QT_X-M+Z#_@H;_P $Q/CUX@N?@Q)XPL;? MXD_ 'Q1?O=VDD-U,L*FU=B3(2Q6)7(^TQ%E/FRH74?4?C?Q_K'BS_@XKU+X& M^+_VBO%'PUO+W]FC3W^%C:/:Z0S:DC:G/-J4$8U2QNT\UVB1F$01V33_ )BP MB !]@^!/^"AW[#WQ'^#6M?M!^&OVHO!T?@[PUJ$EAXFUO5]733DT:[0X:VO M$N_+>UF'_/.54GC/]N'P1IO_">6$=]X7-U> M2*+BTDD:..XD.S%K"S*P62?RT8*2"0":\=^(/_!/G]G;]E9?VN/C#HG[0/CK MQ?\ $7XQ_ S5=2\>Z%XGDTO["\%O87%O!>_9M.TZUC@D<^'OB#\-= ^S:Q\"=4US5-8GL8S/'J5O;7$D.H-, MPW>; 88MC$_(D*H,(H6@#ZA_X*8_\%9?@[_P3_U/X3^ [W4/MOB+XI?$CPYI M-L8K":XM;#1;G4H4OM0EDB4J,6BW(A129)),%498Y"/=-4_:W_9WT7X3Z1\; M=3^)4$7A[Q!<_9O#\QLK@W6JW&9!]GM;01FYN)CY4I$4<;.5C9@I )K\?=7N M_B/>?\$K/^"3-U\5I+IM5/[5'P\$3WA.\V GO!8G)YQ]C%OM_P!G%?5?[8/Q M&U'_ (B#?@O\%_&OQ]U_X>:-K7[.^M1_#C5]'@TN0W'B6?5XC=6R?VI9W4"R M265G&H*HLI^6-6Q*R. ?7WPJ_;^_8R^,_@OQ9\0? O[17AL:7X"NC;^.I=;N MFTJ7PY)DC%_#?+#+9Y(8 S*@;:<$X-<)XJ_X++_\$O?!7PNT?XT>(OVT/"$7 MACQ!>W-KHVJPRS3K=M;W!MII42*-G\A9E,?V@KY1;&'.1G'^"7_!/;X!_L__ M /!1WQ%^UG??M+_$/Q7\6?B?\.I;#6]%\2/I"6&HZ78S:?']L>VT[3+91+"? MLL2R,W*S.N&R2OQK_P $3?AOX F_X-GOB'%+X,TQAK?AOXAQ:P39)F]2*348 MXUE.,N$4 +G[O;% 'WS\9/\ @J]_P3B_9_UWPUX=^+O[8O@G2+GQ=9V=YH+' M4_/AFM;M=UK"9?FCEE9$=06#$ D?*_\ P6^T71-!_;;_ &&/BBWB MK5;59_VB;*UU*.7Q+=#3#:I&)A(UJTOV9&4IN\X('QG+$5X[H_@'P1%_P9Q7 MOE>$M.0W_P #FU.^9;- ;F]CN5,=Q(<9>1?*BVN^(FCVNN6&M?$7PBFL6.JP+/#?))HL'F),C@K(K9.Y6!# D$$&@#[^ M_9I_X*C?\$^/VQ/B?JWP7_9D_:S\(>,?%&BQR27FC:5?-YLD2-M>6 NJK=1J M<9DA+J,@DX(STWQ\_;;_ &8/V9+JYT_XR?$X6%U8:7_:>J6>FZ->ZG/IM@2P M%Y=16,,SVMN2C@33!(R8W 8E3CX>_P""S'P*\*^'_P#@H=^P?\;O@9X2L],^ M)LOQ^M=#NKO1+58;F^\+"'S=327RP#)##;))][(1)Y ,!SEG_!++6/%'[1/[ M4/[:'@76?VO_ !OX,\?:'^TWK@U7PMHVG^'9FG\/+'!9Z1Z=3PT<2LZD$$ @UI?"#]NG]D/X_?''Q=^S7\&/C_X>\2>. M? D0D\6>'=+N3)-IR[Q&VYL;&*2$(X1F,;D*X5B!7Y;?\%6/V'?V9_V /^#< MG]HO]F3]FOXH^*O%^D^'OB9HUW?/XQN[6XFT74KG5M"EFL[=K:UMHDB$3 M;-,%\QXDR2J,Q ))ZDT 9W[2WP3\3_M"> HOA9I7Q@\0>"M(U"^7_A*=1\(W M9M-6NK$(^;2UNU^:R,DGE;YD_>")9$0HSB1/AK]CW]DSXM?L1?\ !:+5_@E^ MS%\:/'_B+X"ZE\&5UWX@>&O''BNZUJV\-Z[+>O#9+;3W+,\<\\<+R>66+F-9 M6/OV)=0 M_P""=?\ P6]^ GQ=_8P^(WC(:+^T3JOB#3?C+X%\0>+;W5X+];+33=+J9DO) M99B8R02\CML98D0A96C(!Z9=_%S4/^"@W_!9[X@_L1>(]=U-/A%^SS\/M/O/ M$GAS2M4GM(O$OB?4_*EA-Z\#HT]K;VK,%MB=AG#.X;8@78_X)[_M#^,?AA_P M4I_:"_X)0^-/%>IZYHG@;3],\:_"._UO49;R]M=!OXH?M6F23S,TLL5K=3HD M#2,[B.386PB >>?\$]?"6H?!7_@X?_;7\"^+(6BN/B%X2\)>,?"TDHP;W38X MFMYY$SU5+F8PDCC='1^RIX3U?XA?\'0'[3GQLT2%Y=#\!? SP_X-U2[0?NO[ M1OO[.U!(@W0LL=K)D#[O0XH _2^O'OVQ?@1\5_VFO">D_!3P5\:=?^'OAK5+ M]Y?'GB7P;J M-;EL(XSLT^RN-K&T:>5D,EPHW+%#(B[6E#K[ CI(N^-PP/0J M)[71M"T:T:YU+4KU]L<,8^F2S$D*JJ"S,0J@D M@$ _+:P_9S^+W_!(C_@K_P#LZ_"?]E[]I+XC^,/A1^T0/$.F^,/AO\0?%,VL MC39]-L4N6U*UDE^:/ DC9FQNQ$ZLS+(JQ^OW?Q^(/[$7B/7=3 M3X1?L\_#[3[SQ)XO Z-/:V]JS!;8G89PSN&V(%]P^ M"WPGO/&WQXOO^"CW[3NFCPYJ"^'3H'PP\,:_(D+>#] FE22:>YW';'J5_(L+ M3#/[F*."V!++,TGS)_P3U\):A\%?^#A_]M?P+XLA:*X^(7A+PEXQ\+22C!O= M-CB:WGD3/54N9C"2.-T= '6_L9_M'_&+X2_MX?M.?\$K--UN;Q1+X"\,VGCC MX#2>+=7FN)8].OK6,OI-SKO:J9[FS&EHHM[>U M=!(D-L@V(-B.)5W!NV_94\)ZO\0O^#H#]ISXV:)"\NA^ O@9X?\ !NJ7:#]U M_:-]_9VH)$&Z%ECM9,@?=Z'%?1G[17ABQ_X*/^)+C]E'2G\_X/>'M?A/QCUN M(_NO$=U:3+*OABU17P9\&OC?^U+ M\4?^#AKP!KOQ>US6=!\)>+_V;=8U[P5\,KEI(!HNFG4Q#;27L.<'4)TA%Q*& M&Z#SDM^?(+-[[_P4XU+]M/QAKWPRT']D#]B[2_CO\-M*UN[U#XA>';;XKZ9X M-;"QGDN4D$MO#=)+-+;JGS36D*2,J+)%+\.>*?VJ_P#@IYJW_!P- M\-OB'XI_X).6FD>/HOV>KW3;;X=#X_:5<+/HSZM(TNK?V@ML(E,;ED^RE=[[ M=P8 T ?MQ7AGQ4_X*5?L1_!;6/$&D?$7XZ6UHGA&_AL?&.K6FC7]YIGAVZEV M^7!J-_;026MA*=Z'9<2QL ZD@ BO7/Q#U?Q1XE\6376KZKXUU_[$[:E-8V[3(FF6IDBC2*:5YG8(2+:+Y9 M& /TG^-O[<7[('[.-KX;NOC;^T=X1\/GQC<6T/A*VNM8C>XUIKAU2%K2&,M) M<(S.GSHK* P)('-8/PU_X*6_L%_&+]H^]_9&^%W[4OA37/B+8QSM+X:T^]+O M)Y&?/2&7;Y4[Q[7WI&[,GEON V-C\T/^"@FCZ5XK_P"#>S]@ZT\1V$5['-XF M^#T-I M8M;UZWGET?PWHFE7FJ:M>P1 >=/#96$4MR\4>Y=\JQ[$W+N89%?G_P#\$(O% M?PV\9_\ !1;]O#7/@U\1K_Q3X3E\7^#6T'5M1\07>IRF)K#4))(C/>2//E)G ME0QR-NC960A2I Z'_@EU\4YOBE_P6M_;O7XL78/C+PSJ7A;0_"EG>G][9^&( M8;LHMLK-CRRU-_P2.T?1]!_P""O'_!133]$T^&UB?Q_P"# M+F2*! H,LVF7LLLA _B>1W$-:U MZXM[*?Q?;(CW.BV#RK]KN;99 RFZ\@2)"6!5)9(Y&#*A4_EU^WG^Q=\4O^". M_P 1_@K^V=^PQ^US\8]>O?$GQGT/P9X_^'_Q%\>7&NVOC"#4I77<5F_Y>249 M"K/]NKX\^%/VN/'5L8?A/\ "^XGU'X0Z;?IL7Q#JSPO"WBB9'QMMXH' MEBL0P!83377W7MR #RW]O/\ :%\7_&C_ (*H? S_ (),>$_%VK:'X9U_PQJ/ MC_XPW6@:E+9WNI:/;">*QTM;F!ED@AGNX&^T;&5WB"H&"NP:OX3^+VI?L)?\ M%HO"_P"P%H6M:C-\*?CQ\,;O7/!>@:GJ+/%+PC M/V6SNTN].@9B.@>Y,:<]=QH ZC]H_P#X(M>/?VN/#'B#XY?&#]O3XR>&?C+J M$5Q?^%KOP?X_FL- \%2Y+VEC:V<(57@A C268D33LLDN^,N O0_\$@OCE^U? M_P %"/\ @B[\//B3\4?B;=^&_B#XHTZ[TR^\=VMA&;R6TMM4FM&U"%'7RUNY M+6%MDK*T8F(F,;K^[/L/[6GB;Q7^T3,_V$/B5^PW_ ,%4 MOVF:@["36; M_P"0>1%M4@',D2Y8A=TL:YW.H/YV_P#!83]AFZ_9=_:*^$G_ 5*_8L^)'C? M2OBU=?&/PWX3\1:'>^--0U*T\6Z9J-YY+6!ANYI2B@L,0Q%85C\QA&K(KK^F M?C7X0?"7XE:[X?\ %'Q%^%_AW7]3\)ZE_:'A;4=:T6"ZGT:\V[?M%K)*C-;R MXXWQE6QWH Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H=1M9[W3Y[*V MU&:SDFA9([NW5#) Q! =1(K(6!Y&Y67(Y!'%344 ?,OP$_X)6_ W]F_]J7Q? M^V/\-_BI\1_^$Z^(4\Z_>ZK+;0+')J.H MB+S[@@??D\I$3<>^U5'M7DG[;O[!?P#_ &_O 6@>!?CFFOVK^$_%=IXE\*>( M/"FO2Z9J>C:I;AA%?$'XBV.N?!G[4_PXN+3Q4)?[,GN@OVVYD:YBE>^GN67?-+=-,TK,VXX M)%;FK?\ !.7X2:W^VYIG_!0;4?B7X[?XCZ/H1T'3[E=7MULH]',SS-IQM1;^ M6T+/(Y+$&7+;A(&56'T#10!\2_M$?\$!/V!OVA?VFM1_:T27X@^ O%OB%MWC M%_AAXYN-$@\2$D;S=I""V9,#>8FB+G+,2Y+'Z]^&'PR\ ?!?X=Z+\)OA7X4M M-#\.>'=-BL-%TBPCVQ6MO&H5$7.2>!R222$_MC?\ !.S]GG]N M#Q9\/OB'\6;OQ;I'B;X8:I=7O@WQ1X&\6W6BZC8_:HTCNH5N+9E<1S)'&K[2 MK87"LN6SBS?\$OO@*/VLO"_[9^D^./'&G>,O!7A=/#/A5;+6H18:?HB[O^)> MML\#))$=[9:3=*20?,W*I'TA10!\Z>$O^":OPM\"_M7>,?VV/"WQD^(MM\1? M'FBQZ3XEU@ZO9R0W%G$B+!$MJ]H8(O*\M"C(@;*G);>^[0_8;_X)V?!;_@GQ MIGB7P]\ _&/C2;2?%FOW&NZUI/B775OXI-4GV>=>JSQ"1)'$:A@KA#U*DX(] M[HH ^)_VD/\ @@3^P5^T=^TU??M;&;X@^ ?&.N_\C=<_"_QQ/HD7B+.-WVM8 M@3EP!O:)HRY^9B6)8^Q_'G_@FO\ L6_M'_LA6O["WQ-^"&GR_#73+2WAT+1+ M&1X'TAX%*PW%M,I\R.==S?O-Q9][A]XD<-[K10!\N_L'?\$C/V5_^"?.MS>+ M_AEKOCOQ;K_]F-I>F:_\2?%\NL7.D:(_@=\7?#,6L^%_%FC7&E:]IH:__ ,$M?@'K7[3'@7]K.U\?>/\ M3_%WPST231_ \MIXB22#3K*6-TN(FCGAD^UM-YDC2S7)EE=G+%\A2OTI10!\ M_P#AO_@G-\(_"_[;FI_\%!;'XD^.I?B-K.@KH6J7%QK%NUE/I"RI*EA]E%N( MUB5HT(90LN06\PLS$\+H?_!%;]D3P/\ M!^*OCW\(?%OQ-\!P>/+XWOCSP#X M&^(-UI?AWQ!/^ M":OP0B^ 7[-DGBDZ&DS3R_\ "3>*[K4"\S,S/(D4C"WMBS,2PMXHE<\L">:C M_;._X)Y_!O\ ;LU?P/JGQI\9>,K9/AUXGM?$GA&S\-ZU'916>LV[,8+\D1,\ MDJ;L*'8H!T0%F+>\44 ?.WQN_P"";7PL_:"_:"^'/[47Q&^+_P 0I/&GPFCF M'@'4K'5K.WCTR2XACANYO(2T$4KW C!E$B,IR5550*@GC_X)Q_"*+]N*;_@H M;#\2O':_$F?P^?#[W0UBW^Q?V+YXG&F"U-OY?D!P&SCS=PW&0O\ -7T%10!\ M[? +_@FQ\*_V:?C%\2OCW\*_B_\ $.#Q3\7+E+OQ[J%_JUG=)J%W&DJP7"PR MVAB@>(2OL$2JF,*590%J+]F/_@EO^S'^RQ\-?B%\%_"DOB/Q'X-^*>J:AJ?C MGPOXVU./4[34KV^18[NX;?$'#2HBJRAMAQG;GFOHZB@#X@_98_X-]_\ @G]^ MR'\5K'XE?#5_B'J.G:)K/]K^%_ 7B?QYQ;"O-&WS)).TK( MP#@[U5A]NSQO+"\4<[1,RD+(@&Y"1U&01D>X(]J=10!\[?L\?\$V?A5^R[\4 MOB5\9_A)\7?B%!XB^+E]_:'CN^U'5[2[6^O@L@CNDBEM3'!)'YK[5C58\;59 M&5540_LR?\$R?A%^Q_X$\>?#OX"?%_XCZ5I_Q&UV[USQ&]QKUO=S_P!JW1B% MS?0RSVS-#-*D01BIV@$LJJX5U^CZ* /FCX%_\$F?V/O@5^QIK7_!/JU\/ZOX MH^#^MQS)+X,\8ZD+R*V$TS3R^3*J)-&6F83 [R8Y%5XRC9)=\,/^"7/P6\!6 M7@OPUXS^+7Q*^(GAGX;:C;W_ ,/?"'Q"\2Q7NGZ%GV,P<36PMFMVCE63S'W-*'?D88;$VGA'_@G-\(_!O[;&L?\ !0#3 MOB3XZF^(OB#0TT36;BZUBW:RN=*1T>.Q^RBW$:1JT2$,@63()+DLY;Z HH ^ M:OA=_P $J?V9O@A\;/'_ ,>_@YK_ (Z\-ZU\1-?O-?U.QL/&$[Z7I^LWB,EW MJEII\P>VCO)4>1#,\;LBR,L?EJ<51^"'_!)?]G[]G7]E#Q1^Q3\)/B;\1=-^ M'OBX7JZMI^$/PS^/OPPUWX+_ !D\ M%V/B+PMXETV2PUS1=1CW0W=NXPRG!!!Z$,I#*P#*00"/D[]CG_@@I^PG^Q-\ M3-/^)/PUOOB)KL?A^^DO?!WA;QIXYGU'1?#5TX8?:+.R(6,3 .X667S'4L6# M!L,/M2B@#Y[\$_\ !.'X3_#_ /;%\4_MV>'/BEX]7XA^--)BTKQ'>SZO:R6E MU8Q!!!;"U:V\J-8_+CVLBJ^5)+'>^YG[.W_!-'X#_LV?$[XF_%7PKXJ\7:W> M?&6[:Z^)NG^*]2M[ZQUVQW/PMT_P")]TOA_3)+I65Y[6U93\X+ M;E69I8]ZHQ1BBD>C>/?^"/O["?Q0_8=TW_@GI\0OASJ^M_#G0XX/^$?BUGQ7 M?7NH:1-#%Y4,UI=W$KR6Q1,JL<96$*S((]C,A^GJ* /F;]@__@E#^S#_ ,$^ M]2N_%'PQUWQSXM\1W.F_V9#XI^)7BZ76+ZPTW>K_ &&U+A8[6 NB,R1(I [;Q[?->^._A_X&^(-UI?AS7[EB M2\MQ:0X92Q9LB*2-2'9=NUF!^NZ* /#/V /^">7[//\ P36^!T/[/_[-LGBD MZ%',9I/^$F\5W6HL\S,S/(D4C>1;%V8LPMXHE<\LI/-7_P!K7]A']GW]M>Y\ M(WOQTLM?>X\!ZI-JOA*\\.^*+S2+G3-1= BWD<]G)'*)8U!V?/L^=MRMQCV2 MB@#YLG_X)C_#/QKXS\,^*OVC/CW\4OBY9>"]8BU;PKX6^(6O6WLK2V^VS19)1[LS["=PYYI?^"A?_!*/]C__ (*9Z5X?_P"&B_#6KVFO^$KE MI_"GC;PCJ[:=K&DLS*S+%.H8%2RJVUUW+9FZ=!;JQRRP0J@)]\"@#QK]L?_@G[^SA^W%\%]!^!?Q>T34]- MTKPGX@L-<\'WO@[5'TJ]T#4+)62VGLY8<>2R([HH P W !52.+_:P_X(_?L0 M?MH?L\^&_P!G3XX^"]:O;3P==27GA;Q7%XDN3X@TZ\E?S+BZ&H3-)+-+,^9) M3,9!(^'8%E5E^H** /G7]DS_ ()E? ?]B[X=^(?"/P;\;^/9_$'BJWAM]<^) M/BGQ0=6\1SPP[A#$+JZC=(HXP\FR-(U13(S!=YW5E? G_@E#\ OV;/V1_$'[ M#WP=^)7Q#TOX=>(X[R*\TMM?@GG@CO XO$AN9+9IHA,)&W8;*GE"A+%OI^B@ M#Y>A_P""37[/L'["[?\ !..+XC_$(?"=K0V)T3^WK?[1]A,AE-G]K^S>?Y)D M.[&_=CY-VSY*N_$7_@E9^S)\6/V=?A_^SCX^U?QI>6OPFN[.Z^&'BNW\426> MN^&9[2)8K:6VO+98RS1QJ%!E63. 6W$ CZ4HH \;^$?[$OPY^&WQ1MOCOXT\ M=>+?B1X]T[1I-(T?QC\0M1@N;K2K&0J98+2*V@@MK8RE$\V6.%9I@BB21PJ@ M>._ME?\ !#/]A_\ ;2_:$M_VKO$DOCGP)\1A:I:ZGXO^%OBZ31;S5H$4(D=R MR*PCTFU6V@U/Q#<1S7DL:C""62.-!(0N%WD;FQEBS$L=^B@#QO]LC]B M?P+^VGX=\.Z-XM^*_P 2/!=YX5UU=6T37OAGXUGT:]AN A0AFCW)*A!Z.C8Y MP1ELW_@G^R#\-O@SXM;XGW?B3Q1XU\:OI/\ 97_";>/=<;4=1BL=ZNUM!\J0 MVL;NB/(L$$+:YM/ M#WCSP?>10:C;V=QM\^SD$\4T%U;N51C#/%(BNBNH5QNH^%7[)'P,_9W^#GBK MX=>"-)U=;?Q7-J&I^-=>>_N+O6M=OKJ,K"9?%MIX%UCQ[+JO@#P]XWU076I:=IYLK2&2 M2?:JK ]S=0W-T( %,:3H'5)3*B^@?MX?\$[?@E_P43\)Z#X%^/?C#QU9:/X> MU4:G::?X.\6S:4D]XI4Q3S>4,R/$5)C)/R,S,.<$>\T4 ?#_ ,)O^#?S]A3X M2?%CPO\ &&U\5?%KQ#?^$-?MM:T?3_%_Q0OM2L!>V[B2"5[>5BCF.15=<]&4 M'M7T3\>/V/?AG\=?B%X;^-1US7O"7Q \(6US:>'O'G@^\B@U&WL[C;Y]G()X MIH+JW*1%=%=0KC=7J]% 'D/PZ_8G^#GPC^"GBKX+?#._\ $>BGQQ=7 MM]XM\8V>O2_\)!JFHW:[;C4)+]LR?:6 61<")518A&J(%^5-)_X-H_^"?.@ MZ8FB:'\2?CK964881VEI\9=2CB7<2S812 ,DDGCDDU^A-% '%?LY?L_?#/\ M96^!OAC]GCX.Z5-9^&O">EI8Z7%LZ';CQO(]T^HVD?E6ES+]V1M'.F !G8&VA5W;40+J_LJ_\ !++]EG]CKX^>.?VE?A#< M^.9/%?Q#FMY/$USKOQ U&]ANC#!Y2&6%Y=ET_P TDGG7(FF#S2,L@W$5]'44 M >5_ME_LA?#;]N;X$:E^SC\8?$GBG3_#&LRH=:A\)Z\^G37\*ALVTLJ LT#$ M@O'P'V '*Y!^49?^#:__ ()[WT(T_P 0>//C=JVGL5%SI.K?&+4I[2ZC!!,4 ML3-AXV P5/4'%?H%10!YK^T5^R?\'_VF_#F@Z-X]TZ\L;_PAK<&L^"O$?A^[ M^QZCX>U"%2J7%I,H(0[&9&C96BD1F21'4E:J? O]C_X8? ?Q-XJ^)>EZOKGB M#QUXW6!/%?Q!\47L=QJU_' A2WA!2-(+>"(,VR""*.$,S-L+,S'U6B@#X$U' M_@W&_85U7Q%J_BV]^+GQZ.I:_JLVIZU>1_&;44>]O)3F2>3:1N=L#+'G@#L* M]9\/_P#!(K]E;P=^Q9JW[#'@CQ!\0M$\-:WX@.N:AXDTGQW=P^()=2,L4@N6 MOP=[N/)B3#AEV1H"#M!KZBHH \.^#7[!'PT^%NN^'_%_C?XI?$3XHZYX15_^ M$4UCXJ>+7U632'>-HGGAC5(X?M!C9X_M31M/L=T$@61PUK]IW]A+X(_M:_%C MX1_&7XJ7WB2+5_@KXO/B3P>FB:Z]I!)>$(,74:@B>/\ =I\O!QN7.R216]GH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKE M?B_\-?C9\3-%\+:7-=I:6UWK6H) +FY?.RWB#',TK8.V- SM@X M!KC/V6?V[OV4/VR] LM6_9_^-.B:Q?W6AVNK7/ADW\<>KZ?;7$221M%Y/$NLV^D^'8-:U6*"75 M+Z>5(HK:WC8AIY&=U&U 2,Y. ":[&@ HK$^)'Q+^'?P=\#:G\3OBSXYTCPUX M20.IKSG]E[_@H)^Q-^VI=:EIW[*G M[3W@[QU>:.@DU/3]!UA)+FVC)"B5H3B01DD 2;=I/&PT5P_QF_:4^!/[ M/:Z:@8U#2^1;1!II@BD,Y1"$!!; -:?PB^,OP MG^/O@&R^*7P2^(VC>*_#NHAOL6LZ#J$=S;R%6*NF]"0'5@59#AE8$$ @B@#I M:*^=]6_X*Y?\$L]"U6YT/6O^"BOP5M;RSN'@N[6?XEZ8KPRHQ5D8&;((((([ M$5['\(?C-\)/V@/A_8_%CX&?$O0O&'AC4VE&G>(?#>J17ME=&*5HI!'-$S(^ MV1'0X/#*0>0: .EHKA_V@_VEOV?_ -E#X=3?%O\ :4^,/A_P1X;AG2 ZOXCU M)+:)YF!*Q)N.9)"%8A$!8A20.#4/[.7[4W[.7[7GP_\ ^%I_LQ_&GP[XY\/B MZ:VEU/P[J27"03J 6AE"G=%( RML^N+0&41,R*S& OM5F W8R<9KNOC2 WP< M\6JPR#X9O\@_]>\E?'/_ ;._P#*#SX#_P#8,UK_ -/NHT ?=E?-_P#P5%_X M*;_ O_@E3^S3-^T1\:;"^U>2:_BL= \+:.Z"]U6X=U#!"_RI'&IWO(WRK\J\ MO(BM[S\0/'W@SX5>!=8^)GQ%\1VNCZ!H&FS:AK.JWLFV*TMH4+R2N>P55)]> M*_(O_@OA\/?&?Q'_ ."-7QR_;D^._ANZTOQ/XL3PU8>!O"^I1[9O!_A<^(]- MEAM70_ZN^NV5+J\[AQ!;DL+-&8 _4?\ :@_:E^#?['GP$UO]H_X[>(9--\.: M';1O-]GMVGN;J:5UC@M;>)?FFGEE=(T0=6<<@9(\\\%_M]BU^-O@OX!?M+? M+Q!\*=<^)MA(O"7[5WA2^T*ZA.)!*+?4&,8(Y(;8N5[[ M10!]C?'S]MGPY\*/CKX;_9.^&_P_U+Q]\5/%.B7&N6GA'2+R"V33='@D$4FI MW]S.P6UMC*RPH0'DEE;:B-AV74_93_;"^'W[5=MXKT31]$U+PYXP^'WB)]!^ M(/@?7O*^WZ%?A1(@8Q.\*;18$D&K:3/"L+,PY3#G.1WKFM-_;'\8I MXUT+P;XV_9B\3^'#XAO_ +)876J7UL%>3:6(50V6.!T% 'NM%8__ DNK_\ M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7 MO_?2T ;%%8__ DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__ DNK_\ 0H7O_?2U&OB^^>Y:S7PM M=&5%#-&)%R >AQF@#_P#?2T ;%%8_ M_"2ZO_T*%[_WTM'_ DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2 MZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_ DNK_\ 0H7O_?2T ;%%8_\ MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_ DN MK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ?G?\ M\%H/&7QX_8S_ &UOV?\ _@J=;?!W6/B/\'OA5I>O:1\1M#T"(37OAM=1C2,Z MU#$3@D1C8TAPH6+8SQB;>/6/^"3EA^S!^TS^S!^SA^UU\(?&VB:]K_P_^!-M MX$U*^TAD>:W>2TTLW>GW1XDC>&>Q4B-QQYC,HQ)EO7_%/[(_!BZ]X8BU74X8O[:074MO<6T2/@/)'MB?8&9G65B% C8G\M_\ M@EW\#_#G[/'_ 4<_9JUK]@:SOK32_'7[+UGJ_[5?@_1+WS=+MISH\!TO4)H MP2EM>7-ZY(3Y7*QS.J@2RE@#Z+_X.+_AG\.E3]DWXLQ^!=(3Q1_PVCX#T]O$ M::;$+YK1A?.;> M%[/XW^'K?Q#X?\+ZPVL1>%-4MDFT^_U!8VCMYKF)P5G6$22ND;@IYK1R8W1( M1\'_ +5O[&?PR\)?\%Z/V2OB!^QU\/M*\(>+%T/Q7J?Q@;PGI\=G!/X9@M8; M>WEO8H55&,ES<-;1N1N=BH)Q I3Z!^/?_!9W]BGX%?L?>'_VU;SXC:=J7A+Q MPBI\/9$U%+9O$-RS%!%&)@K0A'!$SR*!;A7,@!7:?#_V3/\ @K'_ ,$T-&\? MS>(S^U-X?^)WQX^,&N:=INH0^#(IKF6XE:3R;#1M.C9!Y&GVOG/M:1D!9Y[F M9E>5R "S^Q5\7KKQ=_P<3?M?_#_XQW('B'0/A]X.L_A9:79^:W\.+;_:+_[- MGK')>75M+)M_C(!^X .=_8\NKOP;_P %\?VT/V(_AWXBO]&\%>-OA[I/C>[@ MT698SH?B"XM+.WNKNVRK+%<3B[^T,Q4[GC0D$*!7O'_!0_X4_P#!.+4O[*_; M(_;+^%-S;^(O!L367A?Q5X9\4:AI'B&YD8L$TRSDTFY@NKV21W98[0%]S2L MOS-GS+_@B9^PEX__ &?$$=[:>"8W5I/"?AZ#<+& MPG@#8_;X_8/_ ."7'[#W[ 'CKXH^!_\ @FM\$;_6 MO#WA;^SO!4.I?"[2K^[OM:NF2RTR)Y[F!Y;AY+R>W4O(S.VXDDFOJ+]A3]F' M0OV+OV.?AK^ROX?$31>!_"%EIEU/",+=7:QAKJX^LMPTLI]Y#7@_[:^N:G^T M9^WA^SS^QW!X9NI=,\-:M=?%WQY:JRY-KI&+;2(W[;9-5NXI@#U_LYL=":]L M_:N_;H^ 7[#OPK'QM_:K\2GP?X6;5K?3%U:]MY9E-U.2(HPD".YSM8D[<*JL MS$*I( -WXW>!?V9M-U&+]I/]HVU\.)!X,TF>.TUWQC-%]AT.&9T\Z9///E0R M2;8D:7ARJJ@."0WPU_P0GM/V-?B5^UC^UU^UU^Q!\5?#4O@KQ]XXT>TTSX?> M' ;?^RUL+.2.;5)K0JAA6_NY+R:'"@&-&1$-*U?QI)JJW#F)XOW4\\- MG;1?:&CR4DG4.1(\@H _1^BL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK' M_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)= M7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A) M=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0 MO?\ OI: -BBL?_A)=7_Z%"]_[Z6HU\7WSW+6:^%KHRHH9HQ(N0#T.,T ;E%8 M_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_" M2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/ M_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM> M6^._VMO$WACXFWGPM\*?L\>(?$M_86$-W=C2[VW#11R9VED8[@..O0T >U45 MY!X%_:/^+'BSQ=8>'-;_ &2?&&AVEW.(Y]6O[B PVJX/SN%.+/'UCJE[9>(+SP[)9:/%#86L\\OESW M&QKIB8=@,*/'\X)DZ _2-?G;^VZ!_P 1$W[$+8Y/@;XB9/\ W"C0!]H?M3?M M0?!S]C;X%:]^T3\=_$3Z=XW::XNYY'6*"UMXE^::>65TC1!U9QD@ M9(\Z\%_M]BU^-O@OX!?M+? +Q!\*=<^)MAH%/_ .#HCQ%J'PY_9G_9^^,_A61H/$7A+]J[ MPI?:%=0G$@E%OJ#&,$.:":)EEAN(V9)8 MVR"&#HOQ%_P3DUO5?B9_P<2_MS>-/%4K/<>$_#OA#PWH44AS]FL&M?,9$ST5 MY(!*1T+2$T_]G/Q%J'A;_@ZH_:#^'VA2-'I?BS]FW1-=U^&,X66_LI]-M+>1 MQT++!<2*"><,?>@#]-**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH X?]I/Q'+X9^!?BF[M/"^MZ MU=7&A7=M8Z5X>TB:]NKJ>2!UCC5(E.,M@;VVHN?F8#FOEW_@WN^'_P 5/@3_ M ,$L?AM^S3\=_A'XG\&>-/ ]OJ,&NZ1XBT:2!?W^JWMQ"\,V#%.#%(A.QB4) MPP7(S]M44 ?%_@/]HZ'_ (*0?%[XZ?\ !,_]MG_@G]XH\%^%].@F&DW/B#6I M?LOCK0HK[[.;V-[=87MU:5(G01R2!E<@291@?D7_ (+#?\&VO[#?AK_@GOXW MUG_@G'^P5+)\8(KC2AX731?$NJW=R4.I6PNMD5U>/$W^BF?.Y3@9(P0#7ZN^ M!?@QX3\"^--?^)<=S?:IXD\2^3%JFNZM.LDYM(&E:VLHPBJD-O#YTNR-%4%I M9)'WR222-UM 'Y]?MK_\$9OA_H?[$'@#X=_\$X_A98>&_%'P&^*FG?$WX:>& MI]9G:'4=3M;CSKFQ>YNY9&C%P"V"S;!*D62J;B+7[6_P?\=_\%;?C7^S]X(/ MP0\:^$/A=\+/B';?$7XE7WC_ ,/OI4MSJ5E Z6&B6T$OSW;-)/-Y\\6;98Q\ MDTC,JU]]T4 ?#?B?]G?QS^Q=_P %;_%'_!0KP;\.]?\ $_PY^-OP^M-#^)EM MX2TB74=1T+7M-,:V.H?8X T]Q:RVJ&!A!'(\ M?^"H_P <_!-YX7U7XK+IGA[X>^$=5*?;])\,Z?;Q1B:[5&8137DT27!@W%H5 M5 ^'+(GVC10 4444 %>%_M8?\EL^!_\ V/Z5X7^UA_P EL^!__8]R M_P#I,U 'NE%%% !1110 4444 %%%% !6/9?\CO>_]>47\S6Q6/9?\CO>_P#7 ME%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_B7_ M )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/_P!?I_\ 036Q0 4444 %%%% !1110 44 M44 %%%% !1110!SGQ+^#_P )/C1H:^&/C%\+?#GBS35?>NG^)M$M[^ -TR(Y MT9<^^*R?V<_V;O@M^RA\(]%^"/P&\ Z=X?T#0].M[.""PLHHGN/)B6(33M&J M^=,RH"\K?,[9).37[>O944 >-_ S]AKX _!_X$>&O@;KGP[\-^*;?P M])?W276K^&+5H_MM_>2WU]+! RLMK')_9R_9Z\(ZU M;^)/"GP'\&:9J-H^^TO].\+VD$T+8(W(Z1AE."1D'O79T4 <'X&^#OPC7Q;/ M\7E^%GAP>+'GEB?Q0-#M_P"T6CP$V&YV>:5V*JXW8PH'05WE8_@?_D$2_P#7 M[-_Z%6Q0!EP^!_!5OXTN/B1;^#]+C\17>FQ:==:\FGQB]FLXI'DCMGG"^8T2 M/+(ZQD[5:1R "Q)C\=?#OX?_ !0T'_A%?B9X%T;Q%I?VF*X_LW7=,BN[?SHG M#QR>7*K+N1P&5L94@$8(K8HH X_XH_L]_ +XX2V5Q\:O@?X/\82:;N_LY_%/ MAFUU VN[!;RS/&VS.!G;C.!73:)H>B^&M(M] \.:/:Z?86<0BM+*RMUBA@0= M%1% 55'H!BK5% !1110 4444 %%%% !5/Q!XAT#PEH5YXH\5:Y9Z9IFG6KW. MH:CJ%RD,%K"BEGEDDEZ5!>:M%;KKTSV=K=J=.>1@+Y3'=Q@&(L2 M0V 5PQ]F\=^/O OPN\(W_C_XE^,])\.Z%IX-;=?-'_!&7_E$Q^S MA_V1?P]_Z015]+T <5EC12YRQ"+D\5M?\%Z_V\?BG M^RWX3\$?LS?LX^);W0_B5^T'XKMO"FB>)-,TV>\N] TW?&-1U&V@MU>::XC2 M>%$6-6DS,60;T4$ ^V(?VG?@'??%:?X&Z'\3].U;Q?9RK'JGA_0B]_@-?,?["/[5_P"P'^SQX\\._P#!++X;?#_Q MM\+?%(T:34?#&D?$OPA/IESXT #-=:C'#]?M]1@M[C8K^4[P.RJ^UE;:3G# ]Q7::KJNF:%IESK>MZE!9V5G M \]W=W4RQQ01(I9Y'=B JJH)))P "37S_P#\$NOBY^P;\>_V0]&^,?\ P3I^ M'/A?PE\/_$%W-<3^'O#'A:UT;[#J8"1W$5U:VJJB72[$5C\VY5C96="C'YT_ MX.&]:UZ\T]M0TO3+:^VR:I9K]ZZL M]X O(!QF6 R( 02V",^K5^:/_!S?XGTSX4?\$Z/!W[9_PFU>SLO%_P )?BEX M=\0?#77=.=>&DD,+P1NGWK>:WD.^,'9(L:Y! %?I/IEXVHZ;;Z@]L\+3P)(8 M9/O1EE!VGW&<4 3T444 %>%^ ?\ E()X_P#^Q$TK_P!&-7NE>%^ ?^4@GC__ M +$32O\ T8U 'NE%%% !7YW?MGZ#\6=;_P""X?[,?[1/A;]GOX@ZQX!^%GAO MQ;I_C?Q9I?A"YFMK*?4;%X+<1J%\RY4.%W-"CJ XP3@@?HC10!\B_P#!8O\ M8A^(G[8GP(\&>._V?[2UG^*?P4^)>D?$/X=65[<+;QZI>:?+O?3GE?B(3QY" MLV%$L<6XJNXCS[]K?X/^._\ @K;\:_V?O!!^"'C7PA\+OA9\0[;XB_$J^\?^ M'WTJ6YU*R@=+#1+:"7Y[MFDGF\^>+-LL8^2:1F5:^^Z* /AOQ/\ L[^.?V+O M^"M_BC_@H5X-^'>O^)_AS\;?A]::'\3+;PEI$NHZCH6O::8UL=0^QP!I[BUE MM4,#"".1XY0'8;&)&G^P%^R3\1[O]NSX\_\ !4?XY^";SPOJOQ673/#WP]\( MZJ4^WZ3X9T^WBC$UVJ,PBFO)HDN#!N+0JJ!\.61/M&B@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HKSO]K#PEXG\:?L[^+M'\'_ !9\1^"M0'A^]EM]>\*RV\=Y"RV\A4*\ M\,H3YL'<@5P5&UEYS\V?\&ZWCSQQ\3_^"-/P6\?_ !*\9:KXAU[5;36I]3UK M7-0DN[N[E.NZ@"\LTK,\C8 &6)/% 'VO165XZN/&%IX(UF[^'FG6=YK\6E7# MZ'::C,8[>>\$3&%)7'*H9-H8CD DU^6/_!2[_@D]\2/V?/V1O'7_ 4*^&O_ M 4H^.P^/?PX\/7'BZ\\7ZAXX==+U62T0W%S9+I:*(+>U=%D2&V3Y$'EH_FK MN# 'ZQT5^;?[=?\ P4?_ &CM!_X)H_LQ6WA"\;P?\:OVL=3\%^%DU&QMP)?# MDVKV]O)J-Y!&X.V2/S?+C#9,;3HW6.K?[>>M:?\ \$<_B;^SO^T-\$M?\0P^ M _%_Q2LOAO\ %_P_K7BF]U.+5K;48)6M]9E-Y+(1>VTEL[M<*1),LC1R,P*[ M0#]&:*_/O4?B[J/_ 4#_P""T'CW]AOQ%KNJ1_"/]GOX>6%_XG\.Z5JL]I'X ME\3ZGY4L'VV2!T:>UM[5VVVQ.PS@NX;8H77_ ."??[0WC#X6_P#!2_\ : _X M)0>,O%>IZYH7@K2],\;_ BOM;U&6\O;/0KZ. 7>F23S,TDL-K=SHD#.SN(Y M-A;"( ?=M%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\ );/@?_V/1T."J$@_A3ZCN_^/27_ *YM_*@#X*_X;5_:9_Z*7_Y1K+_X MS1_PVK^TS_T4O_RC67_QFO+** /4_P#AM7]IG_HI?_E&LO\ XS1_PVK^TS_T M4O\ \HUE_P#&:\LHH ]3_P"&U?VF?^BE_P#E&LO_ (S1_P -J_M,_P#12_\ MRC67_P 9KRRB@#TVQ_;%_:.TV$P67Q%V(SER/[(LSR3DGF&IO^&U?VF?^BE_ M^4:R_P#C->644 >I_P##:O[3/_12_P#RC67_ ,9H_P"&U?VF?^BE_P#E&LO_ M (S7EE% 'J?_ VK^TS_ -%+_P#*-9?_ !FC_AM7]IG_ **7_P"4:R_^,UY9 M10!]I_L/_&CXE_&"W\2O\1?$O]HG3WM!:'['##Y>\3;O]4BYSL7KGI7O-?+O M_!-3_CT\9?\ 72P_E<5]14 %%%% !1110 5Y9^U;^UQ\*OV./#WA3QS\:M8M M=)\.>(_'%EX:O=?O[U8+;2I+N.?R)YG8;1&9HXHF9BJH)MY8!"#ZG537M T+ MQ3H]QX>\3Z+::CI]Y$8[NQO[99H9T/571P58>Q&* /Q9_P""LWP$^&^K_&KQ MQ^V)^R3KZ:;^UC9_M1^%]+^"MWX4U#_3/$]M-X4\+-*/'WP,^!/A;PQJOB[4UO=6NM%T"UM64K: M6UKY,1BC4QPE;5)#&#M,KRR8W2,:[?QM\./AY\2]/BTGXC^ ]%\06L$WG06V MMZ7#=QQR8*[U656 ;!(R.<$T ?/7_!%/5=+UC_@DE^SG<:3J,%S'%\']"@D> MWE#A)8[.-)$)'1E=64CJ""#7=?L??\%!/V//V^=.\3ZI^R/\;]/\91>#=:.E M>)!:6EQ;O9W/S;WLTMT\<;2-*O# M"_\ !UOX:TMO$-D+G_ABJ6S\@W2;_M)\27$PAQG/F>4/,V==GS8QS6=_P6I\ M#ZA\,_V]/V2/^"C&NV+R> ?@[\0I]-^)%_L+1Z'8:RD%M%JD^/\ 5V\$L?[R M3^'S(Z^_I/V;?V=9M<;Q/+\ _!3:DUV;IM1;PM:&.:-LAD96!#*02"#P0: /@S_@JW\) M[7]JK_@H?^Q#X=^"EY;ZCXN\#_$^3QUK>H:9*LO]E>$;=;>6YFG="?+ANI8K M>WB+8$SL0N=K8^GHO^"F_P#P3Y_X6-XU^$6J_M@^ M(\2_#N]:U\8Z-XBU^+ M3)M/D50S'%V8_-0 @&2+>@)VEL\5Z;\,?@I\&O@EIUSH_P &?A)X8\(VEY,) M;NU\,:#;V$<\@X#NL"*&;D\GGFJNJ?L[?L_:Y\2(_C)K7P+\'7GB^'9Y/BJZ M\,6DFI)L "8N6C,HV@ ##< <4 ?+W_!+3X0>%/V5?A;^T%^TGJ.F2>#/AY\1 M_C+X@^(?A[3-1L7M!IV@_9;>,WSV[*'MUG^RS72QE598)(055@4'N?@+XA?L M=_\ !3S]D1?&/A6?1OB7\(?B'IUS;M_:>E2K:ZC!%.\,JO!=1I)&R30N/F56 M1XPPP0#7K=W:6E_:RV%_;1SP3QM'-#,@9)$(P58'@@@X(-$9/!UB!]B\)R>&[4Z9;X)8;+4Q^4F"S'A1RQ/>@#\J/B%_P3+_92 M_;?_ &HOAA^R#^Q7\-;UOV?/@CXMB\0?%;Q]J7B_5-]M0RVWA'19M1NK M@!/_P#L1-*_]&-7NE>%^ ?^4@GC_P#[ M$32O_1C4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 OCC_@V=_P"4'GP'_P"P;K7_ *?=1K[(^+_PUB^,'P\U/X;W M?C/6]"M=7M9+6^O?#T\,5TT$B,DD:R2Q2>7N5B-R@..JLIYK@?V'_P!B+X6? M\$_O@G9?LZ? GQ/XGF\%Z2TAT+1/$6IQWBZ9YL\L\PAE\I9=KRS.Q5W< _=" MY.0#V)71RRHX)4X8 ]#C.#^!'YU\N_M&>&;+_@H[XCN?V3=(E,WP@T#7H?\ MA=?LK_ /!,'PM\+/VM M/VB_BU\*?%GQ3\+>#_C/9S1^(I]2\2RP7M_K\][<2W5_IRL@ELH;>-_)@G<& M1S-*R'RXX9).>TK_ (-H_P#@GSH.F)HNA_$KXZV5G'N\NTM/C-J4<2[B6;"J M0!DDD\ MP1-)(4.V,0RV31,#C;(RH<$XJY_P*58 BI\+_P!@_P"%O@'X MKZ'\+(6BG^(G@SPGXQ\*R2C!O=-BB- MM/(F>JQW4IA)'&Z.C]ESPGJ_Q#_X.AOVEOC3HD3R:'X ^ ^@>#]5NT'[L:C? MG3]0CBW="PBMI?V/?AE\=_B!X:^-#ZWKWA+Q_X/M[FU\.>//!] MW%!J-M:7 'VBS<3Q307-O(51C#/%(BNBNH5P&K4_9P_9>^$7[+'A74_#7PKT MFZ^T:_K<^M>*=>U>^>[U+7M3GQYU[>7$A+2RMM51T1$5414154 'H=%%% 'E M_P 5O"G[6>K^+GO/@_\ %?POI&BF! EEJVA/<3"0#YV+@C@GH*\2^+OAC]J+ M2?CE\'F^+OQ/\-:O')XT(TY=*T1K47\S0 M ?8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^-;%% &/]B\;_P#0;LO_ &/ M^-'V+QO_ -!NR_\ 8_XUL44 8_V+QO_ -!NR_\ 8_XT?8O&_\ T&[+_P ! MC_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^-;%% &/]B\;_P#0 M;LO_ &/^-'V+QO_ -!NR_\ 8_XUL44 8_V+QO_ -!NR_\ 8_XT?8O&_\ MT&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_ &/^-;%% &/ M]B\;_P#0;LO_ &/^-'V+QO_ -!NR_\ 8_XUL44 8_V+QO_ -!NR_\ 8_X MT?8O&_\ T&[+_P !C_C6Q10!RFN6OBE=1TU;K5+9W:Y(@98" K;>I]:T_L7C M?_H-V7_@,?\ &CQ+_P A?1_^OT_^@FMB@#'^Q>-_^@W9?^ Q_P :/L7C?_H- MV7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_ M^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H- MV7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_ M^@W9?^ Q_P :CNK+QM]EDSK=GCRS_P NQ]/K6Y4=W_QZ2_\ 7-OY4 ?EO111 M0 4444 %%%% !1110 4444 %%%% 'T[_ ,$ZH-N_$'S[*_URUM M[N'^R;1?,C>559-_P#H-V7_ (#'_&C[%XW_ .@W9?\ M@,?\:V** ,?[%XW_ .@W9?\ @,?\:\<^&$=_%^WUX^34[B.6;_A!=*W/&FT' M]X^.*][KPOP#_P I!/'_ /V(FE?^C&H ]THHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BO#(/\ @H)\$XIOBKJGB7P_XJT'PQ\&FOE\<>.]TC669+>? MS"UVP1@<1(Q#?(VU_DKS+_@G[_P6'^''[?NN6%MI'[,'Q9^'NB^*8KJX^&OB MOQ_X41-C?''(R,XCDV@'V!1110 45QWQ[^-OA MG]G?X5:Q\7?%WAWQ'JMAHUG+RK'&TA"0P*Q'RH?F$/'?QY^%WP"\7>,_@]\,=7O-.\:_ M$[1)[3R=UD<:A<:?:/*)]0M;3YO.F0*#Y4OD".ZV"SCLT3F>6X:6)8T7[QD'09(X[P7 M^WV+7XV^"_@%^TM\ O$'PIUSXFV%S<_#IM>U6QO;?59K>-99].EDM)76UU!( MF$GD-N1U#^7+(R,H /H>BO$?CY^VSX<^%'QU\-_LG?#?X?ZEX^^*GBG1+C7+ M3PCI%Y!;)INCP2"*34[^YG8+:VQE984(#R2RMM1&P[+J?LI_MA?#[]JNV\5Z M)H^B:EX<\8?#[Q$^@_$'P/KWE?;]"OPHD0,8G>.:":)EEAN(V9)8VR"&#HH! MZU1110 5X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS4 >Z4 M444 %%%% !1110 4444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^)?^0OH_\ U^G_ M -!-;%8_B7_D+Z/_ -?I_P#036Q0 4444 %%%% !1110 4444 %%%% !4=W_ M ,>DO_7-OY5)4=W_ ,>DO_7-OY4 ?EO1110 4444 %%%% !1110 4444 %%% M% 'U5_P34_X]/&7_ %TL/Y7%?45?+O\ P34_X]/&7_72P_E<5]14 %%%% !1 M110 5\6?\%$/^2XV'_8LP?\ H^XK[3KXL_X*(?\ )<;#_L68/_1]Q0!X-111 M0 4444 %%%% !1110 4444 %==\ O^2X^#_^QFL?_1Z5R-==\ O^2X^#_P#L M9K'_ -'I0!^CU%%% !7A?@'_ )2">/\ _L1-*_\ 1C5[I7A?@'_E()X__P"Q M$TK_ -&-0![I1110 45'>/(_"WB'[7<1Z5::1:Q3* M;>(O]EM[>WMT\N64-$ZR2-+N /V,HK\U?VW_ -M_]M7X$_\ !-#]FGX1^+]8 MD\+_ +1_[1FO^$_ .K:Q:VL:W.@7E^L2ZC?K'C8ER@8)A1MCFN-RC$8K1_;S MUK3_ /@CG\3?V=_VAO@EK_B&'P'XO^*5E\-_B_X?UKQ3>ZG%JUMJ,$K6^LRF M\ED(O;:2V=VN%(DF61HY&8%=H!^C-%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^?/[='_!*/]L3]KW2 M[W]D'1/VI_"?AS]FOQ9\0IO%7CG3K?P]=#Q9<)<:@VI7>DQW(F-M);27LDLR MR,B21[HT(E6+$GM&N?"SXF:'^U_\%?"C:K\.?"GPB\ PZA%X \#Z3=74FLZC M?QZ-<64$VTP+%!;6UC+=Q^4&(!E4F4MY:5\ ?$']DK_@BK^T5^W?^T)JG_!7 M_P#;.\#>)/&UC\1G'@NP\1?M 1:39:)X<:VA$&GQ0PWL/D75O<1WD$]O)AU, M<M75QH M5W;6.E>'M(FO;JZGD@=8XU2)3C+8&]MJ+GYF YKY=_X-[OA_\5/@3_P2Q^&W M[-/QW^$?B?P9XT\#V^HP:[I'B+1I(%_?ZK>W$+PS8,4X,4B$[&)0G#!";J2#6O#/P?\3:KI$\+8>.ZM]*N9HF4CH0Z*?PK MYD_X(N3,^)_\ @EU8?L_^+_&'Q$\-V^O^ M'/@_XMTG2LZ'K^FW\UQ)I^IW6H9^SZ<+876V>"=DE_T8^4LV]"P!^_%G_@FA_P3 ^ GC/4+BX\/ZC^U]]EU 3.2+NVT_7,6T#$_>14O98U7H!$O M'RBOT2_X.B/$6H?#G]F?]G[XS^%9&@\1>$OVKO"E]H5U"<2"46^H,8P1R0VQ M\O[7S9/\ 4QW,LTQC+\*R0!R%#$=E^UO\'_'?_!6WXU_L_>"#\$/&OA#X M7?"SXAVWQ%^)5]X_\/OI4MSJ5E Z6&B6T$OSW;-)/-Y\\6;98Q\DTC,JT <' M_P $Y-;U7XF?\'$O[2 2D="T MA-/_ &<_$6H>%O\ @ZH_:#^'VA2-'I?BS]FW1-=U^&,X66_LI]-M+>1QT++! M<2*"><,?>O4/$_[._CG]B[_@K?XH_P""A7@WX=Z_XG^'/QM^'UIH?Q,MO"6D M2ZCJ.A:]IIC6QU#[' &GN+66U0P,((Y'CE =AL8D:?[ 7[)/Q'N_V[/CS_P5 M'^.?@F\\+ZK\5ETSP]\/?".JE/M^D^&=/MXHQ-=JC,(IKR:)+@P;BT*J@?#E MD0 ^T:*** .#^(/[3WP ^%7B-O"7Q$^*FEZ1J20I*UG=R,'"-RK< \&O$/CE M^TA\#/BG\-FDO%M)&/E(T!12<@<%B!7TOJW@CP7KUX=0 MUSPAI=[<%0IGN]/CD<@=!N92<5X9^TYX-\(:%\;?@FVB>%--LS+XYD$IM;&. M/>!;L0#M SSS0![K_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[ M]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8 M?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\ M8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^S MM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU67:>)=!3Q;=WKZI$ M(GM8U23/!()R*Z#^SM/_ .?&'_OT*R+.RLSXSO8C:1;19QD+Y8P#DT 6_P#A M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ M% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_ M]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ M #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z% M']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_] M^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^, M/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ M #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z MJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 <_KWB70;G4],F@U2)EANBTK _=&W MJ:U/^$Q\,?\ 0:@_[ZJIXCLK--5TE4M(@&O"& C'(VFM?^SM/_Y\8?\ OT* M*?\ PF/AC_H-0?\ ?5'_ F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&' M_OT* *?_ F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ MY\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/ M_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L M[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^ M_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?51W7C#PP;60#6H?]6>_M6A_9VG M_P#/C#_WZ%1W>G:?]EE_T&'_ %;?\LAZ4 ?E[1110 4444 %%%% !1110 44 M44 %%%% 'U#_ ,$Y=9TO2;7Q>-2ODA\R2QV;SUP+C/\ .OIG_A,?#'_0:@_[ MZKYL_P"";5M;W%KXQ\^!'Q)88WJ#CBXKZ?\ [.T__GQA_P"_0H I_P#"8^&/ M^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ M"8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@" MG_PF/AC_ *#4'_?5?&__ 4!U*QU3XUV-QI]RLJ#PY I9#QGSY^/UK[4_L[3 M_P#GQA_[]"OB_P#X*%PPP?&^Q2")4'_"-0'"K@?Z^XH \)HHHH **** "BBB M@ HHHH **** "NK^!,\-M\:_"5Q<2!$C\1V3.QZ "=,FN4KK?@*JO\;_ @C MJ"#XEL@01P?WZ4 ?H;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]5\PZK8?&_P 5?MV^-I_@/\0] M"TF3_A$-,,\^K:6URCPY(" C#!PQSZ$"OJK^SM/_P"?&'_OT*\/^'L4OT44 4_$6N6?ACP_?^)=0CF>WT^SEN9TMX]\C)&A=@JC[ MS8!P.YK\8X/^"?GQ3_X*E?LXZ-_P7Q_9?\=P?#?]J+4K^^\3?#^ST2UMQI;: M79S3VEIHMX/+_P!+N9((/WEY-N+23M"R^0D:1?M17SOX9_X)K_"+X<^'M?\ MAG\&OBI\0O _P]\3W]U>:Q\-O"NNP0:4'NG9[M;1WMWO-,CF=W=H[*YMT5G8 MH$+'(!^(_'W M[5'AR#3[:(9=;>*VOOM%QQT2(21LS=%4DG %?=?C3]DW]G+X@?LU3?L>>*?A M#H\_PSF\/1:(/!\=OY5I#8Q*JPQ1!"#$8]B,CH0Z,BLI#*#7+?"_]@_X6^ ? MBOH?QQ\:>._&?Q%\6>$M'FTKP3K7Q"UJ.]D\.6VT444 %%%% 'C'_!0O]H7Q?\ LG_L;^-_VD/ GAR?6=4\&V=M MJ4&AVR@R:HJ7D'F6:91\--&7A#!2RF3*C*M/72O$.G1W5NE MW;W2Q2YP)H)DGB?CNLL:,.V5&:\M_;Y^&'Q:^,7['?C_ ,!? 2>T3QS-H9N_ M!R:@0+>;5+61+JUAE)( CDFA2-B2 %'KR['B'Q+X)N[;3M+\N!W^U74KV96."/&]V;@*I)XK]4O"%]= M:IX3TO4[Z7S)[G3H)9GV@;G:-23@<#D]J_'?XH_\%=O^"CO_ 4G\!ZM_P $ MQOAO_P $C/B)\-O'_P 1-+E\*_$;QCXP6<:+X3TVZ0V^H7RL]M'O7R'F\HLZ M\LFSSFVJ_P"R>G6%MI>GP:99H5AMH5BB4G.%4 ?D* )J*** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** /R'_P""A/BG_@E5\./VW?B# MX#\$?\$@M;_:X^.7B'4K/7/B+9>&/ L>I6_A>1W=2X6O8/^"7^@?\$W/&GQ\TS7?AY_P3'U_P#95^-WAK2+R]B\+^)O "Z% M<:WI4L8MKE[:9%\K4;5'F@WE=LD4@CRJJQWZ_P 1/V\/!G_!'CQGX_\ "W[1 M_P"R5\3[SPMXP^(&J>+M&^+'P[\(KJ^GZL=1E\]K?4&CD62TO+=B;5%D!62W MMH&1^J+7_9$_;8^+_P#P5J_:_P# OQL^%?[)'C;X<_ SX3#5-27QQ\2].6PU M#Q=JEW82Z?%9V5LK/_HJ)<33R2AW5GBA!V,H# 'Z$T444 %%%% ')>!?@QX3 M\"^--?\ B7')/$ODQ:IKNK3K).;2!I6MK*,(JI#;P^=+LC15!:621]\ MDDDC=;110 4444 %%%% !1110 5X7^UA_P EL^!__8]R_P#I,U>Z5X7^UA_R M6SX'_P#8]R_^DS4 >Z4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/ M9?\ ([WO_7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!-;% !1110 4444 %%% M% !1110 4444 %1W?_'I+_US;^525'=_\>DO_7-OY4 ?EO1110 4444 %%%% M !1110 4444 %%%% 'U5_P $U/\ CT\9?]=+#^5Q7U%7R[_P34_X]/&7_72P M_E<5]14 %%%% !1110 5\6?\%$/^2XV'_8LP?^C[BOM.OBS_ (*(?\EQL/\ ML68/_1]Q0!X-1110 4444 %%%% !1110 4444 %==\ O^2X^#_\ L9K'_P!' MI7(UUWP"_P"2X^#_ /L9K'_T>E 'Z/4444 %>%^ ?^4@GC__ +$32O\ T8U> MZ5X7X!_Y2">/_P#L1-*_]&-0![I1110 4444 %%%% !1110 4444 >%_\%,/ MVP;G]@;]@_XF_M>:=X636[WP5X=-SIFES%A%/>2RQV]N)=N&\H331E\$'8&P M0>:^$_ '[*W_ 6$O_@'X/\ VQ_VH?\ @KQX[T'QSXU\4>%(T\ ^!O#6E1Z) MX>MM9UBPM/L\D4\$D=U)##=DG* ;UVEI0"[_ *!_MZ^*_P!GCP5^Q]X]U[]K M7PY#JWPQ_L3[-X\L[B)Y$_LN>5(+B0K'\Y\M)#)^[_>?)\F&VFOSY^-W_!0? M_@BY\;OV#+[]@G5?^"SMU8:7Y^DIX?\ '%C%<1^(-*M-.O;2[MHA-;OPEXFU_0 M+4V]GJES!#!<)$_ C_ E_ T\NOZU=7=R/$4?B$7#"*&&,'R3:F'822N[<7^9= MJJ_JM?'G[?\ X6_X+.>*/VA_#.D?\$Y/C+\+_"W@BY\&W,WB*X^(7AR6[\C5 M(+I%54DB1V_?0W*E5( 'V.4YRP% '"?%GXT?\'$NI_M)_$7P5^S+^SK^S=-\ M/?#7B867A7Q%X^NM9M;K5+22TM[I)-L%RPD*"X$+R*BJ9890 -M;/[,_C;_@ MNOJ/[6/@K1_V\?A?\%-'^&4L6I->W_P=O-2GF>_%G(;:*[^V2,4M^)&!5<&5 M8@6!*JW#?\*)_P"#HO\ Z/B_9?\ _"(O_P#Y&KL_V7/@_P#\%RO#G[5G@GQ' M^WA^T9\*?&/PVM4U,7>F?#31;BRGAOWLI%MI[GS8$\R #S4P&P))8R5;AD / MNNBBB@ HHHH CO'N8[262RA6298V,4;OM#-C@$]@3WK\=_V/OVG/V<_VEO\ M@F+\6_CO^UE\7_$FG?M0>"9M?B^(:OXJOK+Q'X6\0_:[B/2K32+6*93;Q%_L MMO;V]NGERRAHG621I=W[ >(M)OA_9Z):VXTM MM+LYI[2TT6\'E_Z7ZG%JUMJ M,$K6^LRF\ED(O;:2V=VN%(DF61HY&8%=OSI^W+^T5XI_;2_9D_X)K?\ !5CQ MEX/71=-T[]H+P]/X_MX%;[/ICW-[%!+=C<24MO.L'*%B<":)2Q+9/NO_ (_'W[5'AR#3[:(9=;>*VOOM%QQT2(21LS=%4DG M% '5ZC\7=1_X*!_\%H/'O[#?B+7=4C^$?[/?P\L+_P 3^'=*U6>TC\2^)]3\ MJ6#[;) Z-/:V]J[;;8G89P7<-L4+K_\ !/O]H;QA\+?^"E_[0'_!*#QEXKU/ M7-"\%:7IGC?X17VMZC+>7MGH5]' +O3))YF:26&UNYT2!G9W$$M0^"W_!Q1^VGX(\60M%/\1/!GA/QCX5DE&#>Z;%$;:>1,]5CNI3"2.-T M='[+GA/5_B'_ ,'0W[2WQIT2)Y-#\ ? ?0/!^JW:#]V-1OSI^H1Q;NA816TN M1V[XH _2^BBB@ KPO]K#_DMGP/\ ^Q[E_P#29JZ3XK>%/VL]7\7/>?!_XK^% M](T4P($LM6T)[B82 ?.Q<$<$]!7B7Q=\,?M1:3\-_\ H-V7_@,? M\: -BBL?[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,?\: -BBL?[%XW_P"@W9?^ M Q_QH^Q>-_\ H-V7_@,?\: -BBL?[%XW_P"@W9?^ Q_QH^Q>-_\ H-V7_@,? M\: -BL>R_P"1WO?^O*+^9H^Q>-_^@W9?^ Q_QK,M;7Q2?%-U''JEL+@6T9DD M,!VE-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[ M%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH M V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ M (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E M_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>- M_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: #Q+_R%]'_Z_3_Z":V*Y37+7Q2N MHZ:MUJEL[M,O^NE MA_*XKZBKY0_X)U0:Y-:^+O[&OH80)+'S/.BW9XN,8_6OI?[%XW_Z#=E_X#'_ M !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@ M,?\ &C[%XW_Z#=E_X#'_ !H V*^+/^"B'_)<;#_L68/_ $?<5]=_8O&__0;L MO_ 8_P"-?'?[?D6J1?&BQ75KJ*:7_A'("&B3:-OG3\8_.@#P^BBB@ HHHH * M*** "BBB@ HHHH *Z[X!?\EQ\'_]C-8_^CTKD:ZKX&+-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&@#8KPOP#_ M ,I!/'__ &(FE?\ HQJ]<^Q>-_\ H-V7_@,?\:\<^&$=_%^WUX^34[B.6;_A M!=*W/&FT']X^.* />Z*** "BBB@ HHHH **** "BBB@#EOC5\)_AM\] ='GLU34>&#PSX?:F MVH^+M5U?PC-\,9&FTN+P_9I\27#(K76R$A5F;>QB$*EW*EC].5\J_\$?? M$G_"=?LM:I\2?"OP(UWX8?#[Q/X\U/5?A1X"\26"6=WI.@3+"1FV1F6UCFO! M?7,<*DHD5S&$^3;7U50 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 5\=_M_\ [+O_ 54^/'[1'AG4/V'_P#@HP?@IX$7P;5/[#U"ZDN&E74Y5/S?:%5A&#UPB891O5P#XU_P"':?\ MP7P_Z6&O_-;]$_\ CM=?^S%^PW_P5/\ @Y^UCX$^)_[8'_!4>+XY>#=/.IP_ M\(Q)\.M/\.&QO9;"98;Q?LSDW1"B6/8?F43%@-N\C*^,7_!(;]MGXV?M'?$? MXJ6/_!9/XZ_#WPMK?B@77@OP?X1UMGM].LGM+=I4/F2#8!=M=*D:J%6)8N22 M0+W[-7_!,OXZ_LF?M@?#SXL_%C_@JS\4OC%9DZM86G@GXF:D9(C-+I\K?:[5 M5=@98UC93N7A)GPZGY7 /O>BBB@ HHHH *^=_#/_ 37^$7PY\/:_P##/X-? M%3XA>!_A[XGO[J\UCX;>%==@@TH/=.SW:VCO;O>:9',[N[1V5S;HK.Q0(6.? MHBB@#SOQI^R;^SE\0/V:IOV//%/PAT>?X9S>'HM$'@^.W\JTAL8E588H@A!B M,>Q&1T(=&164AE!KEOA?^P?\+? /Q7T/XX^-/'?C/XB^+/"6CS:5X)UKXA:U M'>R>'+.952=;18HHD$TJ(B274BR74B*%>9E)!]MHH \H^//['OPR^._Q \-? M&A];U[PEX_\ !]O*:"YMY"J,89XI$5T5U"N M U:G[.'[+WPB_98\*ZGX:^%>DW7VC7];GUKQ3KVKWSW>I:]J<^/.O;RXD):6 M5MJJ.B(BJB*B*JCT.B@ HHHH *\+_:P_Y+9\#_\ L>Y?_29J]TKPO]K#_DMG MP/\ ^Q[E_P#29J /=**** "BBB@ HHHH **** "L>R_Y'>]_Z\HOYFMBL>R_ MY'>]_P"O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH Q_$O_ "%]'_Z_3_Z":V*Q_$O_ "%]'_Z_3_Z":V* "BBB@ HHHH **** M"BBB@ HHHH *CN_^/27_ *YM_*I*CN_^/27_ *YM_*@#\MZ*** "BBB@ HHH MH **** "BBB@ HHHH ^JO^":G_'IXR_ZZ6'\KBOJ*OEW_@FI_P >GC+_ *Z6 M'\KBOJ*@ HHHH **** "OBS_ (*(?\EQL/\ L68/_1]Q7VG7Q9_P40_Y+C8? M]BS!_P"C[B@#P:BBB@ HHHH **** "BBB@ HHHH *Z[X!?\ )HHHH *\+\ _\I!/'_P#V(FE?^C&K MW2O"_ /_ "D$\?\ _8B:5_Z,:@#W2BBB@ HHKQ+XT_MT?#?X9?&W3OV6? 'A M+7/B+\5-2T[^T3X&\') TNE:=G;_ &AJ5Q<2QV^GVVX@*TK^9*3B&.5OEH ] MMHKROX[?M7>"/V2/V9M3_:7_ &KS;>&+'1+97U+3](NWU-Y)Y)1%;VEL1%$U MS<3.T2*@0?.^,E1OKC/!?[?8M?C;X+^ 7[2WP"\0?"G7/B;87-S\.FU[5;&] MM]5FMXUEGTZ62TE=;74$B82>0VY'4/Y6)6< E5+'!Q M@_!WPYT'_@X'\9?!#PG^V7\=_P#@I1X7^&]QXX\2^&8-.^#GA[X*:7J5EI%I MK.K65G&+FZN&6Y:2..[#M"LI8%-GG@EB/OG]O:V_9GO_ -C[Q[H_[9-K%)\+ MM1T7[#XVDF98M0C2>\(L] MC7,?D+F0.(05(< ^VOV3/C-XU^+7@K7-"^+%OHR>-O GBFX\,^,W\-M(=.N+ MV&*"X2XMA(6>-)K:ZMIC"[,T+2O$7D,?F-ZG7RU_P1S\-_LG^&_V(=-B_8]^ M+NK?$+P]/XJUQM<^('B'5!>ZCXGUJ/4)H+[4KB8$^89I(=\;=X&A/.0S '(D@W,@$JR2^C?L9_\ !.3_ ((U_LF?MM> ?B;^PI\8;&X\>7-K MJVGMH.G_ !-/B'[7ISV,CSR-&]Q*\ 1XX/WH^7+!""7!7PO4OA]_P;^Z/^W5 M^TA>?\%._BS\,/&'Q'U;XHR7]AJ?CCQ',YT[26M8(HM)$6\+!+:30W,17:28 MC;L&*L$C]N_8FTG_ (-\[#]M7P')_P $RKCX>'XF_9]6$J_#B[DESI1L9?M' MVK+%!'Y@M]O\>_&WY3)0!^D]%%% !1110 5RWQ:^.'P=^ OAV+Q;\:OB?H7A M;3KB[2TM+K7=3CMA ":UO&GB_P]\/O!VK>/O%VH MK9Z3H>F3ZAJ=VXX@MX8VDDBO-FH&RT^]!EFL7;:EY$K &> MV9OE6XCW1,> Q-? _P#P7+_:F\)?M&_!S]DS]GCX'^/;;6O '[5'QW\-Z=K6 ML:5.3#J_AD74#W%OGA@LCS0;U.#B)XV'+"NB_P"#A#QY<_LD6G[+?[_8](BOI_W^HW.TMY-M"H,MQ)M#,4C5F"J6(P":TOA M=\6/AG\;O!%G\2?A#X\TKQ)H-_O%IJVC7J3PNR,4=-RDX='5D9#AE92K $$5 M^?G[*'Q#U3]J;_@XT_:-USQ9(;O2OV>OAGHOA#P):3',=A+J@CN[^Y1#PDTD MD+Q&0?,8D5"<#%3?L:?$74O@S_P$O'7P\T?XHV^D*<06.K MJMC87TT:]%>Z:=)93_$T2GM0!^CM%%% !7A?[6'_ "6SX'_]CW+_ .DS5[I7 MA?[6'_);/@?_ -CW+_Z3-0![I1110 4444 %%%> ^/\ _@J+^P/\+OC /@GX MZ_:>\)Z?JL5M?2:I>S:Q"-/TB6TFM(9;:]NMWE6L^Z]BQ'(RD -NV_*& /?J M*JZ)K>B^)='M?$7AS5[74-/OK=)[*^LKA98;B)P&21'4E75@00P)!!R*YK4_ MC]\%]&^-VE_LVZG\2M*B\>ZSH4^M:9X4:Y!O9]/AD$R_P"1WO?^O*+^9KSW]J+]O#]C;]BFUTVZ_:N_:2\)>!#K#,-)MM?U M9(I[P+@.T4(S(Z*2 SA2JD@$C(K?^#/Q>^%?QXM8_BO\%/B+HOBSPSJ^FQRZ M9KWA[4H[NTN5#%3LDC)4D,"I&'K3QSXIBGE\/>$)=5B_M*^BAA>:65+?/F&-8XW8N1M&W&+O@AX'^)6DZKXM\ K8MXST&RN1)<:/]MC>2U$X'W#(D;LHS MG"Y(&1D Z^BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\2_\A?1_^OT_ M^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH **** "BBB@ HHHH *CN_^/27 M_KFW\JDJ.[_X])?^N;?RH _+>BBB@ HHHH **** "BBB@ HHHH **** /JK_ M ()J?\>GC+_KI8?RN*^HJ^7?^":G_'IXR_ZZ6'\KBOJ*@ HHHH **** "OBS M_@HA_P EQL/^Q9@_]'W%?:=?%G_!1#_DN-A_V+,'_H^XH \&HHHH **** "B MBB@ HHHH **** "NN^ 7_).;'1H;CP;I<$,EXY >0$N5& >=K M_C7T]7S[X9\,^&_$/_!0#Q]%K_A^QOE3P/I3HMY:)*%;>PR-P.#@ 9H [OPI M^UW^S3XY\1VGA'PC\8]'O]2OY?*L[."5B\KXSM&5Z\5Z/6/8_#[P#I=Y'J&F M>"-'M[B)MT4\&F1(Z'U#!<@UL4 O:K\0/'#^*/$E^FM^)K.VEEACL+00V_E6:0PP2_9H6>5VN87AE /8E';FOA+_ ()S-^TE M_P $X?V([O\ X)[_ !5_9K\:>,_&/PTFU73OACK'AGP[)<:-X[TV>YGN+"5K MX?Z-IC+Y_DS1WLD/EB+^\1:%>R O;W>G7T5K+8S$8$@266Y4' #A4< 9&/:/^#HCQ%J M'PY_9G_9^^,_A61H/$7A+]J[PI?:%=0G$@E%OJ#&,$'9=6^'&FV]E<^.--B7?]HTM+^W:X5DV.94\L M-NB W2*&0,A8.OYV77_!2C_@S:&GR1+\,_@-(/)($<7[*EXLC<= QT08;WW# MGG(ZU^D7_!03XP?"3]GW]C;Q[\<_CI\.;WQ=X7\(:2FKZCX9T^#S9=1:WGCD MAA"DA64S+%N#Y3:&WAEW _(-G_P5)_X*13P17EG_ ,&X_P 1$1T5XO,^(&D1 M.H(R,JUN"A]B 1T- 'IW_!!;Q%X0\5?L+W6M?"W]GJV^'O@23XD>(%^'"1^$ MH=%GU_PXMSMT[5+F")$#W#VXCA:=@7F^RB1F8L2?M.OA_P#X)C_\%)?VQOVK M/B!XV\"_M5?\$]O&GPXMM/\ &5Y9>'?$27-I?65I'&JE].OWB=72XB8D"98S M'(K*&*,I+_<% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110!XS??\$\/V']=^)?B[XP>,_P!E3P!XC\2>-]7AU'7]7\2^#[&_GEEB ML[>S15DGB9DC$=LAV XWM(_5V)T/"'[#?['WPX^(VC?%OX6?LT>!O"7B/0OM M"V6L>%/"MGIT[13PM%+#(]O$IDB8,&*$XW1HW5:^3O'W_!3W_@IO\6?V@OB3 M\-/^"=G_ 3%TOQYX/\ A;XPG\)ZYXW\:_$RUT47^L6\<3W$5O;2 /Y<8E3$ MF6#A@?E)VUT7[-/[3/\ P67\=?M8>"?!7[9O[#'A'X5?#F_CU(W>M>&?'4&N M37E_'92O;VLOEOF")@))-VSEH%&\9VL ?_VKVL/"^H? W3/$/A/XW^%-(?@%\"?%WC^R^*_BOX*^$M3\4Z:%&G>)=1\.6LVH6H4Y7R[AXS(F#TVL M,4 ?B;I/[ ?[1_[,7_!$K]BW]I#XB^#=6;Q#^S5\:;3XE>,?"IMG>[TWPM=Z MQ)>72>2!O$D4)MII8\ Q@S[@/+-?7'_!:WP]H7_!1;QG^RO^PS\"_$EAXD?Q M%\8],^(GBF\T.\2ZBT[PAIMM/YU_*\9*QQ3&[2.!F($TN%0DYQ^DSHDBE'4, MK#!!&017-?#GX+_!WX/+?K\)/A/X9\+#5;CS]3'AS0;>Q^V2\_O)?)1?,;D_ M,V3R: /@WX&_#V7]BS_@X1^,^L^.I$T[PK^U)\/-)UGP/K-TX2WN-;T=$M[W M2@[8!N?+>2["=XF)&=I 7]@+X:77[0?_ 6\_:<_X*4>&V6Y\ :?X7TOX7>! MO$$)W6^NSVZ6DVK26[CB2*"[M5@\Q249]X!)1@/OOXA_#'X;?%WPU)X,^*_P M]T/Q/H\LBR2Z3XATF&]MG=?NL8IE9"1V..*TM#T+1/#&C6OAWPUHUIIVGV," MPV5A8VZPPV\2C"HB( J*!P * +5%%% 'E_Q6_9*^&OQB\7/XT\4:_XHM[M MX$A,>D^(YK:':@P#L0XSZGO7B7Q=_9:^'GPA^.7P>N/#&N>);AM1\:&*<:KK M\UR%"0EQL#GY3DN?\ "#Z1_P _ M-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!; M5L44 <;\1OA9>>)OA[KWAOP?XIOM)U;4-&NK;2]5%TY-EDWEFY^S6[S>4'VMM+;-N[!QG.#TK\YO^"ENF_P#!,?\ X*B>$_ 7 MQ4^-GQ,\.7GPRD_9T\?>(M%\=VNKQI/X>ODOO"303Q2*V4NXC*Z&W;+,S/$R M$L5H ^O+[P[\'?\ @G+^QOH?A>RCUG5-.\%:)I_ASP?H&G3?Z=KEWA+73]-M MD)PT\TABB7)VKDLQ5%9A\%?";]G;Q=\+_P#@XY^&^J_&OQ1)JOC_ ,9*Y/7_LJ?L2?\%/OVP/^ M"?O[)WQA\:_M]:[\&OBA\/\ PGJ7$>I.!%>II82 M(R,C3#[7< LIDD#>&^,/V2/^"EFD?\' /PR^&_B;_@KE=ZOX[F_9^O\ 4K3X MD'X%Z# UMI*:HZRZ3]@0^0XD<,_VD_O%W8' % 'ZCWG_ 3M_96\4?%+Q;\9 M?BI\+]*\:>(?%H@MKB^\6:;#?FRTV&W2*/3K?SE;R[;<)9F067P6?X[WEI\+M-ANG^S1-:;H-1>U.<-;BX"V MRL"0?L9&25)KT[_@H1_P5Z_8\^$OQ=D_84U/]L[PS\./$5U8B7X@>,9]1'G^ M%M/< ?9[4*KYU6=21$&&VV0FXDR1!#<=[_P3Q_;)_P"">OQKUVY_9O\ ^">' MC73/$/AKX>>#[)9V\+6DQTW1X6#[+3+_P 3>#/'\NOZA86R0SZA)'I*_#%A_P<:?L1Z7?>(;*&Y3P3X]5X M);I%=3-I;K"""<@NR.%_O%2!G%?:O[67[8_[-/[#'PI'QO\ VK?BI:^#_"S: MM;:8NK7=G<7"FZG)$482WCD'-(^&_P8 MA.I?%'X@WKZ3\/\ 3+VY=K>"4)NN-4NU4AA9641\^4@@N?*@4B2XB!^(?^", M/[._AOX'?\%:K>W&CWMS=WL[#@RS7$L MLS *#(0H50 /H?]J+_@G=^W+\6OVNM2_:O_ &7?^"J5U\)%U'PE9:!;Z#_P MI?1_$8M+2%VFD$-Q?R$Q":9_,D$:KO,<0"]3\!2?%6=OA-I%M_P +&BGT6Z:TB98SC2?LR?)NMN9O^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A M!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$ M'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^ M;W_P+:MBB@#XU_:0_P""@FE>!_B%XC^#O[,7P9U[XD>(/ OC#PCH7C_4%URW ML=*T:YUS5;.TAL//FF5YKUHKH.%BC>*$NAF=/N'TOX%_M0?"_P"+?@/X@>,/ M'7@GQG\-;KX5:O/IOQ#T;QT\,?VT?\ @E]^TEXW_P""A'[-ND#XD? ?XJ?$[P/XE^,?PWA'_$ZT MG6--U[39K>XT[O+]IGACAPH8@W15HRL:2Q_H[^P;^UW^R#_P4 ^"LW[4/[*& MNVNJZ9XGO$'B6&>#R[VTU"&"*,VU] 2?*GCB6)< M"_A%\;_!7@?]IW]ACXZ?"WP%\2/$<6A>"OBGXRM;>*QGO9CB!;NWCG:;3Q)@ ME5F E"@L\:!9"GTW^U7\?OA7^RCH7AM_$.E^(?$'B/QQXHM_#?@3P?H%RAOM M#]K:R^&/Q#^#GAS]K_P#8 MC\?3?LV^'?BQIFO^,_BIIEW87-N;^U,@L(FMH)I9H[3SY4DE,PADE6/RHU8L M0?6/^"[7P0A^+O[)7A/]I/X4_M!6?@/XC_"/QI8>*_@]XADA:ZAU?5W!A@TE M8(ED>Z-Z94B2.-)&=]B[&1G4@'IEA^U/;Z'^TWX*_92_:#^$FK^ _%7CVRO[ M[P/G:ZME&DEY;0W$6UXKJ&-UE:.2)5:,ED=]KA:?_!2K]O\ ^!7_ M 3&^#\?Q<^+'P^^(OB."ZOK>RM8O"VD32VZ33N8XOM%Y)MMK=2PP0SF3D8C M;(S\A_\ !/?]L&]_X*-?\%(_#UQ_P4$\+/\ "O\ :#_9YTB]L/#7P-FLGAB\ MV_M8H]3\0Q7$C$W8EC"Q10*2L$#&0/<"82KZI_P=+ '_ () ^*"1T\<^%\?^ M#>WH ^^O^$'TC_GYO?\ P+:N$_:6^+'P._9(^".O?M!?'#Q7?:;X<\/6ZR7< MD,DDT\\LDBQ0V\$2_-+/+*\<4<:\L[J.]>IU^?W_ ^^%WQ:\/^.-<\-:5$TEQJ6F6#3&6-8U!,@1Y8IF !PL+-CY: /3 M=3_;ITOX3?%#X?> OVM_V=/&7PKTWXKZJFC^!?$^K^(K*^L_[8D0O#I.H&TF M?[#>2J&\M09879'4397GZ<_X0?2/^?F]_P# MJ_'G_@X6_X*3?L>?MI_\$B] M,_X9,^+2>+/%'B/XB>&G\)6NBV4[W>D:KYS2K!_^!;4?\(/I'_/S M>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_ MS\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U1W7@C21:R'[3>? MZL_\O;>E;E1W?_'I+_US;^5 'Y;T444 %%%% !1110 4444 %%%% !1110!] M._\ !.K0K/6;7Q<;J69?+DL=ODS%>HN.N.O2OI?_ (0?2/\ GYO?_ MJ^=?^ M":G_ !Z>,O\ KI8?RN*^HJ ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\ MJV** ,?_A!](_Y^;W_ ,"VKX[_ M &_-+M](^-%C:VSRLI\.0,3+(6.?.G[GZ5]N5\6?\%$/^2XV'_8LP?\ H^XH M \&HHHH **** "BBB@ HHHH **** "NJ^!ENEW\:/"=K(6"R>([)6*M@X,R= M#VKE:Z[X!?\ )]UX7X!_P"4@GC_ /[$32O_ $8U 'NE%%% !1110 4444 %%%% !1110!X1 M_P %//C'XU_9_P#^"?7Q=^,7P\^$^E^.-6T+P3>30>%]=M?/L+Q&7RY3=19' MFVR1.\LJ$@-'&X)4'(\$_9V\:?\ !87X'^ V_9R_:;U?X':WX[\7^#[EO@9X MTTB+4(M"MM;MK7S3H>JQJHFD7R%>XBG@!:2*SNMWS*F[OOVP?VJ?V=?VF- ^ M,O\ P3:^!7[?'A_X??'.Q\#W,DLZZ@;>XT$^0)S*96 0JL7,WE,TD$3LY"D MU\_$SQC\+O$>A?'WX8^#?"WQ.\+^-;G2 M_B9;?#Z5Y-&O]7:VM;P7]J\JK*R3VMW:2D2CS$9F1B2F3[M7CW[#'[)7PD_8 MQ_9\L/A/\'?&WB#Q797M[/K6I>,_%FO?VIJ?B.]NR))+^YN@ )W<; &4!=B( M .,GV&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKR MK6_V?_B;JO[9&B_M+V?[3_BFR\):7X'GT.\^$<$,1TC4+U[AI5U21C\XG52( MP .D:89075P#XJ\5?L[_ /!??3?VT_C=XY_9"^*G[/W@_P"'WB'QC;2:=%XT M\.Z@9]8VZ;:E=0\NWC=&F6-X[&2;>AE.G#*#8K-Z%^S;X _X+A^'?VL_ NI? MMW_'#X.>)/AF!J2367PMTR]LKH:D;";[.]RMS&!) %$P 5^)&C)4X5EP_C)_ MP2A_X*#?&C]HWXC?$S0?^"S7Q>^'/A+5_% N/!/A#PXD=S#8V+VEN\J%GE78 M!=M=(D87"Q1QG)+$#<_96_X)9_M?_LY_M4>#_CK\6?\ @J1\2/C;H&C0:E;W M7A/QU L4%K)<6CQQWT/ERLK2H1Y6&7.RXD'[ G[-%E\2](\*0>(_&WC#Q- MIOA'X:^%Y[DPQZMK^H/LMXY' )2% ))7(Y*1%1AF6O/_ (G?M;?M'_L!?'GX M+>$?VP_B7X<\;^"/C;XE7P=+XETCPJ='?PQXJFB\RRC1?/E$UA/=1TG M^T'T>":5(K'2[.W9T0W,OBK^T'\8OV$_P!H M=-+7XI?!34[)KK5-%M&MK/Q-H5_ MQ8:I% [N89-C>5<1!W5)0"K8D"* ?4% M%%% !7A?[6'_ "6SX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-0![I111 M0 4444 %>1W7[!W['EW\>-*_:5/[-_@N/QCH]A>VUKJ\/A>S61VN9K65KAV$ M6YYT:T01RD[HQ+, ?WC9]^% M;.6:>1CEG=VC+,Q/)).32_#KX7_#3X9>,-5M?AM\.]"\/175K"UU'H>D0VBS M%=VTN(E7<1DXSTR:[6L>R_Y'>]_Z\HOYF@##U[]F_P#9W\5:S<>(O%'P$\%Z MEJ%Y(9+N^O\ PM:333N>K.[QEF/N36WXX^'/P]^)WA__ (1/XD^!-&\0Z4+B M*<:9KFEQ7=OYL3AXI/+E5EW(P#*V,J0",$5LT4 %9VF>$/"6BZ[J/BG1O"^G M6FIZP8CJ^HVUE''/?>4I6/SI% :78I(7<3M!P,5HT4 %%%% !1110 4444 % M%%% !1110!\$?M6?M9_&?PEX6\0_"?\ :<_9M^(EFND?M'^#+KP+XQ\/>$)- M8TSQ!H*^-M'NK8!],65K>Z2,- (9TC>5HX@IDDEVU1_8/_9\^,G[(>O?M>?\ M%"=-_93URQ7XP>)[37O OP'TJ>TBU:2WT^UE1KB1!)Y%O>7\T\UPT&]F0;5; M,A\L??VH:;IVK0+:ZII\%S$D\4RQW$0=1)&ZR1N 1]Y7574]0R@C! J>@#X, M_:A\6_$O_@KU^Q+K/[(/A;]C+XJ_#JX^(Z6=AXMU3XN>%X]*M_"EFEU#/<7( M#RLU].JQ$6Z6ZN#*8VD:% S#H_\ @I-^RU\6;O6?V9?C/\!O ]_XP\/_ +/? MQ*M]7\0_#FPGC^UZCIGV%[);RU65E2XN[-7\V.(LK2!I AW[5;[0HH ^"_V@ M/@-IG[:O_!2C]FG]J[X4?"3Q/X;?X1ZAJMSXM^('B;PC>:!<7ME/9/%!HD<- M]%#2=ML*';&0$+[R6&%QDC[D\2_\ (7T?_K]/ M_H)K8H Y27XG7FH_!V^^*G@[X>:_?WD&C7-Y8>%;_3GT[4+N>)'*VGEW(7RY M'==BLWR'<&!*D$^?_LW_ +6/CKXE?LA^&OVEOVC/V7?&OPLU_68ICJOPV;2+ MS7=4TIUN)8HPT=E:^#?A'\%M0;5/A/\ ##69(FU/7_$!P%U_5(XG=+6. !?LMH6:8-ND MF\K+0'[:HHH **** "BBB@ HHHH *CN_^/27_KFW\JDJ.[_X])?^N;?RH _+ M>BBB@ HHHH **** "BBB@ HHHH **** /JK_ ()J?\>GC+_KI8?RN*^HJ^7? M^":G_'IXR_ZZ6'\KBOJ*@ HHHH **** "OBS_@HA_P EQL/^Q9@_]'W%?:=? M%G_!1#_DN-A_V+,'_H^XH \&HHHH **** "BBB@ HHHH **** "NN^ 7_)+&,1W VXW'.Y\8_A!_P0@_82^,5MHO_ 5'^#-CH-E-X%T;_A4= MIKGA+5=0\,0V"V<8U&*RMK**6W@OVU 7$]R&19'$]O(,M)(S?>W_ 4)^!W_ M 3ZTOX7^(OVOOVVOA\EWX?\#:?!K?B,KJ=[%;:H-/?S;-+RQMYXX-5>.4@0 M1722A7D 4#<:^3/"/_!6/_@I-^U1\.-$_:1\._\ !&#P[+\%M?\ $FDVG@^7 MXC_%"VM-6U@7]]#8V=Y%;M:2"!7DN8B&92FQRRR.IWT ?2G_ 1D\:?!'XB_ MLCZAXV_9.\-ZKH_P5OO'NJK\'M,U=I ]OI$)CM[@11RLTD$!U.+4WBA;?:)KESJ-Q? M:E!,WFRJVZZNI9D:-VB>*:-XB8FCKU^@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ KE_B=\;O@O\$K.SU'XS?%[POX1M]1N#!I\_B?7[ M:P2ZE R8XVG=0[8YVC)Q745\!?\ !1/XH:I^SW_P4&^&?QW^-/CWX/>%?!UE MX&UO3_ASXK^*MO>+I^EZU+-827B/<(ZQ6][-;Q?N')4M##=(IR6# 'VO\2_C M1\(_@U\,+_XU_%?XE:)X>\(Z79+=W_B75]2C@LH8&QM,_93_;M_8]_;BT/4?$/[)?[0_AGQU;Z/,L6K)HE]NGLF;.PRPN%DC5MK;6 M90K;6VDX./R1N=;_ &M?^#DW]JH>#M&U+P/??LP? /Q&EWJ.I1Z=JEKH'Q(U M]0I2W*NXGFAB4OT*@1L2.=7T M_6[/5=/\ >&[S3Y;GPC#8M)-]KBC.?CW\5];T+7/&-S M#\//$-A;W5W#JMC*;*VGOK"*.*RLK6$P6Z.ZEDB+D---(7_H5KYH_P""OG[" MGBS_ (*3_P#!/_QM^QQX(\=Z=X:U/Q5<:7);ZSJMM)-! +34K:\8,D?S'/'$_B'X:2_M@^&0S:[J'[5OA.'0$ MB_UANS;:EL*8YSGC(_O#UK[(_;]_8<\%_M[_ +-4WP*\3^);C0-6T[5;+7?! M/B^QMUEN/#VNV3^9:7\:,0'VMN5D)&^.21=RE@PX+7/V)/CK^U3^T'\*/C3^ MW-K/@E=+^">H/K?A7PAX$:[GM]9\2&(11ZQ=RW:1M MN-[P6D:R%))-SW$@4 M*0#YR_X)EV>H6/\ P<,_M^)XO##59;+P7+IQE'S-8G3_ )"OJH3[../0#M3O M@"NIWW_!V!\=+S1PQTVP_9=TNVUID^X+Q[S2I( V/XO*$A&>P-?4/QE_8F\= M:/\ MO:=_P %$OV4]2\/V_CBX\%2>$/'OA?Q3//;:;XITH3+/;2&YMXY7M+N MWE0;9O)F#Q,8BJ@*PU/V*_V'Y_V=_B1\4OVGOBSXJL?$GQ:^-.NVNH>-M:TV MS:"RLK2T@%MI^E6:2,S_ &>VA&WS'.^9RSL%RJ( ?0M%%% 'E_Q6^//Q*^'W MBY_#GA?]F7Q1XIM%@20:MI,\*PLS#E,.O$OB[\;OB'X_^.7P>B\3_LY^ M)?"ZV?C0O ^JS0L+HM"5*IL/4 [CGL*^O:\+_:P_Y+9\#_\ L>Y?_29J /7/ M^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:^4_VBOVJ M_CUX)^,NM>%_"_BY],L+5X!;V,FF6LABW01L?%SX7_"ZXTF MR^(GC[2=&N->U.'3M$MM0O4CEO[J618XX84)W2,6=1A0<9R<#F@#W7_AM7]I MG_HI?_E&LO\ XS4*?MB_M'1WSZDGQ%Q-(@1W_LBSY Z#'DXKS*L[Q9XO\)^ MO#UUXN\<^)M/T;2K&,R7NI:I>);P0)_>>1R%4>Y- 'LG_#:O[3/_ $4O_P H MUE_\9H_X;5_:9_Z*7_Y1K+_XS7C7A3QCX7\<>$-.\?>$];@OM&U;3XK[3M1A M;]U/;2('252?X2I# ^AK"^'7Q\^#GQ:U2?1?AS\0=/U:ZM[-+SR;=V!FM7=D M6YA+ ">!G1E$T>Z,LI ;- 'T%_PVK^TS_P!%+_\ *-9?_&:/^&U?VF?^BE_^ M4:R_^,UXUJ_B_P -:#K6E>'-6U:.&_UN>2'2K3!9[AHXFEDP #A5122QPHRH M)RR@Z5 'J?\ PVK^TS_T4O\ \HUE_P#&:[O]FO\ :G^._CKXRZ3X7\5^*WU2 MPN$N#-8QZ;:QF3;!(R_,D:L,, >#VKYQKU?]B3_DY7P__P!<[S_TDFH ^W?^ M$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\ OI:/^$EU M?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275 M_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6O%_\ @HQ_R1W2/^QFC_\ 2>>OC.@#]-/^ M$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK\RZ\R\.?MG_LH^+_BU+\"?#'[0/A: M^\713/"VA6VK(TS2IG?$O.UY%PV44EAM;(&#@ _8'_A)=7_Z%"]_[Z6C_A)= M7_Z%"]_[Z6ORQ\>?$3P/\,-!_P"$F^('BBSTFQ-Q';QS7DNWS9G.(X8U^])( MQX5%!9CP :/ ?Q%\#_$_0CXD\ ^)K75+-+A[>:2V?F"=#AX9$.&BD4\,C@,O M<"@#].]_$#XE>+=/T+1-.56OM5U2Z6&" ,ZHNYV( R[*H]2P'>O//"O[>_[% M?CGQ+8>#?!W[47@C4]6U6[CM=-TZR\00R37,SL%2-%#99B2 /6@#]D/^$EU M?_H4+W_OI:/^$EU?_H4+W_OI:_)J]_: ^#&G?$%/A;??$33H]=DO8[(632'" MW+O%OAOP'X:O/&'B_5XK#3=/A,MW=3 M9PBCC@ $L22 % )8D D@4 ?J+_PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM?F M4K!U##.",C(P:6@#]-/^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK\RZ_2?X+_ M /)'?"?_ &+-A_Z3I0!=_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:V** , M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6H[KQ+JQ MM9!_PB%Y_JS_ !+Z5N5'=_\ 'I+_ -NI/"L#+;^(7L45A+:I(7MSC>O\ M#RB@'T'17Q9^T?\ 'S_@HW^QMX;M?VI_B[J7P[\1^ X-7M(?&/@CP]I-Q%=: M-:7$R0H]M>2/FZD5Y$4LR*&9AA #\OVG0 45\_:!\=/BG^TA\=_B/\,?@;XP MT[PWHGPPFM]+N]:NM'%\^JZW)&TLD.UG41VT ")(!B1W<[7C"Y;BX_\ @H;X MD\>?L^?#WQ!X3T&TT;QIXT^+EM\.O$$$RFXA\/ZBLDHO954D>;B.!GB5C_RV MC+ [64@'UK17BW[*_P >_%?COQ7\4_A-\2[^WN=1^%_C#^S?[=2!8%OK":VC MNK>655PBS*CLDFP*AV!@J[MHZWX(>.?%GQ6CU/XGW#+;^%=3E1/!5D;<++<6 M4>[_ (F,C'YO])9MT:=!"D+$!I'50#O**** /IW_ ()U:G>:=:^+A:Z/-=[Y M+'=Y) VX%QUS_GBOI?\ X275_P#H4+W_ +Z6OG7_ ()J?\>GC+_KI8?RN*^H MJ ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275_P#H4+W_ +Z6 MC_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EKX[_;\O;B_P#C18S7.G2VK#PY M !'*1DCSI^>/\\5]N5\6?\%$/^2XV'_8LP?^C[B@#P:BBJ'B?Q1X;\$^'KWQ M;XQU^STK2M.MVGO]1U"Y6&"VB499W=R%50.I)H OT5P'P/\ VI_V=?VDTOV^ M!'QBT+Q0VELHU"'2[T/);AL[69#A@IP<-C:<'!.#6[X\^+GPO^%UQI-E\1/' MVDZ-<:]J<.G:);:A>I'+?W4LBQQPPH3ND8LZC"@XSDX'- '1445G>+/%_A/P M%X>NO%WCGQ-I^C:58QF2]U+5+Q+>"!/[SR.0JCW)H T:*S?"GC'POXX\(:=X M^\)ZW!?:-JVGQ7VG:C"W[J>VD0.DJD_PE2&!]#6%\.OCY\'/BUJD^B_#GX@Z M?JUU;V:7GDV[L#-:N[(MS"6 $\#.C*)H]T992 V: .OHK-U?Q?X:T'6M*\.: MMJT<-_K<\D.E6F"SW#1Q-+)@ '"JBDECA1E03EE!TJ "NJ^!DKP?&CPG-' T MK)XCLBL:]6(F3@5RM==\ O\ DN/@_P#[&:Q_]'I0!^@W_"2ZO_T*%[_WTM'_ M DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM>.?#"ZFO?V^O'UQ<64EN MQ\"Z5F*0C(_>/Z5[W7A?@'_E()X__P"Q$TK_ -&-0![I1110 4444 %%%% ! M1110 4444 >/_M^_L@>&/V^/V-_B!^R#XO\ $4^D6?CC0C9IJUM$)&LKA)$G MMY]A(\Q4GBB8ID;E4KD9R/(OV@_AI^WIK/\ P3,M/A=\%?A7X+A^-W@G4?"1 M\/6-[JX?PYJ4^D:MIMR;N-P8I4M6BMI&$,@CE4J8QN 5W^O:* /!/^"=7[.? MQ[_9X^!FHR?M7_%+3O&'Q3\<^*[OQ3\0-6T2V,.G1W\\<,"6MFC*K"W@MK:V M@0L S>46(&[ ][HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *P_B-\,?AK\8?"5SX ^+?P]T/Q3H-[M^V:)XCTF&^M)]IRN^&961L$ M C(."*W** ,;P!\.OA]\*/"=IX!^%O@71O#6A:>A6PT70-,BL[2V4DDB.&%5 M1 22< #DFL'PG^S+^S=X!^*^K_'CP+^S[X(T7QSK\$D.N^,])\*6=MJVI1R2 M))(EQ=QQB:96D1'(=B"R*3R :[>B@ HHHH **** "BBO M3_ ."I_P#P3BT; MX\G]F+5?VV/AQ;^/%U 6#^'9?%$ E2\W;?LK/N\M9]WR>26#[OEVYXH ]]HJ MMK6M:/X;T>[\0^(M6MK#3["V>XOKZ]G6*&WA12SR2.Q"HBJ"2Q( )->??!/ M]L/]E_\ :-UJX\-_!#XX^'_$FH6^GIJ!LM/O099K%VVI>1*P!GMF;Y5N(]T3 M'@,30!Z517&_&?\ :%^"7[/&D6.M_&KXEZ7X>BU2]^QZ1%?3_O\ 4;G:6\FV MA4&6XDVAF*1JS!5+$8!-:7PN^+'PS^-W@BS^)/PA\>:5XDT&_P!XM-6T:]2> M%V1BCIN4G#HZLC(<,K*58 @B@#H**** "O"_VL/^2V? _P#['N7_ -)FKW2O M"_VL/^2V? __ +'N7_TF:@#W2BBB@ KX"_;+_P"3E?$__72U_P#22&OOVO@+ M]LO_ ).5\3_]=+7_ -)(: /,*R_%GA#PKXRL8+/QAH<.HVMG>1WD=K"- M)6^O+>-PV;EH2Z,T2E0&V;F^<84C) !\T?!+XA_L\?$G_@K/XN\2Z&FJ^%?% MNG_#./1(-!UOPS15&]T$>_ M,A7%_P""F.A^,/&%G\(-*\"_#[Q%K\_A[XW>'?$NLC1="N+E;73+228SS,Z( M5++E?W8)D.00I'- 'U!7E'[='AW0/$7[''Q2AU_1+2]6W^'FN3VXN[=9/*E7 M3Y]LB[@=K#)PPY&:W?CI\8]<^$OP:O/BOX-^#_B7QQ=0+;-;>&/#]BPU"X66 M5$)$4@#KL5R[*5W *<@8.,K]L!M4U?\ 9-\?Z%HOA?5[_5-?\#ZGIVEZ5INF MR75Q+=7%E,D416$,$R[!2[$(IZL* ///@QX#\4?%/_@D;X8^&?@C4!::SXA_ M9^M--TJY:38([B?1ECC);^$;F&3VZUP?P6\,>+=.^,'PA^*_B/P?JW@OPY\( MOV?Y])^(&H^(=-EL88[DQVJ_8D:15%PD)M99C+%OA 52')8"O=/V$[/6=#_8 M]^&W@SQ-X;U32-6\.^"M+TG5].U?39;66"ZM[2*.10)%&]0RG#KE3V)P:L^- MM(U;XW_%>'X>W^EW,/@OPE<6]_K\EQ R1Z[J0VS6MDF1^\MX/DN)2/E:3R(\ MD+.E &#X'\>^!M#\4'X^_M#>,M*\+ZYXKLC!X/T+Q#J$=M-I&A+(A5"DC I- M-(T4MPW&UWMX&)\E"WMX((R#7QK^U#X.\:>&_C[\:_%7B7P+KGB'2O'_ , U M\/\ @@:3HL]\'O5^U))IF(D;RGEDN(I1OVJP+'/[M]OTC^S#X0\;?#_]FWP! MX$^)5R9O$.C>"],L=>OC.OLS_@HQ_R1W2/^QFC_P#2>>OC.@"#4M/MM6TZ MXTJ]$AAN8'BF$4S1MM8$'#H0RG!X*D$=00:^+OV]?$G[+&C?&SX"? OQCH-W MX)@\._$?3]4TOQ?'X/GM=-LQ;*S1:9!=B)8_W\I@#[&,<:(S.595K[)\5:W< M>&O"^I>([30+[5I=/L)KF+2],1&N;QD0L(8@[*ID/?#=QXBU/3VU6Y\=^%9=*_P"$>@ANXIY;@/+\L\OEQO'& MMNTF6D&XHF]@ 5?B7XDU#Q__ ,%C/AU\)-4P\ MTCHS)",*3ROF/C&3E_@#Q/?>!?\ @L?X\^%.DRLFD^-O@[I_BC4;93\G]I6M MV+%9<= S0$*QZML3.<#'3?'_ .$/B;P7^VI\/_VVO"?AV_U>PL?#=[X2\=V6 MDV;W-Y#ITS&>VNXH(P7G6.Y)$B(&?;(&56VD4WX'?"+Q1XH_;-^(7[<7BCPK MJ.FV5YX5L_"O@73-1M3;WUS80L+BYN9(),- );@*L:2;'VQEG5=P% 'M7Q+^ M$_P^^,.DV?A[XF>&+76M,L]2COO[*U")9;6XEC5A'YT3 K*JLP<*P(#HC=5% M>%>)/@[\)/$/[>'@/P3X%^%OAS2K?X=>'[KQAKUQI6B6\#-=W.^PTR%FC0'I M_:$V">L$9QP*]D_9\^*WB+XV?"C3OB/XJ^$7B#P+?7SSK-X:\3PB.\MA',\8 M9U'0.%#C(!PP[8)X_P#9-\+>);O6OB-\>/'/AZ^TS5/'/C:<6%GJ=H\$\&C: M>/L%@K1N R!UAEN@"/\ E\)[T ?-?BW]GKXY2>#_ !K^SW:^"M)/VIH MO&6C>)XM.E-C!I#7=M>"_:\"^5&T,4+P&$N)=R*JH0RD_1GBKQIX0^)7Q"?Q M9XY\36.F?#?X>:TD27>HW2Q6^M^)$D"* 6($D=I(0B*,[[PX #VJ[NO^.>M^ M.KJTT[X5_#$7=KK/BF22&3Q!#;EH]"L4 -S>EB"GG!65($.=TTB,5,</X9]?TG3+:6YDMK8V4]O!>M&H:240RR!G M?#,/,:0\!F !]"^%O%GA?QQH%OXJ\&>(K'5M,NU+6NH:==)-#* 2IVNA(."" M#SP01U%:%?/O_!/GP?XW\/Z%\4?%OB;1+_3-)\8_&77=>\(:?J=J]O,--F:) M5F,,@#PB:2.68(RJ<2!B!OKZ"H *_2?X+_\ )'?"?_8LV'_I.E?FQ7Z3_!?_ M )([X3_[%FP_])TH Z6BBB@ HHHH *CN_P#CTE_ZYM_*I*CN_P#CTE_ZYM_* M@#\MZ*** ,GQUX:U+QAX4O?#6D>-]5\.7%W"8X]9T06YNK;/\4?VB*6,'W*' M';!YKYJ_X)N6WQG^$_CKXN_L>_%#QF_BK3/AKKFG3^%_%5Q:K'<7MOJD,MX\ M]GW36ES!-"\F6(\S:'Q@9^5<:FC? KPCX8\ :UX%\*:KK&F2^(GF MFUCQ':ZB3JMS=2H$>Z:YD#-YVQ556QB-418PBH@4 X?XP>%[/]K?Q?9?"")5 MG\">%O$5OJ'CB\ZQ:K?6DJS6^DQ]G5)UCEN&Z*8DA&6:7RO:H9HKB);BWE5X MW4,CHV0P/(((ZBOEW3_^"3GP;TK0U\+Z7^T3\<[;3$C:-=.@^*MXD 0DDJ(P M N"2UNK;0M$TC5V@TZ>*:!8-E MS" ?-"(HV$=BV:VVF6%N"4A0>I)+,Q)+,S$LS$L222: /$+/X'^$I?&>N_LZ>!KW4 M+^SUS6#XC^-WB;4ID>YU1IU40Z6S1(D:&>.- \<:*L=I'MVJ;I'KD/#W[??C M^ZTGPW\:7T/15\ ^)/C@WP\L=%BL9%OK:V,\MG!J!G\TH6-Q#EH1$ (G #;D M+/\ 2WPL^&>D?"KPN?#^G7US?7-U>37VKZO?%33-NEN)2H W$X 4 *B* MB*%1%4>:6?[!WPHL_%=AJ":_K)\.Z5\09?&^F^#"\ L+?77#'[0&$7G>6LCR M3+#YFQ97)^Z%10#V^BBB@#ZJ_P"":G_'IXR_ZZ6'\KBOJ*OEW_@FI_QZ>,O^ MNEA_*XKZBH **** "BBB@ KXL_X*(?\ )<;#_L68/_1]Q7VG7Q9_P40_Y+C8 M?]BS!_Z/N* /!JR_%GA#PKXRL8+/QAH<.HVMG>1WD=K"-)6^O+>-PV;E MH2Z,T2E0&V;F^<84C) !\T?!+XA_L\?$G_@K/XN\2Z&FJ^%?%NG_ SCT2#0 M=;\,W.E3>)5^U_:)]1VSQH9%C5((DW#>ZJ[8V1J:U_\ @JGX=T"3_A0GB=]$ MM#J2?M)^$($U#[.OGB+S;@^7OQNVY.=N<9YKK;CX?/\ M)_M(](DTZ[U2XU"!+=;5;:8+,(HD\Z1GD51O=!'OS(5Q?^"F.A M^,/&%G\(-*\"_#[Q%K\_A[XW>'?$NLC1="N+E;73+228SS,Z(5++E?W8)D.0 M0I'- 'U!7E'[='AW0/$7[''Q2AU_1+2]6W^'FN3VXN[=9/*E73Y]LB[@=K#) MPPY&:W?CI\8]<^$OP:O/BOX-^#_B7QQ=0+;-;>&/#]BPU"X665$)$4@#KL5R M[*5W *<@8.,K]L!M4U?]DWQ_H6B^%]7O]4U_P/J>G:7I6FZ;)=7$MU<64R11 M%80P3+L%+L0BGJPH \\^#'@/Q1\4_P#@D;X8^&?@C4!::SXA_9^M--TJY:38 M([B?1ECC);^$;F&3VZUP?P6\,>+=.^,'PA^*_B/P?JW@OPY\(OV?Y])^(&H^ M(=-EL88[DQVJ_8D:15%PD)M99C+%OA 52')8"O=/V$[/6=#_ &/?AMX,\3>& M]4TC5O#O@K2])U?3M7TV6UE@NK>TBCD4"11O4,IPZY4]B<&K/C;2-6^-_P 5 MX?A[?Z7W@8GR4+>W@@C(-?&O[4/@[QIX;^/OQK\5>)? NN>(=*\?_ #7P_X(&DZ+ M/?![U?M22:9B)&\IY9+B*4;]JL"QS^[?;](_LP^$/&WP_P#V;? '@3XE7)F\ M0Z-X+TRQUR0R^83=Q6L:2Y?)W_.K#=_%C/>@#N:Z[X!?\EQ\'_\ 8S6/_H]* MY&NN^ 7_ "7'P?\ ]C-8_P#H]* /T>HHHH *\+\ _P#*03Q__P!B)I7_ *,: MO=*^5/$6A?'K6?V]?'$?P4\>:)HMPO@_2VN9-8TMKE7AY 4 $8;?N.?0@4 ? M5=%>0>!?!O[:=AXNL+SX@?&?P?J&BQS@ZC96'AQXII8\'Y4/K[PWX>^%\^AQ_$SQ?I%P\4U[JEYJ5E'!X? MMID(*&."Y6\NG4Y4-:0_,)IPGZ-_M>:[^T9X;_9E\;:S^R+X'LO$?Q-BT"8> M"='U&^AMH)K]@%C9Y)V6,*FXR8=@&V; O\ @B3X MT_9L^+G_ 2)7X8> HKG1YO$'Q+O/VB](\1WTE^^N6MS+>W-M;VLX9R-J[: /T2_X+8_ME?%+]FWX$?#+X%?L_>*IM#^(G[07Q4T3X>>'/ M$-LBM/HD-[*J7>H1!@1YJ(5C0G[KSJX^Y7!_MYZUI_\ P1S^)O[._P"T-\$M M?\0P^ _%_P 4K+X;_%_P_K7BF]U.+5K;48)6M]9E-Y+(1>VTEL[M<*1),LC1 MR,P*[?'/^"L&N?M+^.]._88_;3_:N_9B3X33_#[]K'1K?QEX7A\:VWB"/2[" MZN[<07\EY;1QQ[#]EZ;1L:1%)RPKTW_@YI\)ZO\ &GX-_LV_LO\ @N%[CQ'X M^_:H\.0:?;1#+K;Q6U]]HN..B1"2-F;HJDDX H _2^BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH RO'7AV^\7^"-9\):7XFO-%N=4TJXM+?6=.(%Q8221,BW$6[C M>A8.N>,J*_/[_@LM_P $Y_\ @GMX!_X(Z_$_PII7[,?A#1O^$3\&LW@"\TCP M_$NIQZ]N6+3Q'<*OGS3W%V\,3DLSSF=@Y8N<_H/XI\5>&? WAK4/&?C3Q#9: M3H^DV2661R%1%4$EB0 2:_-*/_@M'_P $F/VI_C18 M?%?XZ_MM^"-)\"_#O7GNOASX*U*YE\[5=5A+1KX@OHQ&=HCR_P!BMCRF[[3* M/.,"6P!QG_!4O6_CGX0_8>_8/_X)J?&?Q!=3Z_\ &CX@>!/"'QEN9+DO)J-I M:1V2ZG;22 YD$EQ)&7;/SB-@B^$/ EI,U2_ WX> MR_L6?\'"/QGUGQU(FG>%?VI/AYI.L^!]9NG"6]QK>CHEO>Z4'; -SY;R783O M$Q(SM("_L!?#2Z_:#_X+>?M.?\%*/#;+<^ -/\+Z7\+O WB"$[K?79[=+2;5 MI+=QQ)%!=VJP>8I*,^\ DHP !^B]%%% !7A?[6'_ "6SX'_]CW+_ .DS5TGQ M6_9*^&OQB\7/XT\4:_XHM[MX$A,>D^(YK:':@P#L0XSZGO7B7Q=_9:^'GPA^ M.7P>N/#&N>);AM1\:&*<:KK\UR%"0EQL#GY3DT5C_\ "#Z1_P _ M-[_X%M1_P@^D?\_-[_X%M0!L5\!?ME_\G*^)_P#KI:_^DD-?2: /-J*** "BBFRRQP1M-,X M5%!+,QX IQC*4DDKMBE*,8N4G9(=17(:S\1KAI6AT6%50' FD7);W [?C5"# MQ_XDBDWRW$J"BB MBN$[@KU?]B3_ ).5\/\ _7.\_P#22:O**]1_8TL(=2_:*T*SN'=4>.[R8W*G MBUE/44 ??=%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ M #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ MX%M0!XO_ ,%&/^2.Z1_V,T?_ *3SU\9U]>_\%!/#MCH_PDTFXM9KAF;Q'&I$ MLY88^SSGH?I7R%0 4444 %%%9?B3Q39^'H@K+YL[C*1 XX]2>PKNR[+<=FV, MCA<)!SJ2V2_7HDNK>B.',LRP.48.6*QE10IQW;_)=6WT2U9J45P-QX_\232% MHKB.(=E2($?KFK^C?$:X658=:A5D)P9HUP5]R._X5]WB_"GBS"X5UDH3:5^6 M,FY?_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X M%M0!L5'=_P#'I+_US;^59?\ P@^D?\_-[_X%M4=UX(TD6LA^TWG^K/\ R]MZ M4 ?F?1110 4444 %4K[Q%HFFOY5[J4:..J [B/J!G%97COQ)-I<2Z982;9I5 MW.XZHO3CW//Y5Q)))R3DGJ:_6N#/#)Y_@5CL=4=.G+X5&W,UM>[NDNVCOOHK M7_(.-?%%))M4B;3+^0M-$NY'/5EZ<^XX_.CC/PR>08&6 M/P-1SIQ^)2MS);7NDDUWT5M]5>QP5XHKB#'QP&/IJG4E\,HWY6_Y;-MI]M6G MMH[7Z*BBBOR4_7PHHHH ^JO^":G_ !Z>,O\ KI8?RN*^HJ^4/^"=6A6>LVOB MXW4LR^7)8[?)F*]1<=<=>E?2_P#P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U M&Q7Q9_P40_Y+C8?]BS!_Z/N*^N_^$'TC_GYO?_ MJ^._V_-+M](^-%C:VSRL MI\.0,3+(6.?.G[GZ4 >'T444 %%%% !17.^)/'<6ES-8:9$LLR\.['Y4/IQU M-87_ GOB;S-_P!L3']WR5Q_+-?H.4>&7%&;X-8F,8TXR5USMIM=[)2:OTO; MOL?G6<>*'"N3XUX64I5)1=I M$[60L%D\1V2L5;!P9DZ'M0!^D5%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@ M6U &Q7A?@'_E()X__P"Q$TK_ -&-7KG_ @^D?\ /S>_^!;5XY\,-/ATS]OK MQ]9V[R,J^!=*(,CECS(YZF@#WNBBB@ KRO\ ;3_8X^"O[?7[..O?LK_M"V.H MW/A+Q'):/J<.E:@UK.QMKJ*ZBVR*"5_>0H3ZC([UZI10!R/QO^!/PE_:0^#^ MN? 3XW^";3Q%X2\2:>;+6-'OMVR>+(((92&1U95=)$(='164AE!' ?"_]@_X M6^ ?BOH?QQ\:>._&?Q%\6>$M'FTKP3K7Q"UJ.]D\.6Q&*XO_AD_P#99_Z-J^'_ /X1MC_\ M:KOZ* *VE:+HVA:/;^'M$TFVL]/M+=;>TL;6!8X88E4*L:(H"JH4 !0, #%8 M7PY^"_P=^#RWZ_"3X3^&?"PU6X\_4QX% M_M8?\EL^!_\ V/Z5X7^UA_P EL^!__8]R_P#I,U 'NE%%% !7P%^V M7_R_DM M]+BLHVQ]HD._'=5YQ^9'Y5T5<[\1["2XTN*]C7/V>0[\=E;C/Y@?G7U_ 7U7 M_6_!_6+IP7T;8V2#=[KW'Y5Z?7F&C:?)JFIP6,:YWR#=[+W/Y5Z?7\ M^^,_U7^T,)RV]IRRYN_+=%>K_L2?\ )ROA_P#ZYWG_ *235Y17J_[$G_)ROA__ *YWG_I)-0!] MZT444 %%%% !1110!\__ /!1C_DCND?]C-'_ .D\]?&=?9G_ 48_P"2.Z1_ MV,T?_I//7QG0 4444 %>8ZS?R:GJD][(V=\AV^R] /RKTZO,=9L)-,U2>RD7 M&R0[?=>H/Y5^U>#'U7^T,7S6]IRQY>_+=\WX\E_D?B'C;];_ +.PG+?V7-+F M[04445\@?8A7Z3_ 7_ .2.^$_^Q9L/ M_2=*_-BOTG^"_P#R1WPG_P!BS8?^DZ4 =+1110 4444 %1W?_'I+_P!O'N.?SKB2"#@C!'45_6_ &;X/-.&,/&C) MS?\ >:LEU]$SHJ***_D@_L **** /JK_ ()J?\>GC+_KI8?RN*^HJ^7?^":G M_'IXR_ZZ6'\KBOJ*@ HHHH **** "OBS_@HA_P EQL/^Q9@_]'W%?:=?%G_! M1#_DN-A_V+,'_H^XH \&HHHH *I>(KY]-T2YO8CATCPA]"> ?S-7:I>(K%]2 MT2YLHAEWCR@]2.0/S%>CD_U7^U\/]9_A\\.:^W+S+FO\KGFYS]:_L?$?5OXG MLY\MM^;E?+;YV/-"23DG)/4T4$$'!&".HHK^VU:Q_#+O< 2#D'!'0UZ7X=OW MU/1+:]E.7>/#GU(."?S%>: $G &2>@KTOP[8/IFB6UE*,.D>7'H2TYW;OR\KYOE?D/VKP4^M_VOBN6_LO9J_;FYER_.W.7:***_G@ M_HX*Z[X!?\EQ\'_]C-8_^CTKD:Z[X!?\EQ\'_P#8S6/_ */2@#]'J*** "O" M_ /_ "D$\?\ _8B:5_Z,:O=*\+\ _P#*03Q__P!B)I7_ *,:@#W2BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y*^+'[9GQ4^ M+/\ P41_X=J?LJ^(M*T#4/"W@,>+OBQX]U'2?[0?1X)I4BL=+L[=G1#=S;Q. MTDNZ.. <([N-FK^PW^VUXR^*O[0?QB_83_:'32U^*7P4U.R:ZU31;1K:S\3: M%?P+<6&J10.[F&38WE7$0=U24 JV) B_,?\ P3+L]0L?^#AG]OQ/%X8:K+9> M"Y=.,H^9K$Z?\A7U4)]G''H!VIWP!74[[_@[ ^.EYHX8Z;8?LNZ7;:TR?<%X M]YI4D ;'\7E"0C/8&@#].J*** "O"_VL/^2V? __ +'N7_TF:ND^*WQY^)7P M^\7/X<\+_LR^*/%-HL"2#5M)GA6%F8M^#_B/I/[ M%7CMI/ NL2:K_9B- [ZAF(H(E*DE#SUVM]* /L"BOCG_ (>4_M9?](G_ (I_ M^!8_^1Z/^'E/[67_ $B?^*?_ (%C_P"1Z /L:O@+]LO_ ).5\3_]=+7_ -)( M:[?_ (>4_M9?](G_ (I_^!8_^1Z\!^,WQ$_:R^+GQ+U/XB?\.[_BGI_]HM$? ML?\ 9XE\O9$D?W\+G.S/0=<4 5Z*Y_R_VLO^C"/BG_X)A_C1Y?[67_1A'Q3_ M /!,/\: .@ILL4<\;0S(&1@0RL."*P?+_:R_Z,(^*?\ X)A_C1Y?[67_ $81 M\4__ 3#_&G&4HR33LT*48RBXR5TRAK/PYN%E:;19E9"]?I&$\5N+,+A%1;A-I6YI1;E]Z:3? MFTV^MS\SQ?A+PCB\6ZZC.";ORQDE'[G%M+R3272QT'AOPM9^'HRZMYL[C#RD M8X] .PK4KG_+_:R_Z,(^*?\ X)A_C1Y?[67_ $81\4__ 3#_&OA,QS+'9MC M)8K%SK_L2?\G*^'_^N=Y_Z235X1Y? M[67_ $81\4__ 3#_&NL^"/Q+_:R^#GQ+T_XB?\ #NWXIZC]A68?8_L AW^9 M$\?W]K8QOST.<8H _4"BOCG_ (>4_M9?](G_ (I_^!8_^1Z/^'E/[67_ $B? M^*?_ (%C_P"1Z /L:BOCG_AY3^UE_P!(G_BG_P"!8_\ D>C_ (>4_M9?](G_ M (I_^!8_^1Z /L:BOCG_ (>4_M9?](G_ (I_^!8_^1Z/^'E/[67_ $B?^*?_ M (%C_P"1Z /1O^"C'_)'=(_[&:/_ -)YZ^,Z]&_:,_:U_:R^/_@ZS\)_\.R/ MBGI/V34UN_M&P3[L1R)MV^4F/OYSGMTYKQGR_P!K+_HPCXI_^"8?XT =!17/ M^7^UE_T81\4__!,/\:/+_:R_Z,(^*?\ X)A_C0!T%9?B3PM9^(8@S-Y4Z#"2 M@9X]".XJGY?[67_1A'Q3_P#!,/\ &CR_VLO^C"/BG_X)A_C7=EV98[*<9'%8 M2;A4CLU^O1I]4]&<.99;@\7?M&^&M2TS2-<_8F^(UI< MZQ=&WTV"ZT]4>ZE"[BD8/WVQS@=JU/+_ &LO^C"/BG_X)A_C7W>+\5N+,5A7 M13A!M6YHQ:E][;2?FDFNECX#!^$O".$Q:KN,YI._+*2#M)\)_\ #JOXIW']EZ9!:?://">;Y<:INV^0=N=N<9.,]30!]LT5 M\<_\/*?VLO\ I$_\4_\ P+'_ ,CT?\/*?VLO^D3_ ,4__ L?_(] 'V-17QS_ M ,/*?VLO^D3_ ,4__ L?_(]'_#RG]K+_ *1/_%/_ ,"Q_P#(] 'V-4=W_P > MDO\ US;^5?'O_#RG]K+_ *1/_%/_ ,"Q_P#(]-F_X*3?M92Q-%_PZ@^*8W*1 MG[4./_)>@#Y[HKG_ "_VLO\ HPCXI_\ @F'^-'E_M9?]&$?%/_P3#_&@#H** MY_R_VLO^C"/BG_X)A_C1Y?[67_1A'Q3_ /!,/\: .@JE?^'=$U)S+>Z=&[GJ MX&TGZD8S69Y?[67_ $81\4__ 3#_&CR_P!K+_HPCXI_^"8?XUTX7&8O U?: M8:I*$N\6XO[U9G-BL%@\=2]EB:<9Q[22DON::-.P\.Z)ICB6RTV-''1R-Q'T M)SBKM<7X3\7?M&^.--DU?PK^Q-\1M1MHKJ2WDGL-/65%EC;:Z$CHP/!'8UJ> M7^UE_P!&$?%/_P $P_QHQ6,Q>.J^TQ-24Y=Y-R?WN[#"X+!X"E[+#4XTX]HI M17W))'045S_E_M9?]&$?%/\ \$P_QH\O]K+_ *,(^*?_ ()A_C7,=)T%%<_Y M?[67_1A'Q3_\$P_QH\O]K+_HPCXI_P#@F'^- 'V5_P $U/\ CT\9?]=+#^5Q M7U%7YT?LU?M+_M9?L\1:S%_P[2^*>L?VNUN<^2+?RO*\S_IF^[/F>V,=\UZC M_P /*?VLO^D3_P 4_P#P+'_R/0!]C45\<_\ #RG]K+_I$_\ %/\ \"Q_\CT? M\/*?VLO^D3_Q3_\ L?_ "/0!]C45\<_\/*?VLO^D3_Q3_\ L?_ "/1_P / M*?VLO^D3_P 4_P#P+'_R/0!]C5\6?\%$/^2XV'_8LP?^C[BKO_#RG]K+_I$_ M\4__ +'_P CUXK^T1\:OVLOCWXX@\9_\.XOBGI/D:9':?9OL8GW;7D?=NVI MC._&,=NO- &'17/^7^UE_P!&$?%/_P $P_QH\O\ :R_Z,(^*?_@F'^- '045 MS_E_M9?]&$?%/_P3#_&CR_VLO^C"/BG_ ."8?XT -\2>!(M4F:_TR58IFY=& M'RN?7CH:PO\ A O$WF;/L:8_O^IGBB[NSZW),AROA[!?5<#3Y8[OJV M^[;U;_+961T%%<_Y?[67_1A'Q3_\$P_QH\O]K+_HPCXI_P#@F'^->0>P=!77 M? +_ )+CX/\ ^QFL?_1Z5YCY?[67_1A'Q3_\$P_QK7\ ^)OVLO _CC1_&?\ MP[Z^*=U_9.IP7?V;^RPGF^6X?;NYVYQC.#CTH _56BOCG_AY3^UE_P!(G_BG M_P"!8_\ D>C_ (>4_M9?](G_ (I_^!8_^1Z /L:O"_ /_*03Q_\ ]B)I7_HQ MJ\M_X>4_M9?](G_BG_X%C_Y'KT3]D:/XE_%;XC^(OVJOB/\ "75OA_/KFFP: M,G@_7P3=Q"V;<+@MM4%'W8 P#E3[&@#Z"HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH ^9OC+^Q-XZT?\ ;>T[_@HE^RGJ7A^W M\<7'@J3PAX]\+^*9Y[;3?%.E"99[:0W-O'*]I=V\J#;-Y,P>)C$54!6&I^Q7 M^P_/^SO\2/BE^T]\6?%5CXD^+7QIUVUU#QMK6FV;065E:6D MM/TJS21F?[/ M;0C;YCG?,Y9V"Y5$^A:* "BBB@ HHHH **** "BBB@ HHHH **** "O"_ /_ M "D$\?\ _8B:5_Z,:O=*@CTO3(M0DU:+3H%NY8PDMTL*B1U'12V,D#TH GHH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^ MQ[E_])FKW2H+O2],OYX+F^TZ":2UDWVTDT*LT38QN4D?*<=Q4] !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?\ P3W_ .2)ZM_V/>L_ M^E)KW2H-/TO3-(@-MI6G06L;2,[1V\*HI8G); Y)ZFIZ "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH *\+\ _\I!/'_P#V(FE?^C&KW2H(]+TR M+4)-6BTZ!;N6,)+=+"HD=1T4MC) ]* )Z*** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@#D_CO\;_AE^S5\&O$WQ]^,OB:+1_"WA'1I]4US M495+>5!$I9MJCEW/"JBY9F95 )(%?+?[)OQ=_P""@W_!1GX.:?\ M9^'_B)H M/P)\!^+HC>_#?PK_ ,(6FN:[=:4Q/V>_U*XGG6",SH!*MM!%\D;KF=RWR^>? M\'5.G^-=0_X(E_% >$$G>&'5= EUQ(,Y-DNK6NXD#JHD\ICV 4D\"OK3_@GS MJ7AO6/V"O@EJG@YHCI-Q\(_#?\$MOV]-+\/6OQ(O/#Q\0_##QWX3M)K32/'>DKYGF 6LTLKV5]$(9C)!Y MLJ,(9&1E4('O_MEQ_P#!8[QK/XE\2_L.>*OA5X%TCPO'*/#VB^.M!GU/4?&4 M\2;G:26.98M-MW<&.(!9)& \QVC#A$^3/^"V&G:IK7_!>#_@GCI_PS1G\3Q> M*=3N-6%MGS1I$=S923%L<[/L\>H9[8#^]??/_!1'X)?MB?M"?LU>(/A3^QA^ MT?X?^&?B/6-+N;676M:\+2W\DJ2)M\J&=+A/L)8%U,_DW#J&#(JLH- &;_P2 M@_;6\2?\%$?^"??PW_;"\8^ (_#&K^+M-N3JFDVY?R%N+:\GM))8-Y+>3(T! ME0,6(2106;&X\E_P5_\ VJOVI?V3?A5\)?$?[)^E:/=ZQXP_:#\+>$-=CUK3 MVN(_[,U&2:)PH5E*.TPMX]^&X=3M])UZPUK3HYG9?(O[*X2XMIU*D'_P#!/O6/AA\._#G@\0VU_P"-/B=I-W?W'B'5)+>. MX,%E!"-D5G$DT:27+[V:8R(B#R6+9'_!'7_@HC\>OVT-%^*7P-_;#^%>E>%/ MC-\"_&0\-^/H?#CNVEZAO61K>\MM[,RB012Y7RL+7=U ZU\I_! M/PY#_P $MOV//CE_P4(_:F\.O-X\\=:SJ'Q&^)&C:$WVEK.1E$>GZ#;R*")! M;0B&W\WE6E>:3.QA@ P/^"]G_!5#XH?\$Z?V5=>U7]EKP[9:Q\1[+3K+5=1N M=0@$UGX8T>?4H+!;ZY3(WO/<2B""$D&0K<2#VS=F@#RK MP=^V#>_M9_L7>&_VGO\ @G]I.F>*KCX@64)\)R>)IVMK'3)'9DGEU(1$R!;5 MHYEDABR[RQ")67?YJ_-'PP_:R_X*C?LM?\%1?AC^PW^W+KWP[^)G@[XYZ%KE MYX/\9> O"\^D7.AWFE6OVJYBN('FE#0!&B0,69B9XSO&UD/!?\&?6E>.=._X M(]6]WXKCG6QO_B9KD_A@S [6L0+>-BF?X?M4=V..-P;OFG?M*^-_^"@_[ W_ M 5_^#/[1O[0/C'P+\5?A5\;O$EG\)-(;2?!3Z3>^!+C4)O,ACM@]Q<-B>5% MEFE,K^>EH59(_*@P ?J57PA^RK^WK^V_X]L/VM;[QK\)-*\3ZC\,?VA;WP'\ M&O#^E0-8_;T9[=+-+R6EQ-<;&X=/N/%>O-K7B&2%V/VR_:W@MVG8,2%8Q6T"D+@?)G&220#\T/VE_VXO^ M"T?_ 2M\8>"?V@_V[+OX,?$OX)^*_&%GH'C2U^&FAWUA?\ A&2[GP+= M?#KX8^.-.\7_ !GU?&8;B]LU\_3/#<9Z/-+(\5U<@. M=4\'ZAI_PT\3Z9HNNS0;=,U76=&?4;:VDR/GDMH[BW:48S\HE3G!R0,$ ^.? M^"4_[:'[:WQ4_:"^/?["O[>_ASPM=^._@5J>C$>.O UG+;Z;KMAJMM)'_ (O^'-#%A-X@M6NX--:*[C&=OE#RH(H\GR$M#&'D1HB/TSH M**** "BBB@ HHHH **** /S6_P""G/\ P4+_ ."B'_!.?]LKX36_C7Q?\+X/ MV;/B?XNBT34_B'=^ +U[[PC<.QQ;W;#4UA963#K<;5&U)R8_W/[SZV_X*%_' M;XF?L[?LB^(?B;\$]:TAO'BQP67@+2M5T5[^+Q%KMRP@L-,2".XA?-Q<21)O M5_W:EI""J-70?MK?L@_"+]O']F#Q?^RI\;]+^T:#XMTMK=KB- 9K"X4AX+R$ MG@2PRJDB]B4P'_ ;Y2_'W]IF/4/#/[8/Q"L_%0_8S\6ZK\-? HMXY M,7^IQ&2WDUJY+G]Y-%8E+&V.,I%+'[".R9VAM;9=322XF-TT,:/)<1"11(^Q,%1X! M:_MC_P#!42X_X*\7'_!+0_M ?!H0P?!L>.?^$W'P2U'V-O>OTEK\P=-_Y6W]0_P"S/U_].T5 'M?Q3^,7_!4#]GW]DK]HOXE? M%?QC\+[WQ-\)O#]_XG\!>(M*^'>H6^D>)-+MM):\,$]K)J3O#<">">)O+N'" M!HVP-8)+R/Q").=F?,6'C/W&QS[W_P51_Y1@_M'_P#9!?&'_IENZ\S_ .#?K_E# M-^SY_P!B*O\ Z4S4 9W_ 3[_P""KOBSX]_M0>-_^"=G[:'P3M?AA\?O %J+ MZ;2=+U5KS1_%&F'81J&F32*KE-LD;&%P7"N#DE95B^F/VK?&_P 0?AE^RY\2 M?B1\)+&VN?%?A[P#K&I>&;:]B,D,NH064TMLDB@@LAE1 0""02,BOS$_;/MV M\2_\''P!\1?!SP? MX'3XR_%WP*OB#Q!XP\56-S'X=\.ZW)DFN9ENK40VRLJLS32$B.%E M/)_LF_MX?\%&?@1_P4NTC_@F%_P4ZTSP)XHG^(?A2]U[X5?%#X=:?-9PWOV1 M));FSNK>0D(RQQ2'*A2I"#,HE#)]\^ ? W@?X-?#;1?AIX%TJ'2/#7A30[;3 M-'LO.8QV5C:PK%%'OD8L52-%&YB3A,8O#LVO^(=3OH='\$>$K.4)<>(-:N,K:V49/"!B&>24@K##%-,^$B8C MP[_@AQ^VE\9/^"@__!-?P3^UA\?#I8\3^)=2UM;U-&LOL]M'';ZK=6\*(A9B M-L42#)))(R3DU\SZ)_P78_X)8WW[87BOXT_M3?M)7^BZCX!U+4?"?PR\'/\ M#?Q%>#2+>.4PW^L226VGR0M=WKQ[$*NQALXXTRCW%RE5?^#23]K7X >/?^"9 M_A7]D7PIXYENOB%X$&L:CXJT)M%O8UL[:ZUJ[D@<7,D*V\VY9$.V*1V7.& ( M( !^K-%%% !1110 4444 %>??M/Z?^TU?_!K6'_9#\5>$]+\>6]K)-H:^-M# MFOM-O)E1BEM,(+B!X@[;5\X,VS.[8^-I]!HH ^%/^"%/_!1WX\?\%"OA#X\? M]K.[\,Z+\5OAWXUN/#_C7X=:%X;GTZ7P^\;,(VE\^[G>42%)5W?( \,B@'9N M/>^"?C!^V_\ &/\ X*%^./AK\+_B1\/1\#?AW:V5MXBU>X\#W4NJS>(I@TTV MB6]PNH+ WV>U:TEEN#$=CW2Q>66#LGQE_P %H/ OQ0_X)K_\%#/A5_P4Y_8> M\2:3H7B7X[:]#\*?B+H&K6KR:=JMY>0LNGZM+$A&]X#$CN 06-K"!Q)-N_4# M]FK]G_P?^S!\%=$^"_@NZNKR'3(I)=0UC47WWFL:A/(T]YJ%R_\ '<7%Q)+/ M(W=Y6P , 'QY^T;\>/^"NOP%_8E^*W[<7BGXI?!O18_!^F:YKOAWXZ.F6TTQLH[N];6X=L\ENL3/MM@$9B,'I4OP$^-_P#P5Y^-G[%7PG_;<\(_ M%/X-ZZGC'1M \0>)/AU;?"#5+>[73+MX'O(K.]76YM\\4#RE-UOAV0<+T/JG M_!;K_E$3^T9_V276/_2=JN?\$8/^42W[.'_9&?#_ /Z0Q4 >#?'O]M;_ (** MZ!_P6D\*?\$Q/A5\5OA7IOAOQA\*9/&]MXGU_P"%]]J%Y8K'<7L+6;1Q:Q;I M*2;3(ERF!)RIV\[/[;?[;'_!3'_@EQX2B_:3^/'@+X0HS*#MDB/*[MB[I%\Z^./\ RMK?!K_LTN]_ M].6L5]C?\%2=4\$:/_P35^/U_P#$>2!=%'P<\2)?"Y(VN'TV=%09ZNSLJJ!R M6*@VF0.A*GE M& .&1@&5@5(!!%?./Q"_:L_:DT'_ (+4> /V-?#^F:,WPDUSX#ZIXLUZYFL& M-ZNH6VH&V+)-N 5%\VR7;@@_:')YVX\U_P"#7K0_'.@_\$1O@[;^.8[B-K@Z MW@WFB MV&K[V$D5A=3VT\\& =K*TMG;-D@D&/@@,P(!^?\ ^TM\8_\ @O\ 7/PPUO\ M;;_9JTCX+:+X+T?3IMF7 M>C>#[:7)BTF"1!%=ZY=XY2TLHYA(Q/\ K)6@MUS).@/:_LC_ +,OP]_8T_9F M\$?LM?"J.3^P? _AZWTNRFG $MR47,EQ)CCS)9"\KXXW2-C H ^,/"_[6/\ MP53_ &1/^"F'P@_9%_;:\1?#?XH>!?C[;ZU'X;\1^ /"MQI%[X>U#3K7[5,D MD$D\PDM@C(-S,S$,7W*8RC_HI7Y:?MJ>-_\ @H/^P/\ \%4?@G^V!\:O&7@7 MXJ?"'XC^++/X4V6FZ;X*?3+[P%)JTZD36N^XN'9IG@1IIS(?.6V6$QQ_N2/U M+H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!^*'PQ\ _&KX<:[\(OBIX6 MM=;\->)M)GTS7=(ODW17EK,ACDC;&#@JQ&001U!! -?GKXSL?^"@/_!!W]E. M;PK^RO\ J3]J3X.>%YKA_#FA3ZS+IWBSP7I[LT@@D:*WN%UBSB8MM:..*:) M&"E6C3>GZ444 ?!7_!)[X=?"G]M3Q/;?\%J/'7QATOXB_$?QGX630M#M-*L# M:Z=\-M/0EI]"M[>2225;M97D^T7$K;I"[&-8XI,/ZU:>&O\ @K]I/QH\9P1_ M%#X!:M\/=4U>:;P/>:EX>U:'6- M')\N&X@AE$-^8QM!/G0F0AFW(&")[!I_ M[,OP&T/XE77QB\+?#+3M"\3ZC.LNLZUXE= MW0!Y?^R+^ROX._9$^$\WP[\,ZQ=ZQJ6L>(=1\1^,?$VHQHESKVN:A<-IG2FD0I-J#DN$:^D0M'YH'[J%WBCVB69I?6_V'/@; M_P %'O OCGQ%X[_X*!?M=^&/B )M+@L?".@>!?"YTC3]/S(SW5Q.ARUQ,^RW M5&8D1*DH7'FMGZ6HH ^:O^"O/["_BO\ X*2?\$_/''[&_@GQWIWAK4_%DVE/ M;ZSJMM)-!!]DU.UO&W)'\QW+;E1CNP-?2%C;M:64-JS F*)4)'? Q4M% !11 M10 4444 %%%% !1110 4444 ?+/[8O\ P3>_X7+^TEX*_;X_9K^(EOX ^.GP M_LI-/L==O=-:\TKQ)I,F[S-)U6V1XWD@.]]DL;K)"S[QO*H%^._BY^W?^U]^ MVS^TW=?\$7_VW?A7:_LFVWCS2;BSNO&]AK4FM_\ "Q+(,J7&FZ#>RP6UO:M= M0LXWR+<2*A>(QK,0M?K57.?%+X/_ F^./A23P)\9_AEH'BS199%D?2?$FD0 MWMN9%^Z_ES*RAAU# 9!Y!% 'D'Q2_9O^/GP/_9)\)_ #_@E5K7P]^'MWX*N+ M&VTC3_'>AW-]I4^E0JXEM',$BS))(Q1VN/G=B),_-)YBYNG_ +*G[0'[0_Q& M^'?Q1_;N\0^!Y(OA?K?_ D/ACP1\/+:[>PE\0"WEMXM3N;J\(DE\B*>?R;= M8HPDDAD>24J@3WWP/X&\/_#O0$\,>%_MXLHF)ACO]7N;UHQ@ (KW$CLJ ( M"%4= *UZ "O,?VP?"G[4OCKX :YX,_8W^)/AOP=X[U2(6VF^*O%&G27<&E1M MD27$<*?ZR=1_JP^4#$,P8+L;TZB@#\UOAM^P=_P7]^$?PQM?A!\-/^"B?P+T M#2K:*1$O;/X33W%[YLKL\UV\MR[FXNI)'>5YIM[22.SN6+$GZ>^-_@+_ (*6 M>%?'O@9_V.?BM\+M2\$Z-X<33O%V@?%RTU%]2U*Y3A;U-1M"[>8R!=P>,C<' M8[RXV?1=% 'A_P !OV4?$/AO]H#Q#^V1^T!XKTO7_B=XA\,VOAFU;0=.>UTS MP]H4$[W*Z?:+*[RRM)<2---<2,#*RQA8XDC5*]PHHH **** "BBB@ HHHH * M*** */B:?Q-;:#V@=LC[\J12L@QD\(V<8XSD?%O_ M 22_P""=?[4W_!/?QI\8;WXM>/? ?BK2_C%\2[[QM?3>'S>VMQI%Y<[VDA2 M.6-UN(R3& 2\94!C\^0!]P44 %?"-G_P3R_;+M_^"Q4__!5"3Q5\-#I]Q\-Q MX)/@);_4/-6P\Q9O/^W?9L&;S5W8\@+M.SK\]?=U% 'CG[?/P9^,7[27[)/C M_P#9M^#-[X;T^^^(?@[5/#=WK?B6YG$6FV][:R6TDZ0PQ,9W"2MA2\8!P26 M*GP+]BK]D'_@J)^QC^QUX0_8[\%?%OX#R6_@W1CIFE>++[PUK-U,L?F.XEDM M!ON"B@#Y:_8+_X)<>!?V.?B?XV_:C^(OQ7UGXK?'#XENH\ M;?%+Q)9Q6TLENNW98V5K%E+&T7RX\0JSG]U&"Q6.-4^I:** /E/_ (*B?LP_ MM[_M:^#M$^%7[)7QW^'_ ()\,M:=XFU+PQ=ZI-/K.E6TD,$XNM0N+M0J2?,-JS!3GNIKZ:HH **** M"BBB@ HHHH **** /B#_ (+ ?\$Z_P!J+_@HQ=?"O1?A)X^\">$]*^%GQ+L/ M&UM>>(/MEU<:G>VJ$1P-%%&BP1 O)DAY"V5/R8(/V?X5G\57/A^UF\;Z7I]E MJK(?MMMI5_)=6Z-DXV2R11,P(P>47!)'.,G0HH \$_X*6?LY_&?]L#]CCQS^ MRI\&M6\,Z3/\0/#USHVHZ_XEGN"NG03!59XX(8F,[E"X&9(PIVGY^5J?_@G% M^S[\9/V2_P!CSP)^RU\9-3\-:I<_#WPQ9Z%I^O>&[BXV:C;V\?EI))#-$I@< M(J @/(&.3\O"U[I10!\!_&K_ ()U_MX^.O\ @K1X=_X*B?#WQ]\)-,?PI\.' M\%Z5X.UI=3NUFLGFNIFN);B)(2)BUT^%5-JA5'S\L>C_ &H/^";7[4W_ 4? MLM/^%W[=_P"U%H6D_"*WU""\UWX6?"#0+FS?Q.\+B2./4-5N[AY3;AU4^3## M%DX;?O1&7[9HH S/!?@SPI\.?!^E?#_P'X>M-(T/0].AL-'TK3X!%!9VL*". M*&-!PJ*BJH Z "K>KG5ETFZ;04MVOA;O]B6\9EB,NT[ Y4$A=V,D G&<"K%% M 'YM>&?V%?\ @OMX/^)WB_XNZ%^W]\!?[<\9WZRZC?7OPNO+B2WM8]WV;3X& MDE)BM( [^7$.-TDLC;Y99)'][TWX&?\ !53P;^QG_P (]X<_; \!:_\ 'V[\ M5MJNK^*O%OA*8^'9K3S-BZ;;VENR/9Q"W2 ;U#,9!,Y&^8R+]544 ?,MO^RI M^T?^TKXP^'?C3]O?Q%X!^Q?#/Q)#XGT7P7\-[6\>SOO$$$D2-'; M^;))%;)&N)MDCRR!%2OIJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "OB7XK_M=?M#>&OBCXE\.:)\0?(LM/U^\ MMK2'^R;1O+B2=U1P:_+;13?9HHML0@@8+B-5!Y=CG&>?I7KM>!_\$Z?^2): MI_V-4_\ Z36U>^4 %%%% !7B'Q!_X*3_ +!GPJ\>:E\-?B%^U7X.TO5]#N%M M_$"7&J P:-,V,17MPH,-D^"#MG=" 0<8->R:_::G?Z%>V.BZD+.\FM)([2\, M8?R)2I"R;3UVD@X[XK\:?^"/'_!4WX/_ /!.3PJW_!'K_@K!X%E^$/Q%T#7- M4+>-?%$!?1/&POKV>=KZ>\<8W2^:R_:)2894C4F56_=@ _8#X8_%KX8?&KPO M_P )O\(?'VD^)M&^V3VJ:MH=\ES;230N8Y526,E7VNI4E21D$=JXKXO?MQ?L ME_ GQPGPO^)WQVT.R\526GVH>%+.1[W55MSTF:RM5DG6,YXRLI]>U;=9I&HRCP02W MP<*/E,4(4<5W/_!$']F#0O@!_P $^? ?Q"UB>36/B%\6O#UEXX^)WC34W,VI M:YJNI0K=L;B=LM((5F$*#. L>0,LQ(![C\*?VS/V4_CCXBA\&_"/]H#PMK^M MRK.7T'3M6C>_M_)"&43VV?-MV421DK*JGYUXY%=SXR\9^#_AUX4U'QW\0/%6 MG:'H>D6CW6JZQJ][';6MG @W/+++(0D:* 268@ 5\O?%/QW_ ,$S+G_@H5X% M^*>K_M/_ UT#XX>$K+4= DT1]?LX]8UG3;N)@;"6'S%F?RYXHYHV*OLV3*H M'FLP\9_X.GK^\LO^"1OB672O&6DV5W:^+=#U >']4ODC/B2&VO8YI;)(F8&X MVJOVAHUR=ELYQ\M 'V7\!_VT/V6?VG-:O?#7P*^-FC>(=3L-/BU"YTRWD>*Y M^Q2DK'>)%*JO);.1A9T#1L> QKT^OS>\)_M6:;\:[#2O^#@#Q%\+-8TWX/?# M/X*ZQ:>%?#'AJ\T^\\0:Q;W=S:RZIJ%T!@)K=K\NO^"]'P2^-?_!2#0?''[.G[.?BW4].E_9S\$0_ M$2=M(?#ZGXP=S+I6F CDR1Z=;ZA-M!R)-0L'R ,'[%_X);?MK:-_P4*_8)^& MW[5VGS0?;_$6@)'XFM8, 6FKVY,%]%M_A47$-?'_@CX<:,?$'CWQ78:19 [1<:A=+$K-_=7)^9O89-'C_ M ,:Z-\./!&K>/?$#L++2+"6ZN GWF5%)VKZL<8 ]2*_*+XW_ !O\=?'SQU<^ M./'&I/(TCL+*R5SY-E#GY8HU/0#N>K'DY)K[O@G@FOQ;7G*4^2C"W-*UVV_L MQZ7MN^FFCN? \<\GZCI^KV,6IZ3?0W5M/&'@N+>4/ M'(IZ,K#((/J*_&&OH+]@C]J/Q%\'OB;I_P /-, M%?&YE##9I1C&,VDI0NN5O1(9O"/[/?[6/PX\;:O;1&6XTCPMXTL;Z[CC !+M##*SA<$?-C'O7P7_P= M52:;9_LS_LY:KJ*?$W]K+Q+#\9-7_9Q_9K^$$?Q!\;>&M"M=7\5P7OB1 M-(TS1(+HRBTAGNS%._VJX$$S1PI"^$C+RM$KQ&3P?PK_ ,%R/ACXF_8W^+O[ M3B?LS>/#XE^ FN7^C?ݮ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end GRAPHIC 19 ew-20240930_g8.jpg begin 644 ew-20240930_g8.jpg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

  •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ew-20240930_g9.jpg begin 644 ew-20240930_g9.jpg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�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�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end XML 22 R1.htm IDEA: XBRL DOCUMENT v3.24.3
    COVER - shares
    shares in Millions
    		 9 Months Ended
    Sep. 30, 2024
    Oct. 31, 2024
    Cover [Abstract]    
    Document Type 10-Q  
    Document Quarterly Report true  
    Document Period End Date Sep. 30, 2024  
    Document Transition Report false  
    Entity File Number 1-15525  
    Entity Registrant Name EDWARDS LIFESCIENCES CORPORATION  
    Entity Incorporation, State or Country Code DE  
    Entity Tax Identification Number 36-4316614  
    Entity Address, Address Line One One Edwards Way  
    Entity Address, City or Town Irvine  
    Entity Address, State or Province CA  
    Zip Code 92614  
    City Area Code 949  
    Local Phone Number 250-2500  
    Title of 12(b) Security Common Stock, par value $1.00 per share  
    Trading Symbol EW  
    Security Exchange Name NYSE  
    Entity Current Reporting Status Yes  
    Entity Interactive Data Current Yes  
    Entity Filer Category Large Accelerated Filer  
    Entity Small Business false  
    Entity Emerging Growth Company false  
    Entity Shell Company false  
    Entity Common Stock, Shares Outstanding   589.8
    Entity Central Index Key 0001099800  
    Current Fiscal Year End Date --12-31  
    Document Fiscal Year Focus 2024  
    Document Fiscal Period Focus Q3  
    Amendment Flag false  
    XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Current assets    
    Cash and cash equivalents $ 3,676.4 $ 1,132.3
    Short-term investments (Note 6) 769.7 500.5
    Accounts receivable, net of allowances of $12.6 and $8.2, respectively 716.0 771.5
    Other receivables 95.5 56.6
    Inventories (Note 2) 1,104.2 903.5
    Prepaid expenses 114.9 128.8
    Other current assets 231.0 224.9
    Current assets of discontinued operations (Note 5) 20.0 317.6
    Total current assets 6,727.7 4,035.7
    Long-term investments (Note 6) 319.6 583.9
    Property, plant, and equipment, net 1,675.7 1,591.0
    Operating lease right-of-use assets 104.4 84.4
    Goodwill 1,605.3 1,145.1
    Other intangible assets, net 956.1 399.4
    Deferred income taxes 888.4 749.4
    Other assets (Note 2) 683.5 463.2
    Non-current assets of discontinued operations (Note 5) 10.5 311.1
    Total assets 12,971.2 9,363.2
    Current liabilities    
    Accounts payable 172.8 186.6
    Accrued and other liabilities (Note 2) 1,745.3 856.4
    Operating lease liabilities 24.2 22.9
    Current liabilities of discontinued operations (Note 5) 1.8 129.5
    Total current liabilities 1,944.1 1,195.4
    Long-term debt 597.5 597.0
    Taxes payable 1.1 80.6
    Operating lease liabilities 85.0 65.2
    Uncertain tax positions 345.6 335.0
    Litigation settlement accrual 63.9 94.2
    Other liabilities 322.6 251.3
    Non-current liabilities of discontinued operations (Note 5) 0.0 25.1
    Total liabilities 3,359.8 2,643.8
    Commitments and contingencies (Note 13)
    Stockholders' equity    
    Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding           0.0 0.0
    Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively 654.3 650.5
    Additional paid-in capital 2,452.1 2,274.4
    Retained earnings 12,781.4 8,992.4
    Accumulated other comprehensive loss (Note 14) (252.5) (242.8)
    Treasury stock, at cost, 64.5 and 49.4 shares, respectively (6,089.7) (5,024.5)
    Total Edwards Lifesciences Corporation stockholders' equity 9,545.6 6,650.0
    Noncontrolling interest 65.8 69.4
    Total stockholders' equity 9,611.4 6,719.4
    Total liabilities and equity $ 12,971.2 $ 9,363.2
    XML 24 R3.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Statement of Financial Position [Abstract]    
    Allowance for doubtful accounts $ 12.6 $ 8.2
    Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
    Preferred stock, shares authorized (in shares) 50,000,000.0 50,000,000.0
    Preferred stock, shares outstanding (in shares) 0 0
    Common stock, par value (in dollars per share) $ 1.00 $ 1.00
    Common stock, shares authorized (in shares) 1,050,000,000 1,050,000,000
    Common stock, shares issued (in shares) 654,300,000 650,500,000
    Common stock, shares outstanding (in shares) 589,800,000 601,100,000
    Treasury stock (in shares) 64,500,000 49,400,000
    XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Income Statement [Abstract]        
    Net sales $ 1,354.4 $ 1,243.4 $ 4,053.7 $ 3,743.6
    Cost of sales 262.9 250.6 825.3 727.4
    Gross profit 1,091.5 992.8 3,228.4 3,016.2
    Selling, general, and administrative expenses 421.4 381.9 1,297.3 1,165.9
    Research and development expenses 253.4 242.8 781.9 720.8
    Intellectual property agreement and certain litigation expenses (Note 3) 10.8 2.2 27.8 193.6
    Change in fair value of contingent consideration liabilities (Note 9) 0.0 0.0 0.0 (26.2)
    Restructuring expenses (Note 4) 32.9 0.0 32.9 0.0
    Other operating expenses, net 22.4 0.0 22.4 0.0
    Operating income, net 350.6 365.9 1,066.1 962.1
    Interest income, net (24.3) (15.1) (56.3) (32.8)
    Other non-operating income, net (27.9) (6.6) (35.6) (10.3)
    Income from continuing operations before provision for income taxes 402.8 387.6 1,158.0 1,005.2
    Provision for income taxes 40.7 52.7 107.0 118.3
    Net income from continuing operations 362.1 334.9 1,051.0 886.9
    Income from discontinued operations, net of tax 2,707.3 48.8 2,734.4 142.8
    Net income 3,069.4 383.7 3,785.4 1,029.7
    Net loss attributable to noncontrolling interest (1.4) (1.2) (3.6) (2.8)
    Net income attributable to Edwards Lifesciences Corporation $ 3,070.8 $ 384.9 $ 3,789.0 $ 1,032.5
    Basic:        
    Continuing operations (in dollars per share) $ 0.61 $ 0.55 $ 1.76 $ 1.47
    Discontinued operations (in dollars per share) 4.53 0.08 4.55 0.23
    Basic earnings per share (in dollars per share) 5.14 0.63 6.31 1.70
    Diluted:        
    Continuing operations (in dollars per share) 0.61 0.55 1.75 1.46
    Discontinued operations (in dollars per share) 4.52 0.08 4.54 0.23
    Diluted earnings per share (in dollars per share) $ 5.13 $ 0.63 $ 6.29 $ 1.69
    Weighted-average number of common shares outstanding:        
    Basic (in shares) 597.2 607.0 600.3 607.2
    Diluted (in shares) 598.1 609.5 602.2 610.2
    XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Statement of Comprehensive Income [Abstract]        
    Net income $ 3,069.4 $ 383.7 $ 3,785.4 $ 1,029.7
    Other comprehensive (loss) income, net of tax (Note 14):        
    Foreign currency translation adjustments 4.3 (23.4) (20.8) (31.1)
    Unrealized (loss) gain on hedges (42.7) 18.2 (8.9) 6.3
    Unrealized pension credits 0.0 0.0 0.2 0.1
    Unrealized gain on available-for-sale investments 6.1 10.6 19.8 29.5
    Other comprehensive (loss) income, net of tax (32.3) 5.4 (9.7) 4.8
    Comprehensive income 3,037.1 389.1 3,775.7 1,034.5
    Comprehensive loss attributable to noncontrolling interest (1.4) (1.2) (3.6) (2.8)
    Comprehensive income attributable to Edwards Lifesciences Corporation $ 3,038.5 $ 390.3 $ 3,779.3 $ 1,037.3
    XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Cash flows from operating activities    
    Net income $ 3,785.4 $ 1,029.7
    Adjustments to reconcile net income to net cash provided by operating activities:    
    Depreciation and amortization 112.6 108.2
    Non-cash operating lease cost 21.6 20.7
    Stock-based compensation 130.6 108.9
    Gain on sale of business (Note 5) (3,337.4) 0.0
    Change in fair value of contingent consideration liabilities (Note 9) 0.0 (26.2)
    Deferred income taxes (224.9) (180.7)
    Gain on remeasurement of previously held interest upon acquisition (Note 8) (24.6) 0.0
    Other 2.7 8.8
    Changes in operating assets and liabilities:    
    Accounts and other receivables, net 15.3 (123.0)
    Inventories (204.9) (189.7)
    Accounts payable and accrued liabilities 92.6 112.6
    Income taxes 301.8 106.3
    Prepaid expenses and other current assets 27.4 (63.7)
    Intellectual property agreement accrual (24.3) (26.0)
    Long-term prepaid royalties (Note 3) 6.2 (111.9)
    Other (10.3) (14.8)
    Net cash provided by operating activities 669.8 759.2
    Cash flows from investing activities    
    Capital expenditures (202.6) (164.7)
    Purchases of held-to-maturity investments (Note 6) (36.3) (23.5)
    Proceeds from held-to-maturity investments (Note 6) 50.4 91.5
    Purchases of available-for-sale investments (Note 6) (518.8) (8.4)
    Proceeds from available-for-sale investments (Note 6) 539.1 486.9
    Investments in intangible assets (25.4) (13.3)
    Proceeds from sale of business 3,927.4 0.0
    Business combination, net of cash (763.6) (141.2)
    Payment for acquisition options (Note 7) (16.2) (15.0)
    Issuances of notes receivable (28.0) (47.5)
    Other (36.4) (5.1)
    Net cash provided by investing activities 2,889.6 159.7
    Cash flows from financing activities    
    Purchases of treasury stock (1,059.3) (431.2)
    Equity forward contract related to accelerated share repurchase agreement (Note 12) (100.0) 0.0
    Proceeds from stock plans 150.9 136.7
    Other (3.2) (3.3)
    Net cash used in financing activities (1,011.6) (297.8)
    Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash (12.4) 20.2
    Net increase in cash, cash equivalents, and restricted cash 2,535.4 641.3
    Cash, cash equivalents, and restricted cash at beginning of period 1,148.0 772.6
    Cash, cash equivalents, and restricted cash at end of period (Note 2) $ 3,683.4 $ 1,413.9
    XML 28 R7.htm IDEA: XBRL DOCUMENT v3.24.3
    CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
    shares in Millions, $ in Millions
    Total
    Total Edwards Lifesciences Corporation Stockholders' Equity
    Common Stock
    Treasury Stock
    Additional Paid-in Capital
    Retained Earnings
    Accumulated Other Comprehensive Loss
    Noncontrolling Interest
    Common stock, beginning balance (in shares) at Dec. 31, 2022     646.3          
    Beginning balance at Dec. 31, 2022 $ 5,806.7 $ 5,806.7 $ 646.3 $ (4,144.0) $ 1,969.3 $ 7,590.0 $ (254.9) $ 0.0
    Treasury stock, beginning balance (in shares) at Dec. 31, 2022       38.0        
    Increase (Decrease) in Stockholders' Equity                
    Net income 340.5 340.5       340.5    
    Other comprehensive gain (loss), net of tax (0.5) (0.5)         (0.5)  
    Common stock issued under stock plans (in shares)     0.8          
    Common stock issued under stock plans 41.9 41.9 $ 0.8   41.1      
    Stock-based compensation expense 38.9 38.9     38.9      
    Purchases of treasury stock (in shares)       3.1        
    Purchases of treasury stock (249.5) (249.5)   $ (249.5)        
    Changes to noncontrolling interest 84.0             84.0
    Common stock, ending balance (in shares) at Mar. 31, 2023     647.1          
    Ending balance at Mar. 31, 2023 6,062.0 5,978.0 $ 647.1 $ (4,393.5) 2,049.3 7,930.5 (255.4) 84.0
    Treasury stock, ending balance (in shares) at Mar. 31, 2023       41.1        
    Common stock, beginning balance (in shares) at Dec. 31, 2022     646.3          
    Beginning balance at Dec. 31, 2022 5,806.7 5,806.7 $ 646.3 $ (4,144.0) 1,969.3 7,590.0 (254.9) 0.0
    Treasury stock, beginning balance (in shares) at Dec. 31, 2022       38.0        
    Increase (Decrease) in Stockholders' Equity                
    Net income 1,029.7              
    Common stock, ending balance (in shares) at Sep. 30, 2023     649.9          
    Ending balance at Sep. 30, 2023 6,727.1 6,657.5 $ 649.9 $ (4,576.1) 2,211.3 8,622.5 (250.1) 69.6
    Treasury stock, ending balance (in shares) at Sep. 30, 2023       43.4        
    Common stock, beginning balance (in shares) at Mar. 31, 2023     647.1          
    Beginning balance at Mar. 31, 2023 6,062.0 5,978.0 $ 647.1 $ (4,393.5) 2,049.3 7,930.5 (255.4) 84.0
    Treasury stock, beginning balance (in shares) at Mar. 31, 2023       41.1        
    Increase (Decrease) in Stockholders' Equity                
    Net income 305.5 307.1       307.1   (1.6)
    Other comprehensive gain (loss), net of tax (0.1) (0.1)         (0.1)  
    Common stock issued under stock plans (in shares)     2.0          
    Common stock issued under stock plans 60.8 60.8 $ 2.0   58.8      
    Stock-based compensation expense 37.4 37.4     37.4      
    Purchases of treasury stock (in shares)       0.1        
    Purchases of treasury stock (7.5) (7.5)   $ (7.5)        
    Changes to noncontrolling interest (11.6)             (11.6)
    Common stock, ending balance (in shares) at Jun. 30, 2023     649.1          
    Ending balance at Jun. 30, 2023 6,446.5 6,375.7 $ 649.1 $ (4,401.0) 2,145.5 8,237.6 (255.5) 70.8
    Treasury stock, ending balance (in shares) at Jun. 30, 2023       41.2        
    Increase (Decrease) in Stockholders' Equity                
    Net income 383.7 384.9       384.9   (1.2)
    Other comprehensive gain (loss), net of tax 5.4 5.4         5.4  
    Common stock issued under stock plans (in shares)     0.8          
    Common stock issued under stock plans 34.0 34.0 $ 0.8   33.2      
    Stock-based compensation expense 32.6 32.6     32.6      
    Purchases of treasury stock (in shares)       2.2        
    Purchases of treasury stock (175.1) (175.1)   $ (175.1)        
    Common stock, ending balance (in shares) at Sep. 30, 2023     649.9          
    Ending balance at Sep. 30, 2023 $ 6,727.1 6,657.5 $ 649.9 $ (4,576.1) 2,211.3 8,622.5 (250.1) 69.6
    Treasury stock, ending balance (in shares) at Sep. 30, 2023       43.4        
    Common stock, beginning balance (in shares) at Dec. 31, 2023 601.1   650.5          
    Beginning balance at Dec. 31, 2023 $ 6,719.4 6,650.0 $ 650.5 $ (5,024.5) 2,274.4 8,992.4 (242.8) 69.4
    Treasury stock, beginning balance (in shares) at Dec. 31, 2023 49.4     49.4        
    Increase (Decrease) in Stockholders' Equity                
    Net income $ 351.0 351.9       351.9   (0.9)
    Other comprehensive gain (loss), net of tax 9.5 9.5         9.5  
    Common stock issued under stock plans (in shares)     1.3          
    Common stock issued under stock plans 62.1 62.1 $ 1.3   60.8      
    Stock-based compensation expense 44.6 44.6     44.6      
    Purchases of treasury stock (0.2) (0.2)   $ (0.2)        
    Common stock, ending balance (in shares) at Mar. 31, 2024     651.8          
    Ending balance at Mar. 31, 2024 $ 7,186.4 7,117.9 $ 651.8 $ (5,024.7) 2,379.8 9,344.3 (233.3) 68.5
    Treasury stock, ending balance (in shares) at Mar. 31, 2024       49.4        
    Common stock, beginning balance (in shares) at Dec. 31, 2023 601.1   650.5          
    Beginning balance at Dec. 31, 2023 $ 6,719.4 6,650.0 $ 650.5 $ (5,024.5) 2,274.4 8,992.4 (242.8) 69.4
    Treasury stock, beginning balance (in shares) at Dec. 31, 2023 49.4     49.4        
    Increase (Decrease) in Stockholders' Equity                
    Net income $ 3,785.4              
    Common stock, ending balance (in shares) at Sep. 30, 2024 589.8   654.3          
    Ending balance at Sep. 30, 2024 $ 9,611.4 9,545.6 $ 654.3 $ (6,089.7) 2,452.1 12,781.4 (252.5) 65.8
    Treasury stock, ending balance (in shares) at Sep. 30, 2024 64.5     64.5        
    Common stock, beginning balance (in shares) at Mar. 31, 2024     651.8          
    Beginning balance at Mar. 31, 2024 $ 7,186.4 7,117.9 $ 651.8 $ (5,024.7) 2,379.8 9,344.3 (233.3) 68.5
    Treasury stock, beginning balance (in shares) at Mar. 31, 2024       49.4        
    Increase (Decrease) in Stockholders' Equity                
    Net income 365.0 366.3       366.3   (1.3)
    Other comprehensive gain (loss), net of tax 13.1 13.1         13.1  
    Common stock issued under stock plans (in shares)     1.7          
    Common stock issued under stock plans 54.3 54.3 $ 1.7   52.6      
    Stock-based compensation expense 43.9 43.9     43.9      
    Purchases of treasury stock (in shares)       1.8        
    Purchases of treasury stock (158.1) (158.1)   $ (158.1)        
    Common stock, ending balance (in shares) at Jun. 30, 2024     653.5          
    Ending balance at Jun. 30, 2024 7,504.6 7,437.4 $ 653.5 $ (5,182.8) 2,476.3 9,710.6 (220.2) 67.2
    Treasury stock, ending balance (in shares) at Jun. 30, 2024       51.2        
    Increase (Decrease) in Stockholders' Equity                
    Net income 3,069.4 3,070.8       3,070.8   (1.4)
    Other comprehensive gain (loss), net of tax (32.3) (32.3)         (32.3)  
    Common stock issued under stock plans (in shares)     0.8          
    Common stock issued under stock plans 34.5 34.5 $ 0.8   33.7      
    Stock-based compensation expense 42.1 42.1     42.1      
    Purchases of treasury stock (in shares)       13.3        
    Purchases of treasury stock $ (1,006.9) (1,006.9)   $ (906.9) (100.0)      
    Common stock, ending balance (in shares) at Sep. 30, 2024 589.8   654.3          
    Ending balance at Sep. 30, 2024 $ 9,611.4 $ 9,545.6 $ 654.3 $ (6,089.7) $ 2,452.1 $ 12,781.4 $ (252.5) $ 65.8
    Treasury stock, ending balance (in shares) at Sep. 30, 2024 64.5     64.5        
    XML 29 R8.htm IDEA: XBRL DOCUMENT v3.24.3
    BASIS OF PRESENTATION
    		 9 Months Ended
    Sep. 30, 2024
    Accounting Policies [Abstract]  
    BASIS OF PRESENTATION BASIS OF PRESENTATION
    The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.

    The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

    On September 3, 2024, the Company sold its Critical Care product group ("Critical Care"). The historical results of Critical Care are reflected as discontinued operations in the Company's consolidated condensed financial statements for all periods presented. In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the historical results of a small non-core product group that the Company plans to sell are also included in discontinued operations. Unless otherwise indicated, the information in the notes to the consolidated condensed financial statements refer only to Edwards Lifesciences' continuing operations. For more information, see Note 5.

    The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

    In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

    There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.

    Recently Adopted Accounting Standards

    In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

    New Accounting Standards Not Yet Adopted

    In November 2024, the FASB issued an amendment to the accounting guidance on income statement presentation to require disclosure, in the notes to the financial statements, of disaggregated information about certain costs and expenses, including purchases of inventory, employee compensation, and depreciation and amortization included in each relevant expense caption within continuing operations. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.

    In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay
    to allow the legal process to proceed. The Company is currently evaluating the disclosure impact the guidance will have on its consolidated financial statements.

    In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

    In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.
    XML 30 R9.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
    		 9 Months Ended
    Sep. 30, 2024
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
    Composition of Certain Financial Statement Captions
    (in millions)

    Components of selected captions in the consolidated condensed balance sheets consisted of the following:
    September 30,
    2024    		December 31, 2023
    Inventories
    Raw materials$248.8 $196.3 
    Work in process244.4 195.8 
    Finished products611.0 511.4 
    $1,104.2 $903.5 

    At September 30, 2024 and December 31, 2023, $187.8 million and $164.6 million, respectively, of the Company's finished products inventories were held on consignment.
    September 30,
    2024    		December 31, 2023
    Other assets
    Tax receivable (Note 16)$293.7 $— 
    Notes and other receivables132.9 155.1 
    Acquisition options117.5 161.3 
    Long-term prepaid royalties103.7 109.9 
    Fair value of derivatives21.8 23.4 
    Other long-term assets13.9 13.5 
    $683.5 $463.2 
    Accrued and other liabilities 
    Employee compensation and withholdings$312.1 $316.4 
    Taxes payable (Note 5)715.1 52.7 
    Property, payroll, and other taxes83.7 53.8 
    Research and development accruals79.0 71.6 
    Accrued rebates140.0 123.5 
    Fair value of derivatives24.3 15.2 
    Accrued marketing expenses14.5 13.7 
    Legal and insurance29.5 28.9 
    Litigation settlement75.1 69.1 
    Accrued relocation costs16.2 16.9 
    Accrued professional services62.2 8.5 
    Accrued realignment reserves39.6 6.4 
    Unfavorable contract liability66.0 — 
    Other accrued liabilities88.0 79.7 
    $1,745.3 $856.4 

    Supplemental Cash Flow Information
    (in millions)
    Nine Months Ended
    September 30,
    20242023
    Cash paid during the year for:
    Income taxes (a) (Note 16)
    		$633.8 $219.1 
    Amounts included in the measurement of operating lease liabilities$21.0 $19.1 
    Non-cash investing and financing transactions:  
    Right-of-use assets obtained in exchange for new lease liabilities$38.9 $19.9 
    Capital expenditures accruals$22.9 $32.5 
    ______________________________________
    (a)     Includes cash paid for income taxes from discontinued operations of $29.7 million and $22.7 million for the nine months ended September 30, 2024 and 2023, respectively.
    Cash, Cash Equivalents, and Restricted Cash
    (in millions)
    September 30,
    2024    		December 31, 2023
    Continuing operations
    Cash and cash equivalents$3,676.4 $1,132.3 
    Restricted cash included in other current assets3.2 3.3 
    Restricted cash included in other assets0.9 0.7 
    Total$3,680.5 $1,136.3 
    Discontinued operations
    Cash and cash equivalents$2.9 $11.7 
    Total$2.9 $11.7 
    Total cash, cash equivalents, and restricted cash$3,683.4 $1,148.0 

    Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.
    XML 31 R10.htm IDEA: XBRL DOCUMENT v3.24.3
    INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES
    		 9 Months Ended
    Sep. 30, 2024
    Commitments and Contingencies Disclosure [Abstract]  
    INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSESOn April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalties tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in Intellectual Property Agreement and Certain Litigation Expenses in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in Intellectual Property Agreement and Certain Litigation Expenses in April 2023 related to products currently in development.
    XML 32 R11.htm IDEA: XBRL DOCUMENT v3.24.3
    RESTRUCTURING EXPENSES
    		 9 Months Ended
    Sep. 30, 2024
    Restructuring and Related Activities [Abstract]  
    RESTRUCTURING EXPENSES RESTRUCTURING EXPENSES
    In September 2024, the Company recorded an expense of $32.9 million related primarily to severance expenses associated with a global workforce realignment impacting approximately 360 employees. As of September 30, 2024, the Company's remaining severance obligations of $30.6 million are expected to be substantially paid within the next 12 months.
    XML 33 R12.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS
    		 9 Months Ended
    Sep. 30, 2024
    Discontinued Operations and Disposal Groups [Abstract]  
    DISCONTINUED OPERATIONS DISCONTINUED OPERATIONS
    On June 3, 2024, the Company entered into a definitive agreement to sell its Critical Care product group ("Critical Care") to Becton, Dickinson and Company ("BD"). In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the Company has committed to a plan to sell a non-core product group, with the sale expected to occur within the next 12 months.

    Critical Care and the aforementioned non-core product group (collectively, the "discontinued product groups") were historically reported in each of the Company's segments (United States, Europe, Japan, and Rest of World).

    The Company concluded that the Critical Care product group met the criteria to be classified as held-for-sale in June 2024 and that the non-core product group met the criteria to be classified as held-for-sale in September 2024. The Company determined that, when considered together, the conditions for discontinued operations presentation had been met with respect to the discontinued product groups. A component of an entity is reported in discontinued operations after meeting the criteria for held-for-sale classification if the disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial results. The Company analyzed the quantitative and qualitative factors relevant to the discontinued product groups, including their significance to the Company’s overall net income and total assets, and determined that those
    conditions for discontinued operations presentation had been met. As such, the historical financial condition and results of the discontinued product groups have been reflected as discontinued operations in the Company's consolidated condensed financial statements. The assets and liabilities associated with discontinued product groups are classified as assets and liabilities of discontinued operations in the Company's consolidated condensed balance sheets. Prior period amounts have been adjusted to reflect the discontinued operations presentation.

    On September 3, 2024, Critical Care was sold for $4.2 billion, which is subject to a further working capital adjustment, resulting in a gain of $3.3 billion which was included in Income from Discontinued Operations, net of tax.

    In connection with the sale of Critical Care, the Company entered into a Transition Services Agreement ("TSA") to provide certain support services for up to 36 months from the closing date of the sale (with certain extension rights as provided therein). These support services may be in the areas of accounting, information technology, human resources, quality assurance, regulatory affairs, customer support, and global supply chain, among others. In connection with the TSA, the Company recognized an unfavorable contract liability of $115.1 million, which will be recognized over the TSA term.

    In addition, Edwards and BD entered into other agreements to provide a framework for the ongoing activities between the Company and BD after the sale and until the end of the TSA including, but not limited to, interim operating model agreements to support the commercial operations until full transfer of all regulatory licenses to BD and completion of services under the TSA agreement, a manufacturing and supply agreement, and a quality agreement. Under these agreements, the Company will continue to provide certain services to BD during the term of these agreements including serving as an undisclosed selling and purchasing agent for the Critical Care business on behalf of BD for a period of up to 36 months.

    As of September 30, 2024, the Company had a receivable of approximately $24.6 million from BD related to the services under the agreements. The Company recorded income from the TSA of $7.6 million during the three and nine months ended September 30, 2024, which is recorded in Other Operating Expenses, net on the Company's consolidated condensed statements of operations.

    Details of Income from Discontinued Operations are as follows (in millions):

     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net sales$177.2 $237.5 $708.4 $727.1 
    Cost of sales65.4 99.8 265.1 295.5 
    Gross profit111.8 137.7 443.3 431.6 
    Selling, general, and administrative expenses40.9 57.7 163.2 178.7 
    Research and development expenses21.4 27.5 81.3 81.0 
    Separation costs81.5 — 202.5 — 
    Operating (loss) income, net(32.0)52.5 (3.7)171.9 
    Other non-operating (income) expense, net(3,338.9)0.8 (3,337.5)0.7 
    Income from discontinued operations before provision for income taxes3,306.9 51.7 3,333.8 171.2 
    Provision for income taxes from discontinued operations599.6 2.9 599.4 28.4 
    Net income from discontinued operations2,707.3 48.8 2,734.4 142.8 

    Separation costs related primarily to consulting, legal, tax, and other professional advisory services associated with the sale of Critical Care.
    Details of assets and liabilities of discontinued operations are as follows (in millions):

     September 30,
    2024    		December 31,
    2023
    Cash and cash equivalents$2.9 $11.7 
    Accounts receivable, net of allowances— 3.6 
    Other receivables— 5.2 
    Inventories17.1 264.7 
    Prepaid expenses— 18.0 
    Other current assets— 14.4 
    Total current assets of discontinued operations$20.0 $317.6 
    Property, plant, and equipment, net3.1 158.4 
    Operating lease right-of-use assets — 9.6 
    Goodwill 7.4 108.4 
    Other intangible assets, net— 29.0 
    Deferred income taxes— 5.2 
    Other assets— 0.5 
    Total non-current assets of discontinued operations$10.5 $311.1 
    Accounts payable$— $14.8 
    Accrued and other liabilities1.8 112.7 
    Operating lease liabilities— 2.0 
    Total current liabilities of discontinued operations$1.8 $129.5 
    Operating lease liabilities — 7.8 
    Uncertain tax positions— 4.3 
    Other liabilities— 13.0 
    Total non-current liabilities of discontinued operations$— $25.1 

    Cash flows attributable to the Company's discontinued operations are included in the Company's consolidated condensed statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following (in millions):

     Nine Months Ended
    September 30,
     20242023
    Depreciation and amortization12.1 16.2 
    Stock-based compensation16.7 11.6 
    Inventory write off17.0 13.2 
    Capital expenditures16.4 21.0 
    XML 34 R13.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS
    		 9 Months Ended
    Sep. 30, 2024
    Investments, Debt and Equity Securities [Abstract]  
    INVESTMENTS INVESTMENTS
    Debt Securities

    Investments in debt securities at the end of each period were as follows (in millions):
     September 30, 2024December 31, 2023
    Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
    Bank time deposits$50.5 $— $— $50.5 $64.5 $— $— $64.5 
    Available-for-sale
    Bank time deposits$17.6 $— $— $17.6 $— $— $— $— 
    Commercial paper112.9 — — 112.9 — — — — 
    U.S. government and agency securities185.2 0.1 (1.2)184.1 72.7 0.1 (2.8)70.0 
    Asset-backed securities80.2 — (1.6)78.6 192.1 — (7.8)184.3 
    Corporate debt securities502.2 0.1 (4.0)498.3 658.5 — (16.7)641.8 
    Municipal securities2.8 — (0.1)2.7 2.8 — (0.2)2.6 
    Total$900.9 $0.2 $(6.9)$894.2 $926.1 $0.1 $(27.5)$898.7 
    The cost and fair value of investments in debt securities, by contractual maturity, as of September 30, 2024, were as follows:
    Held-to-MaturityAvailable-for-Sale
     Amortized CostFair ValueAmortized CostFair Value
     (in millions)
    Due in 1 year or less$50.5 $50.5 $721.1 $719.2 
    Due after 1 year through 5 years— — 81.4 79.2 
    Instruments not due at a single maturity date (a)
    		— — 98.4 95.8 
    $50.5 $50.5 $900.9 $894.2 
    _______________________________________
    (a)     Consists of mortgage-backed and asset-backed securities.
    Actual maturities may differ from the contractual maturities due to call or prepayment rights.
    The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024 and December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

    September 30, 2024
    Less than 12 Months12 Months or GreaterTotal
    Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
    U.S. government and agency securities$— $— $34.0 $(1.2)$34.0 $(1.2)
    Asset-backed securities3.6 (0.1)65.3 (1.5)68.9 (1.6)
    Corporate debt securities— — 193.0 (4.0)193.0 (4.0)
    Municipal securities— — 2.7 (0.1)2.7 (0.1)
    $3.6 $(0.1)$295.0 $(6.8)$298.6 $(6.9)
    December 31, 2023
    Less than 12 Months12 Months or GreaterTotal
    Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
    U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
    Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
    Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
    Municipal securities— — 2.6 (0.2)2.6 (0.2)
    $35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)

    The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of September 30, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

    Investments in Unconsolidated Entities

    The Company has a number of equity investments in unconsolidated entities. These investments are recorded in Long-term Investments on the consolidated condensed balance sheets, and are as follows:
     September 30,
    2024    		December 31,
    2023
     (in millions)
    Equity method investments  
    Carrying value of equity method investments$32.3 $33.6 
    Equity securities  
    Carrying value of marketable equity securities7.4 — 
    Carrying value of non-marketable equity securities104.9 87.6 
    Total investments in unconsolidated entities$144.6 $121.2 

    The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

    Marketable equity securities consist of investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $0.5 million and a downward adjustment of $2.4 million during the nine months ended September 30, 2024 based on observable price changes. As of September 30, 2024, the Company had recorded cumulative upward adjustments of $9.3 million based on observable price changes, and cumulative downward adjustments of $5.5 million due to impairments and observable price changes.
    During the three and nine months ended September 30, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material.
    XML 35 R14.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS IN VARIABLE INTEREST ENTITIES
    		 9 Months Ended
    Sep. 30, 2024
    Variable Interest Entities [Abstract]  
    INVESTMENTS IN VARIABLE INTEREST ENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES
    The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

    Consolidated VIEs

    In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. The total assets and liabilities of the Company's consolidated VIE was $258.1 million and $26.7 million, respectively, as of September 30, 2024, and were $272.1 million and $31.5 million, respectively, as of December 31, 2023. The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company.

    Unconsolidated VIEs

    Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

    In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $42.5 million had been advanced as of September 30, 2024. The remaining $5.0 million was advanced in October 2024. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The option and the note receivable are included in Other Assets on the consolidated balance sheets.

    In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee"). The secured promissory note provides for borrowings up to $45.0 million. At both September 30, 2024 and December 31, 2023, the Company had advanced $30.0 million under the promissory note (included in Other Assets). As of September 30, 2024 and December 31, 2023, the Company had invested $42.8 million and $39.3 million, respectively, in the Investee's preferred equity securities (included in Long-term Investments) and had paid $20.9 million and $13.1 million, respectively, for an option to acquire the Investee (included in Other Assets). Pursuant to the agreements, the Company may be required to invest up to an additional $3.0 million in the Investee's preferred equity securities and up to an additional $6.6 million for the option to acquire the Investee.

    In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option
    to acquire that medical device company, of which $30.0 million had been paid as of September 30, 2024. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. In addition, as of September 30, 2024 and December 31, 2023, the Company had invested $3.5 million and $3.3 million, respectively, in the medical device company's preferred equity securities. The option and the note are included in Other Assets on the consolidated balance sheets, and the equity investment is included in Long-term Investments. In July 2024, the Company exercised its option to acquire the medical device company and the transaction closed in October 2024. For more information, see Note 18.

    In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 6.
    XML 36 R15.htm IDEA: XBRL DOCUMENT v3.24.3
    BUSINESS COMBINATIONS
    		 9 Months Ended
    Sep. 30, 2024
    Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
    BUSINESS COMBINATIONS BUSINESS COMBINATIONS
    Endotronix, Inc.

    On August 19, 2024, the Company acquired all the remaining outstanding shares of Endotronix, Inc. ("Endotronix"). Endotronix is a developer of an implantable sensor for management of heart failure patients. The acquisition was completed primarily to expand the Company's structural heart portfolio into a new therapeutic area to address the large unmet needs of patients suffering from heart failure.
    Prior to the acquisition date, the Company had previously paid $60.0 million for an option to acquire Endotronix, which was historically recorded in Other Assets using the measurement alternative for fair value, and had an existing preferred stock investment in Endotronix of $10.0 million, which represented an ownership interest in Endotronix of approximately 7% (collectively, the "previously held equity interest"). In July 2024, the Company exercised its option to acquire the remaining equity interest in Endotronix which was accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations." Accordingly, the Company allocated the purchase price of the acquired company to the net tangible assets and intangible assets acquired based upon their preliminary estimated fair values. The Company remeasured the previously held equity interest to its fair value, as of the date of acquisition. The Company considered multiple factors in determining the fair value of the previously held equity interest, including, (i) the price negotiated with the selling shareholders for the remaining 93% interest in Endotronix and (ii) an income approach valuation model. As a result of the remeasurement of the previously held equity interest, the Company recognized a gain of $24.6 million in Other income, net in the third quarter of 2024.

    The purchase consideration for the acquisition of Endotronix was $798.8 million, which consisted of cash consideration of $649.1 million (net of cash acquired of $1.2 million), the fair value of the Company's previously held equity interest of $94.6 million, and the settlement of pre-existing relationships of $53.1 million. In addition, the Company agreed to pay an additional $2.0 million in a pre-specified milestone-driven payment that is dependent on the receipt of CE Mark approval for the CorPASS before June 30, 2025. The Company recognized a $2.0 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payment will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations.
    In connection with the acquisition of Endotronix, the Company placed $35.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement and for purchase price adjustments. Acquisition-related costs of $5.6 million were recorded in Selling, General, and Administrative Expenses during the nine months ended September 30, 2024.

    The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

    Cash consideration paid at closing$650.3 
    Settlement of pre-existing relationships53.1 
    Fair value of previously held equity interest94.6 
    Fair value of contingent consideration2.0 
    Total purchase price800.0 
    Less: cash acquired(1.2)
    Total purchase price, net of cash acquired$798.8 
    Current assets$7.7 
    Property and equipment, net12.6 
    Goodwill412.0 
    In-process research and development69.0 
    Developed technology385.0 
    Operating lease right-of-use assets9.9 
    Other assets0.7 
    Liabilities assumed(26.3)
    Deferred tax liabilities(70.6)
    Net assets acquired800.0 
    Less: cash acquired(1.2)
    Total purchase price, net of cash acquired$798.8 

    The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.
    Goodwill includes Endotronix's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. The fair value of the developed technology was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the developed technology was 15.5%. The fair value of the IPR&D was also determined using the income approach. IPR&D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The discount rate used to determine the fair value of the IPR&D was 18.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $47.1 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2027 and in Japan and Europe in 2028. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life.

    The results of operations for Endotronix have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of Endotronix are not material in relation to the consolidated financial statements of Edwards Lifesciences.

    JC Medical, Inc.

    On July 22, 2024, the Company acquired all the outstanding shares of JC Medical, Inc. ("JC Medical") for purchase consideration of $116.3 million, net of cash acquired. In addition, the Company agreed to pay up to an additional $200.0 million in pre-specified milestone-driven payments over the next 12 years. The Company recognized a $1.8 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations.

    The Company placed $12.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement. Any funds remaining 15 months after the acquisition date will be disbursed to JC Medical's former shareholders. Acquisition-related costs of $1.6 million were recorded in Selling, General, and Administrative Expenses during the nine months ended September 30, 2024.

    JC Medical, Inc. is a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart disease. The acquisition was completed primarily to expand the Company's TAVR portfolio to enable the treatment of patients with aortic regurgitation. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill.
    The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

    Cash consideration paid at closing$114.8 
    Fair value of contingent consideration1.8 
    Total purchase price116.6 
    Less: cash acquired(0.3)
    Total purchase price, net of cash acquired$116.3 
    Current assets$0.3 
    Property and equipment, net0.3 
    Goodwill46.9 
    In-process research and development86.6 
    Current liabilities assumed(1.0)
    Deferred tax liabilities(16.5)
    Net assets acquired116.6 
    Less: cash acquired(0.3)
    Total purchase price, net of cash acquired$116.3 

    The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.

    Goodwill includes JC Medical's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. IPR&D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The fair value of the IPR&D was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the IPR&D was 15.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $55.8 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2028 and Europe in 2029. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life.

    The results of operations for JC Medical have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of JC Medical are not material in relation to the consolidated financial statements of Edwards Lifesciences.
    XML 37 R16.htm IDEA: XBRL DOCUMENT v3.24.3
    FAIR VALUE MEASUREMENTS
    		 9 Months Ended
    Sep. 30, 2024
    Fair Value Disclosures [Abstract]  
    FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

    Level 1—Quoted market prices in active markets for identical assets or liabilities.
    Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
    Level 3—Unobservable inputs that are not corroborated by market data.
    In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

    The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of September 30, 2024, the fair value of the notes payable, based on Level 2 inputs, was $600.0 million.

    Assets and Liabilities Measured at Fair Value on a Recurring Basis

    The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
    September 30, 2024Level 1Level 2Level 3Total
    Assets    
    Cash equivalents$2,287.8 $852.3 $— $3,140.1 
    Available-for-sale investments:
    Bank time deposits
    		— 17.6 — 17.6 
    Corporate debt securities
    		— 498.3 — 498.3 
    Asset-backed securities
    		— 78.6 — 78.6 
    United States government and agency securities49.3 134.8 — 184.1 
    Commercial paper
    		— 112.9 — 112.9 
    Municipal securities
    		— 2.7 — 2.7 
    Equity investments in unconsolidated entities7.5 — — 7.5 
    Investments held for deferred compensation plans143.9 — — 143.9 
    Derivatives— 27.6 — 27.6 
    $2,488.5 $1,724.8 $— $4,213.3 
    Liabilities    
    Derivatives$— $24.3 $— $24.3 
    Contingent consideration liabilities— — 3.8 3.8 
    Other— — 5.0 5.0 
    $— $24.3 $8.8 $33.1 
    December 31, 2023    
    Assets    
    Cash equivalents$579.2 $— $— $579.2 
    Available-for-sale investments:
    Corporate debt securities
    		— 641.8 — 641.8 
    Asset-backed securities
    		— 184.3 — 184.3 
    United States government and agency securities— 70.0 — 70.0 
    Municipal securities
    		— 2.6 — 2.6 
    Investments held for deferred compensation plans125.8 — — 125.8 
    Derivatives— 39.5 — 39.5 
    $705.0 $938.2 $— $1,643.2 
    Liabilities    
    Derivatives$— $15.2 $— $15.2 
    Other— — 10.3 10.3 
    $— $15.2 $10.3 $25.5 
    Cash Equivalents and Available-for-sale Investments

    Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, commercial paper, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

    Deferred Compensation Plans

    The Company holds investments related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.

    Derivative Instruments

    The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures. All derivative instruments are recognized on the balance sheet at their fair value, which was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates. The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.

    Contingent Consideration Liabilities

    Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows
    (ranging from 0.0% to 11.7%; with a weighted average of 5.6%), (2) the probability of milestone achievement (ranging from 60% to 100%; with a weighted average of 80.9%), (3) the projected payment dates (ranging from 2025 to 2032; with a weighted average of 2029), and (4) the volatility of future revenue (27%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.

    The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):
     Contingent ConsiderationOtherTotal
    Balance at December 31, 2023
    		$— $10.3 $10.3 
    Additions3.8 — 3.8 
    Payments— — — 
    Changes in fair value— (5.3)(5.3)
    Balance at September 30, 2024$3.8 $5.0 $8.8 
    Contingent ConsiderationOtherTotal
    Balance at December 31, 2022
    		$26.2 $14.0 $40.2 
    Changes in fair value(26.2)(3.7)(29.9)
    Balance at September 30, 2023$— $10.3 $10.3 
    XML 38 R17.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
    		 9 Months Ended
    Sep. 30, 2024
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
    The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
     Notional Amount
     September 30,
    2024    		December 31, 2023
     (in millions)
    Foreign currency forward exchange contracts$2,219.8 $1,460.3 
    Cross-currency swap contracts300.0 300.0 

    Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

    The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately one year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions).

    All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings and offsets the loss or gain on the underlying hedged item. The Company reports in Accumulated Other Comprehensive Loss the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in Accumulated Other Comprehensive Loss as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.
    The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
      Fair Value
    Derivatives designated as hedging instrumentsBalance Sheet
    Location    		September 30,
    2024    		December 31, 2023
    Assets   
    Foreign currency contractsOther current assets$5.8 $16.1 
    Cross-currency swap contractsOther assets$21.8 $23.4 
    Liabilities   
    Foreign currency contractsAccrued and other liabilities$21.2 $15.2 
    Derivatives not designated as hedging instruments    
    Liabilities
    Foreign currency contractsAccrued and other liabilities$3.1 $— 

    The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
        Gross Amounts
    Not Offset in
    the Consolidated
    Balance Sheet    		 
      Gross Amounts
    Offset in the
    Consolidated
    Balance Sheet    		 
      Net Amounts
    Presented in the
    Consolidated
    Balance Sheet
    September 30, 2024Gross
    Amounts    		Financial
    Instruments    		Cash
    Collateral
    Received    		Net
    Amount
    Derivative assets      
    Foreign currency contracts$5.8 $— $5.8 $(3.8)$— $2.0 
    Cross-currency swap contracts$21.8 $— $21.8 $— $— $21.8 
    Derivative liabilities      
    Foreign currency contracts$24.3 $— $24.3 $(3.8)$— $20.5 
    December 31, 2023      
    Derivative assets      
    Foreign currency contracts$16.1 $— $16.1 $(9.4)$— $6.7 
    Cross-currency swap contracts$23.4 $— $23.4 $— $— $23.4 
    Derivative liabilities   
    Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
    The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
     Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative
    (Effective Portion)
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     
    2024202320242023
    Cash flow hedges
    Foreign currency contracts$(40.9)$33.5 $17.0 $60.4 
    Net investment hedges
    Cross-currency swap contracts$(8.7)$3.8 $(1.6)$(5.2)

    The cross-currency swap contracts have an expiration date of June 15, 2028. At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
    The following tables present the effect of derivative instruments on the consolidated condensed statements of operations (in millions):
     Location and Amount of Gain or (Loss) Recognized in Income
     Three Months Ended
    September 30, 2024    		Nine Months Ended
    September 30, 2024
     Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
    Total amounts presented in the consolidated condensed statements of operations$(262.9)$24.3 $27.9 $(825.3)$56.3 $35.6 
    The effects of fair value hedges:
    Foreign currency contracts:
    Hedged items$— $— $— $— $— $(4.0)
    Derivatives designated as hedging instruments$— $— $— $— $— $4.0 
    Amount excluded from effectiveness testing (amortized)$— $— $— $— $— $0.8 
    The effects of cash flow hedges:
    Foreign currency contracts:
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$17.0 $— $— $31.9 $— $— 
    The effects of net investment hedges:
    Cross currency swap contracts:
    Amount excluded from effectiveness testing$— $1.6 $— $— $5.1 $— 
    The effects of non-designated hedges:
    Foreign currency contracts$— $— $(29.6)$— $— $3.7 
     Location and Amount of Gain or (Loss) Recognized in Income
     Three Months Ended
    September 30, 2023    		Nine Months Ended
    September 30, 2023
     Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
    Total amounts presented in the consolidated condensed statements of operations$(250.6)$15.1 $6.6 $(727.4)$32.8 $10.3 
    The effects of fair value hedges:
    Foreign currency contracts:
    Hedged items$— $— $(3.6)$— $— $(12.5)
    Derivatives designated as hedging instruments$— $— $3.6 $— $— $12.5 
    Amount excluded from effectiveness testing (amortized)$— $— $1.2 $— $— $3.6 
    The effects of cash flow hedges:
    Foreign currency contracts:
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$9.3 $— $— $53.0 $— $— 
    The effects of net investment hedges:
    Cross currency swap contracts:
    Amount excluded from effectiveness testing$— $1.7 $— $— $5.2 $— 
    The effects of non-designated hedges:
    Foreign currency contracts$— $— $14.6 $— $— $19.1 

    The Company expects that during the next twelve months it will reclassify to earnings a $4.1 million gain currently recorded in Accumulated Other Comprehensive Loss.
    XML 39 R18.htm IDEA: XBRL DOCUMENT v3.24.3
    STOCK-BASED COMPENSATION
    		 9 Months Ended
    Sep. 30, 2024
    Share-Based Payment Arrangement [Abstract]  
    STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
    Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2024 and 2023 was as follows (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Cost of sales$6.1 $4.7 $20.8 $16.3 
    Selling, general, and administrative expenses20.4 17.2 62.4 57.3 
    Research and development expenses8.7 7.2 28.3 23.7 
    Total stock-based compensation expense35.2 29.1 111.5 97.3 
    Income tax benefit(6.0)(4.7)(17.5)(14.5)
    Total stock-based compensation expense, net of tax$29.2 $24.4 $94.0 $82.8 

    At September 30, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $289.7 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 33 months.

    On May 7, 2024, the Company’s stockholders approved the amendment and restatement of the Company’s Long-term Stock Incentive Compensation Program (the “Long-term Stock Program”) to (1) increase the total number of shares of the Company’s common stock available for issuance under the Long-term Stock Program by 6.9 million shares to a new total share limit of 334.5 million shares, (2) increase the total number of shares of the Company’s common stock available for issuance as restricted stock and restricted stock unit awards under the Long-term Stock Program by 2.0 million shares to a new limit on the total number of shares available for these types of awards of 35.6 million shares, and (3) extend the term within which new awards may be granted under the Long-term Stock Program through February 21, 2034.

    During the nine months ended September 30, 2024, the Company granted 1.5 million stock options at a weighted-average
    exercise price per share of $85.94, and 1.9 million restricted stock units at a weighted-average grant-date fair value per share of $85.09. During the nine months ended September 30, 2024, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $97.66. The market-based restricted stock units granted during the nine months ended September 30, 2024 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.

    Fair Value Disclosures

    The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2024 and 2023 included a risk-free interest rate of 4.5% and 3.6%, respectively, and an expected volatility rate of 32.4% and 32.6%, respectively.

    The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
     Option Awards
    		Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Risk-free interest rate4.2 %4.3 %4.5%3.4%
    Expected dividend yieldNoneNoneNoneNone
    Expected volatility31.0 %32.7 %30.9%32.8%
    Expected term (years)5.55.25.35.1
    Fair value, per option$32.15 $31.16 $31.30 $31.02 
    The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
     ESPP
    		Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Risk-free interest rate5.3 %5.3 %5.2%4.6%
    Expected dividend yieldNoneNoneNoneNone
    Expected volatility29.5 %34.8 %33.5%31.5%
    Expected term (years)0.60.60.60.6
    Fair value, per share$16.51 $18.53 $25.01$19.03 
    XML 40 R19.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCELERATED SHARE REPURCHASE
    		 9 Months Ended
    Sep. 30, 2024
    Equity [Abstract]  
    ACCELERATED SHARE REPURCHASE ACCELERATED SHARE REPURCHASE
    During 2024 and 2023, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
      Initial DeliveryFinal Settlement
    Agreement DateAmount
    Paid    		Shares
    Received    		Price per
    Share    		Value of
    Shares as %
    of Contract
    Value    		Settlement
    Date    		Total Shares
    Received    		Average Price
    per Share
    February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
    April 2024$150.0 1.4 $85.95 80 %May 20241.7 $86.72 
    August 2024$500.0 5.8 $68.93 80 %(a)
    ______________________________________
    (a)     The ASR agreement has a scheduled settlement date of December 27, 2024. At the conclusion of the ASR agreement, the Company may receive additional shares or may be required to pay additional cash or shares (at our election).

    The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in Additional Paid-in Capital and subsequently, upon settlement, will be transferred to Treasury Stock on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.
    XML 41 R20.htm IDEA: XBRL DOCUMENT v3.24.3
    COMMITMENTS AND CONTINGENCIES
    		 9 Months Ended
    Sep. 30, 2024
    Commitments and Contingencies Disclosure [Abstract]  
    COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
    In 2021, the Company initiated an internal review and investigation into whether certain business activities in Japan and other markets violated provisions of the Foreign Corrupt Practices Act (“FCPA”). The Company voluntarily notified the SEC and the United States Department of Justice (“DOJ”) about the matter and thereafter provided status updates. In September 2024, the Company received a letter from the SEC Staff stating that the SEC is not recommending an enforcement action.

    On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (“Edwards”) in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company is vigorously defending itself in this litigation.

    The European Commission (the “Commission”) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is cooperating with the Commission and believes its business practices support healthy competition. The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.
    On October 14, 2024, a purported stockholder of the Company filed a putative securities class action complaint against the Company and certain of the Company’s executive officers in the United States District Court for the Central District of California, captioned Patel v. Edwards Lifesciences Corporation, et al., No. 24-cv-02221. The complaint alleges violations of various securities laws based on alleged false or misleading statements regarding the Company’s business prospects. The complaint seeks damages, interest, costs and other fees. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to defend against the lawsuit vigorously.

    The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the “Lawsuits”). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.
    The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.
    XML 42 R21.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCUMULATED OTHER COMPREHENSIVE LOSS
    		 9 Months Ended
    Sep. 30, 2024
    Equity [Abstract]  
    ACCUMULATED OTHER COMPREHENSIVE LOSS ACCUMULATED OTHER COMPREHENSIVE LOSS
    The following tables summarize the activity for each component of Accumulated Other Comprehensive Loss (in millions):
     Foreign
    Currency
    Translation
    Adjustments
    Unrealized Gain (Loss) on Hedges

    Unrealized Loss on Available-for-sale Investments
    Unrealized
    Pension
    Costs
    		Total
    Accumulated
    Other
    Comprehensive
    Loss
    December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
    Other comprehensive (loss) income before reclassifications
    		(23.3)43.4 7.0 0.4 27.5 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(7.2)2.5 — (6.4)
    Deferred income tax expense
    		(1.1)(9.3)(1.1)(0.1)(11.6)
    March 31, 2024$(240.6)$27.6 $(16.4)$(3.9)$(233.3)
    Other comprehensive income (loss) before reclassifications
    		3.4 21.8 4.2 (0.1)29.3 
    Amounts reclassified from accumulated other comprehensive loss(1.8)(12.5)1.0 — (13.3)
    Deferred income tax (expense) benefit
    		(0.6)(2.4)0.1 — (2.9)
    June 30, 2024$(239.6)$34.5 $(11.1)$(4.0)$(220.2)
    Other comprehensive income (loss) before reclassifications
    		3.8 (41.0)6.8 — (30.4)
    Amounts reclassified from accumulated other comprehensive loss(1.6)(17.0)(0.8)(19.4)
    Deferred income tax benefit
    		2.1 15.3 0.1 — 17.5 
    September 30, 2024$(235.3)$(8.2)$(5.0)$(4.0)$(252.5)

     Foreign
    Currency
    Translation
    Adjustments    		Unrealized Gain on Hedges
    Unrealized Loss on Available-for-sale Investments    		Unrealized
    Pension
    Credits    		Total
    Accumulated
    Other
    Comprehensive
    Loss
    December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
    Other comprehensive income (loss) before reclassifications
    		4.9 6.7 9.0 (0.1)20.5 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
    Deferred income tax benefit
    		0.6 5.9 — — 6.5 
    March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
    Other comprehensive (loss) income before reclassifications
    		(11.3)33.5 2.1 0.2 24.5 
    Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
    Deferred income tax benefit (expense)
    		1.6 (3.0)— — (1.4)
    June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)
    Other comprehensive (loss) income before reclassifications
    		(20.7)38.6 9.4 — 27.3 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(14.1)1.2 — (14.6)
    Deferred income tax (expense) benefit
    		(1.0)(6.3)— — (7.3)
    September 30, 2023$(249.9)$30.1 $(36.1)$5.8 $(250.1)
    The following table provides information about amounts reclassified from Accumulated Other Comprehensive Loss (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,    		 
     Affected Line on Consolidated Condensed
    Statements of Operations
    Details about Accumulated Other
    Comprehensive Loss Components
    		2024202320242023
    Foreign currency translation adjustments$1.6 $1.7 $5.1 $5.2 Other non-operating income, net
    (0.5)(0.5)(1.3)(1.3)Provision for income taxes
    $1.1 $1.2 $3.8 $3.9 Net of tax
    Gain (Loss) on hedges
    		$17.0 $9.3 $31.9 $53.0 Cost of sales
    — 4.8 4.8 16.1 Other non-operating income, net
    17.0 14.1 36.7 69.1 Total before tax
    (4.2)(2.9)(8.9)(14.8)Provision for income taxes
    $12.8 $11.2 $27.8 $54.3 Net of tax
    Loss on available-for-sale investments
    		$0.8 $(1.2)$(2.7)$(9.0)Interest income, net
    (0.2)0.4 0.7 2.3 Provision for income taxes
    $0.6 $(0.8)$(2.0)$(6.7)Net of tax
    XML 43 R22.htm IDEA: XBRL DOCUMENT v3.24.3
    EARNINGS PER SHARE
    		 9 Months Ended
    Sep. 30, 2024
    Earnings Per Share [Abstract]  
    EARNINGS PER SHARE EARNINGS PER SHARE
    Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
    The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Income for Earnings Per Share Calculations:
    Income from continuing operations, net of tax$362.1 $334.9 $1,051.0 $886.9 
    Net loss attributable to noncontrolling interests(1.4)(1.2)(3.6)(2.8)
    Income from continuing operations attributable to Edwards Lifesciences Corporation363.5 336.1 1,054.6 889.7 
    Income from discontinued operations2,707.3 48.8 2,734.4 142.8 
    Net income attributable to Edwards Lifesciences Corporation$3,070.8 $384.9 $3,789.0 $1,032.5 
    Weighted Average Shares:
    Basic weighted-average shares outstanding597.2 607.0 600.3 607.2 
    Dilutive effect of stock plans0.9 2.5 1.9 3.0 
    Dilutive weighted-average shares outstanding598.1 609.5 602.2 610.2 
    Earnings per Share:
    Basic:
    Continuing operations$0.61 $0.55 $1.76 $1.47 
    Discontinued operations4.53 0.08 4.55 0.23 
    Basic earnings per share$5.14 $0.63 $6.31 $1.70 
    Diluted:
    Continuing operations$0.61 $0.55 $1.75 $1.46 
    Discontinued operations4.52 0.08 4.54 0.23 
    Diluted earnings per share$5.13 $0.63 $6.29 $1.69 

    Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 10.4 million and 6.5 million common shares for the three months ended September 30, 2024 and 2023, respectively, and 7.8 million and 6.1 million shares for the nine months ended September 30, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive. Additionally, 1.9 million shares that would have been received if the ASR agreement discussed in Note 12 was settled as of September 30, 2024 were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.
    XML 44 R23.htm IDEA: XBRL DOCUMENT v3.24.3
    INCOME TAXES
    		 9 Months Ended
    Sep. 30, 2024
    Income Tax Disclosure [Abstract]  
    INCOME TAXES INCOME TAXES
    The Company's effective income tax rates attributable to continuing operations were 10.1% and 13.6% for the three months ended September 30, 2024 and 2023, respectively and 9.2% and 11.8% for the nine months ended September 30, 2024 and 2023, respectively. The decrease in the effective rate between the nine months ended September 30, 2024 and 2023 is primarily due to an increase in tax benefits from foreign earnings taxed at lower rates and favorable global income tax audit settlements. In addition, the effective rates for the nine months ended September 30, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. The effective rates include a tax benefit from employee share-based compensation attributable to continuing operations of $0.6 million and $1.8 million for the three months ended September 30, 2024 and 2023, respectively, and $10.1 million and $12.8 million for the nine months ended September 30, 2024 and 2023, respectively.

    The Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each taxing authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect
    potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

    As of September 30, 2024 and December 31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $656.5 million and $583.9 million, respectively. The Company estimates that these liabilities would be reduced by $326.1 million and $250.7 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $330.4 million and $333.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.

    The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The APA renewal between Singapore and Japan covering tax years 2020 through 2026 is pending.

    The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years. The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.

    During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for the 2015 through 2017 period of approximately $250 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

    During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.

    The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2024 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $75 million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. In March 2024, the Company made an additional deposit with the IRS of $305 million to further mitigate interest on potential tax liabilities and interest thereon while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.

    Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2024 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September 30, 2024. The Company has considered this information, as well as information regarding the NOD and other proceedings described above in its evaluation
    of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.

    During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (“ITA”) wherein the ITA claimed that the Company owes approximately $110 million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative proceedings including a formal appeal of the assessment that was filed during the third quarter of 2024. If necessary, the Company will defend that position through judicial proceedings. There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.
    XML 45 R24.htm IDEA: XBRL DOCUMENT v3.24.3
    SEGMENT INFORMATION
    		 9 Months Ended
    Sep. 30, 2024
    Segment Reporting [Abstract]  
    SEGMENT INFORMATION SEGMENT INFORMATION
    Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

    The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

    Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

    The table below presents information about Edwards Lifesciences' reportable segments (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Segment Net Sales    
    United States$804.6 $735.9 $2,393.1 $2,203.6 
    Europe315.1 282.7 968.4 878.0 
    Japan85.8 84.9 265.6 251.5 
    Rest of World153.2 136.1 440.9 399.0 
    Total segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
    Segment Operating Income    
    United States$551.2 $498.4 $1,619.2 $1,510.2 
    Europe177.3 156.1 540.3 489.2 
    Japan54.4 53.7 159.8 158.5 
    Rest of World67.2 59.5 184.7 170.6 
    Total segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
    The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Sales Reconciliation    
    Segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
    Foreign currency(4.3)3.8 (14.3)11.5 
    Consolidated net sales$1,354.4 $1,243.4 $4,053.7 $3,743.6 
    Pre-tax Income Reconciliation    
    Segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
    Unallocated amounts:    
    Corporate items(468.7)(410.1)(1,396.5)(1,259.4)
    Restructuring expenses (Note 4)(32.9)— (32.9)— 
    Intellectual property agreement and certain litigation expenses
    		(10.8)(2.2)(27.8)(193.6)
    Change in fair value of contingent consideration liabilities— — — 26.2 
    Foreign currency12.9 10.5 19.3 60.4 
    Consolidated operating income350.6 365.9 1,066.1 962.1 
    Non-operating income52.2 21.7 91.9 43.1 
    Consolidated pre-tax income$402.8 $387.6 $1,158.0 $1,005.2 

    Enterprise-wide Information
    (in millions)

    The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Sales by Geographic Region    
    United States$804.6 $735.9 $2,393.1 $2,203.6 
    Europe319.8 286.5 978.0 877.7 
    Japan81.4 85.8 253.9 266.4 
    Rest of World148.6 135.2 428.7 395.9 
    $1,354.4 $1,243.4 $4,053.7 $3,743.6 
    Net Sales by Major Product Group    
    Transcatheter Aortic Valve Replacement$1,023.3 $960.9 $3,069.8 $2,900.4 
    Transcatheter Mitral and Tricuspid Therapies91.1 52.4 247.0 141.6 
    Surgical Structural Heart240.0 230.1 736.9 701.6 
    $1,354.4 $1,243.4 $4,053.7 $3,743.6 
    XML 46 R25.htm IDEA: XBRL DOCUMENT v3.24.3
    SUBSEQUENT EVENTS
    		 9 Months Ended
    Sep. 30, 2024
    Subsequent Events [Abstract]  
    SUBSEQUENT EVENTS SUBSEQUENT EVENTS
    In October 2024, the Company acquired all the remaining outstanding shares of Innovalve Bio Medical Limited ("Innovalve") for an aggregate cash purchase price of $300.0 million, subject to certain adjustments, plus an additional $25.0 million upon achievement of a certain regulatory milestone. Innovalve is a developer of a transcatheter mitral valve replacement system.
    Prior to the acquisition date, the Company had previously paid $30.0 million for an option to acquire Innovalve, which the Company exercised in July 2024, and had an existing preferred stock investment in Innovalve of $3.5 million, which represented approximately a 4% interest in Innovalve (collectively, the "previously held interest"). The acquisition of the remaining equity interest in Innovalve is expected to be accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations."
    XML 47 R26.htm IDEA: XBRL DOCUMENT v3.24.3
    Pay vs Performance Disclosure - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Pay vs Performance Disclosure        
    Net Income (Loss) $ 3,070.8 $ 384.9 $ 3,789.0 $ 1,032.5
    XML 48 R27.htm IDEA: XBRL DOCUMENT v3.24.3
    Insider Trading Arrangements
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    shares
    Sep. 30, 2024
    shares
    Trading Arrangements, by Individual    
    Non-Rule 10b5-1 Arrangement Adopted false  
    Non-Rule 10b5-1 Arrangement Terminated false  
    Scott B. Ullem [Member]    
    Trading Arrangements, by Individual    
    Material Terms of Trading Arrangement  
    On August 19, 2024, Scott B. Ullem, Corporate Vice President, Chief Financial Officer, entered into a Plan providing for the potential sale of 56,250 shares of the Company’s stock commencing December 9, 2024. Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.
    Name Scott B. Ullem  
    Title Corporate Vice President, Chief Financial Officer  
    Rule 10b5-1 Arrangement Adopted true  
    Adoption Date August 19, 2024  
    Expiration Date May 9, 2025  
    Arrangement Duration 151 days  
    Aggregate Available 56,250 56,250
    Bernard J. Zovighian [Member]    
    Trading Arrangements, by Individual    
    Material Terms of Trading Arrangement   In addition, on September 23, 2024, Bernard J. Zovighian, Chief Executive Officer and Director, terminated a Plan that had provided for the potential sale of 25,147 shares of the Company’s stock commencing May 20, 2024. Following the termination date, no remaining shares can be sold pursuant to the Plan.
    Name Bernard J. Zovighian  
    Title Chief Executive Officer and Director  
    Rule 10b5-1 Arrangement Terminated true  
    Termination Date September 23, 2024  
    Aggregate Available 25,147 25,147
    XML 49 R28.htm IDEA: XBRL DOCUMENT v3.24.3
    BASIS OF PRESENTATION (Policies)
    		 9 Months Ended
    Sep. 30, 2024
    Accounting Policies [Abstract]  
    Basis of Presentation
    The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.
    Consolidation
    The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

    On September 3, 2024, the Company sold its Critical Care product group ("Critical Care"). The historical results of Critical Care are reflected as discontinued operations in the Company's consolidated condensed financial statements for all periods presented. In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the historical results of a small non-core product group that the Company plans to sell are also included in discontinued operations. Unless otherwise indicated, the information in the notes to the consolidated condensed financial statements refer only to Edwards Lifesciences' continuing operations. For more information, see Note 5.
    Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.
    Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted
    Recently Adopted Accounting Standards

    In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.

    New Accounting Standards Not Yet Adopted

    In November 2024, the FASB issued an amendment to the accounting guidance on income statement presentation to require disclosure, in the notes to the financial statements, of disaggregated information about certain costs and expenses, including purchases of inventory, employee compensation, and depreciation and amortization included in each relevant expense caption within continuing operations. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.

    In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay
    to allow the legal process to proceed. The Company is currently evaluating the disclosure impact the guidance will have on its consolidated financial statements.

    In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

    In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.
    XML 50 R29.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Schedule of Components of Selected Captions in the Consolidated Balance Sheets
    Components of selected captions in the consolidated condensed balance sheets consisted of the following:
    September 30,
    2024    		December 31, 2023
    Inventories
    Raw materials$248.8 $196.3 
    Work in process244.4 195.8 
    Finished products611.0 511.4 
    $1,104.2 $903.5 
    Schedule of Accrued and Other Liabilities
    September 30,
    2024    		December 31, 2023
    Other assets
    Tax receivable (Note 16)$293.7 $— 
    Notes and other receivables132.9 155.1 
    Acquisition options117.5 161.3 
    Long-term prepaid royalties103.7 109.9 
    Fair value of derivatives21.8 23.4 
    Other long-term assets13.9 13.5 
    $683.5 $463.2 
    Accrued and other liabilities 
    Employee compensation and withholdings$312.1 $316.4 
    Taxes payable (Note 5)715.1 52.7 
    Property, payroll, and other taxes83.7 53.8 
    Research and development accruals79.0 71.6 
    Accrued rebates140.0 123.5 
    Fair value of derivatives24.3 15.2 
    Accrued marketing expenses14.5 13.7 
    Legal and insurance29.5 28.9 
    Litigation settlement75.1 69.1 
    Accrued relocation costs16.2 16.9 
    Accrued professional services62.2 8.5 
    Accrued realignment reserves39.6 6.4 
    Unfavorable contract liability66.0 — 
    Other accrued liabilities88.0 79.7 
    $1,745.3 $856.4 
    Schedule of Supplemental Cash Flow Information
    Supplemental Cash Flow Information
    (in millions)
    Nine Months Ended
    September 30,
    20242023
    Cash paid during the year for:
    Income taxes (a) (Note 16)
    		$633.8 $219.1 
    Amounts included in the measurement of operating lease liabilities$21.0 $19.1 
    Non-cash investing and financing transactions:  
    Right-of-use assets obtained in exchange for new lease liabilities$38.9 $19.9 
    Capital expenditures accruals$22.9 $32.5 
    ______________________________________
    (a)     Includes cash paid for income taxes from discontinued operations of $29.7 million and $22.7 million for the nine months ended September 30, 2024 and 2023, respectively.
    Schedule of Cash and Cash Equivalents
    Cash, Cash Equivalents, and Restricted Cash
    (in millions)
    September 30,
    2024    		December 31, 2023
    Continuing operations
    Cash and cash equivalents$3,676.4 $1,132.3 
    Restricted cash included in other current assets3.2 3.3 
    Restricted cash included in other assets0.9 0.7 
    Total$3,680.5 $1,136.3 
    Discontinued operations
    Cash and cash equivalents$2.9 $11.7 
    Total$2.9 $11.7 
    Total cash, cash equivalents, and restricted cash$3,683.4 $1,148.0 
    Schedule of Restricted Cash
    Cash, Cash Equivalents, and Restricted Cash
    (in millions)
    September 30,
    2024    		December 31, 2023
    Continuing operations
    Cash and cash equivalents$3,676.4 $1,132.3 
    Restricted cash included in other current assets3.2 3.3 
    Restricted cash included in other assets0.9 0.7 
    Total$3,680.5 $1,136.3 
    Discontinued operations
    Cash and cash equivalents$2.9 $11.7 
    Total$2.9 $11.7 
    Total cash, cash equivalents, and restricted cash$3,683.4 $1,148.0 
    XML 51 R30.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Discontinued Operations and Disposal Groups [Abstract]  
    Disposal Groups, Including Discontinued Operations
    Details of Income from Discontinued Operations are as follows (in millions):

     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net sales$177.2 $237.5 $708.4 $727.1 
    Cost of sales65.4 99.8 265.1 295.5 
    Gross profit111.8 137.7 443.3 431.6 
    Selling, general, and administrative expenses40.9 57.7 163.2 178.7 
    Research and development expenses21.4 27.5 81.3 81.0 
    Separation costs81.5 — 202.5 — 
    Operating (loss) income, net(32.0)52.5 (3.7)171.9 
    Other non-operating (income) expense, net(3,338.9)0.8 (3,337.5)0.7 
    Income from discontinued operations before provision for income taxes3,306.9 51.7 3,333.8 171.2 
    Provision for income taxes from discontinued operations599.6 2.9 599.4 28.4 
    Net income from discontinued operations2,707.3 48.8 2,734.4 142.8 
    Details of assets and liabilities of discontinued operations are as follows (in millions):

     September 30,
    2024    		December 31,
    2023
    Cash and cash equivalents$2.9 $11.7 
    Accounts receivable, net of allowances— 3.6 
    Other receivables— 5.2 
    Inventories17.1 264.7 
    Prepaid expenses— 18.0 
    Other current assets— 14.4 
    Total current assets of discontinued operations$20.0 $317.6 
    Property, plant, and equipment, net3.1 158.4 
    Operating lease right-of-use assets — 9.6 
    Goodwill 7.4 108.4 
    Other intangible assets, net— 29.0 
    Deferred income taxes— 5.2 
    Other assets— 0.5 
    Total non-current assets of discontinued operations$10.5 $311.1 
    Accounts payable$— $14.8 
    Accrued and other liabilities1.8 112.7 
    Operating lease liabilities— 2.0 
    Total current liabilities of discontinued operations$1.8 $129.5 
    Operating lease liabilities — 7.8 
    Uncertain tax positions— 4.3 
    Other liabilities— 13.0 
    Total non-current liabilities of discontinued operations$— $25.1 

    Cash flows attributable to the Company's discontinued operations are included in the Company's consolidated condensed statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following (in millions):

     Nine Months Ended
    September 30,
     20242023
    Depreciation and amortization12.1 16.2 
    Stock-based compensation16.7 11.6 
    Inventory write off17.0 13.2 
    Capital expenditures16.4 21.0 
    XML 52 R31.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Investments, Debt and Equity Securities [Abstract]  
    Schedule of Investments in Debt Securities
    Investments in debt securities at the end of each period were as follows (in millions):
     September 30, 2024December 31, 2023
    Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
    Bank time deposits$50.5 $— $— $50.5 $64.5 $— $— $64.5 
    Available-for-sale
    Bank time deposits$17.6 $— $— $17.6 $— $— $— $— 
    Commercial paper112.9 — — 112.9 — — — — 
    U.S. government and agency securities185.2 0.1 (1.2)184.1 72.7 0.1 (2.8)70.0 
    Asset-backed securities80.2 — (1.6)78.6 192.1 — (7.8)184.3 
    Corporate debt securities502.2 0.1 (4.0)498.3 658.5 — (16.7)641.8 
    Municipal securities2.8 — (0.1)2.7 2.8 — (0.2)2.6 
    Total$900.9 $0.2 $(6.9)$894.2 $926.1 $0.1 $(27.5)$898.7 
    Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity
    The cost and fair value of investments in debt securities, by contractual maturity, as of September 30, 2024, were as follows:
    Held-to-MaturityAvailable-for-Sale
     Amortized CostFair ValueAmortized CostFair Value
     (in millions)
    Due in 1 year or less$50.5 $50.5 $721.1 $719.2 
    Due after 1 year through 5 years— — 81.4 79.2 
    Instruments not due at a single maturity date (a)
    		— — 98.4 95.8 
    $50.5 $50.5 $900.9 $894.2 
    _______________________________________
    (a)     Consists of mortgage-backed and asset-backed securities.
    Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position
    The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024 and December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

    September 30, 2024
    Less than 12 Months12 Months or GreaterTotal
    Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
    U.S. government and agency securities$— $— $34.0 $(1.2)$34.0 $(1.2)
    Asset-backed securities3.6 (0.1)65.3 (1.5)68.9 (1.6)
    Corporate debt securities— — 193.0 (4.0)193.0 (4.0)
    Municipal securities— — 2.7 (0.1)2.7 (0.1)
    $3.6 $(0.1)$295.0 $(6.8)$298.6 $(6.9)
    December 31, 2023
    Less than 12 Months12 Months or GreaterTotal
    Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
    U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
    Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
    Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
    Municipal securities— — 2.6 (0.2)2.6 (0.2)
    $35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)
    Schedule of Investments in Unconsolidated Affiliates These investments are recorded in Long-term Investments on the consolidated condensed balance sheets, and are as follows:
     September 30,
    2024    		December 31,
    2023
     (in millions)
    Equity method investments  
    Carrying value of equity method investments$32.3 $33.6 
    Equity securities  
    Carrying value of marketable equity securities7.4 — 
    Carrying value of non-marketable equity securities104.9 87.6 
    Total investments in unconsolidated entities$144.6 $121.2 
    XML 53 R32.htm IDEA: XBRL DOCUMENT v3.24.3
    BUSINESS COMBINATIONS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
    Schedule of Fair Values of Assets Acquired and Liabilities Assumed
    The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

    Cash consideration paid at closing$650.3 
    Settlement of pre-existing relationships53.1 
    Fair value of previously held equity interest94.6 
    Fair value of contingent consideration2.0 
    Total purchase price800.0 
    Less: cash acquired(1.2)
    Total purchase price, net of cash acquired$798.8 
    Current assets$7.7 
    Property and equipment, net12.6 
    Goodwill412.0 
    In-process research and development69.0 
    Developed technology385.0 
    Operating lease right-of-use assets9.9 
    Other assets0.7 
    Liabilities assumed(26.3)
    Deferred tax liabilities(70.6)
    Net assets acquired800.0 
    Less: cash acquired(1.2)
    Total purchase price, net of cash acquired$798.8 
    The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):

    Cash consideration paid at closing$114.8 
    Fair value of contingent consideration1.8 
    Total purchase price116.6 
    Less: cash acquired(0.3)
    Total purchase price, net of cash acquired$116.3 
    Current assets$0.3 
    Property and equipment, net0.3 
    Goodwill46.9 
    In-process research and development86.6 
    Current liabilities assumed(1.0)
    Deferred tax liabilities(16.5)
    Net assets acquired116.6 
    Less: cash acquired(0.3)
    Total purchase price, net of cash acquired$116.3 
    XML 54 R33.htm IDEA: XBRL DOCUMENT v3.24.3
    FAIR VALUE MEASUREMENTS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Fair Value Disclosures [Abstract]  
    Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
    The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
    September 30, 2024Level 1Level 2Level 3Total
    Assets    
    Cash equivalents$2,287.8 $852.3 $— $3,140.1 
    Available-for-sale investments:
    Bank time deposits
    		— 17.6 — 17.6 
    Corporate debt securities
    		— 498.3 — 498.3 
    Asset-backed securities
    		— 78.6 — 78.6 
    United States government and agency securities49.3 134.8 — 184.1 
    Commercial paper
    		— 112.9 — 112.9 
    Municipal securities
    		— 2.7 — 2.7 
    Equity investments in unconsolidated entities7.5 — — 7.5 
    Investments held for deferred compensation plans143.9 — — 143.9 
    Derivatives— 27.6 — 27.6 
    $2,488.5 $1,724.8 $— $4,213.3 
    Liabilities    
    Derivatives$— $24.3 $— $24.3 
    Contingent consideration liabilities— — 3.8 3.8 
    Other— — 5.0 5.0 
    $— $24.3 $8.8 $33.1 
    December 31, 2023    
    Assets    
    Cash equivalents$579.2 $— $— $579.2 
    Available-for-sale investments:
    Corporate debt securities
    		— 641.8 — 641.8 
    Asset-backed securities
    		— 184.3 — 184.3 
    United States government and agency securities— 70.0 — 70.0 
    Municipal securities
    		— 2.6 — 2.6 
    Investments held for deferred compensation plans125.8 — — 125.8 
    Derivatives— 39.5 — 39.5 
    $705.0 $938.2 $— $1,643.2 
    Liabilities    
    Derivatives$— $15.2 $— $15.2 
    Other— — 10.3 10.3 
    $— $15.2 $10.3 $25.5 
    Schedule of Changes in Fair Value of Contingent Consideration and Other Liability
    The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):
     Contingent ConsiderationOtherTotal
    Balance at December 31, 2023
    		$— $10.3 $10.3 
    Additions3.8 — 3.8 
    Payments— — — 
    Changes in fair value— (5.3)(5.3)
    Balance at September 30, 2024$3.8 $5.0 $8.8 
    Contingent ConsiderationOtherTotal
    Balance at December 31, 2022
    		$26.2 $14.0 $40.2 
    Changes in fair value(26.2)(3.7)(29.9)
    Balance at September 30, 2023$— $10.3 $10.3 
    XML 55 R34.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk
    The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
     Notional Amount
     September 30,
    2024    		December 31, 2023
     (in millions)
    Foreign currency forward exchange contracts$2,219.8 $1,460.3 
    Cross-currency swap contracts300.0 300.0 
    Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets
    The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
      Fair Value
    Derivatives designated as hedging instrumentsBalance Sheet
    Location    		September 30,
    2024    		December 31, 2023
    Assets   
    Foreign currency contractsOther current assets$5.8 $16.1 
    Cross-currency swap contractsOther assets$21.8 $23.4 
    Liabilities   
    Foreign currency contractsAccrued and other liabilities$21.2 $15.2 
    Derivatives not designated as hedging instruments    
    Liabilities
    Foreign currency contractsAccrued and other liabilities$3.1 $— 
    Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets
    The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
        Gross Amounts
    Not Offset in
    the Consolidated
    Balance Sheet    		 
      Gross Amounts
    Offset in the
    Consolidated
    Balance Sheet    		 
      Net Amounts
    Presented in the
    Consolidated
    Balance Sheet
    September 30, 2024Gross
    Amounts    		Financial
    Instruments    		Cash
    Collateral
    Received    		Net
    Amount
    Derivative assets      
    Foreign currency contracts$5.8 $— $5.8 $(3.8)$— $2.0 
    Cross-currency swap contracts$21.8 $— $21.8 $— $— $21.8 
    Derivative liabilities      
    Foreign currency contracts$24.3 $— $24.3 $(3.8)$— $20.5 
    December 31, 2023      
    Derivative assets      
    Foreign currency contracts$16.1 $— $16.1 $(9.4)$— $6.7 
    Cross-currency swap contracts$23.4 $— $23.4 $— $— $23.4 
    Derivative liabilities   
    Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
    Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities
    The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
        Gross Amounts
    Not Offset in
    the Consolidated
    Balance Sheet    		 
      Gross Amounts
    Offset in the
    Consolidated
    Balance Sheet    		 
      Net Amounts
    Presented in the
    Consolidated
    Balance Sheet
    September 30, 2024Gross
    Amounts    		Financial
    Instruments    		Cash
    Collateral
    Received    		Net
    Amount
    Derivative assets      
    Foreign currency contracts$5.8 $— $5.8 $(3.8)$— $2.0 
    Cross-currency swap contracts$21.8 $— $21.8 $— $— $21.8 
    Derivative liabilities      
    Foreign currency contracts$24.3 $— $24.3 $(3.8)$— $20.5 
    December 31, 2023      
    Derivative assets      
    Foreign currency contracts$16.1 $— $16.1 $(9.4)$— $6.7 
    Cross-currency swap contracts$23.4 $— $23.4 $— $— $23.4 
    Derivative liabilities   
    Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
    Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income
    The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
     Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative
    (Effective Portion)
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     
    2024202320242023
    Cash flow hedges
    Foreign currency contracts$(40.9)$33.5 $17.0 $60.4 
    Net investment hedges
    Cross-currency swap contracts$(8.7)$3.8 $(1.6)$(5.2)
    Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations
    The following tables present the effect of derivative instruments on the consolidated condensed statements of operations (in millions):
     Location and Amount of Gain or (Loss) Recognized in Income
     Three Months Ended
    September 30, 2024    		Nine Months Ended
    September 30, 2024
     Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
    Total amounts presented in the consolidated condensed statements of operations$(262.9)$24.3 $27.9 $(825.3)$56.3 $35.6 
    The effects of fair value hedges:
    Foreign currency contracts:
    Hedged items$— $— $— $— $— $(4.0)
    Derivatives designated as hedging instruments$— $— $— $— $— $4.0 
    Amount excluded from effectiveness testing (amortized)$— $— $— $— $— $0.8 
    The effects of cash flow hedges:
    Foreign currency contracts:
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$17.0 $— $— $31.9 $— $— 
    The effects of net investment hedges:
    Cross currency swap contracts:
    Amount excluded from effectiveness testing$— $1.6 $— $— $5.1 $— 
    The effects of non-designated hedges:
    Foreign currency contracts$— $— $(29.6)$— $— $3.7 
     Location and Amount of Gain or (Loss) Recognized in Income
     Three Months Ended
    September 30, 2023    		Nine Months Ended
    September 30, 2023
     Cost of salesInterest income, netOther non-operating income, netCost of salesInterest income, netOther non-operating income, net
    Total amounts presented in the consolidated condensed statements of operations$(250.6)$15.1 $6.6 $(727.4)$32.8 $10.3 
    The effects of fair value hedges:
    Foreign currency contracts:
    Hedged items$— $— $(3.6)$— $— $(12.5)
    Derivatives designated as hedging instruments$— $— $3.6 $— $— $12.5 
    Amount excluded from effectiveness testing (amortized)$— $— $1.2 $— $— $3.6 
    The effects of cash flow hedges:
    Foreign currency contracts:
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income$9.3 $— $— $53.0 $— $— 
    The effects of net investment hedges:
    Cross currency swap contracts:
    Amount excluded from effectiveness testing$— $1.7 $— $— $5.2 $— 
    The effects of non-designated hedges:
    Foreign currency contracts$— $— $14.6 $— $— $19.1 
    XML 56 R35.htm IDEA: XBRL DOCUMENT v3.24.3
    STOCK-BASED COMPENSATION (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Share-Based Payment Arrangement [Abstract]  
    Schedule of Stock-Based Compensation Expense
    Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2024 and 2023 was as follows (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Cost of sales$6.1 $4.7 $20.8 $16.3 
    Selling, general, and administrative expenses20.4 17.2 62.4 57.3 
    Research and development expenses8.7 7.2 28.3 23.7 
    Total stock-based compensation expense35.2 29.1 111.5 97.3 
    Income tax benefit(6.0)(4.7)(17.5)(14.5)
    Total stock-based compensation expense, net of tax$29.2 $24.4 $94.0 $82.8 
    Schedule of Weighted-Average Assumptions for Options Granted
    The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
     Option Awards
    		Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Risk-free interest rate4.2 %4.3 %4.5%3.4%
    Expected dividend yieldNoneNoneNoneNone
    Expected volatility31.0 %32.7 %30.9%32.8%
    Expected term (years)5.55.25.35.1
    Fair value, per option$32.15 $31.16 $31.30 $31.02 
    Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted
    The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
     ESPP
    		Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Risk-free interest rate5.3 %5.3 %5.2%4.6%
    Expected dividend yieldNoneNoneNoneNone
    Expected volatility29.5 %34.8 %33.5%31.5%
    Expected term (years)0.60.60.60.6
    Fair value, per share$16.51 $18.53 $25.01$19.03 
    XML 57 R36.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCELERATED SHARE REPURCHASE (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Equity [Abstract]  
    Schedule of Accelerated Share Repurchases The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
      Initial DeliveryFinal Settlement
    Agreement DateAmount
    Paid    		Shares
    Received    		Price per
    Share    		Value of
    Shares as %
    of Contract
    Value    		Settlement
    Date    		Total Shares
    Received    		Average Price
    per Share
    February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
    April 2024$150.0 1.4 $85.95 80 %May 20241.7 $86.72 
    August 2024$500.0 5.8 $68.93 80 %(a)
    ______________________________________
    (a)     The ASR agreement has a scheduled settlement date of December 27, 2024. At the conclusion of the ASR agreement, the Company may receive additional shares or may be required to pay additional cash or shares (at our election).
    XML 58 R37.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Equity [Abstract]  
    Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss
    The following tables summarize the activity for each component of Accumulated Other Comprehensive Loss (in millions):
     Foreign
    Currency
    Translation
    Adjustments
    Unrealized Gain (Loss) on Hedges

    Unrealized Loss on Available-for-sale Investments
    Unrealized
    Pension
    Costs
    		Total
    Accumulated
    Other
    Comprehensive
    Loss
    December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
    Other comprehensive (loss) income before reclassifications
    		(23.3)43.4 7.0 0.4 27.5 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(7.2)2.5 — (6.4)
    Deferred income tax expense
    		(1.1)(9.3)(1.1)(0.1)(11.6)
    March 31, 2024$(240.6)$27.6 $(16.4)$(3.9)$(233.3)
    Other comprehensive income (loss) before reclassifications
    		3.4 21.8 4.2 (0.1)29.3 
    Amounts reclassified from accumulated other comprehensive loss(1.8)(12.5)1.0 — (13.3)
    Deferred income tax (expense) benefit
    		(0.6)(2.4)0.1 — (2.9)
    June 30, 2024$(239.6)$34.5 $(11.1)$(4.0)$(220.2)
    Other comprehensive income (loss) before reclassifications
    		3.8 (41.0)6.8 — (30.4)
    Amounts reclassified from accumulated other comprehensive loss(1.6)(17.0)(0.8)(19.4)
    Deferred income tax benefit
    		2.1 15.3 0.1 — 17.5 
    September 30, 2024$(235.3)$(8.2)$(5.0)$(4.0)$(252.5)

     Foreign
    Currency
    Translation
    Adjustments    		Unrealized Gain on Hedges
    Unrealized Loss on Available-for-sale Investments    		Unrealized
    Pension
    Credits    		Total
    Accumulated
    Other
    Comprehensive
    Loss
    December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
    Other comprehensive income (loss) before reclassifications
    		4.9 6.7 9.0 (0.1)20.5 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
    Deferred income tax benefit
    		0.6 5.9 — — 6.5 
    March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
    Other comprehensive (loss) income before reclassifications
    		(11.3)33.5 2.1 0.2 24.5 
    Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
    Deferred income tax benefit (expense)
    		1.6 (3.0)— — (1.4)
    June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)
    Other comprehensive (loss) income before reclassifications
    		(20.7)38.6 9.4 — 27.3 
    Amounts reclassified from accumulated other comprehensive loss(1.7)(14.1)1.2 — (14.6)
    Deferred income tax (expense) benefit
    		(1.0)(6.3)— — (7.3)
    September 30, 2023$(249.9)$30.1 $(36.1)$5.8 $(250.1)
    Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss
    The following table provides information about amounts reclassified from Accumulated Other Comprehensive Loss (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,    		 
     Affected Line on Consolidated Condensed
    Statements of Operations
    Details about Accumulated Other
    Comprehensive Loss Components
    		2024202320242023
    Foreign currency translation adjustments$1.6 $1.7 $5.1 $5.2 Other non-operating income, net
    (0.5)(0.5)(1.3)(1.3)Provision for income taxes
    $1.1 $1.2 $3.8 $3.9 Net of tax
    Gain (Loss) on hedges
    		$17.0 $9.3 $31.9 $53.0 Cost of sales
    — 4.8 4.8 16.1 Other non-operating income, net
    17.0 14.1 36.7 69.1 Total before tax
    (4.2)(2.9)(8.9)(14.8)Provision for income taxes
    $12.8 $11.2 $27.8 $54.3 Net of tax
    Loss on available-for-sale investments
    		$0.8 $(1.2)$(2.7)$(9.0)Interest income, net
    (0.2)0.4 0.7 2.3 Provision for income taxes
    $0.6 $(0.8)$(2.0)$(6.7)Net of tax
    XML 59 R38.htm IDEA: XBRL DOCUMENT v3.24.3
    EARNINGS PER SHARE (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Earnings Per Share [Abstract]  
    Schedule of Computation of Basic and Diluted Earnings Per Share
    The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Income for Earnings Per Share Calculations:
    Income from continuing operations, net of tax$362.1 $334.9 $1,051.0 $886.9 
    Net loss attributable to noncontrolling interests(1.4)(1.2)(3.6)(2.8)
    Income from continuing operations attributable to Edwards Lifesciences Corporation363.5 336.1 1,054.6 889.7 
    Income from discontinued operations2,707.3 48.8 2,734.4 142.8 
    Net income attributable to Edwards Lifesciences Corporation$3,070.8 $384.9 $3,789.0 $1,032.5 
    Weighted Average Shares:
    Basic weighted-average shares outstanding597.2 607.0 600.3 607.2 
    Dilutive effect of stock plans0.9 2.5 1.9 3.0 
    Dilutive weighted-average shares outstanding598.1 609.5 602.2 610.2 
    Earnings per Share:
    Basic:
    Continuing operations$0.61 $0.55 $1.76 $1.47 
    Discontinued operations4.53 0.08 4.55 0.23 
    Basic earnings per share$5.14 $0.63 $6.31 $1.70 
    Diluted:
    Continuing operations$0.61 $0.55 $1.75 $1.46 
    Discontinued operations4.52 0.08 4.54 0.23 
    Diluted earnings per share$5.13 $0.63 $6.29 $1.69 
    XML 60 R39.htm IDEA: XBRL DOCUMENT v3.24.3
    SEGMENT INFORMATION (Tables)
    		 9 Months Ended
    Sep. 30, 2024
    Segment Reporting [Abstract]  
    Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
    The table below presents information about Edwards Lifesciences' reportable segments (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Segment Net Sales    
    United States$804.6 $735.9 $2,393.1 $2,203.6 
    Europe315.1 282.7 968.4 878.0 
    Japan85.8 84.9 265.6 251.5 
    Rest of World153.2 136.1 440.9 399.0 
    Total segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
    Segment Operating Income    
    United States$551.2 $498.4 $1,619.2 $1,510.2 
    Europe177.3 156.1 540.3 489.2 
    Japan54.4 53.7 159.8 158.5 
    Rest of World67.2 59.5 184.7 170.6 
    Total segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
    The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Sales Reconciliation    
    Segment net sales$1,358.7 $1,239.6 $4,068.0 $3,732.1 
    Foreign currency(4.3)3.8 (14.3)11.5 
    Consolidated net sales$1,354.4 $1,243.4 $4,053.7 $3,743.6 
    Pre-tax Income Reconciliation    
    Segment operating income$850.1 $767.7 $2,504.0 $2,328.5 
    Unallocated amounts:    
    Corporate items(468.7)(410.1)(1,396.5)(1,259.4)
    Restructuring expenses (Note 4)(32.9)— (32.9)— 
    Intellectual property agreement and certain litigation expenses
    		(10.8)(2.2)(27.8)(193.6)
    Change in fair value of contingent consideration liabilities— — — 26.2 
    Foreign currency12.9 10.5 19.3 60.4 
    Consolidated operating income350.6 365.9 1,066.1 962.1 
    Non-operating income52.2 21.7 91.9 43.1 
    Consolidated pre-tax income$402.8 $387.6 $1,158.0 $1,005.2 
    Schedule of Enterprise-Wide Information
    The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
     Three Months Ended
    September 30,    		Nine Months Ended
    September 30,
     2024202320242023
    Net Sales by Geographic Region    
    United States$804.6 $735.9 $2,393.1 $2,203.6 
    Europe319.8 286.5 978.0 877.7 
    Japan81.4 85.8 253.9 266.4 
    Rest of World148.6 135.2 428.7 395.9 
    $1,354.4 $1,243.4 $4,053.7 $3,743.6 
    Net Sales by Major Product Group    
    Transcatheter Aortic Valve Replacement$1,023.3 $960.9 $3,069.8 $2,900.4 
    Transcatheter Mitral and Tricuspid Therapies91.1 52.4 247.0 141.6 
    Surgical Structural Heart240.0 230.1 736.9 701.6 
    $1,354.4 $1,243.4 $4,053.7 $3,743.6 
    XML 61 R40.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Inventories    
    Raw materials $ 248.8 $ 196.3
    Work in process 244.4 195.8
    Finished products 611.0 511.4
    Total inventories 1,104.2 903.5
    Finished products inventories held on consignment $ 187.8 $ 164.6
    XML 62 R41.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Other assets    
    Tax receivable (Note 16) $ 293.7 $ 0.0
    Notes and other receivables 132.9 155.1
    Acquisition options 117.5 161.3
    Long-term prepaid royalties 103.7 109.9
    Fair value of derivatives 21.8 23.4
    Other long-term assets 13.9 13.5
    Other assets, noncurrent 683.5 463.2
    Accrued and other liabilities    
    Employee compensation and withholdings 312.1 316.4
    Taxes payable (Note 5) 715.1 52.7
    Property, payroll, and other taxes 83.7 53.8
    Research and development accruals 79.0 71.6
    Accrued rebates 140.0 123.5
    Fair value of derivatives 24.3 15.2
    Accrued marketing expenses 14.5 13.7
    Legal and insurance 29.5 28.9
    Litigation settlement 75.1 69.1
    Accrued relocation costs 16.2 16.9
    Accrued professional services 62.2 8.5
    Accrued realignment reserves 39.6 6.4
    Unfavorable contract liability 66.0 0.0
    Other accrued liabilities 88.0 79.7
    Total accrued and other liabilities $ 1,745.3 $ 856.4
    XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Cash paid during the year for:    
    Income taxes $ 633.8 $ 219.1
    Amounts included in the measurement of operating lease liabilities 21.0 19.1
    Non-cash investing and financing transactions:    
    Right-of-use assets obtained in exchange for new lease liabilities 38.9 19.9
    Capital expenditures accruals 22.9 32.5
    Income taxes 633.8 219.1
    Discontinued Operations    
    Cash paid during the year for:    
    Income taxes 29.7 22.7
    Non-cash investing and financing transactions:    
    Income taxes $ 29.7 $ 22.7
    XML 64 R43.htm IDEA: XBRL DOCUMENT v3.24.3
    OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Sep. 30, 2023
    Dec. 31, 2022
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
    Cash and cash equivalents $ 3,676.4 $ 1,132.3    
    Total cash, cash equivalents, and restricted cash 3,683.4 1,148.0 $ 1,413.9 $ 772.6
    Continuing Operations        
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
    Cash and cash equivalents 3,676.4 1,132.3    
    Restricted cash included in other current assets 3.2 3.3    
    Restricted cash included in other assets 0.9 0.7    
    Total cash, cash equivalents, and restricted cash 3,680.5 1,136.3    
    Discontinued Operations        
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
    Cash and cash equivalents 2.9 11.7    
    Total cash, cash equivalents, and restricted cash $ 2.9 $ 11.7    
    XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.3
    INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details) - USD ($)
    $ in Millions
    		 1 Months Ended 3 Months Ended 9 Months Ended
    Apr. 12, 2023
    Apr. 30, 2023
    Mar. 31, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Loss Contingencies [Line Items]              
    Intellectual property agreement term 15 years            
    Intellectual property litigation expense       $ 10.8 $ 2.2 $ 27.8 $ 193.6
    Medtronic Inc              
    Loss Contingencies [Line Items]              
    Payments for legal settlements $ 300.0            
    Intellectual property litigation expense   $ 139.0 $ 37.0        
    Prepaid royalty asset   $ 124.0          
    XML 66 R45.htm IDEA: XBRL DOCUMENT v3.24.3
    RESTRUCTURING EXPENSES (Details)
    $ in Millions
    		 1 Months Ended 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    USD ($)
    employee
    Sep. 30, 2024
    USD ($)
    Sep. 30, 2023
    USD ($)
    Sep. 30, 2024
    USD ($)
    Sep. 30, 2023
    USD ($)
    Restructuring Cost and Reserve [Line Items]          
    Restructuring charges $ 32.9 $ 32.9 $ 0.0 $ 32.9 $ 0.0
    Restructuring and related cost, expected number of positions eliminated | employee 360        
    Employee Severance          
    Restructuring Cost and Reserve [Line Items]          
    Restructuring and related cost, expected cost remaining $ 30.6 $ 30.6   $ 30.6  
    XML 67 R46.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS - Narrative (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 03, 2024
    Jun. 03, 2024
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
    Income from discontinued operations, net of tax     $ 2,707.3 $ 48.8 $ 2,734.4 $ 142.8
    Becton, Dickinson and Company            
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
    Accounts receivable     24.6   24.6  
    Discontinued Operations, Held-for-Sale | Critical Care            
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
    Consideration   $ 4,200.0        
    Income from discontinued operations, net of tax $ 3,300.0          
    Transition services agreement period   36 months        
    Unfavorable contract liability   $ 115.1        
    Term for continued services 36 months          
    Amortization of unfavorable contract liability     $ 7.6   $ 7.6  
    XML 68 R47.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details) - Discontinued Operations, Held-for-Sale - Critical Care - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
    Net sales $ 177.2 $ 237.5 $ 708.4 $ 727.1
    Cost of sales 65.4 99.8 265.1 295.5
    Gross profit 111.8 137.7 443.3 431.6
    Selling, general, and administrative expenses 40.9 57.7 163.2 178.7
    Research and development expenses 21.4 27.5 81.3 81.0
    Separation costs 81.5 0.0 202.5 0.0
    Operating (loss) income, net (32.0) 52.5 (3.7) 171.9
    Other non-operating (income) expense, net (3,338.9) 0.8 (3,337.5) 0.7
    Income from discontinued operations before provision for income taxes 3,306.9 51.7 3,333.8 171.2
    Provision for income taxes from discontinued operations 599.6 2.9 599.4 28.4
    Net income from discontinued operations $ 2,707.3 $ 48.8 $ 2,734.4 $ 142.8
    XML 69 R48.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
    Total current assets of discontinued operations $ 20.0 $ 317.6
    Total non-current assets of discontinued operations 10.5 311.1
    Total current liabilities of discontinued operations 1.8 129.5
    Total non-current liabilities of discontinued operations 0.0 25.1
    Discontinued Operations, Held-for-Sale | Critical Care    
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
    Cash and cash equivalents 2.9 11.7
    Accounts receivable, net of allowances 0.0 3.6
    Other receivables 0.0 5.2
    Inventories 17.1 264.7
    Prepaid expenses 0.0 18.0
    Other current assets 0.0 14.4
    Total current assets of discontinued operations 20.0 317.6
    Property, plant, and equipment, net 3.1 158.4
    Operating lease right-of-use assets 0.0 9.6
    Goodwill 7.4 108.4
    Other intangible assets, net 0.0 29.0
    Deferred income taxes 0.0 5.2
    Other assets 0.0 0.5
    Total non-current assets of discontinued operations 10.5 311.1
    Accounts payable 0.0 14.8
    Accrued and other liabilities 1.8 112.7
    Operating lease liabilities 0.0 2.0
    Total current liabilities of discontinued operations 1.8 129.5
    Operating lease liabilities 0.0 7.8
    Uncertain tax positions 0.0 4.3
    Other liabilities 0.0 13.0
    Total non-current liabilities of discontinued operations $ 0.0 $ 25.1
    XML 70 R49.htm IDEA: XBRL DOCUMENT v3.24.3
    DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details) - Discontinued Operations, Held-for-Sale - Critical Care - USD ($)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
    Depreciation and amortization $ 12.1 $ 16.2
    Stock-based compensation 16.7 11.6
    Inventory write off 17.0 13.2
    Capital expenditures $ 16.4 $ 21.0
    XML 71 R50.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Held-to-maturity    
    Fair Value $ 50.5  
    Available-for-sale    
    Amortized Cost 900.9 $ 926.1
    Gross Unrealized Gains 0.2 0.1
    Gross Unrealized Losses (6.9) (27.5)
    Fair Value 894.2 898.7
    Bank time deposits    
    Held-to-maturity    
    Amortized Cost 50.5 64.5
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses 0.0 0.0
    Fair Value 50.5 64.5
    Available-for-sale    
    Amortized Cost 17.6 0.0
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses 0.0 0.0
    Fair Value 17.6 0.0
    Commercial paper    
    Available-for-sale    
    Amortized Cost 112.9 0.0
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses 0.0 0.0
    Fair Value 112.9 0.0
    U.S. government and agency securities    
    Available-for-sale    
    Amortized Cost 185.2 72.7
    Gross Unrealized Gains 0.1 0.1
    Gross Unrealized Losses (1.2) (2.8)
    Fair Value 184.1 70.0
    Asset-backed securities    
    Available-for-sale    
    Amortized Cost 80.2 192.1
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses (1.6) (7.8)
    Fair Value 78.6 184.3
    Corporate debt securities    
    Available-for-sale    
    Amortized Cost 502.2 658.5
    Gross Unrealized Gains 0.1 0.0
    Gross Unrealized Losses (4.0) (16.7)
    Fair Value 498.3 641.8
    Municipal securities    
    Available-for-sale    
    Amortized Cost 2.8 2.8
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses (0.1) (0.2)
    Fair Value $ 2.7 $ 2.6
    XML 72 R51.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Amortized Cost    
    Due in 1 year or less $ 50.5  
    Due after 1 year through 5 years 0.0  
    Instruments not due at a single maturity date 0.0  
    Amortized Cost 50.5  
    Fair Value    
    Due in 1 year or less 50.5  
    Due after 1 year through 5 years 0.0  
    Instruments not due at a single maturity date 0.0  
    Fair Value 50.5  
    Amortized Cost    
    Due in 1 year or less 721.1  
    Due after 1 year through 5 years 81.4  
    Instruments not due at a single maturity date 98.4  
    Amortized Cost 900.9 $ 926.1
    Fair Value    
    Due in 1 year or less 719.2  
    Due after 1 year through 5 years 79.2  
    Instruments not due at a single maturity date 95.8  
    Fair Value $ 894.2 $ 898.7
    XML 73 R52.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Debt Securities, Available-for-sale [Line Items]    
    Fair value, less than 12 months $ 3.6 $ 35.2
    Gross unrealized losses, less than 12 months (0.1) (1.9)
    Fair value, 12 months or greater 295.0 843.7
    Gross unrealized losses, 12 months or greater (6.8) (25.6)
    Fair value, total 298.6 878.9
    Gross unrealized losses, total (6.9) (27.5)
    U.S. government and agency securities    
    Debt Securities, Available-for-sale [Line Items]    
    Fair value, less than 12 months 0.0 0.0
    Gross unrealized losses, less than 12 months 0.0 0.0
    Fair value, 12 months or greater 34.0 67.1
    Gross unrealized losses, 12 months or greater (1.2) (2.8)
    Fair value, total 34.0 67.1
    Gross unrealized losses, total (1.2) (2.8)
    Asset-backed securities    
    Debt Securities, Available-for-sale [Line Items]    
    Fair value, less than 12 months 3.6 10.2
    Gross unrealized losses, less than 12 months (0.1) (1.8)
    Fair value, 12 months or greater 65.3 172.7
    Gross unrealized losses, 12 months or greater (1.5) (6.0)
    Fair value, total 68.9 182.9
    Gross unrealized losses, total (1.6) (7.8)
    Corporate debt securities    
    Debt Securities, Available-for-sale [Line Items]    
    Fair value, less than 12 months 0.0 25.0
    Gross unrealized losses, less than 12 months 0.0 (0.1)
    Fair value, 12 months or greater 193.0 601.3
    Gross unrealized losses, 12 months or greater (4.0) (16.6)
    Fair value, total 193.0 626.3
    Gross unrealized losses, total (4.0) (16.7)
    Municipal securities    
    Debt Securities, Available-for-sale [Line Items]    
    Fair value, less than 12 months 0.0 0.0
    Gross unrealized losses, less than 12 months 0.0 0.0
    Fair value, 12 months or greater 2.7 2.6
    Gross unrealized losses, 12 months or greater (0.1) (0.2)
    Fair value, total 2.7 2.6
    Gross unrealized losses, total $ (0.1) $ (0.2)
    XML 74 R53.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Equity method investments    
    Carrying value of equity method investments $ 32.3 $ 33.6
    Equity securities    
    Carrying value of marketable equity securities 7.4 0.0
    Carrying value of non-marketable equity securities 104.9 87.6
    Total investments in unconsolidated entities $ 144.6 $ 121.2
    XML 75 R54.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS - Narrative (Details)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    USD ($)
    Debt and Equity Securities, FV-NI [Line Items]  
    Upward price adjustments $ 0.5
    Downward price adjustment, annual amount 2.4
    Increase in non-marketable equity securities due to observable price changes 9.3
    Decrease in non-marketable equity securities due to observable price changes $ 5.5
    Limited Liability Company  
    Debt and Equity Securities, FV-NI [Line Items]  
    Investments taken period 7 years
    New Markets Tax Credit | Limited Liability Company  
    Debt and Equity Securities, FV-NI [Line Items]  
    Investment percentage (in percent) 39.00%
    XML 76 R55.htm IDEA: XBRL DOCUMENT v3.24.3
    INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) - USD ($)
    $ in Millions
    		 1 Months Ended 9 Months Ended 12 Months Ended 19 Months Ended
    Oct. 31, 2024
    Jun. 30, 2022
    Sep. 30, 2024
    Sep. 30, 2023
    Dec. 31, 2019
    Sep. 30, 2024
    Dec. 31, 2023
    Mar. 31, 2023
    Apr. 30, 2021
    Variable Interest Entity [Line Items]                  
    Assets     $ 12,971.2     $ 12,971.2 $ 9,363.2    
    Liabilities     3,359.8     3,359.8 2,643.8    
    Payment for acquisition options     16.2 $ 15.0          
    Variable Interest Entity, Primary Beneficiary                  
    Variable Interest Entity [Line Items]                  
    Assets     258.1     258.1 272.1    
    Liabilities     26.7     26.7 31.5    
    Variable Interest Entity, Not Primary Beneficiary | Subsequent Event                  
    Variable Interest Entity [Line Items]                  
    Remaining financing receivable $ 5.0                
    Variable Interest Entity, Not Primary Beneficiary | Medical Device Company, April 2021 Investment                  
    Variable Interest Entity [Line Items]                  
    Maximum secured promissory note                 $ 45.0
    Investee drew additional amount     30.0     30.0 30.0    
    Carrying value of non-marketable equity securities     42.8     42.8 39.3    
    Investment option to acquire     20.9     20.9 13.1    
    Maximum additional required investment     3.0     3.0      
    Maximum additional option to acquire investment     6.6     6.6      
    Variable Interest Entity, Not Primary Beneficiary | Medical Device Company, March 2023 Investment                  
    Variable Interest Entity [Line Items]                  
    Payment for acquisition options           30.0      
    Carrying value of non-marketable equity securities     3.5     3.5 $ 3.3    
    Option to acquire investment amount               $ 45.0  
    Variable Interest Entity, Not Primary Beneficiary | Medical Device Company, March 2023 Investment | Convertible Promissory Note                  
    Variable Interest Entity [Line Items]                  
    Investee drew additional amount               $ 5.0  
    Variable Interest Entity, Not Primary Beneficiary | Medical Device Company                  
    Variable Interest Entity [Line Items]                  
    Loans receivables, maximum lending amount   $ 47.5              
    Financing receivable     $ 42.5     $ 42.5      
    Payment for acquisition options         $ 35.0        
    XML 77 R56.htm IDEA: XBRL DOCUMENT v3.24.3
    BUSINESS COMBINATIONS - Narrative (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Aug. 19, 2024
    Aug. 18, 2024
    Jul. 22, 2024
    Sep. 30, 2024
    Sep. 30, 2024
    Endotronix, Inc          
    Business Acquisition [Line Items]          
    Cash consideration paid at closing $ 650.3 $ 60.0      
    Fair value of previously held equity interest $ 94.6 $ 10.0      
    Percentage of previously held interest   7.00%      
    Equity interest in acquire, excluding initial acquisition, percentage 93.00%        
    Step acquisition, equity interest in acquire, remeasurement gain       $ 24.6  
    Total purchase price, net of cash acquired $ 798.8        
    Payments to acquire businesses 649.1        
    Less: cash acquired (1.2)        
    Settlement of pre-existing relationships 53.1        
    Contingent consideration liabilities 2.0        
    Business combination, escrow deposit       $ 35.0 $ 35.0
    Acquisition-related costs         5.6
    In-process research and development, expected costs $ 47.1        
    Endotronix, Inc | Developed technology | Discount Rate          
    Business Acquisition [Line Items]          
    Measurement input 15.50%        
    Endotronix, Inc | In-process research and development | Discount Rate          
    Business Acquisition [Line Items]          
    Measurement input 18.00%        
    JC Medical, Inc          
    Business Acquisition [Line Items]          
    Cash consideration paid at closing     $ 114.8    
    Total purchase price, net of cash acquired     116.3    
    Less: cash acquired     (0.3)    
    Contingent consideration liabilities     1.8    
    Business combination, escrow deposit     12.0    
    Acquisition-related costs         $ 1.6
    In-process research and development, expected costs $ 55.8        
    Additional contingent consideration     $ 200.0    
    Contingent consideration liability, term     12 years    
    Escrow deposit, holding period     15 months    
    JC Medical, Inc | In-process research and development | Discount Rate          
    Business Acquisition [Line Items]          
    Measurement input     15.00%    
    XML 78 R57.htm IDEA: XBRL DOCUMENT v3.24.3
    BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
    $ in Millions
    Aug. 19, 2024
    Aug. 18, 2024
    Jul. 22, 2024
    Sep. 30, 2024
    Dec. 31, 2023
    Business Acquisition [Line Items]          
    Goodwill       $ 1,605.3 $ 1,145.1
    Endotronix, Inc          
    Business Acquisition [Line Items]          
    Cash consideration paid at closing $ 650.3 $ 60.0      
    Settlement of pre-existing relationships 53.1        
    Fair value of previously held equity interest 94.6 $ 10.0      
    Fair value of contingent consideration 2.0        
    Total purchase price 800.0        
    Less: cash acquired (1.2)        
    Total purchase price, net of cash acquired 798.8        
    Current assets 7.7        
    Property and equipment, net 12.6        
    Goodwill 412.0        
    Operating lease right-of-use assets 9.9        
    Other assets 0.7        
    Liabilities assumed (26.3)        
    Deferred tax liabilities (70.6)        
    Net assets acquired 800.0        
    Endotronix, Inc | In-process research and development          
    Business Acquisition [Line Items]          
    Intangibles 69.0        
    Endotronix, Inc | Developed technology          
    Business Acquisition [Line Items]          
    Intangibles $ 385.0        
    JC Medical, Inc          
    Business Acquisition [Line Items]          
    Cash consideration paid at closing     $ 114.8    
    Fair value of contingent consideration     1.8    
    Total purchase price     116.6    
    Less: cash acquired     (0.3)    
    Total purchase price, net of cash acquired     116.3    
    Current assets     0.3    
    Property and equipment, net     0.3    
    Goodwill     46.9    
    Current liabilities assumed     (1.0)    
    Deferred tax liabilities     (16.5)    
    Net assets acquired     116.6    
    JC Medical, Inc | In-process research and development          
    Business Acquisition [Line Items]          
    Intangibles     $ 86.6    
    XML 79 R58.htm IDEA: XBRL DOCUMENT v3.24.3
    FAIR VALUE MEASUREMENTS - Narrative (Details)
    $ in Millions
    Sep. 30, 2024
    USD ($)
    Discount Rate | Minimum  
    Financial instruments  
    Contingent consideration liability measurement input 0.000
    Discount Rate | Maximum  
    Financial instruments  
    Contingent consideration liability measurement input 0.117
    Discount Rate | Weighted Average  
    Financial instruments  
    Contingent consideration liability measurement input 0.056
    Probability of Milestone Achievement | Minimum  
    Financial instruments  
    Contingent consideration liability measurement input 0.60
    Probability of Milestone Achievement | Maximum  
    Financial instruments  
    Contingent consideration liability measurement input 1
    Probability of Milestone Achievement | Weighted Average  
    Financial instruments  
    Contingent consideration liability measurement input 0.809
    Revenue Volatility  
    Financial instruments  
    Contingent consideration liability measurement input 0.27
    Level 2  
    Financial instruments  
    Notes payable fair value disclosure $ 600.0
    XML 80 R59.htm IDEA: XBRL DOCUMENT v3.24.3
    FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Assets    
    Available-for-sale investments: $ 894.2 $ 898.7
    Equity investments in unconsolidated entities 7.4 0.0
    Bank time deposits    
    Assets    
    Available-for-sale investments: 17.6 0.0
    Corporate debt securities    
    Assets    
    Available-for-sale investments: 498.3 641.8
    Asset-backed securities    
    Assets    
    Available-for-sale investments: 78.6 184.3
    United States government and agency securities    
    Assets    
    Available-for-sale investments: 184.1 70.0
    Commercial paper    
    Assets    
    Available-for-sale investments: 112.9 0.0
    Municipal securities    
    Assets    
    Available-for-sale investments: 2.7 2.6
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis    
    Assets    
    Cash equivalents 3,140.1 579.2
    Equity investments in unconsolidated entities 7.5  
    Investments held for deferred compensation plans 143.9 125.8
    Derivatives 27.6 39.5
    Assets 4,213.3 1,643.2
    Liabilities    
    Derivatives 24.3 15.2
    Contingent consideration liabilities 3.8  
    Other 5.0 10.3
    Liabilities 33.1 25.5
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Bank time deposits    
    Assets    
    Available-for-sale investments: 17.6  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities    
    Assets    
    Available-for-sale investments: 498.3 641.8
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities    
    Assets    
    Available-for-sale investments: 78.6 184.3
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities    
    Assets    
    Available-for-sale investments: 184.1 70.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Commercial paper    
    Assets    
    Available-for-sale investments: 112.9  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities    
    Assets    
    Available-for-sale investments: 2.7 2.6
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1    
    Assets    
    Cash equivalents 2,287.8 579.2
    Equity investments in unconsolidated entities 7.5  
    Investments held for deferred compensation plans 143.9 125.8
    Derivatives 0.0 0.0
    Assets 2,488.5 705.0
    Liabilities    
    Derivatives 0.0 0.0
    Contingent consideration liabilities 0.0  
    Other 0.0 0.0
    Liabilities 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Bank time deposits    
    Assets    
    Available-for-sale investments: 0.0  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities    
    Assets    
    Available-for-sale investments: 49.3 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Commercial paper    
    Assets    
    Available-for-sale investments: 0.0  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2    
    Assets    
    Cash equivalents 852.3 0.0
    Equity investments in unconsolidated entities 0.0  
    Investments held for deferred compensation plans 0.0 0.0
    Derivatives 27.6 39.5
    Assets 1,724.8 938.2
    Liabilities    
    Derivatives 24.3 15.2
    Contingent consideration liabilities 0.0  
    Other 0.0 0.0
    Liabilities 24.3 15.2
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Bank time deposits    
    Assets    
    Available-for-sale investments: 17.6  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities    
    Assets    
    Available-for-sale investments: 498.3 641.8
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities    
    Assets    
    Available-for-sale investments: 78.6 184.3
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities    
    Assets    
    Available-for-sale investments: 134.8 70.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Commercial paper    
    Assets    
    Available-for-sale investments: 112.9  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities    
    Assets    
    Available-for-sale investments: 2.7 2.6
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3    
    Assets    
    Cash equivalents 0.0 0.0
    Equity investments in unconsolidated entities 0.0  
    Investments held for deferred compensation plans 0.0 0.0
    Derivatives 0.0 0.0
    Assets 0.0 0.0
    Liabilities    
    Derivatives 0.0 0.0
    Contingent consideration liabilities 3.8  
    Other 5.0 10.3
    Liabilities 8.8 10.3
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Bank time deposits    
    Assets    
    Available-for-sale investments: 0.0  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities    
    Assets    
    Available-for-sale investments: 0.0 0.0
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Commercial paper    
    Assets    
    Available-for-sale investments: 0.0  
    Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities    
    Assets    
    Available-for-sale investments: $ 0.0 $ 0.0
    XML 81 R60.htm IDEA: XBRL DOCUMENT v3.24.3
    FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) - USD ($)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Change in fair value of contingent consideration liabilities (Note 9) Change in fair value of contingent consideration liabilities (Note 9)
    Additions $ 3.8  
    Payments 0.0  
    Fair Value on a Recurring Basis | Level 3    
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Fair value beginning balance 10.3 $ 40.2
    Changes in fair value (5.3) (29.9)
    Fair value ending balance 8.8 10.3
    Contingent Consideration    
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Additions 3.8  
    Payments 0.0  
    Contingent Consideration | Fair Value on a Recurring Basis | Level 3    
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Fair value beginning balance 0.0 26.2
    Changes in fair value 0.0 (26.2)
    Fair value ending balance 3.8 0.0
    Other    
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Additions 0.0  
    Payments 0.0  
    Other | Fair Value on a Recurring Basis | Level 3    
    Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
    Fair value beginning balance 10.3 14.0
    Changes in fair value (5.3) (3.7)
    Fair value ending balance $ 5.0 $ 10.3
    XML 82 R61.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Foreign currency forward exchange contracts    
    Derivative Financial Instruments    
    Notional Amount $ 2,219.8 $ 1,460.3
    Cross-currency swap contracts    
    Derivative Financial Instruments    
    Notional Amount $ 300.0 $ 300.0
    XML 83 R62.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)
    € in Millions, $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    USD ($)
    Sep. 30, 2024
    EUR (€)
    Dec. 31, 2023
    USD ($)
    Derivative Financial Instruments      
    Changes due to currency rate movements and expenses expected to occur, maximum term 1 year    
    Cash flow gain to be reclassified in the next twelve months $ 4.1    
    Derivatives designated as hedging instruments | Cross-currency swap contracts      
    Derivative Financial Instruments      
    Derivative liability, fair value 300.0   $ 300.0
    Net investment hedges | Derivatives designated as hedging instruments | Cross-currency swap contracts      
    Derivative Financial Instruments      
    Derivative liability, fair value $ 300.0 € 257.2  
    XML 84 R63.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Assets    
    Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets, Other assets (Note 2) Other current assets, Other assets (Note 2)
    Liabilities    
    Derivative Liability, Statement of Financial Position [Extensible Enumeration] Accrued and other liabilities (Note 2) Accrued and other liabilities (Note 2)
    Foreign currency contracts    
    Assets    
    Fair value of derivative assets $ 5.8 $ 16.1
    Liabilities    
    Fair value of derivative liabilities 24.3 15.2
    Cross-currency swap contracts    
    Assets    
    Fair value of derivative assets 21.8 23.4
    Derivatives designated as hedging instruments | Foreign currency contracts    
    Assets    
    Fair value of derivative assets 5.8 16.1
    Liabilities    
    Fair value of derivative liabilities 21.2 15.2
    Derivatives designated as hedging instruments | Cross-currency swap contracts    
    Assets    
    Fair value of derivative assets 21.8 23.4
    Derivatives not designated as hedging instruments | Foreign currency contracts    
    Liabilities    
    Fair value of derivative liabilities $ 3.1 $ 0.0
    XML 85 R64.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) - USD ($)
    $ in Millions
    Sep. 30, 2024
    Dec. 31, 2023
    Foreign currency contracts    
    Derivative assets    
    Gross Amounts $ 5.8 $ 16.1
    Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
    Net Amounts Presented in the Consolidated Balance Sheet 5.8 16.1
    Gross Amounts Not Offset in the Consolidated Balance Sheet    
    Financial Instruments (3.8) (9.4)
    Cash Collateral Received 0.0 0.0
    Net Amount 2.0 6.7
    Derivative liabilities    
    Gross Amounts 24.3 15.2
    Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
    Net Amounts Presented in the Consolidated Balance Sheet 24.3 15.2
    Gross Amounts Not Offset in the Consolidated Balance Sheet    
    Financial Instruments (3.8) (9.4)
    Cash Collateral Received 0.0 0.0
    Net Amount 20.5 5.8
    Cross-currency swap contracts    
    Derivative assets    
    Gross Amounts 21.8 23.4
    Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
    Net Amounts Presented in the Consolidated Balance Sheet 21.8 23.4
    Gross Amounts Not Offset in the Consolidated Balance Sheet    
    Financial Instruments 0.0 0.0
    Cash Collateral Received 0.0 0.0
    Net Amount $ 21.8 $ 23.4
    XML 86 R65.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) - Derivatives designated as hedging instruments - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Cash flow hedges | Foreign currency contracts        
    Derivative Instruments, Gain (Loss)        
    Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) $ (40.9) $ 33.5 $ 17.0 $ 60.4
    Net investment hedges | Cross-currency swap contracts        
    Derivative Instruments, Gain (Loss)        
    Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) $ (8.7) $ 3.8 $ (1.6) $ (5.2)
    XML 87 R66.htm IDEA: XBRL DOCUMENT v3.24.3
    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Derivative Instruments, Gain (Loss)        
    Cost of sales $ (262.9) $ (250.6) $ (825.3) $ (727.4)
    Interest income, net 24.3 15.1 56.3 32.8
    Other non-operating income, net 27.9 6.6 35.6 10.3
    Foreign currency contracts | Cost of sales        
    Derivative Instruments, Gain (Loss)        
    Hedged items 0.0 0.0 0.0 0.0
    Amount excluded from effectiveness testing (amortized) 0.0 0.0 0.0 0.0
    Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Derivatives designated as hedging instruments 0.0 0.0 0.0 0.0
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income 17.0 9.3 31.9 53.0
    Foreign currency contracts | Cost of sales | Derivatives not designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Foreign currency contracts 0.0 0.0 0.0 0.0
    Foreign currency contracts | Interest income, net        
    Derivative Instruments, Gain (Loss)        
    Hedged items 0.0 0.0 0.0 0.0
    Amount excluded from effectiveness testing (amortized) 0.0 0.0 0.0 0.0
    Foreign currency contracts | Interest income, net | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Derivatives designated as hedging instruments 0.0 0.0 0.0 0.0
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income 0.0 0.0 0.0 0.0
    Foreign currency contracts | Interest income, net | Derivatives not designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Foreign currency contracts 0.0 0.0 0.0 0.0
    Foreign currency contracts | Other non-operating income, net        
    Derivative Instruments, Gain (Loss)        
    Hedged items 0.0 (3.6) (4.0) (12.5)
    Amount excluded from effectiveness testing (amortized) 0.0 1.2 0.8 3.6
    Foreign currency contracts | Other non-operating income, net | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Derivatives designated as hedging instruments 0.0 3.6 4.0 12.5
    Amount of gain (loss) reclassified from accumulated other comprehensive loss into income 0.0 0.0 0.0 0.0
    Foreign currency contracts | Other non-operating income, net | Derivatives not designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Foreign currency contracts (29.6) 14.6 3.7 19.1
    Cross-currency swap contracts | Cost of sales | Net investment hedges | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Amount excluded from effectiveness testing 0.0 0.0 0.0 0.0
    Cross-currency swap contracts | Interest income, net | Net investment hedges | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Amount excluded from effectiveness testing 1.6 1.7 5.1 5.2
    Cross-currency swap contracts | Other non-operating income, net | Net investment hedges | Derivatives designated as hedging instruments        
    Derivative Instruments, Gain (Loss)        
    Amount excluded from effectiveness testing $ 0.0 $ 0.0 $ 0.0 $ 0.0
    XML 88 R67.htm IDEA: XBRL DOCUMENT v3.24.3
    STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Allocation of stock-based compensation expense        
    Total stock-based compensation expense $ 35.2 $ 29.1 $ 111.5 $ 97.3
    Income tax benefit (6.0) (4.7) (17.5) (14.5)
    Total stock-based compensation expense, net of tax 29.2 24.4 94.0 82.8
    Cost of sales        
    Allocation of stock-based compensation expense        
    Total stock-based compensation expense 6.1 4.7 20.8 16.3
    Selling, general, and administrative expenses        
    Allocation of stock-based compensation expense        
    Total stock-based compensation expense 20.4 17.2 62.4 57.3
    Research and development expenses        
    Allocation of stock-based compensation expense        
    Total stock-based compensation expense $ 8.7 $ 7.2 $ 28.3 $ 23.7
    XML 89 R68.htm IDEA: XBRL DOCUMENT v3.24.3
    STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
    $ / shares in Units, shares in Millions, $ in Millions
    		 9 Months Ended
    May 07, 2024
    Sep. 30, 2024
    Sep. 30, 2023
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Total remaining unrecognized compensation cost   $ 289.7  
    Unrecognized compensation cost, recognition period   33 months  
    Options granted (in shares)   1.5  
    Weighted average exercise price of options granted (in dollars per share)   $ 85.94  
    Performance period (years)   3 years  
    Common Stock | Long Term Stock Incentive Compensation Program      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Additional shares authorized (in shares) 6.9    
    New total shares authorized (in shares) 334.5    
    Restricted Stock Units (RSUs)      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Restricted stock units granted (in shares)   1.9  
    Weighted average grant date fair value (in dollars per share)   $ 85.09  
    Restricted Stock Units (RSUs) | Long Term Stock Incentive Compensation Program      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Additional shares authorized (in shares) 2.0    
    New total shares authorized (in shares) 35.6    
    Market Based Restricted Stock Units      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Restricted stock units granted (in shares)   0.1  
    Weighted average grant date fair value (in dollars per share)   $ 97.66  
    Risk-free interest rate   4.50% 3.60%
    Expected volatility   32.40% 32.60%
    Market Based Restricted Stock Units | Minimum      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Shares expected to be granted as percentage of target (as a percent)   0.00%  
    Market Based Restricted Stock Units | Maximum      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Shares expected to be granted as percentage of target (as a percent)   175.00%  
    XML 90 R69.htm IDEA: XBRL DOCUMENT v3.24.3
    STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) - $ / shares
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
     Option Awards        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Risk-free interest rate 4.20% 4.30% 4.50% 3.40%
    Expected dividend yield 0.00% 0.00% 0.00% 0.00%
    Expected volatility 31.00% 32.70% 30.90% 32.80%
    Expected term (years) 5 years 6 months 5 years 2 months 12 days 5 years 3 months 18 days 5 years 1 month 6 days
    Fair value, per option/share (in dollars per share) $ 32.15 $ 31.16 $ 31.30 $ 31.02
     ESPP        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Risk-free interest rate 5.30% 5.30% 5.20% 4.60%
    Expected dividend yield 0.00% 0.00% 0.00% 0.00%
    Expected volatility 29.50% 34.80% 33.50% 31.50%
    Expected term (years) 7 months 6 days 7 months 6 days 7 months 6 days 7 months 6 days
    Fair value, per option/share (in dollars per share) $ 16.51 $ 18.53 $ 25.01 $ 19.03
    XML 91 R70.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCELERATED SHARE REPURCHASE (Details) - USD ($)
    $ / shares in Units, shares in Millions, $ in Millions
    		 1 Months Ended
    Aug. 31, 2024
    May 31, 2024
    Apr. 30, 2024
    Mar. 31, 2023
    Feb. 28, 2023
    Initial Delivery of Shares Settled February 2023          
    Class of Stock [Line Items]          
    Amount Paid         $ 200.0
    Shares Received (in shares)         2.0
    Initial delivery, price per share (in dollars per share)         $ 80.44
    Value of Shares as % of Contract Value         80.00%
    Initial Delivery of Shares Settled April 2024          
    Class of Stock [Line Items]          
    Amount Paid $ 500.0   $ 150.0    
    Shares Received (in shares) 5.8   1.4    
    Initial delivery, price per share (in dollars per share) $ 68.93   $ 85.95    
    Value of Shares as % of Contract Value 80.00%   80.00%    
    February 2023 Stock Repurchase Program Shares Sold in March 2023          
    Class of Stock [Line Items]          
    Shares Received (in shares)       2.5  
    Final settlement per share price (in dollars per share)       $ 79.28  
    April 2024 Stock Repurchase Program Shares Sold in May 2024          
    Class of Stock [Line Items]          
    Shares Received (in shares)   1.7      
    Final settlement per share price (in dollars per share)   $ 86.72      
    XML 92 R71.htm IDEA: XBRL DOCUMENT v3.24.3
    COMMITMENTS AND CONTINGENCIES (Details)
    $ in Millions
    		 9 Months Ended
    Sep. 30, 2024
    USD ($)
    lawsuit
    Commitments and Contingencies Disclosure [Abstract]  
    Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit 1
    Threshold of disclosing material environmental legal proceedings | $ $ 1
    XML 93 R72.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Sep. 30, 2024
    Jun. 30, 2024
    Mar. 31, 2024
    Sep. 30, 2023
    Jun. 30, 2023
    Mar. 31, 2023
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance     $ 6,650.0      
    Other comprehensive (loss) income before reclassifications $ (30.4) $ 29.3 27.5 $ 27.3 $ 24.5 $ 20.5
    Amounts reclassified from accumulated other comprehensive loss (19.4) (13.3) (6.4) (14.6) (23.2) (27.5)
    Deferred income tax expense (benefit) 17.5 (2.9) (11.6) (7.3) (1.4) 6.5
    Ending balance 9,545.6          
    Accumulated Other Comprehensive Loss            
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance (220.2) (233.3) (242.8) (255.5) (255.4) (254.9)
    Ending balance (252.5) (220.2) (233.3) (250.1) (255.5) (255.4)
    Foreign Currency Translation Adjustments            
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance (239.6) (240.6) (214.5) (226.5) (215.0) (218.8)
    Other comprehensive (loss) income before reclassifications 3.8 3.4 (23.3) (20.7) (11.3) 4.9
    Amounts reclassified from accumulated other comprehensive loss (1.6) (1.8) (1.7) (1.7) (1.8) (1.7)
    Deferred income tax expense (benefit) 2.1 (0.6) (1.1) (1.0) 1.6 0.6
    Ending balance (235.3) (239.6) (240.6) (249.9) (226.5) (215.0)
    Unrealized Gain (Loss) on Hedges            
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance 34.5 27.6 0.7 11.9 6.6 23.8
    Other comprehensive (loss) income before reclassifications (41.0) 21.8 43.4 38.6 33.5 6.7
    Amounts reclassified from accumulated other comprehensive loss (17.0) (12.5) (7.2) (14.1) (25.2) (29.8)
    Deferred income tax expense (benefit) 15.3 (2.4) (9.3) (6.3) (3.0) 5.9
    Ending balance (8.2) 34.5 27.6 30.1 11.9 6.6
    Unrealized Loss on Available-for-sale Investments            
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance (11.1) (16.4) (24.8) (46.7) (52.6) (65.6)
    Other comprehensive (loss) income before reclassifications 6.8 4.2 7.0 9.4 2.1 9.0
    Amounts reclassified from accumulated other comprehensive loss (0.8) 1.0 2.5 1.2 3.8 4.0
    Deferred income tax expense (benefit) 0.1 0.1 (1.1) 0.0 0.0 0.0
    Ending balance (5.0) (11.1) (16.4) (36.1) (46.7) (52.6)
    Unrealized Pension Credits (Costs)            
    AOCI Attributable to Parent, Net of Tax            
    Beginning balance (4.0) (3.9) (4.2) 5.8 5.6 5.7
    Other comprehensive (loss) income before reclassifications 0.0 (0.1) 0.4 0.0 0.2 (0.1)
    Amounts reclassified from accumulated other comprehensive loss 0.0 0.0 0.0 0.0 0.0
    Deferred income tax expense (benefit) 0.0 0.0 (0.1) 0.0 0.0 0.0
    Ending balance $ (4.0) $ (4.0) $ (3.9) $ 5.8 $ 5.8 $ 5.6
    XML 94 R73.htm IDEA: XBRL DOCUMENT v3.24.3
    ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Affected Line on Consolidated Condensed Statements of Operations        
    Other non-operating income, net $ 27.9 $ 6.6 $ 35.6 $ 10.3
    Provision for income taxes (40.7) (52.7) (107.0) (118.3)
    Cost of sales (262.9) (250.6) (825.3) (727.4)
    Interest income, net 24.3 15.1 56.3 32.8
    Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments        
    Affected Line on Consolidated Condensed Statements of Operations        
    Other non-operating income, net 1.6 1.7 5.1 5.2
    Provision for income taxes (0.5) (0.5) (1.3) (1.3)
    Net of tax 1.1 1.2 3.8 3.9
    Amount Reclassified from Accumulated Other Comprehensive Loss | Gain (Loss) on hedges        
    Affected Line on Consolidated Condensed Statements of Operations        
    Other non-operating income, net 0.0 4.8 4.8 16.1
    Provision for income taxes (4.2) (2.9) (8.9) (14.8)
    Net of tax 12.8 11.2 27.8 54.3
    Cost of sales 17.0 9.3 31.9 53.0
    Total before tax 17.0 14.1 36.7 69.1
    Amount Reclassified from Accumulated Other Comprehensive Loss | Loss on available-for-sale investments        
    Affected Line on Consolidated Condensed Statements of Operations        
    Provision for income taxes (0.2) 0.4 0.7 2.3
    Net of tax 0.6 (0.8) (2.0) (6.7)
    Interest income, net $ 0.8 $ (1.2) $ (2.7) $ (9.0)
    XML 95 R74.htm IDEA: XBRL DOCUMENT v3.24.3
    EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
    $ / shares in Units, shares in Millions, $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Net Income for Earnings Per Share Calculations:        
    Income from continuing operations, net of tax $ 362.1 $ 334.9 $ 1,051.0 $ 886.9
    Net loss attributable to noncontrolling interest (1.4) (1.2) (3.6) (2.8)
    Income from continuing operations attributable to Edwards Lifesciences Corporation 363.5 336.1 1,054.6 889.7
    Income from discontinued operations 2,707.3 48.8 2,734.4 142.8
    Net income attributable to Edwards Lifesciences Corporation $ 3,070.8 $ 384.9 $ 3,789.0 $ 1,032.5
    Weighted Average Shares:        
    Basic weighted-average shares outstanding (in shares) 597.2 607.0 600.3 607.2
    Dilutive effect of stock plans (in shares) 0.9 2.5 1.9 3.0
    Dilutive weighted-average shares outstanding (in shares) 598.1 609.5 602.2 610.2
    Basic:        
    Continuing operations (in dollars per share) $ 0.61 $ 0.55 $ 1.76 $ 1.47
    Discontinued operations (in dollars per share) 4.53 0.08 4.55 0.23
    Basic earnings per share (in dollars per share) 5.14 0.63 6.31 1.70
    Diluted:        
    Continuing operations (in dollars per share) 0.61 0.55 1.75 1.46
    Discontinued operations (in dollars per share) 4.52 0.08 4.54 0.23
    Diluted earnings per share (in dollars per share) $ 5.13 $ 0.63 $ 6.29 $ 1.69
    XML 96 R75.htm IDEA: XBRL DOCUMENT v3.24.3
    EARNINGS PER SHARE - Narrative (Details) - shares
    shares in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Stock Compensation Plan        
    Anti-dilutive securities        
    Anti-dilutive securities excluded from the computation of earnings per share (in shares) 10.4 6.5 7.8 6.1
    Treasury Stock        
    Anti-dilutive securities        
    Anti-dilutive securities excluded from the computation of earnings per share (in shares)     1.9  
    XML 97 R76.htm IDEA: XBRL DOCUMENT v3.24.3
    INCOME TAXES (Details)
    $ in Millions
    		 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
    Mar. 31, 2024
    USD ($)
    Nov. 30, 2022
    USD ($)
    Sep. 30, 2024
    USD ($)
    Mar. 31, 2024
    USD ($)
    Sep. 30, 2023
    USD ($)
    Sep. 30, 2024
    USD ($)
    Sep. 30, 2023
    USD ($)
    Dec. 31, 2021
    USD ($)
    Dec. 31, 2023
    USD ($)
    Dec. 31, 2020
    agreement
    Income Tax Contingency [Line Items]                    
    Effective income tax rate (as a percent)     10.10%   13.60% 9.20% 11.80%      
    Tax benefit from employee share-based compensation     $ 0.6   $ 1.8 $ 10.1 $ 12.8      
    Liability for income taxes associated with uncertain tax positions     656.5     656.5     $ 583.9  
    Decrease in unrecognized tax benefits is reasonably possible     326.1     326.1     250.7  
    Net amounts that would favorably affect effective tax rate     $ 330.4     $ 330.4     333.2  
    Number of APAs renewed | agreement                   3
    Additional tax expense               $ 250.0    
    Additional tax sought in excess of filing position                 $ 269.3  
    Additional deposit $ 305.0 $ 75.0                
    Israel Tax Authority                    
    Income Tax Contingency [Line Items]                    
    Estimate of additional tax owed       $ 110.0            
    XML 98 R77.htm IDEA: XBRL DOCUMENT v3.24.3
    SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Segment Net Sales        
    Total segment net sales $ 1,354.4 $ 1,243.4 $ 4,053.7 $ 3,743.6
    Operating segments        
    Segment Net Sales        
    Total segment net sales 1,358.7 1,239.6 4,068.0 3,732.1
    Segment Operating Income        
    Total segment operating income 850.1 767.7 2,504.0 2,328.5
    Operating segments | United States        
    Segment Net Sales        
    Total segment net sales 804.6 735.9 2,393.1 2,203.6
    Segment Operating Income        
    Total segment operating income 551.2 498.4 1,619.2 1,510.2
    Operating segments | Europe        
    Segment Net Sales        
    Total segment net sales 315.1 282.7 968.4 878.0
    Segment Operating Income        
    Total segment operating income 177.3 156.1 540.3 489.2
    Operating segments | Japan        
    Segment Net Sales        
    Total segment net sales 85.8 84.9 265.6 251.5
    Segment Operating Income        
    Total segment operating income 54.4 53.7 159.8 158.5
    Operating segments | Rest of World        
    Segment Net Sales        
    Total segment net sales 153.2 136.1 440.9 399.0
    Segment Operating Income        
    Total segment operating income $ 67.2 $ 59.5 $ 184.7 $ 170.6
    XML 99 R78.htm IDEA: XBRL DOCUMENT v3.24.3
    SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) - USD ($)
    $ in Millions
    		 1 Months Ended 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Net Sales Reconciliation          
    Net sales   $ 1,354.4 $ 1,243.4 $ 4,053.7 $ 3,743.6
    Pre-tax Income Reconciliation          
    Consolidated operating income   350.6 365.9 1,066.1 962.1
    Unallocated amounts:          
    Restructuring expenses (Note 4) $ (32.9) (32.9) 0.0 (32.9) 0.0
    Intellectual property agreement and certain litigation expenses   (10.8) (2.2) (27.8) (193.6)
    Change in fair value of contingent consideration liabilities   0.0 0.0 0.0 26.2
    Income from continuing operations before provision for income taxes   402.8 387.6 1,158.0 1,005.2
    Operating segments          
    Net Sales Reconciliation          
    Net sales   1,358.7 1,239.6 4,068.0 3,732.1
    Pre-tax Income Reconciliation          
    Consolidated operating income   850.1 767.7 2,504.0 2,328.5
    Reconciling items          
    Net Sales Reconciliation          
    Net sales   (4.3) 3.8 (14.3) 11.5
    Unallocated amounts:          
    Restructuring expenses (Note 4)   (32.9) 0.0 (32.9) 0.0
    Intellectual property agreement and certain litigation expenses   (10.8) (2.2) (27.8) (193.6)
    Foreign currency   12.9 10.5 19.3 60.4
    Non-operating income   52.2 21.7 91.9 43.1
    Corporate items          
    Unallocated amounts:          
    Corporate items   $ (468.7) $ (410.1) $ (1,396.5) $ (1,259.4)
    XML 100 R79.htm IDEA: XBRL DOCUMENT v3.24.3
    SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2024
    Sep. 30, 2023
    Sep. 30, 2024
    Sep. 30, 2023
    Enterprise-Wide Information        
    Net sales $ 1,354.4 $ 1,243.4 $ 4,053.7 $ 3,743.6
    Transcatheter Aortic Valve Replacement        
    Enterprise-Wide Information        
    Net sales 1,023.3 960.9 3,069.8 2,900.4
    Transcatheter Mitral and Tricuspid Therapies        
    Enterprise-Wide Information        
    Net sales 91.1 52.4 247.0 141.6
    Surgical Structural Heart        
    Enterprise-Wide Information        
    Net sales 240.0 230.1 736.9 701.6
    United States        
    Enterprise-Wide Information        
    Net sales 804.6 735.9 2,393.1 2,203.6
    Europe        
    Enterprise-Wide Information        
    Net sales 319.8 286.5 978.0 877.7
    Japan        
    Enterprise-Wide Information        
    Net sales 81.4 85.8 253.9 266.4
    Rest of World        
    Enterprise-Wide Information        
    Net sales $ 148.6 $ 135.2 $ 428.7 $ 395.9
    XML 101 R80.htm IDEA: XBRL DOCUMENT v3.24.3
    SUBSEQUENT EVENTS (Details) - Innovalve Bio Medical Limited - USD ($)
    $ in Millions
    		 1 Months Ended
    Oct. 31, 2024
    Jul. 31, 2024
    Subsequent Event [Line Items]    
    Cash consideration paid at closing   $ 30.0
    Fair value of previously held equity interest   $ 3.5
    Percentage of previously held interest   4.00%
    Subsequent Event    
    Subsequent Event [Line Items]    
    Cash consideration paid at closing $ 300.0  
    Contingent consideration liabilities $ 25.0  
    EXCEL 102 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 104 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 106 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 509 453 1 false 93 0 false 8 false false R1.htm 0000001 - Document - COVER Sheet http://www.edwards.com/role/COVER COVER Cover 1 false false R2.htm 9952151 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS CONSOLIDATED CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 9952152 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 9952154 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 9952155 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 9952156 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 9952157 - Disclosure - BASIS OF PRESENTATION Sheet http://www.edwards.com/role/BASISOFPRESENTATION BASIS OF PRESENTATION Notes 8 false false R9.htm 9952158 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Notes 9 false false R10.htm 9952159 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES Notes 10 false false R11.htm 9952160 - Disclosure - RESTRUCTURING EXPENSES Sheet http://www.edwards.com/role/RESTRUCTURINGEXPENSES RESTRUCTURING EXPENSES Notes 11 false false R12.htm 9952161 - Disclosure - DISCONTINUED OPERATIONS Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONS DISCONTINUED OPERATIONS Notes 12 false false R13.htm 9952162 - Disclosure - INVESTMENTS Sheet http://www.edwards.com/role/INVESTMENTS INVESTMENTS Notes 13 false false R14.htm 9952163 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES Notes 14 false false R15.htm 9952164 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONS BUSINESS COMBINATIONS Notes 15 false false R16.htm 9952165 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 9952166 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 17 false false R18.htm 9952167 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 18 false false R19.htm 9952168 - Disclosure - ACCELERATED SHARE REPURCHASE Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE ACCELERATED SHARE REPURCHASE Notes 19 false false R20.htm 9952169 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 9952170 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 21 false false R22.htm 9952171 - Disclosure - EARNINGS PER SHARE Sheet http://www.edwards.com/role/EARNINGSPERSHARE EARNINGS PER SHARE Notes 22 false false R23.htm 9952172 - Disclosure - INCOME TAXES Sheet http://www.edwards.com/role/INCOMETAXES INCOME TAXES Notes 23 false false R24.htm 9952173 - Disclosure - SEGMENT INFORMATION Sheet http://www.edwards.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 24 false false R25.htm 9952174 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.edwards.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 25 false false R26.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 26 false false R27.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 27 false false R28.htm 9954471 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://www.edwards.com/role/BASISOFPRESENTATIONPolicies BASIS OF PRESENTATION (Policies) Policies 28 false false R29.htm 9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Tables http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS 29 false false R30.htm 9954473 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONSTables DISCONTINUED OPERATIONS (Tables) Tables http://www.edwards.com/role/DISCONTINUEDOPERATIONS 30 false false R31.htm 9954474 - Disclosure - INVESTMENTS (Tables) Sheet http://www.edwards.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.edwards.com/role/INVESTMENTS 31 false false R32.htm 9954475 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSTables BUSINESS COMBINATIONS (Tables) Tables http://www.edwards.com/role/BUSINESSCOMBINATIONS 32 false false R33.htm 9954476 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.edwards.com/role/FAIRVALUEMEASUREMENTS 33 false false R34.htm 9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 34 false false R35.htm 9954478 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.edwards.com/role/STOCKBASEDCOMPENSATION 35 false false R36.htm 9954479 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables) Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables ACCELERATED SHARE REPURCHASE (Tables) Tables http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE 36 false false R37.htm 9954480 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS 37 false false R38.htm 9954481 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.edwards.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE (Tables) Tables http://www.edwards.com/role/EARNINGSPERSHARE 38 false false R39.htm 9954482 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.edwards.com/role/SEGMENTINFORMATION 39 false false R40.htm 9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details) Details 40 false false R41.htm 9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) Details 41 false false R42.htm 9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) Details 42 false false R43.htm 9954486 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Details 43 false false R44.htm 9954487 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details) Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details) Details http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES 44 false false R45.htm 9954488 - Disclosure - RESTRUCTURING EXPENSES (Details) Sheet http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails RESTRUCTURING EXPENSES (Details) Details http://www.edwards.com/role/RESTRUCTURINGEXPENSES 45 false false R46.htm 9954489 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails DISCONTINUED OPERATIONS - Narrative (Details) Details 46 false false R47.htm 9954490 - Disclosure - DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details) Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details) Details 47 false false R48.htm 9954491 - Disclosure - DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details) Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details) Details 48 false false R49.htm 9954492 - Disclosure - DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details) Sheet http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details) Details 49 false false R50.htm 9954493 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails INVESTMENTS - Schedule of Investments in Debt Securities (Details) Details 50 false false R51.htm 9954494 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Details 51 false false R52.htm 9954495 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) Details 52 false false R53.htm 9954496 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Details 53 false false R54.htm 9954497 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.edwards.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 54 false false R55.htm 9954498 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Details http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES 55 false false R56.htm 9954499 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails BUSINESS COMBINATIONS - Narrative (Details) Details 56 false false R57.htm 9954500 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 57 false false R58.htm 9954501 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 58 false false R59.htm 9954502 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 59 false false R60.htm 9954503 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) Details 60 false false R61.htm 9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Details 61 false false R62.htm 9954505 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Details 62 false false R63.htm 9954506 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Details 63 false false R64.htm 9954507 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Details 64 false false R65.htm 9954508 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Details 65 false false R66.htm 9954509 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details) Details 66 false false R67.htm 9954510 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) Details 67 false false R68.htm 9954511 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 68 false false R69.htm 9954512 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) Details 69 false false R70.htm 9954513 - Disclosure - ACCELERATED SHARE REPURCHASE (Details) Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails ACCELERATED SHARE REPURCHASE (Details) Details http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables 70 false false R71.htm 9954514 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES 71 false false R72.htm 9954515 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Details 72 false false R73.htm 9954516 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Details 73 false false R74.htm 9954517 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Details 74 false false R75.htm 9954518 - Disclosure - EARNINGS PER SHARE - Narrative (Details) Sheet http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails EARNINGS PER SHARE - Narrative (Details) Details 75 false false R76.htm 9954519 - Disclosure - INCOME TAXES (Details) Sheet http://www.edwards.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.edwards.com/role/INCOMETAXES 76 false false R77.htm 9954520 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) Details 77 false false R78.htm 9954521 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) Details 78 false false R79.htm 9954522 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Details 79 false false R80.htm 9954523 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.edwards.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.edwards.com/role/SUBSEQUENTEVENTS 80 false false All Reports Book All Reports ew-20240930.htm ew-20240930.xsd ew-20240930_cal.xml ew-20240930_def.xml ew-20240930_lab.xml ew-20240930_pre.xml ew-20240930_g1.jpg ew-20240930_g10.jpg ew-20240930_g11.jpg ew-20240930_g2.jpg ew-20240930_g3.jpg ew-20240930_g4.jpg ew-20240930_g5.jpg ew-20240930_g6.jpg ew-20240930_g7.jpg ew-20240930_g8.jpg ew-20240930_g9.jpg http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 109 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ew-20240930.htm": { "nsprefix": "ew", "nsuri": "http://www.edwards.com/20240930", "dts": { "inline": { "local": [ "ew-20240930.htm" ] }, "schema": { "local": [ "ew-20240930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "ew-20240930_cal.xml" ] }, "definitionLink": { "local": [ "ew-20240930_def.xml" ] }, "labelLink": { "local": [ "ew-20240930_lab.xml" ] }, "presentationLink": { "local": [ "ew-20240930_pre.xml" ] } }, "keyStandard": 396, "keyCustom": 57, "axisStandard": 36, "axisCustom": 0, "memberStandard": 60, "memberCustom": 31, "hidden": { "total": 12, "http://fasb.org/us-gaap/2024": 6, "http://xbrl.sec.gov/dei/2024": 5, "http://xbrl.sec.gov/ecd/2024": 1 }, "contextCount": 509, "entityCount": 1, "segmentCount": 93, "elementCount": 827, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 1655, "http://xbrl.sec.gov/dei/2024": 29, "http://xbrl.sec.gov/ecd/2024": 16, "http://fasb.org/srt/2024": 3 }, "report": { "R1": { "role": "http://www.edwards.com/role/COVER", "longName": "0000001 - Document - COVER", "shortName": "COVER", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "longName": "9952151 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS", "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ShortTermInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R3": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "longName": "9952152 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "longName": "9952153 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:GrossProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R5": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME", "longName": "9952154 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R6": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "longName": "9952155 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R7": { "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "longName": "9952156 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-63", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-72", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R8": { "role": "http://www.edwards.com/role/BASISOFPRESENTATION", "longName": "9952157 - Disclosure - BASIS OF PRESENTATION", "shortName": "BASIS OF PRESENTATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS", "longName": "9952158 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES", "longName": "9952159 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.edwards.com/role/RESTRUCTURINGEXPENSES", "longName": "9952160 - Disclosure - RESTRUCTURING EXPENSES", "shortName": "RESTRUCTURING EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONS", "longName": "9952161 - Disclosure - DISCONTINUED OPERATIONS", "shortName": "DISCONTINUED OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.edwards.com/role/INVESTMENTS", "longName": "9952162 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES", "longName": "9952163 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONS", "longName": "9952164 - Disclosure - BUSINESS COMBINATIONS", "shortName": "BUSINESS COMBINATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS", "longName": "9952165 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "longName": "9952166 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATION", "longName": "9952167 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE", "longName": "9952168 - Disclosure - ACCELERATED SHARE REPURCHASE", "shortName": "ACCELERATED SHARE REPURCHASE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES", "longName": "9952169 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS", "longName": "9952170 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.edwards.com/role/EARNINGSPERSHARE", "longName": "9952171 - Disclosure - EARNINGS PER SHARE", "shortName": "EARNINGS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.edwards.com/role/INCOMETAXES", "longName": "9952172 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.edwards.com/role/SEGMENTINFORMATION", "longName": "9952173 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.edwards.com/role/SUBSEQUENTEVENTS", "longName": "9952174 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-5", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies", "longName": "9954471 - Disclosure - BASIS OF PRESENTATION (Policies)", "shortName": "BASIS OF PRESENTATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables", "longName": "9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONSTables", "longName": "9954473 - Disclosure - DISCONTINUED OPERATIONS (Tables)", "shortName": "DISCONTINUED OPERATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.edwards.com/role/INVESTMENTSTables", "longName": "9954474 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSTables", "longName": "9954475 - Disclosure - BUSINESS COMBINATIONS (Tables)", "shortName": "BUSINESS COMBINATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables", "longName": "9954476 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "longName": "9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables", "longName": "9954478 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables", "longName": "9954479 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)", "shortName": "ACCELERATED SHARE REPURCHASE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "longName": "9954480 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.edwards.com/role/EARNINGSPERSHARETables", "longName": "9954481 - Disclosure - EARNINGS PER SHARE (Tables)", "shortName": "EARNINGS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables", "longName": "9954482 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails", "longName": "9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions in the Consolidated Balance Sheets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails", "longName": "9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeTaxReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeTaxReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails", "longName": "9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R43": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "longName": "9954486 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-118", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R44": { "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails", "longName": "9954487 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-122", "name": "ew:IntellectualPropertyAgreementTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-122", "name": "ew:IntellectualPropertyAgreementTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails", "longName": "9954488 - Disclosure - RESTRUCTURING EXPENSES (Details)", "shortName": "RESTRUCTURING EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-127", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-127", "name": "us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R46": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails", "longName": "9954489 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details)", "shortName": "DISCONTINUED OPERATIONS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-129", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R47": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "longName": "9954490 - Disclosure - DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details)", "shortName": "DISCONTINUED OPERATIONS - Income from Discontinued Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-133", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-133", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "longName": "9954491 - Disclosure - DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details)", "shortName": "DISCONTINUED OPERATIONS - Assets and Liabilities Held for Sale (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-137", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R49": { "role": "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "longName": "9954492 - Disclosure - DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details)", "shortName": "DISCONTINUED OPERATIONS - Consolidated Condensed Statements of Cash Flows (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-134", "name": "ew:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortizationNoncash", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-134", "name": "ew:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortizationNoncash", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "longName": "9954493 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R51": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "longName": "9954494 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "longName": "9954495 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)", "shortName": "INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails", "longName": "9954496 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "longName": "9954497 - Disclosure - INVESTMENTS - Narrative (Details)", "shortName": "INVESTMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "longName": "9954498 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-154", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R56": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "longName": "9954499 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)", "shortName": "BUSINESS COMBINATIONS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-169", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-168", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R57": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "longName": "9954500 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "shortName": "BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-169", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R58": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "longName": "9954501 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-233", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-233", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954502 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-188", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R60": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "longName": "9954503 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "longName": "9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-260", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-260", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "longName": "9954505 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "longName": "9954506 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-268", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-264", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R64": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "longName": "9954507 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-268", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-268", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "longName": "9954508 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-272", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-272", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "longName": "9954509 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effects of Hedge (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-281", "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R67": { "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails", "longName": "9954510 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)", "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "longName": "9954511 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "longName": "9954512 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)", "shortName": "STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-350", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-350", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails", "longName": "9954513 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)", "shortName": "ACCELERATED SHARE REPURCHASE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-358", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-358", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails", "longName": "9954514 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-1", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "unitRef": "lawsuit", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "unitRef": "lawsuit", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "longName": "9954515 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R73": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "longName": "9954516 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherNonoperatingIncomeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-422", "name": "us-gaap:OtherNonoperatingIncomeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R74": { "role": "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails", "longName": "9954517 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "shortName": "EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R75": { "role": "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails", "longName": "9954518 - Disclosure - EARNINGS PER SHARE - Narrative (Details)", "shortName": "EARNINGS PER SHARE - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-434", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-434", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.edwards.com/role/INCOMETAXESDetails", "longName": "9954519 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "longName": "9954520 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-460", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R78": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails", "longName": "9954521 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-460", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R79": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "longName": "9954522 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-488", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "unique": true } }, "R80": { "role": "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails", "longName": "9954523 - Disclosure - SUBSEQUENT EVENTS (Details)", "shortName": "SUBSEQUENT EVENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-502", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-502", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20240930.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcceleratedShareRepurchasesDateAxis", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchases, Date [Axis]", "label": "Accelerated Share Repurchases, Date [Axis]", "documentation": "Information by date of execution of accelerated share repurchases." } } }, "auth_ref": [ "r194" ] }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcceleratedShareRepurchasesDateDomain", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchases, Date [Domain]", "label": "Accelerated Share Repurchases, Date [Domain]", "documentation": "Date upon which the accelerated share repurchase agreement was executed." } } }, "auth_ref": [ "r194" ] }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Final settlement per share price (in dollars per share)", "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time." } } }, "auth_ref": [ "r194" ] }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial delivery, price per share (in dollars per share)", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement." } } }, "auth_ref": [ "r194" ] }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcceleratedShareRepurchasesTextBlock", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accelerated Share Repurchases", "label": "Accelerated Share Repurchases [Table Text Block]", "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity." } } }, "auth_ref": [ "r194" ] }, "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of Shares as % of Contract Value", "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount", "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r132", "r1070" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r924", "r986", "r1093", "r1379", "r1380" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowances of $12.6 and $8.2, respectively", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1245" ] }, "ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold of disclosing material environmental legal proceedings", "label": "Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure", "documentation": "Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure" } } }, "auth_ref": [] }, "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, payroll, and other taxes", "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "ew_AccruedAndOtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccruedAndOtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities (Note 2)", "totalLabel": "Total accrued and other liabilities", "label": "Accrued And Other Liabilities, Current", "documentation": "Accrued And Other Liabilities, Current" } } }, "auth_ref": [] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes payable (Note 5)", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r134", "r214" ] }, "ew_AccruedLitigationAndInsuranceReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccruedLitigationAndInsuranceReserves", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal and insurance", "label": "Accrued Litigation And Insurance Reserves", "documentation": "Accrued Litigation And Insurance Reserves" } } }, "auth_ref": [] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued marketing expenses", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional services", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r134" ] }, "ew_AccruedRebates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccruedRebates", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates", "label": "Accrued Rebates", "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates." } } }, "auth_ref": [] }, "ew_AccruedRelocationCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AccruedRelocationCostsCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued relocation costs", "label": "Accrued Relocation Costs, Current", "documentation": "Accrued Relocation Costs, Current" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Pension Credits (Costs)", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r7", "r20", "r37", "r156", "r1221", "r1222", "r1223" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Gain (Loss) on Hedges", "verboseLabel": "Gain (Loss) on hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r328", "r336", "r337", "r664", "r1015", "r1221" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Loss on Available-for-sale Investments", "verboseLabel": "Loss on available-for-sale investments", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r324", "r325", "r326", "r328", "r336", "r337", "r1221" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated Other Comprehensive Loss", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r335", "r336", "r722", "r724", "r725", "r726", "r727", "r728" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss (Note 14)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r36", "r37", "r157", "r311", "r838", "r883", "r884" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r335", "r336", "r722", "r724", "r725", "r726", "r727", "r728" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r20", "r37", "r677", "r680", "r739", "r879", "r880", "r1221", "r1222", "r1223", "r1233", "r1234", "r1235", "r1236" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Adjustments", "verboseLabel": "Foreign currency translation adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r5", "r20", "r37", "r154", "r155", "r336", "r337", "r724", "r725", "r726", "r727", "r728", "r1221" ] }, "ew_AcquisitionOptionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "AcquisitionOptionsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition options", "label": "Acquisition Options, Noncurrent", "documentation": "Acquisition Options, Noncurrent" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r1137" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r142" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r895", "r1233", "r1234", "r1235", "r1236", "r1340", "r1415" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1150" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1150" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1150" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1150" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r66", "r67", "r587" ] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1183" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1109", "r1119", "r1129", "r1161" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r1112", "r1122", "r1132", "r1164" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1184" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1150" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1157" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1157", "r1165", "r1169", "r1177" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1175" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r616", "r621" ] }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stock-based compensation expense, net of tax", "label": "Share-Based Payment Arrangement, Expense, after Tax", "documentation": "Amount, after tax, of expense for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r312", "r422", "r468" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r380" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r48" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive securities", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r48" ] }, "ew_April2024StockRepurchaseProgramSharesSoldInMay2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "April2024StockRepurchaseProgramSharesSoldInMay2024Member", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "April 2024 Stock Repurchase Program Shares Sold in May 2024", "label": "April 2024 Stock Repurchase Program Shares Sold In May 2024 [Member]", "documentation": "April 2024 Stock Repurchase Program Shares Sold In May 2024" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r1044", "r1071", "r1249", "r1252", "r1255" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "terseLabel": "Assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r212", "r229", "r304", "r350", "r384", "r391", "r409", "r413", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r660", "r666", "r716", "r833", "r930", "r1024", "r1025", "r1070", "r1100", "r1292", "r1293", "r1363" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r298", "r316", "r350", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r660", "r666", "r716", "r1070", "r1292", "r1293", "r1363" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r689", "r690", "r1057" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 8.0 }, "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets of discontinued operations (Note 5)", "totalLabel": "Total current assets of discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184", "r296", "r297" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r431" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r432" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r428", "r475", "r832" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-sale", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale", "label": "Available-for-Sale Securities, Debt Maturities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1250" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1250" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1251" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1251" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r1248", "r1249" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r434", "r828", "r1248" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 3.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "verboseLabel": "Available-for-sale investments:", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r429", "r475", "r689", "r818", "r1057", "r1061", "r1246", "r1344", "r1345", "r1346" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1172" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1173" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1168" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1168" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1168" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1168" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1168" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1168" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1171" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1170" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1169" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1169" ] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank time deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r224" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "ew_BectonDickinsonAndCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BectonDickinsonAndCompanyMember", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Becton, Dickinson and Company", "label": "Becton, Dickinson And Company [Member]", "documentation": "Becton, Dickinson And Company" } } }, "auth_ref": [] }, "ew_BernardJ.ZovighianMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BernardJ.ZovighianMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Bernard J. Zovighian [Member]", "documentation": "Bernard J. Zovighian" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r495", "r496", "r497", "r498", "r499", "r652", "r1047", "r1048" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r69", "r71", "r495", "r496", "r497", "r498", "r499", "r652", "r1047", "r1048" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r652" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition-related costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r68" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "ew_BusinessCombinationAssetsAcquiredMeasurementInput": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationAssetsAcquiredMeasurementInput", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement input", "label": "Business Combination, Assets Acquired, Measurement Input", "documentation": "Business Combination, Assets Acquired, Measurement Input" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "ew_BusinessCombinationConsiderationTransferredNetOfCashAcquired", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase price", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r18" ] }, "ew_BusinessCombinationConsiderationTransferredNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationConsiderationTransferredNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase price, net of cash acquired", "totalLabel": "Total purchase price, net of cash acquired", "label": "Business Combination, Consideration Transferred, Net Of Cash Acquired", "documentation": "Business Combination, Consideration Transferred, Net Of Cash Acquired" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of contingent consideration liabilities (Note 9)", "negatedLabel": "Change in fair value of contingent consideration liabilities", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement." } } }, "auth_ref": [ "r656", "r1226" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional contingent consideration", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid." } } }, "auth_ref": [ "r75" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liabilities", "verboseLabel": "Fair value of contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r74", "r199", "r655", "r691", "r692", "r693" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liability measurement input", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "documentation": "Value of input used to measure contingent consideration liability from business combination." } } }, "auth_ref": [ "r691", "r692", "r693" ] }, "ew_BusinessCombinationContingentConsiderationLiabilityTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationContingentConsiderationLiabilityTerm", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liability, term", "label": "Business Combination, Contingent Consideration, Liability, Term", "documentation": "Business Combination, Contingent Consideration, Liability, Term" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "BUSINESS COMBINATIONS", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r196", "r653" ] }, "ew_BusinessCombinationEscrowDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationEscrowDeposit", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business combination, escrow deposit", "label": "Business Combination, Escrow Deposit", "documentation": "Business Combination, Escrow Deposit" } } }, "auth_ref": [] }, "ew_BusinessCombinationEscrowDepositHoldingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationEscrowDepositHoldingPeriod", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow deposit, holding period", "label": "Business Combination, Escrow Deposit, Holding Period", "documentation": "Business Combination, Escrow Deposit, Holding Period" } } }, "auth_ref": [] }, "ew_BusinessCombinationInProcessResearchAndDevelopmentExpectedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationInProcessResearchAndDevelopmentExpectedCosts", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development, expected costs", "label": "Business Combination, In-process Research and Development, Expected Costs", "documentation": "Business Combination, In-process Research and Development, Expected Costs" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangibles", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r72", "r73" ] }, "ew_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesExcludingDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesExcludingDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Excluding Deferred Tax Liabilities", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Excluding Deferred Tax Liabilities" } } }, "auth_ref": [] }, "ew_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r72", "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r73" ] }, "ew_BusinessCombinationSettlementOfPreExistingRelationships": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationSettlementOfPreExistingRelationships", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement of pre-existing relationships", "label": "Business Combination, Settlement Of Pre-Existing Relationships", "documentation": "Business Combination, Settlement Of Pre-Existing Relationships" } } }, "auth_ref": [] }, "ew_BusinessCombinationStepAcquisitionEquityInterestInAcquireeExcludingInitialAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeExcludingInitialAcquisitionPercentage", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity interest in acquire, excluding initial acquisition, percentage", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Excluding Initial Acquisition, Percentage", "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Excluding Initial Acquisition, Percentage" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of previously held equity interest", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value", "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages." } } }, "auth_ref": [ "r23" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of previously held interest", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage", "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Step acquisition, equity interest in acquire, remeasurement gain", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain", "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination." } } }, "auth_ref": [ "r70" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on remeasurement of previously held interest upon acquisition (Note 8)", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net", "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination." } } }, "auth_ref": [ "r70" ] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures accruals", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r45", "r46", "r47" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "ew_BusinessCombinationConsiderationTransferredNetOfCashAcquired", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: cash acquired", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r43", "r300", "r1003" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1342", "r1343" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period (Note 2)", "totalLabel": "Total cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r173", "r348" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r173" ] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow gain to be reclassified in the next twelve months", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r107" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flow hedges", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r93" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing transactions:", "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement." } } }, "auth_ref": [ "r209" ] }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedged items", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement." } } }, "auth_ref": [ "r209" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1148" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r1145" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r1143" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r307", "r308", "r309", "r386", "r558", "r559", "r560", "r562", "r565", "r570", "r572", "r887", "r888", "r889", "r890", "r1041", "r1187", "r1230" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1149" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1149" ] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommercialPaperMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r188", "r528", "r1094", "r1095", "r1096", "r1097" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note\u00a013)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r138", "r216", "r835", "r915" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r186", "r520", "r521", "r987", "r1277", "r1285" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1090", "r1091", "r1092", "r1094", "r1095", "r1096", "r1097", "r1233", "r1234", "r1236", "r1340", "r1413", "r1415" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r141" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r141", "r916" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r141" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Common stock, beginning balance (in shares)", "periodEndLabel": "Common stock, ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r21", "r141", "r916", "r936", "r1415", "r1416" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r141", "r837", "r1070" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1154" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1153" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1155" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1152" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to Edwards Lifesciences Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r38", "r332", "r334", "r341", "r823", "r851", "r853" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive loss attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r12", "r79", "r88", "r332", "r334", "r340", "r822", "r851", "r852" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r88", "r201", "r332", "r334", "r339", "r821", "r851" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r153", "r338", "r820", "r849" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r252", "r272", "r354", "r660", "r661", "r666", "r667", "r743", "r992", "r1206", "r1209", "r1210", "r1291", "r1294", "r1295" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r252", "r272", "r354", "r660", "r661", "r666", "r667", "r743", "r992", "r1206", "r1209", "r1210", "r1291", "r1294", "r1295" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r227", "r252", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r354", "r384", "r393", "r407", "r408", "r409", "r410", "r411", "r413", "r414", "r415", "r529", "r530", "r531", "r532", "r534", "r535", "r536", "r537", "r538", "r1024", "r1025", "r1207", "r1208", "r1292", "r1293" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r227", "r252", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r354", "r384", "r393", "r407", "r408", "r409", "r410", "r411", "r413", "r414", "r415", "r529", "r530", "r531", "r532", "r534", "r535", "r536", "r537", "r538", "r1024", "r1025", "r1207", "r1208", "r1292", "r1293" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r80", "r1016" ] }, "ew_ContingentConsiderationLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ContingentConsiderationLiabilityMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration", "label": "Contingent Consideration Liability [Member]", "documentation": "Contingent Consideration Liability" } } }, "auth_ref": [] }, "ew_ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ConvertiblePromissoryNoteMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Promissory Note", "label": "Convertible Promissory Note [Member]", "documentation": "Convertible Promissory Note" } } }, "auth_ref": [] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate debt securities", "verboseLabel": "Corporate debt securities", "netLabel": "Corporate debt securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r1044", "r1046", "r1057", "r1071", "r1087", "r1410" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate items", "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r27", "r408", "r409", "r410", "r411", "r414", "r1241" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "negatedTerseLabel": "Cost of sales", "negatedLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r162", "r163", "r783" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Corporate items", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r169" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r288", "r289", "r352", "r353", "r543", "r560", "r742", "r766", "r830", "r1011", "r1014" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ew_CriticalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "CriticalCareMember", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Critical Care", "label": "Critical Care [Member]", "documentation": "This element represents the critical care product line." } } }, "auth_ref": [] }, "us-gaap_CurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrencySwapMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cross-currency swap contracts", "terseLabel": "Cross-currency swap contracts", "label": "Currency Swap [Member]", "documentation": "Swap involving the exchange of principal and interest in one currency for another currency." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r33", "r133", "r134", "r213", "r215", "r354", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r1036", "r1037", "r1038", "r1039", "r1040", "r1068", "r1231", "r1278", "r1279", "r1280", "r1360", "r1361" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r33", "r354", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r1036", "r1037", "r1038", "r1039", "r1040", "r1068", "r1231", "r1278", "r1279", "r1280", "r1360", "r1361" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, 12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r239", "r479", "r1032" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross unrealized losses, 12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r239", "r479" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r239", "r479", "r1032" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross unrealized losses, less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r239", "r479" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Fair value, total", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss." } } }, "auth_ref": [ "r237", "r477", "r1032" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Gross unrealized losses, total", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r238", "r478" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r236", "r1032", "r1263" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r424", "r442", "r444", "r818" ] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r240" ] }, "us-gaap_DeferredCompensationPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationPlanAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments held for deferred compensation plans", "label": "Deferred Compensation Plan Assets", "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements." } } }, "auth_ref": [ "r1215" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r626", "r627" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r15", "r384", "r396", "r413", "r1024", "r1025" ] }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetFairValueGrossLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r25", "r32", "r205", "r206", "r977", "r978" ] }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial Instruments", "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset." } } }, "auth_ref": [ "r26", "r30", "r247" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r668" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Fair value of derivative assets", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r318", "r321", "r689", "r690", "r703", "r715", "r897", "r898", "r899", "r900", "r901", "r903", "r904", "r905", "r906", "r907", "r922", "r923", "r970", "r973", "r976", "r977", "r979", "r980", "r1014", "r1057", "r1061", "r1092", "r1344", "r1345", "r1346", "r1414" ] }, "us-gaap_DerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Derivative Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivatives", "label": "Derivative Asset, Noncurrent", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r318" ] }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeCollateralObligationToReturnCash", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash Collateral Received", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset", "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets." } } }, "auth_ref": [ "r30", "r104", "r319", "r1012" ] }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeCollateralRightToReclaimCash", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash Collateral Received", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset", "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities." } } }, "auth_ref": [ "r30", "r104", "r319", "r1012" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r905", "r907", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r931", "r932", "r933", "r934", "r944", "r945", "r946", "r947", "r950", "r951", "r952", "r953", "r970", "r971", "r976", "r979", "r1090", "r1092", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1354", "r1355" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r152", "r205", "r206", "r317", "r1014" ] }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r30", "r103" ] }, "ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet", "label": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]", "documentation": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r152", "r205", "r206", "r317", "r1014" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement." } } }, "auth_ref": [ "r30", "r103" ] }, "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet", "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency contracts", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1339" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r97", "r99", "r100", "r207", "r905", "r907", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r931", "r932", "r933", "r934", "r944", "r945", "r946", "r947", "r950", "r951", "r952", "r953", "r970", "r971", "r976", "r979", "r1014", "r1090", "r1092", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1354", "r1355" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r204", "r674", "r683" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r22", "r97", "r99" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r22", "r97", "r99", "r100", "r105", "r106", "r673" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss)", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r673" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount excluded from effectiveness testing", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings." } } }, "auth_ref": [ "r682" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Fair value of derivative liabilities", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r318", "r321", "r689", "r690", "r703", "r715", "r897", "r898", "r899", "r900", "r903", "r904", "r905", "r906", "r907", "r931", "r933", "r934", "r971", "r972", "r973", "r976", "r977", "r979", "r980", "r1014", "r1344", "r1345", "r1346", "r1414" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivatives", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r318" ] }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityFairValueGrossAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r25", "r32", "r205", "r206", "r977", "r978", "r1012" ] }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial Instruments", "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability." } } }, "auth_ref": [ "r26", "r30", "r247" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r668" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Financial Instruments", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r683" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "verboseLabel": "Derivative liability, fair value", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1337", "r1338" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date." } } }, "auth_ref": [ "r22", "r89", "r90", "r92", "r95", "r98", "r99", "r101", "r102", "r106", "r683" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivatives designated as hedging instruments", "terseLabel": "Derivatives designated as hedging instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r198", "r1267", "r1268", "r1269", "r1270", "r1272", "r1273", "r1275", "r1276" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "terseLabel": "STOCK-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r585", "r589", "r617", "r618", "r620", "r1050" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from discontinued operations before provision for income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax", "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal." } } }, "auth_ref": [ "r115", "r116", "r125" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income from discontinued operations", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal." } } }, "auth_ref": [ "r115", "r116", "r129" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations (in dollars per share)", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes from discontinued operations", "label": "Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period", "documentation": "Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal." } } }, "auth_ref": [ "r116", "r129", "r1332" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsHeldforsaleMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DiscontinuedOperationsHeldforsaleMember", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations, Held-for-Sale", "label": "Discontinued Operations, Held-for-Sale [Member]", "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale." } } }, "auth_ref": [ "r10", "r11", "r296" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r296" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowances", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r111", "r127", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current", "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 }, "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets of discontinued operations (Note 5)", "totalLabel": "Total non-current assets of discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184", "r296", "r297" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationCapitalExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationCapitalExpenditures", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures", "label": "Disposal Group, Including Discontinued Operation, Capital Expenditures", "documentation": "Disposal Group, Including Discontinued Operation, Capital Expenditures" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r111", "r127", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration", "label": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r126", "r297" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets", "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r111", "r127", "r184" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortizationNoncash": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortizationNoncash", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Disposal Group, Including Discontinued Operation, Depreciation And Amortization, Noncash", "documentation": "Disposal Group, Including Discontinued Operation, Depreciation And Amortization, Noncash" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent", "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r126", "r297" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent", "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Disposal Group, Including Discontinued Operation, Inventory, Current", "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationInventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryWriteDown", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory write off", "label": "Disposal Group, Including Discontinued Operation, Inventory Write-Down", "documentation": "Disposal Group, Including Discontinued Operation, Inventory Write-Down" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating (loss) income, net", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r126" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right Of Use Asset, Noncurrent", "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right Of Use Asset, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current", "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationOtherNonOperatingExpenseIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonOperatingExpenseIncomeNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating (income) expense, net", "label": "Disposal Group, Including Discontinued Operation, Other Non-Operating Expense (Income), Net", "documentation": "Disposal Group, Including Discontinued Operation, Other Non-Operating Expense (Income), Net" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent", "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent", "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationOtherNonrecurringIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonrecurringIncomeExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation costs", "label": "Disposal Group, Including Discontinued Operation, Other Nonrecurring (Income) Expense", "documentation": "Disposal Group, Including Discontinued Operation, Other Nonrecurring (Income) Expense" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationOtherReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Disposal Group, Including Discontinued Operation, Other Receivables, Current", "documentation": "Disposal Group, Including Discontinued Operation, Other Receivables, Current" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Disposal Group, Including Discontinued Operation, Prepaid Expense, Current", "documentation": "Disposal Group, Including Discontinued Operation, Prepaid Expense, Current" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment, net", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "documentation": "Disposal Group, Including Discontinued Operation, Research And Development Expense" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r126", "r297" ] }, "ew_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "label": "Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expense", "documentation": "Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expense" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementNoncash": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationShareBasedPaymentArrangementNoncash", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Noncash", "documentation": "Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement, Noncash" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationUncertainTaxPositionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationUncertainTaxPositionsNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions", "label": "Disposal Group, Including Discontinued Operation, Uncertain Tax Positions, Noncurrent", "documentation": "Disposal Group, Including Discontinued Operation, Uncertain Tax Positions, Noncurrent" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationsTermForContinuedServices": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationsTermForContinuedServices", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term for continued services", "label": "Disposal Group, Including Discontinued Operations, Term For Continued Services", "documentation": "Disposal Group, Including Discontinued Operations, Term For Continued Services" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiability", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unfavorable contract liability", "label": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability", "documentation": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiabilityAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiabilityAmortization", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of unfavorable contract liability", "label": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Amortization", "documentation": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Amortization" } } }, "auth_ref": [] }, "ew_DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupIncludingDiscontinuedOperationsUnfavorableContractLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unfavorable contract liability", "label": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Current", "documentation": "Disposal Group, Including Discontinued Operations, Unfavorable Contract Liability, Current" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "DISCONTINUED OPERATIONS", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r110", "r182" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r1047", "r1048" ] }, "ew_DisposalGroupsIncludingDiscontinuedOperationsTransitionServicesAgreementPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "DisposalGroupsIncludingDiscontinuedOperationsTransitionServicesAgreementPeriod", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transition services agreement period", "label": "Disposal Groups, Including Discontinued Operations, Transition Services Agreement, Period", "documentation": "Disposal Groups, Including Discontinued Operations, Transition Services Agreement, Period" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r1104" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1136" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r1147" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Basic earnings per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r342", "r360", "r361", "r362", "r363", "r364", "r365", "r370", "r373", "r377", "r378", "r379", "r383", "r650", "r658", "r686", "r687", "r824", "r854", "r1017" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted earnings per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r342", "r360", "r361", "r362", "r363", "r364", "r365", "r373", "r377", "r378", "r379", "r383", "r650", "r658", "r686", "r687", "r824", "r854", "r1017" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted:", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARE" ], "lang": { "en-us": { "role": { "terseLabel": "EARNINGS PER SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r369", "r380", "r381", "r382" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r721" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r629", "r1053" ] }, "ew_EmployeeAndNonemployeeStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EmployeeAndNonemployeeStockOptionsMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Option Awards", "label": "Employee and Nonemployee Stock Options [Member]", "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee compensation and withholdings", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r134" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocation of stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total remaining unrecognized compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r619" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost, recognition period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r619" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax benefit", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r616" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Severance", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "ESPP", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ew_EndotronixIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EndotronixIncMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Endotronix, Inc", "label": "Endotronix, Inc [Member]", "documentation": "Endotronix, Inc" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1102" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1102" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1102" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1186" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1102" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1102" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1102" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1102" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r1141" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r1182" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r1182" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1182" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r21", "r293", "r335", "r336", "r337", "r355", "r356", "r357", "r359", "r364", "r366", "r368", "r385", "r466", "r467", "r504", "r573", "r638", "r639", "r647", "r648", "r649", "r651", "r657", "r658", "r676", "r677", "r678", "r679", "r680", "r681", "r685", "r722", "r724", "r725", "r726", "r727", "r728", "r730", "r732", "r739", "r849", "r879", "r880", "r881", "r895", "r957" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r462", "r463", "r464", "r646", "r1188", "r1189", "r1190", "r1333", "r1334", "r1335", "r1336" ] }, "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment percentage (in percent)", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r462" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r384", "r401", "r413", "r461", "r1214", "r1260" ] }, "ew_EquityMethodInvestmentsInvestmentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquityMethodInvestmentsInvestmentPeriod", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments taken period", "label": "Equity Method Investments, Investment Period", "documentation": "Equity Method Investments, Investment Period" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum additional option to acquire investment", "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum additional required investment", "label": "Equity Securities, FV-NI, Maximum Additional Required", "documentation": "Equity Securities, FV-NI, Maximum Additional Required" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum secured promissory note", "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment option to acquire", "label": "Equity Securities, FV-NI, Option To Acquire Investment", "documentation": "Equity Securities, FV-NI, Option To Acquire Investment" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIPromissoryNoteOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EquitySecuritiesFVNIPromissoryNoteOutstanding", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investee drew additional amount", "label": "Equity Securities, FV-NI Promissory Note Outstanding", "documentation": "Equity Securities, FV-NI Promissory Note Outstanding" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of non-marketable equity securities", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r305", "r713", "r1005" ] }, "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of marketable equity securities", "verboseLabel": "Equity investments in unconsolidated entities", "label": "Equity Securities, FV-NI", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r305", "r689", "r713", "r830", "r831", "r1057", "r1086", "r1089", "r1344", "r1345", "r1346" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of non-marketable equity securities", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r458" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Downward price adjustment, annual amount", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount", "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r459" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in non-marketable equity securities due to observable price changes", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r459" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Upward price adjustments", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount", "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r460" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in non-marketable equity securities due to observable price changes", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r460" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1151" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r1109", "r1119", "r1129", "r1161" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r1106", "r1116", "r1126", "r1158" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Estimate of Fair Value Measurement", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r548", "r715", "r1037", "r1038" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EuropeMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r1202", "r1203", "r1204", "r1205", "r1417", "r1418", "r1419", "r1420" ] }, "ew_EuropeSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "EuropeSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe Segment [Member]", "documentation": "Represents the Europe reportable segment of the entity." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1157" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of financial instruments measured on a recurring basis", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r689", "r690", "r703", "r1057" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r689", "r690", "r703", "r1057" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r108", "r109" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r548", "r577", "r578", "r579", "r580", "r581", "r582", "r688", "r690", "r691", "r692", "r693", "r702", "r703", "r705", "r750", "r751", "r752", "r1037", "r1038", "r1044", "r1045", "r1046", "r1057", "r1061" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r694", "r695", "r696", "r697", "r698", "r699", "r704" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r548", "r1037", "r1038" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r689", "r690", "r691", "r693", "r1057", "r1345", "r1356" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r548", "r1037", "r1038" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE MEASUREMENTS", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r698", "r700", "r701", "r702", "r705", "r706", "r707", "r708", "r709", "r816", "r1057", "r1062" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r548", "r577", "r582", "r690", "r703", "r750", "r1044", "r1045", "r1046", "r1057" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r548", "r577", "r582", "r690", "r691", "r703", "r751", "r1037", "r1038", "r1044", "r1045", "r1046", "r1057" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r548", "r577", "r578", "r579", "r580", "r581", "r582", "r690", "r691", "r692", "r693", "r703", "r752", "r1037", "r1038", "r1044", "r1045", "r1046", "r1057", "r1061" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r694", "r695", "r696", "r697", "r698", "r699", "r704" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r694", "r695", "r696", "r697", "r698", "r699" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input." } } }, "auth_ref": [ "r694", "r695", "r696", "r697", "r698", "r699", "r704" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration and Other Liability", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r694", "r699", "r704" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r689", "r690", "r691", "r693", "r1057", "r1345", "r1356" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in fair value", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r695", "r704" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r697", "r704" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r697", "r704" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Fair value beginning balance", "periodEndLabel": "Fair value ending balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r694", "r704" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r548", "r577", "r578", "r579", "r580", "r581", "r582", "r688", "r690", "r691", "r692", "r693", "r702", "r703", "r705", "r750", "r751", "r752", "r1037", "r1038", "r1044", "r1045", "r1046", "r1057", "r1061" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value on a Recurring Basis", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r1057", "r1342", "r1343", "r1344", "r1345", "r1346", "r1356" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r695", "r704" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Disclosure of information about location and fair value of derivative instrument and nonderivative instrument designated as hedging instrument." } } }, "auth_ref": [ "r96", "r98", "r105" ] }, "ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "February2023StockRepurchaseProgramSharesSoldInMarch2023Member", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "February 2023 Stock Repurchase Program Shares Sold in March 2023", "label": "February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]", "documentation": "February 2023 Stock Repurchase Program Shares Sold In March 2023" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r469", "r470", "r471", "r472", "r473", "r476", "r480", "r481", "r556", "r570", "r683", "r710", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r764", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r850", "r1032", "r1057", "r1059", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1071", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1256", "r1257", "r1258", "r1259", "r1341", "r1344", "r1345", "r1346", "r1353", "r1356" ] }, "ew_FinancingReceivableAdvancementOnLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "FinancingReceivableAdvancementOnLoans", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining financing receivable", "label": "Financing Receivable, Advancement On Loans", "documentation": "Financing Receivable, Advancement On Loans" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r494", "r495", "r496", "r497", "r499", "r500", "r501", "r502", "r784", "r785", "r1000" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r494", "r495", "r496", "r497", "r499", "r500", "r501", "r502", "r1000" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r717", "r718", "r719", "r720", "r954" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r1014", "r1044", "r1056", "r1057" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward exchange contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r922", "r927", "r933", "r946", "r952", "r974", "r975", "r976", "r1092" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1165" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1165" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1165" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1165" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1165" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r1146" ] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on sale of business (Note 5)", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r665", "r1227" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r302", "r484", "r817", "r1025", "r1034", "r1058", "r1070", "r1265", "r1266" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r158", "r164", "r228", "r350", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r716", "r1019", "r1024", "r1239", "r1240", "r1242", "r1243", "r1244", "r1292" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22", "r673" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r22" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r22" ] }, "us-gaap_HeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r231", "r440", "r471", "r1262" ] }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held-to-maturity", "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain", "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r233", "r450" ] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r234", "r451" ] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held-to-Maturity", "label": "Debt Securities, Held-to-Maturity, Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r235", "r452", "r828" ] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r444", "r827" ] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 3.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r232", "r449", "r690", "r702", "r818", "r832" ] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r1253", "r1374" ] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r1254", "r1375" ] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development", "label": "In Process Research and Development [Member]", "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process." } } }, "auth_ref": [ "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276" ] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from continuing operations attributable to Edwards Lifesciences Corporation", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r78", "r160", "r176", "r360", "r361", "r362", "r363", "r364", "r375", "r379", "r658" ] }, "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss attributable to noncontrolling interest", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest." } } }, "auth_ref": [ "r76", "r201", "r364" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from continuing operations before provision for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r159", "r221", "r228", "r825", "r844", "r1019", "r1024", "r1239", "r1240", "r1242", "r1243", "r1244" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total before tax", "verboseLabel": "Total segment operating income", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r228", "r855", "r1019", "r1239", "r1240", "r1242", "r1243", "r1244" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Operating Income", "verboseLabel": "Pre-tax Income Reconciliation", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income from continuing operations", "terseLabel": "Income from continuing operations, net of tax", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r201", "r228", "r350", "r358", "r364", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r650", "r658", "r687", "r716", "r844", "r1019", "r1239", "r1240", "r1242", "r1243", "r1244", "r1292" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r160", "r222", "r342", "r358", "r360", "r361", "r362", "r363", "r364", "r373", "r377", "r378", "r650", "r658", "r687", "r824", "r1381" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Continuing operations (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r160", "r342", "r358", "r360", "r361", "r362", "r363", "r364", "r373", "r377", "r378", "r379", "r658", "r687", "r824", "r1381" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from discontinued operations, net of tax", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r115", "r116", "r117", "r118", "r119", "r129", "r297", "r643", "r845" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r115", "r116", "r117", "r118", "r119", "r125", "r129", "r201" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations (in dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r161", "r342", "r374", "r377", "r378", "r1373", "r1381" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations (in dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r203", "r374", "r377", "r378" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r1047", "r1048" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSConsolidatedCondensedStatementsofCashFlowsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSIncomefromDiscontinuedOperationsDetails", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r17", "r24", "r34", "r111", "r120", "r121", "r122", "r123", "r124", "r128", "r130", "r131", "r185" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r505", "r507", "r512", "r695", "r699", "r704", "r876", "r878", "r941", "r1000", "r1060", "r1383" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r507", "r512", "r695", "r699", "r704", "r876", "r878", "r941", "r1000", "r1060", "r1383" ] }, "ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "IncomeTaxAssessmentEstimateOfAdditionalTaxExpense", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional tax expense", "label": "Income Tax Assessment, Estimate Of Additional Tax Expense", "documentation": "Income Tax Assessment, Estimate Of Additional Tax Expense" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Axis]", "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r633", "r1331" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Domain]", "label": "Income Tax Authority, Name [Domain]", "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [ "r633", "r1331" ] }, "us-gaap_IncomeTaxContingencyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxContingencyLineItems", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Contingency [Line Items]", "label": "Income Tax Contingency [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxContingencyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxContingencyTable", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Contingency [Table]", "label": "Income Tax Contingency [Table]", "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months." } } }, "auth_ref": [ "r1327" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r351", "r624", "r629", "r630", "r631", "r632", "r636", "r637", "r640", "r642", "r644", "r645", "r892", "r1053" ] }, "ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional deposit", "label": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities", "documentation": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExaminationEstimateOfPossibleLoss", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of additional tax owed", "label": "Income Tax Examination, Estimate of Possible Loss", "documentation": "Estimated amount of loss resulting from an adverse tax position." } } }, "auth_ref": [ "r1328" ] }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional tax sought in excess of filing position", "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority", "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "negatedLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r241", "r248", "r367", "r368", "r384", "r399", "r413", "r628", "r629", "r641", "r856", "r1053" ] }, "us-gaap_IncomeTaxReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReceivable", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax receivable (Note 16)", "label": "Income Taxes Receivable", "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable." } } }, "auth_ref": [ "r1218" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax benefit from employee share-based compensation", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1053", "r1325", "r1326" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Taxes Paid", "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r44", "r175", "r1228", "r1329", "r1330" ] }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts and other receivables, net", "label": "Increase (Decrease) in Accounts and Other Receivables", "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income taxes", "label": "Increase (Decrease) in Deferred Income Taxes", "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r14" ] }, "ew_IncreaseDecreaseInLegalSettlementAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "IncreaseDecreaseInLegalSettlementAccrual", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement accrual", "label": "Increase (Decrease) In Legal Settlement Accrual", "documentation": "Increase (Decrease) In Legal Settlement Accrual" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInPrepaidRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidRoyalties", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Long-term prepaid royalties (Note 3)", "label": "Increase (Decrease) in Prepaid Royalties", "documentation": "Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1157", "r1165", "r1169", "r1177" ] }, "ew_InitialDeliveryOfSharesSettledApril2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "InitialDeliveryOfSharesSettledApril2024Member", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery of Shares Settled April 2024", "label": "Initial Delivery Of Shares Settled April 2024 [Member]", "documentation": "Initial Delivery Of Shares Settled April 2024" } } }, "auth_ref": [] }, "ew_InitialDeliveryOfSharesSettledFebruary2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "InitialDeliveryOfSharesSettledFebruary2023Member", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery of Shares Settled February 2023", "label": "Initial Delivery Of Shares Settled February 2023 [Member]", "documentation": "Initial Delivery Of Shares Settled February 2023" } } }, "auth_ref": [] }, "ew_InnovalveBioMedicalLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "InnovalveBioMedicalLimitedMember", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Innovalve Bio Medical Limited", "label": "Innovalve Bio Medical Limited [Member]", "documentation": "Innovalve Bio Medical Limited" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1175" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r1105", "r1181" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r1105", "r1181" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r1105", "r1181" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r494", "r1273", "r1274" ] }, "ew_IntellectualPropertyAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "IntellectualPropertyAgreementTerm", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement term", "label": "Intellectual Property Agreement Term", "documentation": "Intellectual Property Agreement Term" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest income, net", "terseLabel": "Interest income, net", "verboseLabel": "Interest income, net", "label": "Interest Income (Expense), Operating", "documentation": "Amount of interest income (expense) classified as operating." } } }, "auth_ref": [ "r819", "r1240" ] }, "us-gaap_InterestIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income, net", "label": "Interest Income [Member]", "documentation": "Primary financial statement caption in which reported facts about interest income have been included." } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finished products", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r181", "r1008" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories (Note\u00a02)", "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r313", "r1004", "r1070" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNetAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r181", "r1010" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r181", "r1009" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsAllOtherInvestmentsAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, Debt and Equity Securities [Abstract]", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments in unconsolidated entities", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate." } } }, "auth_ref": [ "r1216" ] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r225", "r249", "r423", "r426", "r711", "r712", "r1372" ] }, "us-gaap_IsraelTaxAuthorityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IsraelTaxAuthorityMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Israel Tax Authority", "label": "Israel Tax Authority [Member]", "documentation": "Designated tax department of the government of Israel." } } }, "auth_ref": [] }, "ew_JCMedicalInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "JCMedicalInc.Member", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "JC Medical, Inc", "label": "JC Medical, Inc. [Member]", "documentation": "JC Medical, Inc." } } }, "auth_ref": [] }, "country_JP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "JP", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan", "label": "JAPAN" } } }, "auth_ref": [] }, "ew_JapanSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "JapanSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan", "label": "Japan Segment [Member]", "documentation": "Represents the Japan reportable segment of the entity." } } }, "auth_ref": [] }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LegalMattersAndContingenciesTextBlock", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSES" ], "lang": { "en-us": { "role": { "terseLabel": "INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES", "label": "Legal Matters and Contingencies [Text Block]", "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies." } } }, "auth_ref": [ "r187" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "terseLabel": "Liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r33", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r350", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r661", "r666", "r667", "r716", "r914", "r1018", "r1100", "r1292", "r1363", "r1364" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r146", "r218", "r841", "r1070", "r1232", "r1261", "r1357" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r135", "r299", "r350", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r661", "r666", "r667", "r716", "r1070", "r1292", "r1363", "r1364" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r690", "r1342" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities of discontinued operations (Note 5)", "totalLabel": "Total current liabilities of discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r111", "r127", "r183", "r184", "r296", "r297" ] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 8.0 }, "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/DISCONTINUEDOPERATIONSAssetsandLiabilitiesHeldforSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities of discontinued operations (Note 5)", "totalLabel": "Total non-current liabilities of discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3", "r8", "r111", "r127", "r184", "r296", "r297" ] }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent." } } }, "auth_ref": [ "r137" ] }, "us-gaap_LimitedLiabilityCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LimitedLiabilityCompanyMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Liability Company", "label": "Limited Liability Company [Member]", "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.)." } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseAxis", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]", "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]", "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information." } } }, "auth_ref": [] }, "us-gaap_LitigationReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LitigationReserveCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation settlement", "label": "Estimated Litigation Liability, Current", "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position." } } }, "auth_ref": [ "r138", "r1286" ] }, "us-gaap_LitigationReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LitigationReserveNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation settlement accrual", "label": "Estimated Litigation Liability, Noncurrent", "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r138", "r1286" ] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LitigationSettlementExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement and certain litigation expenses (Note 3)", "verboseLabel": "Intellectual property litigation expense", "negatedLabel": "Intellectual property agreement and certain litigation expenses", "label": "Litigation Settlement, Fee Expense", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [ "r1193" ] }, "ew_LoansReceivablesMaximumLendingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "LoansReceivablesMaximumLendingCapacity", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans receivables, maximum lending amount", "label": "Loans Receivables, Maximum Lending Capacity", "documentation": "Loans Receivables, Maximum Lending Capacity" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r306" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term investments (Note\u00a06)", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r301" ] }, "ew_LongTermStockIncentiveCompensationProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "LongTermStockIncentiveCompensationProgramMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Stock Incentive Compensation Program", "label": "Long Term Stock Incentive Compensation Program [Member]", "documentation": "Long Term Stock Incentive Compensation Program" } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r522", "r523", "r524", "r527", "r622", "r1035", "r1287", "r1288" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r522", "r523", "r524", "r527", "r622", "r1035", "r1287", "r1288" ] }, "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "presentation": [ "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows", "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number" } } }, "auth_ref": [] }, "ew_MarketBasedRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MarketBasedRestrictedStockUnitsMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Market Based Restricted Stock Units", "label": "Market Based Restricted Stock Units [Member]", "documentation": "Market Based Restricted Stock Units" } } }, "auth_ref": [] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciling items", "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r408", "r411", "r414", "r1024", "r1025" ] }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes due to currency rate movements and expenses expected to occur, maximum term", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "documentation": "Maximum period of hedging exposure to variability in future cash flows for forecasted transaction of foreign currency cash flow hedge, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transaction for payment of variable interest on existing financial instrument." } } }, "auth_ref": [ "r19" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r253", "r255", "r257", "r258", "r260", "r291", "r292", "r523", "r524", "r525", "r526", "r584", "r622", "r693", "r782", "r875", "r877", "r885", "r906", "r907", "r963", "r965", "r967", "r968", "r981", "r998", "r999", "r1029", "r1041", "r1049", "r1061", "r1062", "r1066", "r1067", "r1081", "r1296", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r1149" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r1149" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount Rate", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1344", "r1345", "r1346" ] }, "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Probability of Milestone Achievement", "label": "Measurement Input, Probability Of Milestone Achievement [Member]", "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]" } } }, "auth_ref": [] }, "ew_MeasurementInputRevenueVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MeasurementInputRevenueVolatilityMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Volatility", "label": "Measurement Input, Revenue Volatility [Member]", "documentation": "Measurement Input, Revenue Volatility" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r691", "r692", "r693", "r1061" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r691", "r692", "r693", "r1061" ] }, "ew_MedicalDeviceCompanyApril2021InvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MedicalDeviceCompanyApril2021InvestmentMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Device Company, April 2021 Investment", "label": "Medical Device Company, April 2021 Investment [Member]", "documentation": "Medical Device Company, April 2021 Investment" } } }, "auth_ref": [] }, "ew_MedicalDeviceCompanyMarch2023InvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MedicalDeviceCompanyMarch2023InvestmentMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Device Company, March 2023 Investment", "label": "Medical Device Company, March 2023 Investment [Member]", "documentation": "Medical Device Company, March 2023 Investment" } } }, "auth_ref": [] }, "ew_MedicalDeviceCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MedicalDeviceCompanyMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Device Company", "label": "Medical Device Company [Member]", "documentation": "Medical Device Company" } } }, "auth_ref": [] }, "ew_MedtronicIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "MedtronicIncMember", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medtronic Inc", "label": "Medtronic Inc [Member]", "documentation": "Medtronic Inc" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r253", "r255", "r257", "r258", "r260", "r291", "r292", "r523", "r524", "r525", "r526", "r584", "r622", "r693", "r782", "r875", "r877", "r885", "r906", "r907", "r963", "r965", "r967", "r968", "r981", "r998", "r999", "r1029", "r1041", "r1049", "r1061", "r1062", "r1066", "r1081", "r1296", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r145", "r217", "r350", "r465", "r529", "r532", "r533", "r534", "r538", "r539", "r716", "r840", "r918" ] }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestPeriodIncreaseDecrease", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Changes to noncontrolling interest", "label": "Noncontrolling Interest, Period Increase (Decrease)", "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period." } } }, "auth_ref": [ "r77" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1168" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1176" ] }, "us-gaap_MunicipalBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MunicipalBondsMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Municipal securities", "verboseLabel": "Municipal securities", "netLabel": "Municipal securities", "label": "Municipal Bonds [Member]", "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments." } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r1150" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r347" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r347" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r173", "r174", "r176" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Edwards Lifesciences Corporation", "terseLabel": "Net Income (Loss)", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r165", "r176", "r223", "r297", "r330", "r333", "r337", "r350", "r358", "r360", "r361", "r362", "r363", "r364", "r367", "r368", "r375", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r650", "r658", "r687", "r716", "r848", "r938", "r955", "r956", "r1098", "r1292" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r87", "r202", "r330", "r333", "r364", "r367", "r368", "r847", "r1223" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "netLabel": "Net of tax", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r343", "r360", "r361", "r362", "r363", "r370", "r371", "r376", "r379", "r658" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income for Earnings Per Share Calculations:", "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment hedges", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r94" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ew_NewMarketsTaxCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "NewMarketsTaxCreditMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Markets Tax Credit", "label": "New Markets Tax Credit [Member]", "documentation": "New Markets Tax Credit" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r1149" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r1113", "r1123", "r1133", "r1157", "r1165" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1140" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1139" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r1157" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1176" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1176" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r76", "r573", "r1233", "r1234", "r1235", "r1236", "r1415" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NondesignatedMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives not designated as hedging instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r22" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r167" ] }, "us-gaap_NotesPayableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable fair value disclosure", "label": "Notes Payable, Fair Value Disclosure", "documentation": "Fair value portion of notes payable." } } }, "auth_ref": [ "r33", "r133", "r134", "r1343", "r1353" ] }, "us-gaap_NotesReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesReceivableGross", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing receivable", "label": "Financing Receivable, before Allowance for Credit Loss", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease." } } }, "auth_ref": [ "r230", "r231", "r250", "r251", "r310", "r421", "r471", "r474", "r1030", "r1031", "r1201", "r1262" ] }, "ew_NumberOfAdvancePricingAgreementsRenewed": { "xbrltype": "integerItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "NumberOfAdvancePricingAgreementsRenewed", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of APAs renewed", "label": "Number Of Advance Pricing Agreements Renewed", "documentation": "Number Of Advance Pricing Agreements Renewed" } } }, "auth_ref": [] }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income before reclassifications", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r37" ] }, "us-gaap_OffsettingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingAssetsLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Assets [Line Items]", "label": "Offsetting Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingAssetsTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Assets [Table]", "label": "Offsetting Assets [Table]", "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements." } } }, "auth_ref": [ "r150", "r151" ] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets", "label": "Offsetting Assets [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r150", "r320" ] }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingDerivativeAssetsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Offsetting Derivative Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingDerivativeLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Offsetting Derivative Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OffsettingLiabilitiesTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities", "label": "Offsetting Liabilities [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r150", "r320" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income, net", "terseLabel": "Consolidated operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r228", "r1019", "r1239", "r1240", "r1242", "r1243", "r1244" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r734" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r734" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts included in the measurement of operating lease liabilities", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r735", "r736" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r733" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash operating lease cost", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1227" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r407", "r408", "r409", "r410", "r411", "r414", "r1024", "r1025" ] }, "ew_OptionToAcquireInvestmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "OptionToAcquireInvestmentAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option to acquire investment amount", "label": "Option To Acquire Investment, Amount", "documentation": "Option To Acquire Investment, Amount" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATION" ], "lang": { "en-us": { "role": { "terseLabel": "BASIS OF PRESENTATION", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r177", "r178", "r179", "r200" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r134" ] }, "us-gaap_OtherAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r315", "r1070" ] }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsMiscellaneousNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term assets", "label": "Other Assets, Miscellaneous, Noncurrent", "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets (Note 2)", "totalLabel": "Other assets, noncurrent", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r303" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (loss) gain on hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r322", "r327", "r849" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion)", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r322", "r327", "r669", "r670", "r675" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of gain (loss) reclassified from accumulated other comprehensive loss into income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r327", "r329" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount excluded from effectiveness testing (amortized)", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax", "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r323", "r327", "r329", "r671" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r849" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion)", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r672" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive (loss) income, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r21", "r31", "r331", "r334", "r338", "r364", "r722", "r723", "r728", "r820", "r849", "r1221", "r1222" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive gain (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r12", "r20", "r201", "r331", "r334", "r364" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "verboseLabel": "Other comprehensive (loss) income, net of tax (Note\u00a014):", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unrealized pension credits", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r6", "r7", "r156", "r157", "r849" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred income tax expense (benefit)", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r12", "r20", "r201" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain on available-for-sale investments", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r324", "r327", "r457" ] }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsintheConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished products inventories held on consignment", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller." } } }, "auth_ref": [ "r1219" ] }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Liabilities, Fair Value Disclosure", "documentation": "Fair value portion of other liabilities." } } }, "auth_ref": [ "r1342", "r1343", "r1353" ] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r96", "r105" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r137" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r176" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other non-operating income, net", "terseLabel": "Other non-operating income, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r168" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofHedgeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income, net", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other operating expenses, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherPaymentsToAcquireBusinesses", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment for acquisition options (Note 7)", "terseLabel": "Payment for acquisition options", "label": "Other Payments to Acquire Businesses", "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs." } } }, "auth_ref": [ "r42" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1149" ] }, "us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivableAfterAllowanceForCreditLossNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes and other receivables", "label": "Other Receivable, after Allowance for Credit Loss, Noncurrent", "documentation": "Amount, after allowance for credit loss, of receivable classified as other and noncurrent." } } }, "auth_ref": [ "r1215" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1111", "r1121", "r1131", "r1163" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r1114", "r1124", "r1134", "r1166" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r1114", "r1124", "r1134", "r1166" ] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ParentMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Total Edwards Lifesciences Corporation Stockholders' Equity", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r1138" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "ew_PaymentsForEquityForwardContractRelatedToAcceleratedShareRepurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "PaymentsForEquityForwardContractRelatedToAcceleratedShareRepurchaseAgreement", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity forward contract related to accelerated share repurchase agreement (Note 12)", "label": "Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement", "documentation": "Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement" } } }, "auth_ref": [] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for legal settlements", "label": "Payments for Legal Settlements", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r13" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r1191", "r1224" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of treasury stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r172" ] }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of available-for-sale investments (Note 6)", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r41", "r344", "r425" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash consideration paid at closing", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r42", "r654" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to acquire businesses", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r42" ] }, "ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Business combination, net of cash", "label": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options", "documentation": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireHeldToMaturitySecurities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of held-to-maturity investments (Note 6)", "label": "Payments to Acquire Held-to-Maturity Securities", "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities." } } }, "auth_ref": [ "r41", "r425" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Investments in intangible assets", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r171" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r171" ] }, "us-gaap_PaymentsToAcquireReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireReceivables", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Issuances of notes receivable", "label": "Payments to Acquire Receivables", "documentation": "The cash outflow for the purchase of all receivables." } } }, "auth_ref": [ "r170" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r1148" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1148" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1140" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r1157" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r1150" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1139" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r1141" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1185" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r1140" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r714" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r140", "r558" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r140", "r916" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r140", "r916", "r936", "r1415", "r1416" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r140", "r836", "r1070" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r314", "r482", "r483", "r1006" ] }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrentAndNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term prepaid royalties", "label": "Prepaid Expense", "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs." } } }, "auth_ref": [ "r211", "r314", "r929", "r1376" ] }, "us-gaap_PrepaidRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidRoyalties", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDCERTAINLITIGATIONEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid royalty asset", "label": "Prepaid Royalties", "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1007", "r1033", "r1264" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of business", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r1192", "r1225" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from available-for-sale investments (Note 6)", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale", "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r344", "r345", "r1247" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from held-to-maturity investments (Note 6)", "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities", "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities." } } }, "auth_ref": [ "r39", "r1247" ] }, "us-gaap_ProceedsFromStockPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromStockPlans", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from stock plans", "label": "Proceeds from Stock Plans", "documentation": "The cash inflow associated with the amount received from the stock plan during the period." } } }, "auth_ref": [ "r9" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r262", "r263", "r264", "r265", "r266", "r267", "r290", "r416", "r783", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r1001", "r1042", "r1080", "r1081", "r1082", "r1085", "r1088", "r1211", "r1289", "r1290", "r1298", "r1382", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r262", "r263", "r264", "r265", "r266", "r267", "r290", "r416", "r783", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r1001", "r1042", "r1080", "r1081", "r1082", "r1085", "r1088", "r1211", "r1289", "r1290", "r1298", "r1382", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "verboseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r297", "r330", "r333", "r346", "r350", "r358", "r364", "r367", "r368", "r465", "r529", "r530", "r532", "r533", "r534", "r535", "r536", "r538", "r539", "r650", "r658", "r659", "r662", "r663", "r687", "r716", "r825", "r846", "r894", "r938", "r955", "r956", "r1054", "r1055", "r1099", "r1223", "r1292" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r16", "r738", "r829", "r843", "r1070" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r1138" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r1138" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r253", "r255", "r257", "r258", "r260", "r291", "r292", "r523", "r524", "r525", "r526", "r576", "r584", "r612", "r613", "r614", "r622", "r693", "r753", "r765", "r782", "r875", "r877", "r885", "r906", "r907", "r963", "r965", "r967", "r968", "r981", "r998", "r999", "r1029", "r1041", "r1049", "r1061", "r1062", "r1066", "r1067", "r1081", "r1092", "r1281", "r1296", "r1345", "r1366", "r1367", "r1368", "r1369", "r1370" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r253", "r255", "r257", "r258", "r260", "r291", "r292", "r523", "r524", "r525", "r526", "r576", "r584", "r612", "r613", "r614", "r622", "r693", "r753", "r765", "r782", "r875", "r877", "r885", "r906", "r907", "r963", "r965", "r967", "r968", "r981", "r998", "r999", "r1029", "r1041", "r1049", "r1061", "r1062", "r1066", "r1067", "r1081", "r1092", "r1281", "r1296", "r1345", "r1366", "r1367", "r1368", "r1369", "r1370" ] }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affected Line on Consolidated Condensed Statements of Operations", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r337" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r37" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r337" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "documentation": "Item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r337" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r337" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r337" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Unallocated amounts:", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r1106", "r1116", "r1126", "r1158" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r421", "r583", "r740", "r741", "r834", "r842", "r909", "r910", "r911", "r912", "r913", "r935", "r937", "r962" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r421", "r583", "r740", "r741", "r834", "r842", "r909", "r910", "r911", "r912", "r913", "r935", "r937", "r962", "r1362" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r288", "r289", "r352", "r353", "r543", "r560", "r742", "r766", "r830", "r1013", "r1014" ] }, "ew_ResearchAndDevelopmentAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ResearchAndDevelopmentAccruals", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development accruals", "label": "Research And Development Accruals", "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r623", "r1000", "r1024", "r1371" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "ew_RestOfWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "RestOfWorldMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of World", "label": "Rest of World [Member]", "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan." } } }, "auth_ref": [] }, "ew_RestOfWorldSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "RestOfWorldSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of World", "label": "Rest of World Segment [Member]", "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World)." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r1107", "r1117", "r1127", "r1159" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r1108", "r1118", "r1128", "r1160" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r1115", "r1125", "r1135", "r1167" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash included in other current assets", "label": "Restricted Cash, Current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1213", "r1229" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash included in other assets", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r242", "r1215", "r1229" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSES" ], "lang": { "en-us": { "role": { "terseLabel": "RESTRUCTURING EXPENSES", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r508", "r509", "r511", "r514", "r519" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostExpectedCostRemaining1", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related cost, expected cost remaining", "label": "Restructuring and Related Cost, Expected Cost Remaining", "documentation": "Amount of expected cost remaining for the specified restructuring cost." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related cost, expected number of positions eliminated", "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated", "documentation": "The expected number of positions to be eliminated as a result of restructuring activities." } } }, "auth_ref": [] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring expenses (Note\u00a04)", "terseLabel": "Restructuring charges", "negatedTerseLabel": "Restructuring expenses (Note 4)", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r15", "r515", "r516", "r1282" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r510", "r511", "r516", "r517" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r510", "r511", "r512", "r513", "r516", "r517", "r518" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued realignment reserves", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1217", "r1283", "r1284" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r143", "r193", "r839", "r882", "r884", "r891", "r917", "r1070" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r293", "r355", "r356", "r357", "r359", "r364", "r366", "r368", "r466", "r467", "r504", "r638", "r639", "r647", "r648", "r649", "r651", "r657", "r658", "r676", "r678", "r679", "r681", "r685", "r730", "r732", "r879", "r881", "r895", "r1415" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "verboseLabel": "Total segment net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r226", "r227", "r384", "r392", "r393", "r407", "r413", "r416", "r418", "r420", "r574", "r575", "r783" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Net Sales", "verboseLabel": "Net Sales Reconciliation", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Enterprise-Wide Information", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r737", "r1069" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1176" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1176" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accrued and Other Liabilities", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r37", "r1358", "r1359" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r69", "r71", "r652" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash and Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r208" ] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Supplemental Cash Flow Information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r97", "r99", "r673" ] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://www.edwards.com/role/DISCONTINUEDOPERATIONSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r17", "r24", "r34", "r111", "r120", "r121", "r122", "r123", "r124", "r128", "r130", "r131", "r185" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1237" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r65" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r462", "r463", "r464", "r646", "r1188", "r1189", "r1190", "r1333", "r1334", "r1335", "r1336" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r1342", "r1343" ] }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts." } } }, "auth_ref": [ "r207" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Selected Captions in the Consolidated Balance Sheets", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r35", "r147", "r148", "r149" ] }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments in Unconsolidated Affiliates", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]", "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions." } } }, "auth_ref": [ "r91" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Values of Assets Acquired and Liabilities Assumed", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r197" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Cash", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r29", "r210", "r1378" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r510", "r511", "r512", "r513", "r516", "r517", "r518" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Enterprise-Wide Information", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r55", "r158" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset." } } }, "auth_ref": [ "r55", "r158" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r52", "r53", "r54" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r52", "r53", "r54" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r586", "r588", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r195" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r195" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Stock, Class of Stock [Table]", "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks." } } }, "auth_ref": [ "r56", "r57", "r58", "r59", "r60", "r61", "r189", "r191", "r192", "r193", "r307", "r308", "r309", "r386", "r558", "r559", "r560", "r562", "r565", "r570", "r572", "r887", "r888", "r889", "r890", "r1041", "r1187", "r1230" ] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]", "label": "Debt and Equity Securities, FV-NI [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r710" ] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r710" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Variable Interest Entities [Table]", "label": "Variable Interest Entity [Table]", "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements." } } }, "auth_ref": [ "r81", "r82", "r83", "r84", "r85", "r660", "r661", "r666", "r667", "r761", "r762", "r763" ] }, "ew_ScottB.UllemMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ScottB.UllemMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Scott B. Ullem [Member]", "documentation": "Scott B. Ullem" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1101" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1103" ] }, "us-gaap_SegmentContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentContinuingOperationsMember", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing Operations", "label": "Continuing Operations [Member]", "documentation": "Component of an entity expected to operate in the foreseeable future." } } }, "auth_ref": [] }, "us-gaap_SegmentDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDiscontinuedOperationsMember", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations", "label": "Discontinued Operations [Member]", "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale." } } }, "auth_ref": [ "r11", "r112", "r113", "r114" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r384", "r388", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r413", "r414", "r415", "r420", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r503", "r513", "r518", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r1021", "r1024", "r1025", "r1034", "r1084", "r1382", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r254", "r256", "r259", "r261", "r268", "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r418", "r419", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r899", "r902", "r904", "r964", "r966", "r969", "r982", "r985", "r988", "r989", "r990", "r991", "r993", "r994", "r995", "r996", "r997", "r1002", "r1043", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1083", "r1092", "r1298", "r1382", "r1384", "r1385", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "us-gaap_SegmentOperatingActivitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentOperatingActivitiesDomain", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities [Domain]", "label": "Operating Activities [Domain]", "documentation": "Operations of an entity including continuing and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SEGMENT INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r229", "r384", "r387", "r388", "r389", "r390", "r391", "r403", "r405", "r406", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r1020", "r1022", "r1023", "r1024", "r1026", "r1027", "r1028" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r166" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock units granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r604" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r604" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r613" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r612" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r614" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r586", "r588", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional shares authorized (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New total shares authorized (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r1051" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r597" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, per option/share (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r607" ] }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance period (years)", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period" } } }, "auth_ref": [] }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares expected to be granted as percentage of target (as a percent)", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price of options granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r597" ] }, "ew_ShareInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "ShareInformationAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Share information (Note 15)", "label": "Share Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r611" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments (Note\u00a06)", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r219", "r220", "r1220" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r295", "r384", "r388", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r413", "r414", "r415", "r420", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r503", "r506", "r513", "r518", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r1021", "r1024", "r1025", "r1034", "r1084", "r1382", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r21", "r141", "r144", "r145", "r293", "r335", "r336", "r337", "r355", "r356", "r357", "r359", "r364", "r366", "r368", "r385", "r466", "r467", "r504", "r573", "r638", "r639", "r647", "r648", "r649", "r651", "r657", "r658", "r676", "r677", "r678", "r679", "r680", "r681", "r685", "r722", "r724", "r725", "r726", "r727", "r728", "r730", "r732", "r739", "r849", "r879", "r880", "r881", "r895", "r957" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r254", "r256", "r259", "r261", "r268", "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r418", "r419", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r899", "r902", "r904", "r964", "r966", "r969", "r982", "r985", "r988", "r989", "r990", "r991", "r993", "r994", "r995", "r996", "r997", "r1002", "r1043", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1083", "r1092", "r1298", "r1382", "r1384", "r1385", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1411", "r1412" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r355", "r356", "r357", "r385", "r732", "r783", "r886", "r896", "r908", "r909", "r910", "r911", "r912", "r913", "r916", "r919", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r931", "r932", "r933", "r934", "r935", "r937", "r939", "r940", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r957", "r1093" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOperatingActivitiesSegmentAxis", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities [Axis]", "label": "Operating Activities [Axis]", "documentation": "Information by continuing and discontinuing operations." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r355", "r356", "r357", "r385", "r421", "r732", "r783", "r886", "r896", "r908", "r909", "r910", "r911", "r912", "r913", "r916", "r919", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r931", "r932", "r933", "r934", "r935", "r937", "r939", "r940", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r957", "r1093" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r1110", "r1120", "r1130", "r1162" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Compensation Plan", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r1238" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under stock plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r21", "r140", "r141", "r193" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under stock plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r64", "r140", "r141", "r193" ] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount Paid", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r1297" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Edwards Lifesciences Corporation stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r141", "r144", "r145", "r180", "r918", "r936", "r958", "r959", "r1070", "r1100", "r1232", "r1261", "r1357", "r1415" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r76", "r77", "r86", "r293", "r294", "r336", "r355", "r356", "r357", "r359", "r364", "r366", "r466", "r467", "r504", "r573", "r638", "r639", "r647", "r648", "r649", "r651", "r657", "r658", "r676", "r677", "r678", "r679", "r680", "r681", "r685", "r722", "r724", "r728", "r731", "r739", "r880", "r881", "r893", "r918", "r936", "r958", "r959", "r983", "r1099", "r1232", "r1261", "r1357", "r1415" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" ], "lang": { "en-us": { "role": { "terseLabel": "ACCELERATED SHARE REPURCHASE", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r190", "r349", "r557", "r559", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r571", "r573", "r684", "r960", "r961", "r984" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r729", "r745" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r729", "r745" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r729", "r745" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r729", "r745" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r729", "r745" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTS" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r744", "r746" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r1212" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid during the year for:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ew_SurgicalHeartValveTherapyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "SurgicalHeartValveTherapyMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Surgical Structural Heart", "label": "Surgical Heart Valve Therapy [Member]", "documentation": "This element represents the surgical heart valve therapy product line." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r1156" ] }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes payable", "label": "Taxes Payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes." } } }, "auth_ref": [ "r134", "r214", "r1377" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1148" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r1155" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1175" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1177" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.edwards.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ew_TranscatheterAorticValveReplacementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "TranscatheterAorticValveReplacementMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transcatheter Aortic Valve Replacement", "label": "Transcatheter Aortic Valve Replacement [Member]", "documentation": "Transcatheter Aortic Valve Replacement [Member]" } } }, "auth_ref": [] }, "ew_TranscatheterMitralAndTricuspidTherapiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "TranscatheterMitralAndTricuspidTherapiesMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transcatheter Mitral and Tricuspid Therapies", "label": "Transcatheter Mitral And Tricuspid Therapies [Member]", "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r556", "r570", "r683", "r710", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r764", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r850", "r1057", "r1059", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1071", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1256", "r1257", "r1258", "r1259", "r1341", "r1344", "r1345", "r1346", "r1353", "r1356" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1178" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1179" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r1179" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1177" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1177" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1180" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1178" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r62" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock, beginning balance (in shares)", "periodEndLabel": "Treasury stock, ending balance (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r62" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost, 64.5 and 49.4 shares, respectively", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r62", "r63", "r144" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases of treasury stock (in shares)", "verboseLabel": "Shares Received (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r21", "r141", "r193" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of treasury stock", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r21", "r62", "r193" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.edwards.com/role/RESTRUCTURINGEXPENSESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r510", "r511", "r516", "r517" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "US", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. government and agency securities", "verboseLabel": "U.S. government and agency securities", "netLabel": "United States government and agency securities", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r826", "r1044", "r1071", "r1087", "r1410" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1174" ] }, "ew_UnitedStatesSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "UnitedStatesSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "United States Segment [Member]", "documentation": "Represents the United States reportable segment of the entity." } } }, "auth_ref": [] }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments in Debt Securities", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "documentation": "Tabular disclosure of unrealized gains and losses on investments." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for income taxes associated with uncertain tax positions", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r625", "r634", "r1052" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net amounts that would favorably affect effective tax rate", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r635", "r1052" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r49", "r50", "r51", "r243", "r244", "r245", "r246" ] }, "ew_VariableInterestEntitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20240930", "localname": "VariableInterestEntitiesAbstract", "lang": { "en-us": { "role": { "label": "Variable Interest Entities [Abstract]", "documentation": "Investments in Variable Interest Entities" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS IN VARIABLE INTEREST ENTITIES", "label": "Variable Interest Entity Disclosure [Text Block]", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r200" ] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity [Line Items]", "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r660", "r661", "r666", "r667", "r761", "r762", "r763" ] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Not Primary Beneficiary", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Primary Beneficiary", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r81", "r660", "r661", "r666", "r667" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r1144" ] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "WeightedAverageMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average", "label": "Weighted Average [Member]", "documentation": "Average of a range of values, calculated with consideration of proportional relevance." } } }, "auth_ref": [ "r693", "r765", "r998", "r999", "r1061", "r1365", "r1367", "r1370" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of stock plans (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r1237" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Dilutive weighted-average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r372", "r379" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average number of common shares outstanding:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Basic weighted-average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r370", "r379" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Shares:", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r1142" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-11" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-13" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-8" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-20/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1C" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-4" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/220/tableOfContent" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-9" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481138/505-30-25-5" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479836/810-10-S99-5" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "25", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/942-320/tableOfContent" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r228": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r229": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r230": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r231": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7A" }, "r232": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r233": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r234": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r235": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r236": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6" }, "r237": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6" }, "r238": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6" }, "r239": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7" }, "r240": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "b", "Publisher": "SEC" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(1)", "Publisher": "SEC" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(2)", "Publisher": "SEC" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column C", "Footnote": "5", "Publisher": "SEC" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column C", "Footnote": "4", "Publisher": "SEC" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column C", "Footnote": "2", "Publisher": "SEC" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column F", "Footnote": "7", "Publisher": "SEC" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Footnote": "4", "Publisher": "SEC" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "4", "Publisher": "SEC" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-4" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/320/tableOfContent" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1" }, "r987": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r988": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r989": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r990": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r991": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r992": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r993": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r994": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r995": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r996": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r997": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r999": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r1012": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-20" }, "r1013": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r1014": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r1015": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r1016": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r1017": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r1018": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1019": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r1020": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1021": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1022": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1023": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1024": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r1025": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r1026": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1027": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1028": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1029": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r1030": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-79" }, "r1031": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "80", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-80" }, "r1032": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r1033": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r1034": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r1035": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r1036": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1037": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r1038": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r1039": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r1040": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r1041": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r1042": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1043": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1044": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1045": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1046": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r1047": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r1048": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r1049": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r1050": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1052": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217" }, "r1053": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r1054": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r1055": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r1056": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r1057": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1058": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1059": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r1060": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r1061": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r1062": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1063": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1064": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1065": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1066": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1067": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1068": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r1069": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r1070": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r1071": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r1072": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r1073": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r1074": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r1075": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r1076": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r1077": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r1078": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r1079": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r1080": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r1081": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r1082": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1083": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1084": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1085": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r1086": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14" }, "r1087": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17" }, "r1088": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r1089": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9" }, "r1090": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r1091": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1092": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r1093": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r1094": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1095": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1096": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1097": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1098": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r1099": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r1100": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r1101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r1105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1115": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1116": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1117": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1118": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1119": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1120": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1121": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1122": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1123": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1124": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1125": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1126": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1127": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1128": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1129": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1130": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1131": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1132": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1133": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1134": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1135": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1136": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1137": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1138": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1139": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1140": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1141": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r1142": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r1143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r1144": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r1145": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r1146": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r1147": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r1148": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1149": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1150": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1151": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1152": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1153": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1154": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1155": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1156": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1157": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1158": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1159": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1160": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1161": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1162": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1163": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1164": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1165": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1166": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1167": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1168": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1169": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1170": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1171": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1172": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1173": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1174": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1175": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1176": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1177": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1178": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1179": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1180": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1181": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1182": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r1183": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r1184": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r1185": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r1186": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1187": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r1188": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1189": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1190": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1404", "Paragraph": "a", "Publisher": "SEC" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Subparagraph": "(ii)", "Footnote": "2", "Publisher": "SEC" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "1", "Publisher": "SEC" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/210/tableOfContent" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1" }, "r1247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11" }, "r1248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r1249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r1250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r1251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r1252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r1253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r1254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r1255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r1256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r1257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r1263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r1264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r1265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r1278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3" }, "r1283": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r1331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r1332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r1333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r1372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/940-320/tableOfContent" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1" }, "r1411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" } } } ZIP 110 0001099800-24-000086-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001099800-24-000086-xbrl.zip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�OL9?WZQK7"2HG'IQI@'Y\VW6] C# > M/&6(]+_0VIK[SH^+_U+1DN@ M;AMZK]O4QSVK->ZVQCT#=9J&JJDMS=!TRT#-_R8Y]LE-DT4_^1E(5?W1Q^A' M'8UA@N?(>4'S@"!U&9: R7=TWT2R!,$)L0F(5S&=4+#_ZZ-/I&%]6AN?U5I] M5NL8\M%[QYZU-N&4/C."OT0-\\6UX\S!2;K_"]]_N[H=_P$]7 M_QPJ5S?P>2C\S'^V706>ZI!TY,^PF*'(LD%[_;+SQ& :5/F_:27?PCY99!PT M"_!Y^L=GRPYF#IJ?VRX=%;WI\^K3,XY64K+%/[^):*,9BVD2/TC>G/S<@)\^ MK7]O=!J&9F3^U&RHF=]O>E2WT>X5>]+F[PT]^QUR3(<:4Z?Y\9.V1*:V50XK MQW9=$_8\N\R]/).*E=5QIM7--:N'B8^Q\@VNFP3*$(PNBZZ](SP#6XLDL.C- MLQP[ZQ_Z,H*2Y@:^*4(9$;">;^;Y$RKB]8FL7L3=H?:[D@Y/*&9K3:W%:L+; MLDBJ1#1]7^504;I(,.T-ID.5(^4I(':#0\6FAQV+AIIR,SYWFC@\BOL<\<*3 MWQI\*V_6'V6/%]S/N_.]L1V2\[(U9>SY4Q3^5K-?PW,WFM8M+ZPG]V9$0%O- M6E\_:[9[#5;'QXMHI)P!4L*CXQPLEU)U2E*U98]S6:K6!4<%P>GJC;U[O$JQ MD6)3_JR+B,V6C=T]%B.-+$:=KB$7(RE5IR956S:[]Y J4F+RK*GU!%BK&!U$ MR>WST0V:,I!Q&TZP3XX&SGP\P6Y@/V/E9P>X^TOB#YXI+HYWQ]&K\O.-%^*8 M5VKKE_-W.Z-%#CPE]&(2>M@I/UD.CIO!L4P;[L0;_SS'6KYZ/GQT%3/R?>R: MVHQ:7],S?))?)-*$ M1MJ:(ULZTMID'Z2Q7NE6(DULI*TY=Z4CK5/KZVK&\9VC(ZT$E^_=QG2=7'_> MIA9L26#Z[OH8QOEO;*5>X!.R7050-<'6$PZV>'S5//192,+63-,=).P"!9.O MCO?R!Z'Y[\ \N6 9#[?8]-!06"/@3:IQ&7+51..%/^\BTD-@D*ONO."T,>A[=,3C5^PB\=V M>.? /++1:*L@VEB$31FCC?:BXZ7JD8R=KMJS:= 4/2/;(6>BZ[!P MU0/@H6*[S_C]!O\I!5./8.:^,>(/SR'T25W&6W>$SPB4=6I]M=G@I0FWA-D1L]6/";,NP*R7 ML;LO828^S'8,LQX"9KU:7V-05U'&6D,4I$B8VHO*%=]HCJD'VLC*06 MB2BQ$94W*?8 B%)K?8V'ZA2G&L==,QV'U@ORK4"YML3X] ME[>C,Y"T$-*!-987D7>E\]W#+>2.POEK4C*F#M_*Z#@Q\J*.;T>+X]U=UH[O MOMPL*98C)5E*,A][!UG"JH.P]IK,SGU+496B*D5U_SV5PHMN*]X?Z4E)EI(L M)9FCO:;"DFS$^T:=*DBR;),NVZ07D4M*;?W=?MIN;=*[3-JD-QNR2[KLDI[1 M)7TP^D/Y>GW[YTCX^6[KC7[]7J-KZ$7;G'>T1KNG,6F5K:J-MMYAUK^; MX:!ZLH'W3':IKB!#*]HD5W86WH%H5>XLG#UI4KM3&3O>2Z",?6^J>#-,M@3! MRR!>WS,]5YX'22QZ@/'ML.=7(SME+)PZ+4]AKWZ'-MYYJV)P-]?"8;^*QNX. MU@6UTV;6!951"8\C1,ZE'/ T-R[ZEG8ZS/J6,I*#:MF-V:Q_JX(9D 0S'P.W M3=O!M'9-DH5&SBS )Y.8F#/?>[;![50>YYDVYCD+PTI4V^?(=J3HY&)D*L;+ MA];0>.](>HEG(%]VTH'4M10T)2?'_IV9NEGD\)Z *= ,3:]ELL+?#DXZ5 R6 MJ)NUWI S/0 ;60:RBIC98J;LBAER:J?)3V'86>^:/^B *:9#0E7(JMU)]OO!#' M/%#5M7-?TM[(JV%'$^3C+X2^%TODS1($#2P,718GKR9*MBC2_"C18SMTO7NC MM$./P?/?D\8CM-6(-U8>HP"N"8)87RK&;II27&-BOR/RJT*P5!$=J'L[_I+0 MMF@\N4L/,^AZ1];M$ %"#-5H/@1]V->N:_#6UVZ+BDTS)V&@>#/@#GG5J=G, M%Q/D/I&3^LH8V;[RC)R(K@4$JC ?[(8T>=^V<'PV7W%L]&@[=) M>9E(A1HLI4?;I12^6%#^8IGP ]\GG*)[7#'3KESP2B,7O-0-MUPGK)JK171& MFYG.D,8[CX9+WDHL1X/F.@0[M;[6WJNLU'$\ @&7*\%=EDL\QKZ/K<6F/GK] M(".TFC8F2S?ERC5]$NZ\Q/%_K]R4PO')S0="WRP1[8*(:JT,UUTZ)6(#9HM7 MLC-@R)YC-RLVSEL=+@&5NN ^2!J'(MV-41#%38Z)$S+S\;/M18$S5R;8L19% M9I5H1G)/S+\B.S[0FW@BW5/S1%@N!1GVWBC$L\$;E8?P5SA/2^V!C4=^\C&^ M7^8;8>:M'Z=.KFF!'ME?;>U5WE$Z%1QZN5L6C0- *[<_VU-Y\V=/S6:G[9E. MS$8_6!\U4O84!9/8V-J-B8)HDT!S+ MC$>;6?O8Q/8S*;H2T.;5TO38V_18C_JD=!^X%EUG[M^(GK6\M&I]U=B_BINT M1W@,+!0.&18$#ZD"J.F-)O>AP\I%YJ[<9_"[/?^CLAO5C'X<=I-EB:Y9@&^3 M-/+]-E=DF(Q'H!36E%N 0@Z;=_=KDBZ#6OO9G3,TIT4!Z4E8T_0CO.*[2>.3 MG=9,:7X7DYP<=(P)?OU&[RPIZ=;Z/08G9*7QR2&(=K8]BX*HQ^B!?2MY(!&-=!O0FZ]VLSJ M^$MSM1@0[GP\0[:EX'@':#E<:D:^3_)MXKT'::\>(%B:4#_-E$NVX=+H%SU@ MGF%SZ$VRB9MU\$L:KGRBZ;"Q@%U1I-?Z;5V Q,L*VJPA=AQLAA%IB.*3;=YP MKJ G'\<9CC1<@)P3,V>9-J+&+QF"A0.@]B,F>)1HNF(ZX;)3+. M*C9LMJ7([ D;@YY/VF<_2IJQ.X'@VG.?ZB'VIR0UG!JTOC='SM)A5/W4BA8< MU8*]3ZF=)15ML#/VKRDGC54A%"H+P)#=*U7EX0S9J5FFNZ=DGX@!43B.2BFZ M*"%W@6:DH>(-#K-P3TJV9K69EE:GV* IK"2+@(;L/[4R0N]BVYP]SA7E3=Z* M\?M8G;D[Z0@B- P5+="?](2Z2ZC_9?X](#L."YD9+!B0(3-J$RS2=H_9L88B M'8]X-UA/&7-;]/1^F%-K_8[18^8''11SU3IGDZ^EG.T^XX!%2[F$%I5N@W;D MPS>5IN4I].%)3-AXF]FRP\@_N0Q(EF[F'9K3HEH/7G(>_B[91+ISD!L.7(L< MFY^12[)6(HTV$=VKV((,QO&(FFW-R_9"#:G)W&Y5:+N8:X5Y%_GF!)&$'&], M:]S XE>?(E"<=CA/;)6XK5F\O=&6%6X8JM,_@. /WK>$W"-LDO]NL.M)'>:L M_#49M!,;,T65:1',D'UBO6&4CYE3L#UAE8-!6XF;=SA=*JZ1P;91,"7V5Z U M*4\.5D4J$K?C(B+2KO6-IDQQK"2&MC?998.A3JW?4S/4K- G<_C6MMIF"#[F+&;)25#2K0F*%B]UU YL4*D)\=?7$13O#ZAKM#-N3!0(JBJ@"/D1N,&D)R50-OG%&KZ:3D3H=#LC;\PT M,MNU?J>MRZY%E8/0!A5[ B1HZXM58"6IM6P8F/ND>5OI4N<%S,H"9QW3BUP MSC*R0X\N?B E64) SKWNU]97&JH\0F6+I;H+5'JT7T1U*OYSK2ZO@B!"KAEG M<[B@&H.E'BK2!&47_?ZPSX6ND^:871[*"DDSL]3 ]Q:8D"W"C@!9Q3)BRWOQQ2HV2]2L\*?WCD6]?HT9!]-BRE7'7W^-90N+;\84WG7KNB!"WL'79 MAG7^K DK/0?YIC)$6Y*KOQ%,ZWCIU/HM76[Z'XG?I*I1."S(IMO0C M"&1Q5< G<$_M'-ZACCD3@I)*@%FAK%:3A+*:^Q\_E58NAR@IR:"0Y> L7A3P7Y']#&R%Q?Q,0:ZE^#@(?=LDP>R=SPI7M!O401:& MF&^WXV'"K'O@U:U+9)+\__"-/?<+QM!CHJZU^L72E5F22G89-1;9Q%RL$+)= MV:'#-D>"98=TDSFIMF;B. UVTEF4^ R'7C$J:K(QC+;O)7IW,'S/6F\5FY08 M6!;R6/ +.R%=DB-MZ%D5]CC,5Y6>""_KS+%AO8[<7JW?;JD982D.<7L*CLQ% M_J5&0:'RB)]LUR71+'!]9A00)[9?4$0:6P>4QJ)KAD&VA<_45M;A=%EJ3GRL M=0^*M74XD1[)G:S.E#*KAA-=C>'KA99.$B+7\R%SKK#QQ,]U8(WE1:2P=CK? M_4GNE!1Z*?3LA;['D]"3JO)G M+55GE@=9KM"+D1_W*205C^"_EOW<_Q7^2:^>(A\<1TJ;[JHN,(&[V#\]O\&.\:P?O#!),C)MX41C,G?FY<2XV<,T&TKPA^\I&CS)!/=__""0XP M$0/*;7HH!3Y8V"79'TGJ!UP>A/ 3S>%I+&#WGD23=%@- \8^\^)ZE^?TZ(O] MC#^_V%8X2:5RZ;X$D,VW6] CC"8*-]]R1/)_2.S6*C&6_R6C):)L&WJOV]3' M/:LU[K;&/0-UFH:JJ2W-T'3+0,W_)K6TDILF?CJ#&7K"]4MC/XE#W#RS\']YW-1BB+,L&+ MVYO1[?75Y>!A> D3N[D/,P4FZ_PJ?;B__ZX_;Z?K'YW3=L%TZ*GK3YU6RD1>\6PCI^^*?$Q'M]1JJWB)2FJR*R8L3 6[ M+#^M?Z^U&SVCG?E3LZ%F?K_I47I#:Q=[TN;O]9;!:$Q&K\7=F%2CP]F8C$93 MU;D;DZIIG(VIU>@U><-3I]'6>>-=MZ%V>IR-B4[:"$J"A[2^"Q,BR,LXOTP$ ME90/N/E+A>U8T8L_6:4E!')5BLLSY6T5TBI#MCOD*_]$3K2Y=4!AN:H.<22F M=B+;8.I%;LA^N11C\C!6$IQ%CG*';*MNN\H%FI&P](D2Y!Z'"+ZTE"'R24)9 M'GFJ(AT&IAE-H[B\%3W=JX"%/?/Q!+N!_8R5:^^#GJW5)LV#!^*A#"U2)BA0 MKNTQ#DP;TR8W%YX_\WS:;#&VPB>> VHR^$F)BPN=*,5N/)?63/,!4=6Z,GZWP$#K--Q\EOB"'-(2*X;XI1X>F+*5-9A[*V"-2R*H\5^>+TR9WGD\U/&Y=?R6@X)I+)A",U'XR8/64=:N]5N]_;-0!0&9U.^GH-^+E6G( M6Z>!E:8OF#3:J?6-LZ;6VJLSHQ1/*9[5J4C*9E2,D65S&(F[=HA_P.;M&MBV"8]YUO:7G4! MI?Q)^>-FWH7$S^!Q96RKM7[[C$04617;J*QDGK)85E4FVR6%\=L:B-T1 JQ2 MX*3 \21P6^I,E;0&ZF0-[*@BR*/0U8/RX2FI,>I-\Z3T[C)A[B1HC\;8>2I1 M2FI):DEJ26J)1BW!>N@=P#W9WD-O_/_8>_?FQ)&D7_BK*'B?\VYWA,WH@KBX M-XAPN]WS>$^WW:?MV3W/7QLR%+9V9(F5A-W>3W\RJR002$(2""A$3L2X;="E M*NN769E9>;%#C+O.TFHZK:%A:HWLKDA\1'Q4A8\*2HZNYR.SN7S42&14.Q1) ME8++;W.W!B/=UC"KCVWE&J8$#HG$AEX0Y+L>$CTA-K9VJ]>$C$;ECJQI"JN, MEI+2GBS;/5-<)FK@6;\VVF2+22$=SK=0*7#UP_*9FWDPW&\-![5E=TEP^DM@ M*NN%V &8!DT%TZ'O/WDP%]G&]8.YI\H$YEJ[?JH9=C7_V\8"[>'%^2!=9_B0 M0(DJ*P88K:'803!C8P#+F/G11U,'GKU-O\\&\4YVLJY>)H'IAE/VR\S'\!?> M&TDD[/*?GZV C9'!@+MX=9DLEM%:P_HZ&))O4B;YNQF >*6\\OC1FXH?.D D M:M%QZZYD4YD)J'7RPJG("U./<,(":7I;.VWA MM)/[3Q[ 19Z7>@!L2@7@$PA>X,MV_HAKPT,8XL51V"_\?;-<"#K2H@- HA91 M2T9JT1%*@9E\.?[7+ AY+]8'[W(<5^7'HOPW;E22GV_HCZL;^D_V[YD=V"&[ M9_ZK/6)" _C)1MZ3RY_"E8&L;1_K/G;:74D.68@Y290= [5.7I05&=6'$&4] M$F44_' 8$_P0<.]+!?<"@SUNK0P#9?GHI*OHJF.]Z@3J=/R8^:-G$& !3ZV) M.XT&)3N-TF$-'6W1R4 )FO5U3?]T_.=&C5R=2JG&>D'QJZ4&'5S/NQR!-NBC MAAB$WUGX[(VS-+\!YA[KSGDW1JDF"5O+5T%4G?14Q %UUTE?M.[QN;+\>NKGT=\L?/<>=I3OS+9>/ MK-;^TD>H'57-92QH;%&QN70?2^.;VO:9'50;7RI446W\(CMC3PUBTAQGG!#' MD5 O)]0+.J-4Z2;=[^RGF[0,\"*!WFR!7LUSE&(BJ9I(]\VXB71OAPWYB"N) M*Z52LPJ*ZA^(%[O8.]KH#4Y#"R.&)(:<,V29C.S],V2O-1R<&9W.]O5OB"&E MPN9),F0UO;5L4X3=N23ZL!T:1@;OD6)*;'<\;%>%ZXPRA1WVOP\.6L/>F:;U MMF^ 0PPI%3:)(8L8LJ#Z]\YVOX':&G;[M=6Z)8:3 WO$<$4,5Z:HZ=YWP('& M=\!^]PA.,$X@[:S>]M!2QMS2_<=]?R-CIBL)\H+2-FL[YPWTUM#H=D^][C0A M=[)KY1YV$U$AP5,)&03C4>DA@ M!^FN2:U@][>V^VH%*V5])KJ?[M]Q9&S#I7U!B%#]SM(_N>E+ZJ^A^\O?M5"7>?Z^3CHKU1(S:\E'(O2W/_<1N!0KT M(=C-)'8CN!]&W3X$W+M2P9V*T])5)WW5":0T[;B3EI2>)O)4;7]>W*G2F4"< M$L>M";(V/HP:VK[\E(1>U49BI5)N0R6DE.YAT5$Q-,?L9\3F''6Z ]U/LOW MN4@[Z17740?$KX377>"U2KGH\GC55&GP2G8X77725Q$#T%4G?=4)=DGZV\QE MBJ%2DZ3M734%M>2J-4GJ:!JV;#&H1!R5B#NM$G%%?+2KFHP=33\ACB.A7DZH M%]0KK- DJ:-A3*B6T0^X@? B@=YL@5[M:"+%1#(U2>IH'6R2I/7UC),QJD5/ M7'D\7%F)*0T)*_%V-!.;)'5Z-53@(X:4"IO$D$4,62:Q;O\,V<4F23U-W3Z; ME1A2*FR>)$-6TUO+E@O=G4NB!]NAKF;8C*28$ML=#]M5XKHR^;G[WP?[V"*B M8_2.H$4$,20Q9)T,N:=VNFF>&[2&W1XY3(GA3HSA9&R7V]%5W %-M7,$EN ) M9!35TR0IL00&T'GLS0 QRVMPJ'A<&AH-;5^QVR6&UH C[JRMIJ#V1[+K1<7M M0FL-C3.UI]:6;U9RD8X@58$X03Y., ORY[;@!/U$.>'4X%;)N6RFPMPVZ$75 MT0W,Z$V[I"HGSQ"DI(14)43M3(!UN #K#K;W?>X>;2=0ZC"K]94#ZTJMK^A^ MNO\4"W)5TSS*AF/6WNBEHV.?1'VKWID2UI@C2*6-I_U!JMM$2!WZ?H)TV=B? M'2"Z)PNBJ1$6-<+:46*562;\?-M&6!V]WQK6YW8[,D=(@S"4)9\W U"U-@[Z MH*GX.?7[B7_VTE0CM5'Z:K3OJJ$TA:HS98Y*?:Z+2X8/>LU@;+Z+:&FB%-\G.->B+51#5",WD=:&K3OHJ8@"ZZJ2O.L&F M9_=L&K*71^8KM7<^$]-JB^GF5HGIMXL;H)VGC4[3T'MXBK]VSH&(+2& M6.9& )1V'=IUZG3#I?A4JA9QG0ZP_IG:'V2DLFW:B8,8GQB_D8Q?B>^E+'7> M$5WHS/J"(XGGB>>)YR.>+Z@Y?2">QZ P_:S7SRJG2DQ/3$],OY6&WRU;(FYW M'B9LI@=[>MJ )Q6>.)LX>\/MO)LJ9"[%=M['OK5FQZR[6Q'Q//$\\7RJA/"^ M]G!L"6AN7Y&->)IXFGAZB:?+U%/<^S9NJKB-=[5&&.4\TNHW3I\XTBA1\?;% M\I]LE[^WO\QK(X;4JQM!FAI#B#_Q C/,[=%Z4.D(JH=GIE@CK"UDN>] #\7U M0GB?YWLY&"M!HCR:#/_ZZ"-]6\V:]!XC5)# !E=&S.WJ[AR3,FWV$X8AN".-E5*]9KSQ^B)[567Y69Q\< M,BB**^24OO[RC\N?7^Z5;S=?K^^O;JYOKZ[OE:N[GS_N?EX^W-S=YL+R6"9X M=7=[?_?MYLOEP_47F-CME^O;>_CM_@$^^'Y]^W"OW'V%O^ZN_O=_WWW[8_2V_V>7NE)^9_K@VXM8S+:6B_[F\.-"62M='3JM#O= MJN_>_9C,KFQKUVD;TM&IV^YW.I*-J=M7Y,!6D<4A2)2>FN MV9D:V8;=?%*#,I,2N^MA;/'L646M0^Y+%KM9&Q5\I"2(HVWK(0)=)OEEQR"2 MR@&W0"(E_+=YSJ,,_Y'**D>?" /93K\9OECP/EFSUAPTHS[TK<6::)ZOZ9TL0*PX/NX&2T,^),XLP5SMQ3(;N* MG-EM#7MGYB"K,01Q)G'FL7)F-95VW\6^TFS(2P%TMBK 3_Q'_"?-O"NQGY0U MM\Q^:VB>]=5N1HD]VAE/-#OW9))ONP>HB36Q?['Q^7^8[V6QXP"C'ONZIG_: M-3L2+Q(ORL2+4FZ/775OV^.N>THUH9'Q+0L5&];UI4R<[R83EHZ#RH? [[J3 M'5&+J$74(FI)0:U&=M"LHBWU"OK!_O"]B1UB,':65J.UAD9'W;ZGQG'W=CT& M3! ?[9B/"LIHKN*9>JD(?VP?.9F!3)U.ZUA MEOI8.8Q)@C-80M0:9\#^$&4V$%&'OI\0G3:3]X?HKB2(KNE<7(!#S3"S^=\V MUE8/+\X'Z6K AT1+5/XPP.@)Q0Z"&1L#8,;,CSZ:.O#LC0HK-,_-E)U7VRO( MJ^6!*3>1^ G"9?IU; UB3"L G$,O E^W\$=>&1S3$BZ.P M7_C[9KD)=,)%YX%$+:*6C-1JY#E*G6;RY?A?LR#D;50?O,MQ7#H?*^??N%'= M?+ZA/ZYNZ#_9OV=V8(?LGOFO]H@)#> G&WE/+G\*5P:RMGV=EVC<>ML_[F/# M8P :B3*)J$6BK,"H/H0H,TB4403$84SP0\"](Q7<"PSVN $R#)3EHY.NHJN. M]:H3J)OQ8^:/GD& !3S3)FX'&I1L!TJ'-72T12<#M<>5%53*7>K7(*+)+D>@ M%W%CY[F9#IMH9Z9[!5B*Z$ M>#FB^X\!J;1O2D0MDH5%[JM-96&/9"%%@.PE :<>O/:EP2OYC^BJD[[J!"*> MKIXM]PF>%GJ*N]RXV2[?N/DX3U#H?KJ?[J<3R,U/(%-M=Y8UP.^VZ_F\G+F0 MI.(<\<8=H6;(OC#Q;Y8..&@-^UD-((__V)Q 4V V; R:OBH5:/9]]C:V7W>\ M]KW,M?]L.98[8HH5*M\M?_2L&-J9HJNZ,2'*#FN_;+W:W;DD,!+,--L= M4DR)[8Z8[2IQ7:J2OA3[8!][+P]Z_>U/JX@AI<(F,6010Y8I&;R3W:^FF )B M.*FP1PQ7Q'!EZN#N?0<$($H94'OI^0F9!'/!Z9.K-168CD5'-ZYF*O\KQ>J[' MB-$::NWNX1MN$3CJ%!L%X5#K(8&EQE1S^X.D(PWW/L#:[JS1>9G(0KJ?[C_F M^ZE>P" 5([2WAIT#WH(VK6$>=04,0E3:[M@?HKH-1-2A[R=$IU7B_2&Z)PFB M]^UN']NO\;.C1YSC]1>#^!F)_L>R=3IF_,!FI=5Q]7S+YIF;V0DX@\W:KE5L M>#S "D;2Y"&3RZ)&E\6& *K6]FPP:"I^3OU^XI\]M TT5;4U-/O;=PPG!I+N M_I-GH**CMGH8"*M%J,1 !.#]'_K4 V!=*@"?P-G03AK''H//BNXGG]].5>+] MM_$R5>Q:U\O($SO^EANG?O_)LUN1 GT(=NL0NQ'<#Z-N'P+NIE1PIR+_=-5) M7W4"Z4UU-XD\!D\3>:IJ."\NJ!Y0J9&AJ>;$#!V_5[616*D6W%@%*:6;(9EJ MKS7L;55)4$*TT/TDV64+'*V'6_O$K836/02%UH/6@21H)0NRAB,*FO=-,36T-M>TJ+$AX^DC(*9U/MCER-%F0.$.(Z$>CFA7E#ZMD*_/5/K\'Y[^BG BP1Z MLP5ZM9/M%!/)U&_/U$SLM]=1M8R$Z MUJFO*B,QI!S8)(8L8L@R>=G[9\A>:]@_TXU>AG^.&)(8\L@8LIK>6O;09' M>\>0^DWWT_T[CHYMMK#7U(((V-K;2)EZMS4TMR_N)V$A#$)3DMXN=NNPUT+[,3KO1U#+1R=NVV3/U 993W/IXF9P4 M\LGF31%4K4N,H3850*=^/S&0NH\^88;6&AK&]CF1Q$'2W4\<5&3LUL-!>$;< MV;[7*W$0(;BB@5L/?@VI\'L"!T([:;1W# XKNI\[-%A2CRQ$^Z^H:D%M2 K]E3J:*+#R]9%*^I= MNP.=^QT2F;(YG3K:#J:976 M3QVC->P8M65N'C=":=^A?:=.WW":4:5J+]7!MF]G9J^[E=N..)\X_P0XOQKC M2UDEN6-B"RM=T]H&;??$],3T-3-]04'= S%]%]MD=76][M+HQ/3$](UD^HHZ M?BK^8]^MN#H8#VBJI,03:Q-KU[F?IRI-2[&?]['52=?LT7Y.3$],7SO3%Q25 MW=TNCFW\!G7WLB6F)J8^>::6LFVGJ>(^WM-[&7K[T;$\C[CZC=,GCCA*U$1] ML?PGV^7O[2_SVH@A]>I&D*;&$.)/O,#L8WNT'E0Z@NKAF2G6""O/6.X[T$-Q MO1#>9_GPL:O8,-8GWW*4J>6+]@3/+&"(-4Y)*^15:[#2*]:OF=BNY8YLN#P( MX2N>&]U>#LI*D"@:AM%OZR8,?NH%//GYPF>.%=JO[-.;/0Z?8^PG;HQ66UW< M8CW"<&9A_BU[I/]::G=70M02/W&TR">V:0SZJC$9C#N3?F:FJZUM%- MW1B;EOI/+#(2W?3LQS.86D_L_-%GUI_GU@0F>&$Y;]9[@$A-PA(P&0VHH[=[ M2/<\DD4(CHB-(%[&=$3!X5\??>2&]+3F(8)9EU28;:^5 9ZEFL-Z;[7H,'ZR M\R5.12CR)=;:0I3E_8RD^.WL!9X_6M7%4F6K_2?+M?_#ZP97P-PS-^22'42"S8('>-]G!S: A6#6 MQ/YANS,VO@RCSW T\"AKB@SDSUAK^/GR_N9>N?NJ_/AY?7]]^W#Y<'-W&XOR M:$89"UUYS;(0 R^)ABCJ8\V'?IX]>'V^898D=431%7J]BY\9---7J9,2.-', MT ^]!SB6E.\HTGW[I8H,AYU@K'"Q#!>,[6#D>,$,@*<\6Z],>63,5:8^@RT" MOI[._&!FN:$2>KA9*/[,8?$#GF8.7[L@VDF4>S::^2#"HRNN?XV>+?>)*1C M8PLC_SYX]F;.&%X(S[+&,!,<][]FKE"'WNSPF3]U:6:Y\Q'[ MG,W5'L8?=CU^L_QQH'RS)["P-G-'+/B+00K:^KY M_T85B+_UG5F^PEQ\UA4*= G+QEU5Z$TX:AS*Q/-"',X2 M;5V\Q''>EX:8.9LY[>$"7&I_S$.D.3V>F,M\_ACX!@.FQ_P2 7"X$QYN3QU. M"#Z+/T"GA&ON\>E\F2XY[UBP#K]?7OZ A5BL^0(T0 +OQ0[ASI7M?E4TE.&0 M'.8OS\A+4A<9T561),7._.&^4B;+#WE0":#0-=FNF: 8%L29@C$3LG+93Y/8&"F^(3 M?_/S^]2#?[DZKS@VF#WCB =#Y='S_H0W.C.FO/"$O[:B7 +-^'-&\4QB@N(+ M0Q^651@O24'('!N4+#X!(9\64,Q7A2OQ@HPPO7.3Z1A?PZ+.'('IY2?A_SZ; M.&S$A5S A6FL%BC>%,2@6*M(TD4#^TM0B;^0%9"7IKQF$Y>]J'\QQ,L-("FJ M W6& [ Z[_ Y@S9-/U23.#Q K2L'%@N #3[90,,(Q6.\PK $B<%.P.\=C3C M@A8VCQ>\@]N= -4Q)X#MNMYK-#T<80 2;13.T'![9FBYP=N8%3"Q)-G4M)0 M]QMD)#"R4TO#AY-<4-X] P<>,+B+KX 3>$N[53ZR"$G2'$$.QXS^VL[KD/? -!]44L-N P M9UO#5^(B8.,6KMF@.@*+RQ.U P4F" 8P7HRK_&+]R>!-T?NYN+:"8/8R%2PB M6&LR 5$A-LH7(=9]KN,)[.+GF?X,V!> M1*\,^)*Z=B>(,XFOO<"]WH!$\K? M?!#M57@H2JE5U]:;VC)BY490SYO:;K2FB]41_#USK=G8%I2N;HU$4I[+86M1 MA0^D+3!S@+H(E]+*Q++]Q7VQS1$O6ZRWQR/(D.BH 0S4'L2;SF#P:\(+Q1- M8Q"T/K-1\(.\X.)4*/!G\$(P,7S&9P>S0:&FP6O* BY)0SEP4#4A9 )0P->=; MRF)GQE@6&S19-&*3ME+D/4FPN#+FGI;'A<18/"73;%2*+$9E;BS6LRB5I#80 M/>'\\#T7?AT)GBMPA9@9'A@S[3[:0=9P2:?<3X9N7V":R[''C>#%1-'6=<>H M%*1(?EQ@!['[W?)!6B%^A)S].A>?6?-5/GOP#RC=7R_O/X-E'_5(@Y$#+-QQ MO)DF3$F\_0G-)O0O<-WLE<72%SG ^J6,?-!)P[D&*A@,)+7WMF2^,2[!\2OQ MY)@I0&+C4Z(.;8GGHQQ]@N$*V2OD7>)]H*P^^=:+8,Z%K1H9FHL+@\A.&#&0 MFZ!M+JQ#>,)4''T!N4 C@%^%VS4R"!5[HHPB!PYN4+:0KO@XN" R5.;$ >.8 M<04#Q3/.;6+C<1CG^0"$T1.H[-QT15_]@OTU\RQ:/CL^CTOM!:C]<'&#$BCY MV&@,<[L[@CI<'2RMVM\L$$VP2PI1TXENXY='^_7R+6.;>\N$'+46$A0L$;!_ M\8EK[*EJ9T)5=YS#2!-\3"9#@5F@_ \+8RES_ +EUGL5P%P8]"@L-A(5G!,7 MZM@T<7*!]T:J?,('>I9I^V4!Z@Q!"S=:3T\H)81BF?"Q/GJS,,&\0>3"B5IL M!$ENFR8+GJ+\<<%6?C]3&)C=WCM#VW-1R?F,/V;,8"XPHKD_=TEZ) UB9H%< M\D'VO:)R$;U>@2UR[L 6PB7+&*U3OG3%P%T)2?O1D \\D"E$4',9'> MF[ KA!\9H!?[7>&O#_-0V'M(_+FZ<(9^]W]%JD\LD&(:H<83/H-8Q,"<0)B)+H!-#)VO\B-;87M+ MF!G"<\'E5XJ7^;'17#@@W(";V2\\#9J;(KF+DCR1$FI5C>/HMI7[V6, :Q+M M'PA^E!3))7MD(^M%'&C$M /2 ['LIX0,CMD'L#/?G'#QWI7U/KK?5HZ5LR)4 MXDB)DXA0Z>5'J,@<;)(7'8!6Z+K8 7T_5FDVK>>6$:+7 <7%02L$/3S(#/Q7 M?K!0=L]-2C7:?@NWW[EZDS"8MU)NPS1L4=+HXP>%V^- M8))GC4B<0"7&A.;X@%C^! M&3/8*IUX>L+9&0T'MQ; *_= !/B4Q$!LL6>+[U\8F&:6\F\,3[%#X3F=[[?M M OTZVN#*JLJ=Y3/PL<Y--O@>9QE<7?BMH3K(X&/ M-$Z:^B'I?PD,^-SM$]H>7Q#I._,WHV6;S PB@.,:#\U N/)7S\8S_[LOW**++ MXGTN'A@#]%OH2EJ6,<%)ZA<]_> M_!KF5\(&_@>WAT%:QW6FD_KWFNU\<]W?1YS]W#?U__ M!$Z^O;_[=O/E\N'ZB_+UYO;R]NKF\IMR_P ??+^^?5"^7#]N0UD1BI<)8E.NR[5OV>M315V*EB:P ; M;Z,^BGTU60&ZZ':!U<;7$W-,GF>;D]XD^4 0':R]D_K;7ZPDX) E3D? M.&&_Y'3+9^QG3?% :?!S(U*CB@]$>*WK@_!#V+T-]54?QW:NM7($&M(X),97E9#3(:"DQS M>XVA)LB*'!U!1M7'I1X^'1YN.Q6RGDXS:9F:SA0#0FJF3$ZQ]+(.5EHH%R5*=,=%'N\*BQ[!)F9\I_U;A#W&&4Y!QB N9!QX%_F-L4A5$$$YO!20J/%6-H9>3*Y MD7C+ 5@G5P0_K'06RJ&/J MP]._V=:C[?#@Z9QPJVY_7;@5!1E1D-'1QM50D!$%&24HP+6/*,F#HHQ.,]8'7I=0ZY9O@D;Q%D=NP1=ZX3 +$&#R$&"C)Y',E,4<&%9BZ.V! M)&$E%(FT1[E:%X9TP)!IUM8!C$*3*@'B "<8]=#4*=#_,FG_SW*=SV-9>1$\">ZSX MWKOEA.N2^$AO*- ]?PA27HOZ.%&F_*4[7L\()C""6H-#@C1-"1%3H&ENAA@\ M_%<'TM@F)Z97?L5>&Z)_%I9BAH>\\M-[TBXW%IQ?YD2\Y"<\Z^'?:PUUK4DI MH@24LO*R&E PF=AH3)C[D8E)<6+KS/7,@K-;4A7*.#8%ZK_;P8@YCN4R;U; M IA.;$BC*9!NN6\O9E7 ]%4.F+K"G ^M6E8Y)LV-OCB% ]22DV\.\Y27MNOY M16L-N_T:&*;2.D@::$ <=$H<5'[[6<]!>FO8Z1K;I[_MG(.BS6@EFE_3>3CY MX4(%5Y*'9(IB+!Q:3:XC221)=NAJ%,V?"/1P%H']&\6R%A-!/LF2S4XV MN;\ ?''6 X@DEO^Z75YU8AZ#ZZR^96HX*]$?X[B/^N- 76 M3NSH\"%J4O6>2&$Q4QDL=!Q4=@N(5.MY'/Q:Z)NM84^K(1J3S@TE!$J!K*P$ ME&YK:.K2) B=F!'PP\=V6N'[&8I);'Q[EC"<>=,\.D+<*(@7&,!ROGI^3. ? M@KR7[IA[ZCA3B-^>+;<4$!@% MNN5:8&!.K=Z< +4C$WZ4^[##W(=2'OR!@2U2I$F;)"7Q(-D/Y:""*;9F;8%5 MI"=NI">^6/Z?C'>79R++CU3&;<][OLWJ[^!8O#$H^$ C3STWTB?WJ$^6ATE755O#[D :F)R8+KDXGW&\D1"3(]3]2:'SZV*0L3G<.$%,B#2LBI[TU8$ #=P?C&/D7-R M:^?DCP15O[(U_OFN:H">H-?6]Y/429G 4LX]60$LG=:P+XTK^V1U2CX8'AOI M1_X1TBLW%9A@2(7^;!3.?*!!L55EMH;&0)JH-U(M]R@M*R*E"_LJE?T[S*K_ MX4ZL5\_G"8ZXQDC\><&+=](N2PK+;L*Z^F('4R^PG-^!*M,;=^3,D [PZ;P/ MZ=V4^=SN"A+DOXJH'\>*O*_AF!YP3)>B+1L)K,[^@%6V]U17[=?6>VH_&JWT MQ6!H@/67TSENHR5JF1J9+F5J3I$>6JHJ9*H[]YJ-=0!6>Y]2NAH)EE(%$"N M15-Y_E]3"@]4*5(4U0R,FLFOE W$%2_5&CD79]+)YLHECFHD4',8L/#<,LY( MSV*_I*[JSE[.QUYX'CTMBS?Q8/.LUS&WS[RH?44E+3Q&/$T\O8-#YG4\G69; M'?0OL[YZ9X=E6KXC_Q:B#0[_CNW783RMV]D++,UH^%?X,)[$B^4_V2X?RMQ4 ML=TQ$.I"U]LFKUHL9O_HX\,C2O#'+CUU986T547G?O3,QC.'W4VNK.#YJ^.] MW<^F4Q&7:#GH3G"\8.:SX %'_@!/^NQXHS\7BP0"B,'23>&9(2QQ:VD:N>/> M 8KY$R]L&+4]6L)UJK*OCKA.3E/!N2LX>>7&%7L+P&R9JK+-*L6M?%8?;%>! M%SGH]?FX?@("H".8!/.Q!C;W^L8\)#@!YN%8TX!=Q+]\BLURV^7OYC=]BL : M,1;B=84+^/O$UY_>[''X?#$ 55GMH7B)E-3HQ>);K0US^2W]>:\#=W4SOU+; M6N;G>8_2U';7R/XJ[U'YGYN&4=^@UK^\0+%?:_4-4I=E;,T"$/O9@OJE:G#? MPB?*=[CL.5"N@>O&7.;=LVG(7AZ9KQCJV=)6L V)$NI4A2 MRO8K^X2+>&ZT,_211RM@^ #0EZR/.QET2>I%982U[HJNMHF;L&F&=M84FV,J M:^O]SXG"BS] "&=9QYW6L&O44'91GN,)0GM3T=[;&NTF]@VN(2]+DO.5Y'NU M@>0HOGR!F82!8O,H$X:)_EP=?&$6NH9X1*TW43P1;P*ZH@-?L'6GUEM']4A' M(^I[46I?NXLQ\@TA\L-Z1_!DI*EWM2YO%-Z@J#;"?%,Q7["[E<=\KS6L8X^C M/)%-5OS6<\]'Z/6PW5<6\'T,B]I,;-=R1]P#XL/3Q8H$FWE BLU_^1A!GMY_ MQTJN8X^MI 'NM=FC].; 3_S]W)N2>; R:I&!>8 A]+=Y(^ \6;3=Q&*;MSK"$-?/7]9?9KG+63I3_W6T*BA MM!79#,08![89:F:, 3KQT#D0<<&FN]XV7*"! M[J=+4P7WV"U620:X'"_-?^P9XCRJ]I^E_LL-MUV*U1$!PTL1W>>[B-\9E)K9 M!^NCH@@62?\46>7PKM$\& Q->CL9\C/QO1=EG,@ZCX\!/3? 0\'_JK1):MV* M!\75$H%TG9?*SDO2BP*GN=NWXKBK'G!7'+?!M_BB<>/BX+FLBP&S+R)@EF' MK+(4+*M@0"B?) 8YGF$QI"D;8B4-:R5# OZ.5YDN\!/,(6!U=^/K3 M 5EQD#/?-1(W1H'CZN(6ZS'PG%F8?TM6!/LA),-@A5Z)G\_^@O^?V/FCSZP_ MSZT)C/7"43V;(22U)+G]< M6]GLGANMK1)/+MTQ_G/][YG]"N!WP[Q\$]U,Y9ML^%I>E\@>A6R<,X#TNSM' MFNN",SL322Z)"8KFW LR\ N:F_22E5)UT!P8X.NV*GB[4A*,V3;5?BWY)H.V MV=-KRX&IEDVS)@=&,WM[2LS9UA-5<*1Y5!D/RPDU*/M+)HXTD1A?V"BBA<;U M)6,3.M1T*BB)9R.;4%="'<#XB(7B3^DAS;\,KRS??P>"_!T;WE8VN+NMH7'6[CZ)=%TD='J\Z.!(56:+0+JKZN_G>M.QBRJ]THV/@ M$O62:"A("F1S:9 ,$"1U53 [-$A.P7PI%K5;B-BR2MNQ)QKB1)9*KI+HM.NRN))'0X.,:AN'!-&#%UK.AI4"TYZX M1MO(U2;?)-E1PL6T8CJG#H^7/TA<6=6J-G3N>NJKM?4+*[>@DF8X$"N>%BN6 M<&3MCQ4-X>#JUETW6D)6;)8]EG.HFQVFN$UN<_&";IKU?(Q//DF'ZO:'E)3, M=^S;EJ[6OE0=[ M]>SRLC'A29K$?)/G]O!9RBH664?^\M%XK:V<3E14U4F:Y@BR@J:P^_4G]\71 MCK&?EF82",%==2 D%B<6+]O*=[\L/N!'1IT:VD8?.8N7Z'=8L?]A1KI_5H[Z M@7*6UV8H9U707U&!E*D/F/+AW?#-%+[$$.P)$#I0IHXUBDIK!B/?>U-X107X M)/04+*CYQ,^Q,DHWY)9JJ)3TC___[R^_GY]^Z!B$\8'+,'2*KBJ]5%YL\-GY3L;A[[G MVJ,S>.ZHK7QHS3^!2Z8S/YA9\$QX\]NS/7KFY5VFEH]%=!4+'\:%@*6LQZNN M)UKQ)D<6#VP^K@?FORSM>4#0T<5XYK_!1@,B:0%B[*EMGF-'N%6@*4^.]XCV MG_?*7!R]Z_$9!#,&\[NZO8>9B3I"$^PL-^\?,H*16"#DIB#;A+#DTP4I.8/! M^O#$9W@;;')3$(>*]X;EAN$Q.%??@QF-E<=WA5E )1Y!/8Y.^N<% M_QC*L5&=(+;)FXL\!7S^<"Z9Z%H>AP6UF-Z6 0&I:G M*%$IR<:9OXMR^2X2R/?>+8$227>4XVWQO# @=M1?EL!7## M;.J)E0>^>^&WX!\%#'7&+[KR7D!XO,,TX"-[PE\/'\,"LU=$(HOHP9$ ZXR[ M,HX<&&WJ!X5]XU,LJMT6PZ 32&<]P]$C0TV5TQ$X'Z-$K) >H5N>A M]4L9/8.*R5#([+@!(']B^6(V1=L+(O0J8J$%]92(:,&.)[-VZ$C,[Y8/ AAW MT+E872BV( K@#RZS7V"O&-DP12$7[*C,(X 2K(NGY^@YY7 M'IEBO7B@'/Q'W,,$)I(=7%&DEI2H0/-[F#1LGV6.-^5@34]045*&2ATV M[J#?.RXCMU.3DVN;] M>7W_\/,/,'E_WMS^OF]3-@^<.$XY_4I@X2S*=F&YKCPY[B9=R*]N*+3ZP8O^$ MD8W0).#N1"Y";:#62#3\FH*D^04/QSU/R243>YDZWCMC!;122[+0E1?P70Y] M@0!Q6,N[R8^H%&IP[=@OMHN7S>FF+NB&.>'=]!:GQ",$1?Z2FU!SF B*QF5@ ME_#REP#(\@(;"9)B05;OT8EVE0TJ^NIE\G?7DP1__QF/2ZL*+5-%,ZG=+;)D M?8&?4;3C@"X5S!Z#$*Q&4+8 #%S+1#1%;@D7)JEH>E1G5P;G:_>X]B6SIGT) MMAVPW2WG=S K MQP:U\,JW^2F6XPOZR0^5Q%L#< M ]R6PF=52DO*+P-V_XL MT^T9QH@FHAV&L6"_%R2A-X(E.XUDB^M9F\L MZ&3#Z#*L$"$X?PO6@T,0%@=(E$U1YCR\5!X%@SD='?]RQ/5G!7,">A$/SPQ_ (%CI/83M$YW2,S05SY2_67#E MHM(S/N$?GN^,$=W-7;BDLP@H'AVZW$%N< M?G!&?F)X*B*0"%\(J2:$2U[_AN@86FPTS]88!@E/Q=%S<1&YCG'T^- UZ 8M M%.72%!A&G'R@00*7AN]X?)"$>=Y0>.%\>#4+8U?6G'@X@V5BQ80<15OD)!Y? MW&!@<<2.,AUD*S#-$Z@:P;,]"<7RH2C]X/G"L_9LO;*/<.6+]2_XB$TF..WH ME$+, W@Q.=I%XV \$&'!S,$#CN2*6:[EO/\G.F3X-Y[RV:$EMCBX&3YPXK\G MH+!Z?K XQ2BF]UD4:1#1RH;] XP=3A'4Z*,'1$/Y__^_OJ[U/L$$4..'V>)Q M3=3D@Z.91W.*4D5"DJR@#7YX8%E64(%/L56$IAYGKXA\A5//5#B-U@$[]6PK MV&!7!'LYF(V>A:!<;,<)?IZ_) YE1NZ.]^8U7,G%B'B5SR:.T+"L('>4*0T3 MY3E&>''/!HX"W1U)21/@[L\5 B%LHNZ\.,Q$^]V4?V3=F'&'7-Z8+>L\;[".L *BH5-%C\YRB8[^6GM\O3E^E8S.*.?8&2S,=1U]VWE% M,Q^%7R<^'[.1J1__%6DKH#/,?%Z #QV"N$F.HBZ= E(BH$ P-GX+^+64)SQA MJ>S_,M3UU!*=H;YY0?#5]UZRG1:W++R;/%B_*E/(6%)^X+2.B0#3 M6!6W0\&@_UDXA0W++RF>U^Y+I0P-(4>['> MT>Z.U!-8*8NK,8O ,+2CQ(SP%2$;/;N KZ?W,^5Y!A#"+<*;^2-TN B+C0>@ MS/BY"6X@3S.P9SP?/IU@Z3,_,/7^(T[]9N[$>O5\[EKD@9*P!$ !D#M]040^7_![\5<*? M,^=J_!19SHE<*N.8YW%)YKZ,,^5Q)L*)\5!4:/YG/#K7MU]B31^&\.*-F;,R M])CYA?MK'D65, _$^R(@FX" T1IX#A)3H:M61PRXRG"%U'X":;F,,X\ MXLA:1JNA'YNX1CU),(SM$;.D%"9<2OQD''@@9,Q:G:K >>,H03VD*DO'9XE+< M>N+9+!%2EDV1^( $_6F/[-ER)OAV&!./T8VM/_BHU-ZF;BB1,/#]J^=?Q=_$ M&UR9':V[9D=KM!)4/K2 .UDL%+K,?N6[$7+64K1%1;M*7Q]7<"GV\.#G_(U@ M157>6GJMH=XIC!W@2@L -A&PQ@5;6A LN"DOHM5>6#IST5'=Z,R)0J]QE[X4 M@:85+/<$6?L5BU$8.5'DLLQGT!KV,E!2 )NDS'T&7'"A6:9W<\*ID<"-9,;I M'5H.PY?06GX@P\LX=)2 M XWEN@+/58OJA-I3F2GLMFKVWJ9BW]C?OM[J#:DW;? M /5$^9,R+9J/8K%+]G:OI>%UDXBV42/X$Z + M@6EK,)U"9]=,TW>-21%7PK,?G" E^'FW4M'LP-@HQ^LE?F M9E:6[V(-FUZOML:[5613R7ILN%P';K1%#-9(!BLH>%$/@^FPS1F]W7>R(P8C M!I.-P0HJ']7#8$9KV%/[==<3)@8[--2(P8H9K*"64#T,U@$&TWNYP67R,-@> M^@K)9$AB40@>;95E3,[G3XW1Z[2DD.;!W>1WSQL']YXSSN(7LS7LFMOO1Y(T M3RJD\1Y(OQ@Z\%9JYFL0CV0=&T M[3?O8W!,$/[VK#P6XZ^G8O7?7FU=@PE_QX^_^A3.$OC36L-.)S_YGO!W>OBK M3T1/D M<.;KJOL#5:0W-&I17 M I>4X*HEFW5S<&&]C*ZQ?=0;H4M*=.6HF?M"%[;=Z?6ED5TU^4:/1;W\R0+& M.V>),JWS_CC;J909-&DDZ]2B4L9+ $SS9;$ :S@&CZ:TVD*X#MWWF3"U TVR M,J;PA*J^N%O"E%R8JD6!K(RI06O8UVKS:!*FY,)4+6IC54SU58ZIO!Z-^\94 M@;(8%Z& @;)\")[B542XW1"N>=YOWE 6I=$(XVS(P;UK:X27X;KU7)]AZU2X M2M0=6B.2-2Z298EM(N^0A.9($:B2Y?,F]B\V/O\/\[TLL.E8?*.O:_HGPELC M\5:+J5)=B!F\O@))L8:BJA9CI3XIUI%-BI$^OB]]_ A#J1_;1'D-5^F18N@+-EC\L[I:0_*Q]I"O([-5=F522:3K*M(8E!$BM@29[2XV3O:42 MW4X?&<@&)OJ"\@;*V&XSZCX86K^VRQ3809;W$7%:<:&5-&,MG M?8=4R+_G" M^P7^>+8"=C>+&FY_YJLH;GZP?E46^ 87^&IW]WZ+)KG/3@+%Q6<)NT-Q&JB8 M$:O)7,Z%4"I3?)&,LM84RK4AOK@/G7$\F;!3>33;DPRS&ZX&2,QAL7[2)/#!2 FT3C7HW0,/T M8*I=U%"8;:(2[P9F R'/J!M ,X&VB=:Z"Z#U5!7D60U=D,C%7*F1IUWL9J[! MB2RF>6' 0HR]V:/#1!C4"<>V[=&_#,M\-ZGN[.BI&G#D64_MU5T!=RLT'(\? MA$!_0'?T O1I7&-=W7[='CP"]8F">H_>ZXTEN<$EN=&IN\DD@?Y$0;]'9_2"F8/Q M26>*PYZPS'IH_1*UUCT>GHV=A%B GG3+4:SQJQUX_KL"@WJU1S!:*PB\D"<3+_0&NM:2N$3?Q\ M]N/13*TG=O[H,^O/2,SIQ7;/5VB8-WV T1-<'1&N#U=& MGR#W]M<$1&JNM*G TXNL(-8-!N\=I$_MYHA=' MF&H#IGY+?]XSVGHG^RNUK65^GO88LTU#/.;+JJ=RK,,E-?/E)B?&&C MB!;:G!;&$BV.VM<[*-=JVPI$/?$1_L+^/;-?01-RT]7[=AOC(QM9_FMWTS^0 MM5=NWM6,O5Y]C5D!?9?N&/^Y7F PR[(S:SG=/I(@.V(Z8KI5INL?@.DP:/!( M K2E3^2O*:A19D:^'(U@ MQ_,V* *[##>$X\-S+15+3<47,:X,F]L\9K<>N% M+ !N_^;!''[.UR652+JN&")8Q;(50SSAL!^Y-YU"6%JUR(CSG*$<$TX2^%)4UM# ML[:$($ER?F06NC?N*ZR$Y]ND ^]'!XX)_KZ&"33,BVMKDJ@>I-9*JM:6@9+> M&NK=#A5%V1\:?OAL:MGCQC5"E5:+C0@>%0BJKL-J!NFPC499+3IL#LK2:,)P MO_ZQ=!IL@@HK_ 8CL2)1X!#ILOO093GE(U:XY'2O(G9-\M\V&F?U*;I9.$OC M"0\&:T@>D$O3%;@8R"V!'[S0< M=*W;D^#_NTF5V()\9:V'[?MJ4];J3KZ(%NW \3O$90WDLH+-N5XNPY-4K;?] M6>K.V8P"=@ZO3/SP45,(W\\4F+D;BEPJ# :>OC#\<\M^%@GPK.;.-5TAK\_P MB]?H!Z[0I3N^CI?GUG-'^7( .UG4=JQ10)')XN&L0ZS J9PBIQ[D_-9P&*SDHY3=AT4%"_"-UR#GSB8N\D? >,J M89*92GOZ=(T.6!J-NWJ"A,KB+HTOO36LH9@IG;B41+_I*$52-;DO 609PG MHH?4',2Y4#ZJ2UQ* 6TVU&J.XTQ#+04I@S>G3[<&/VIE]X@B.8'FY_5'EU3J034!L1FRVDUHY)=A,QWA. M;1>17+NH6=]L@VE>WVQJO6-QC2V":2L'G\E&BVWBOM=.OD&2HOYJ;C\$\*HG M7ANU)UY+$!-:3P8&L>()L&+]!>Y663'-ADOP;4'W-;QC N]LSSITK"0CI&J5Q>4AQ8M9ZU2>Z7 Y!MN* MW!,Y!-A!:D$6AY2W'>H[YZ=3)QD!MX.<@G(BN8]-/1H6:'5$9T_QN5.YKF]T M^$1>\8WMA(0\J*G2@3&HTT2@\RGHF-9,YU4R@.8/ M=P2#L6P7DZ$46'<[TP:G8X6:9?R<[@_6KQ\QU3>3[_5%7- QEHQXJT52%^(M MC:M.:]AI&Y)@BNR%P\/VKI9XAA,YZ]A9,E="RZJR2U 1@V;C;6<974MX2^,* MHQV,1IZM]=H],T,@\[]M=PRDN8"9XR42@2:=[+730S2J&.UY3[M(Q8G%C_,2>%Z\Q1C>LRZ\]7VSL=<8?DMQ A_^'=L MOP[_"C_BX29U#5U'72."P_"OCS[>'4VR]'VUP4A3"W'4 QQ=6<&S,G&\MT"Q MPM"W'V=\JDKH*:!E*E?>"PSJ_2]!GEJB6#[#:DV $EZV:>4NN(6OA14RE(<:SRC^1C:BG(/Y+-W'B^IKE[/F &\^J!CA JJP MP(XU#=A%_,NGV&%ANWR9^$V?7BS_R79CV&?HLGPTXNM/;_8X?+X8#-I]TT 9 M$>G9T8O%MUH;Q,=OZ<][>KL[T#._4MM:YN=YC]*T=M?H57I4_N>F4>.@!FL? M56";2.$(2K%U+W-[R):Q\TD-RDQJ! !G_GZFU2\UJUOX1/D.EST'RC4PX)@S MW#V;@C!Y9+YBJ&=+4SZ=!4UHF'D[8<9F*/=JZZK>J6O"F4ZIAA+-J,(#U5HB MZFT]R^-R&$;)*R$Y]4'5Y;L]UQ:L%P]&]Q_^04U!,^LQD?C_M+W M+?>)Q?W V[_* MFV^'3/$FDZ:$H\@K@^=$_P?2_(OWYF8QA@&,T9,F)."$XTSD%;GE@-3AL25U MZ<&DZE:#Q94UM3&8A/T"+7=LAS._.16,Y!6Q$=6O$T3/8@V3J[6R-/,BM59" M&5L22=B%2-M^MZY3C5T^#\>!1;/C\\KZI(8S\VBY.KH(^XM382Y\YL!+7EET M_!DM9^+&Z/!47=QB/0:>,POS;TGY^/>/2AW'I.G+Y$C^Q.$B1FS3&/158S(8 M=R;]SF1@6CW5U'2MHYNZ,38M]9_H0HUN>O87IU]/[/S19]:?Y]8$9GAA.6_6 M>X!KG"#$B^V>KQ ^CV;+1]5X7!%]@HZM_MI53JUUA-)SW',O]-YT.:KS'#_9 M_T$<7Y%N6_!=WL](CMS.7N#YHU7!L1IY<\-#&7@DQ(W[A3UB$_7OEO\GXPR& M[=3#]WLVFOD\R &^O(J21'P+Z2/J1J-P<;P Y,<#O.JSXXW^7$B/GA!>7/)< MAM%G.! &DF:*4/=G#*RUV[]?WS]\O[Y]N(\%332%?(8LOTA9:[XB(A8#QL%E M#%G/X- ]1=#P)UZ@K+9')2""ZZ@L5JU<((G*]!M0=$5P98^JNPD"UF28\]"]%$,.)HC.0.YN16K)#']3"7A_@P:_2L MP(YK>V/EC?G8XS,*^0G*!OPDQ)B8]-[C>3J:636>1S?:6K=32^A,K]W3C=K" M>4P:$XV)QG2\8S*ROSF]*#I=.\XPNJ6 .:5DF-5ZEX"V&DH5;7!''DWUA8TB M0FF<4)5"JZ1 >IEYBI&-V<@3?HF+&2AY/E[5&OXW<\:@^9R_6"'J5^\G%8$8 M18.PL7+E!?D=X2D6,9M\O_M@=R@+4T1!6R3?0TUD+$E&-.?6>/J)CMET_&K9 MOO)WRYFEVC55W>Z:2!V2=23K)"1C@:SK-I &.7+JJ.O7E#R$^VRY?RHA/%$9 M,WY84[[L02TAT=(19)N.7@7S;])Q[&!]?C,:,0_>]\B$67CFLTY;!ZVA65\; M;-FS#8B=B)UJ8Z?+T6CV,G,PUQMW\)'WY.(>_M^>@V1"A:A")9"NNL.JN,2+ MAX+A>!&UZBJ\N,L*U<2+AX(N>1$-.F[/9;&63OHF\=5I\U5'KCS(J??L.NJH95Q'0Z"H"&EW5G*L(:'05 8VN:LY5!#2ZBH!&5S7GJ@AH M\=?S<@(BG;^DP[%,<:02]^?WP\[S6-+H:'0T.AI=3:,[ZDR2;1.:+U\MV\%2 M+.<3SS\/+*=,-N!FQ4CI?KJ?[M_O_375@)7Z1'>+++FR]3FEFW/E%J!-/:@N M"D*>[V]?/?\>=C(*XFSO#')^[,5V$$KX]RZQ^N#RU(XOP9EBOB!^"&; M'Q9Q5CSU?+ENXF<&.B)[L'Y5";;JU]W!FOB'^.?X^ =C%#?BGP'Q#_%/<_EG MP3O+G)3!"CV5]##B@R/A@Z( VNIV2>DMHU=?>C*Q"K&*[*Q2N\G2TXE_B'^( M?S8U67H&\0_Q3W/Y)]]D*<\B]:4#U\0B1WT(7K9!H/?RPOR1;3G*U)HRG_JO MKF$*;>?G*CWL":CI[8$D_3+K/*LE!&V+H/K5^F[=:=\$N), W,9Z<(\ 1X#; MT-?=I[VQRQXKE MCA7KB;FC]T3WXXU*KCI^EW:]C3VST"$ &H1@6I3PK2,8&JHH*T(U05*DB#UE!O]TE!DA]0.\53 M!05IH,+VIK952201%5BCJV2HY->(<,K+(&#A.4Z%C;=UN9[*R86YXBLK3CA!7J#SA MJ=)6GEH"5!,D6!7EJ2^.L@U)1-$I5*Z]\OPIUN3&RK6/(84MEN.!WN[UP$%K M:*HZA2T2@FH\E>^K*IW*'Q.H*NIZ.T)5@:[75[76L)-QPDJG\M(!:J=X*J_K M]54=(#/H;Z_K$7*D1$Y_UQI27S5:PZ[9W[Z9.R&H@0BJVU/65Z6KET6 JUE[ MVA'B"K4G=/EW,^*O27V2#E$[!505]:D+FU]'R_"O2AG5V(A@L^^PV"-[:CD4 M:58._COOB]17>]GAX'1T1?BI7P.LKX\0 4Y.#7 _G7?2R!ID>V7IK%0Z0.T4 M3Q440$W%G6_KG$W"C8RX,6OOW)+&CT::$^%G3YJ31B'Z1P>X:IK3KA!7I#EI M!FI.VQ1,(4 U08)5T9PZN//)$J%?9PV]7KN7541/)A \>*'E5'5./GK^F/GG M8N 7!LQV[,U@[95XO-$%H3>]0%H$GF./^9>GT!.G+NHT1WKLO*A@7S-;PX&J M;E\;O=XU/-"9#_$O\:\\_+MQ;*36S=8EB:6)I8FEM[00#U-0LZ_U6L-NQC9= M.;2"V)G8N=GLO$-NKF*=]UO#_J!#VS#Q+?%M[7R[\V*R?6T EK'>K2W%B/B7 M^)?XMQ[^W=@RUFO-&B26)I9N-DM7LHP/4TFYKV, 2"\C>XI,8^)GXN=];=$5 M3&-=1].X7UNCA@/R+3_U_BU$.L"_8_MU&,_I=O8":S2*21[]N1H>L$K5&_>5 M!2'V8 NN'"L([(G-QI_?K^ NI-',U,L0*\_9Y- M0_;RR'P!.$,]4W15[YPI;\QG>,W$XMK7M\NGRFSXMKTA&;T"^(N+K3V_V.'Q&=FZK@J6CF(OHS='7 M;?CJM_3G9J>M:MW,KT MSOP\[U&#MMG3*STI_W/3R'X'C6EW8^JO?5)!-,_: MJ*]!ZK(,C6$$K,O\_6R._15IT\O<&_^;.6/@Y_-8P.9FQ#6;#/-]_1Q4[G/< MV9<(41(8KS@L2)4SV#H-0;JYE_=P94VQ.6ZJ@@@.U.IA(I%. MO^RDBC1]^.L6GP,8E'B$<:P2/KCSRJ[29Y84=Z%WM8:TUJFT+\0ORR";^L MW56P*8QK[0XAC!"VC51+ TL#];,&[;,F8!5HGW'0$0R4Y>/P%*\BPNV& M<+6?+O'PNT-(I!LW"/V9"#1TO5 9HQ$4*I82P#0<-H\L5,96.#]8K76@78S M+!SIIZD7V"B"+GSF6"'(KT]XO'ENM#/B"1^M@.$#6D/E@_5Q.<:1"H#O1GO^ MAQT^>[/PGL,F&<1[R\(KR_??X0M0:F9N%;O-H'J$A+R-D;>)W688A+@31EQ9 MK3H7> M"WM%R"MGX!;R9#VQ<\0+&_/2'%80L##^8%&%H[URL+12%^4H2Y)<+M43@4G" MK^_*V)Y,F*],?.]%"7G1DE3I$;P4SPY#3P&8.YBG-O79U'K'HT6%,\$JP2H5 MCEG9Z5?$QW(UK1_14>%8#T?L(28R"?8ZHH#OP-WR\7FL$R,!C@Z@5LJ>!,^&R%HE*,[<(M MJ\]1XJ/8]<5F^,N^L%'R*XU_99PIUM.3SYZP&AJ6LEF\', 3LB?/?^=W(]8< MYCZ%S_B>$,@GQ@;TMU_M\6RIP[/R;+TRY9$QEP\[7EEO%JR,>BFG-+\"SM)* M=WC'GFBIAW]]]%%TY]QXX-(Y@T&[;QI5*^<8>EOO5ZOCDO>H?EOO5:OCDO^& MGFI(-Z;!H)X*0TT?4]/7KK.S"D-&^?H-1Y7-/]\IE'B3V*140T$UHN84/_C& M KX9NXJF*R)G:*=50YI(PSGE4"/]'?08&!\1L2(1T\T MY)N#:10I#ED96'!*=^XK5)[A:GBZJARTZD>B&V-K^,BVN' =72D(A&V4Y11*D;# MKJ(%;=A5IU!1[H_V?5MY\F!(+G>W\N.-)^:.WA.>U*JQHB=[ %QY_LTYW]4Z ME>(G5P]LKN;.^>RC&W1]/#Q;KJ8+Z[U"!D='JSN#0XH(CBT*$!%_$G_NF#\3 M[8U$X'-Y=JT]Q:^Q['K2O$J,NA&CQ@QZYW_SW"?F9W&@T1H:G;:Z:_8CWB/> MV_VL*[7TVS/SI7;)-"]V6D,M([2Q?*^_1G/AJ3/BD?'B'EDQFP&S.,SXVMA4[DLBE$[A5/@[ &!D3Y?*9-&1\!J6&,AJ)5,W44*>#%9R5R4@ M$A!W:25WM=90;_<(74>"KHI*YU[A5:R.=G6*BCD2H.T19Z5MY*Y!PNJ8,+1/ M8;6IA=SM2"*2MCU,WB -A9I,[(% WW9^)WXG?3XO?I6'W,@ZH'MAT [/N#'%BT=BG]'_0LM/L5D?\%HU3HZ[TGX*>YK>.$S()[]RJ(^@)&(3MP8 MS5==W&(]PM1F8?XMJ;8+!^IVJ1DKS583/Y_]>#13WK@5P/7GN36!P5Y8SIOU M'B#1D_T9;?=\A89YTR]JW+JF(>2\QVER'2,D]\S>N9[J/8J?&JV\>T1G4CE[ MD2KQU/?;Z1+6JZV*-:O:ZM*HK36A6:VAX+IVB=6:'.YC3(-!;2U!&SVF9J]= M1UO_[NB@>&5_,D3OVVV:*]%E4EY&K4W3VG/UQ39],UU*+.IM395 HB M4F?3(@I16T!J/DDHDYATA#)"F1PHH\K9#;N*%K1A5YU"?3AJ<;J[4]"C/^2L MEO_3D;0<0(]:G!)_$G_NES\W+YK0HQ:GQ*[$KKMEUQ*1_3VC->SV,E)WB F) M"8^7"2LFM>^5"TL$]76PA$)]LUCA6V^?. MMW'0>O<8]C?R]#?LJE,H;TM-3ZOK&]T#E\SI855Q-:,)-)5,DQ->%??8O>*K MQ.[;Q\Y#[YD$F35W61]GONZ3=\$ EKS!%EI M!U!? W'5UZGOZ=&@:)_B:E/?1E]O#7LR:%>G$-=&?4\W$:_] ]N[?:P07E\Q M.0F_V\011U=H&";(CP9=,@FP#>[<+ M!DLWHXX;23+ID+9'H)4W>'L@K_0NR:NC0=$^Y=7&!F^?2Z6TTY?:EU+[TH.+ M5E.5-%^I3^U+"7DR9.(,J'TI 7&G=O* MR_=NOPTH4M*K7._\"K61P>\?6DZ MF(I.A:4#VAYQ5MI('A@DK(X)0_L45IN:R(..)"+I.-J7GE"ZR=;4D9LYJ_#F MG@N+I)D4&Y>:VT=AU[O +$7.?,'-7VGD/6Y8DS>QXE';8MBG$YL3FQ\#F MTG!Y&4]3KS7L=XSM,Q"(NXF[3X*[Y=G$-_#T]7D<:0WQ,,3GQ.?-YO.]L7EY M1^L ]NI>?_OT&^)AXN&3X.'][=4;.KH'J@H[;)?X3'P%NTC/EN9V*[ECFS+0:2/.2)Y(7.76? 2&(P_F?,NFGNY7IA\J/)F MPX.>K5>6^50@Y02?X+,15F_G@\6EL>"Y(>\Y,?*"L*W@$LX6C2@,;?/(*Q/3&^SCA)'Q9>P<2ZX(R/>)ED8JX6)_,]FX:\ MRYO8M0V5MWKKG"U-<@R\B8_A]!MGS=3&-^%3X2UO\&2\.H=V5L@O0KH](F7^ M/;-A=#D/S2)@F$4L_O8S 6*\XRS[,L6"AXTBJ.);8UP#@DMQNK:^1>Z!Y -_ MXH4=PEQ'2Q(CU?F$2XR;9X-R#8)R*2YU[LV4:L8A&")NE1M>K)]:K&_?]Z)F-9PZ[FR06X<:]=,>7 MXU>0CRQX\"XG$]NQD7LSKW[ K>T!WO'9\49_+C9O+=5^&3[#$3#8Z*=(?G_& M^-P#MC0]*V(PV)''.-=T[VZQGME=G*.79+Q:/P#@L]<;71)BCTG0,9[6(0 8 MR_8E4.&^R-P ?GNT',2"$CPS%D:2%5<)H#KQ',=["R[F3);2;=:UZ8Z7)=T0 M'#4QP9!'T?&ZI[<[1K^6;L":UNYJ@UI:%*OMOEY/&VX M +EJ2H_D_K1>NV=*PS(YM8$LWW]'EP]W,"4,LV(FVCI,6CIBE/>H9TU1;JA7 M\8H;Z[WB0LQ^YP!)&'I9GFXP@@Q]^U1Z>?($"/1-!7W!45 %T!L >D.:Y)@3 M4OQ*)/N?@ 9#"A\I?%44OA?+_Y,);R0KS4?-3).K74E:! ]\?;VUKV:^#YO& MI3N^]=R1^"-K ^E@<=2.)/L')5?N7U M2]WCK=^U0ZG[#QOT]1G<;(UAW%^B0!P>PV79_M]Q02Y?@(J98ABSG]1.;:&7 M$L1/$I V%<1; 0GS;7K;&X14 *ZT0?C@A993,KBDZO:W>=#EZG%20QU$-1*H M.?*F8.-:#E-:1";-'@-[;%L^AA\'@3?BGX(J^#?/=L._P^4SGV4ZH;#>9*=3 MFQ>JOC65U'%+7$U<7;L643M78^\P7:NM">)AN;IL"L'Q!KV^6'_"@[-#71W[ MQ48U!"#Q:/,0^Q&_BR<-\/!M?CU>R@/*)S:/77QY03QB@L K<[PI/FZNR2@? M6E=?KH,6!N3#H?6K??'Z[@VJGO/?G62UOA M\?'X8?P1_OMJC^'!$X8Y!XX2POVVBW$O]JM(;A"C]'S^!\XWE1!A!R&@.4B, M'H>*L9;P^![1FPY(N2T[+Y6N T/"67RT6(_F ^$LUZ M8G.N/M?G;*VIK:&1-C/_5QR&OUC_!6U%&@ 0"4CN*ABU7Q B;<['S-[R3K,6 MO\* ;6^\Y&8"AAA=C&?^&\B$@+F+T6NM8< P"^6=67ZP&M;,TRX"MA;O&'3[ M"N*0NT/FF14)6/_]!F$=K>4\7R+.JQG/\QWL8)XZ,O5AK7S,#7'9Q 81NTAK MP*?!YR-KAB':*/28N$]DF.#-WAL0%'-W;)^-Q -Q55ZCI!Y\W8L'8PQ I,'2 MC"PW=-X1OE9T]1S24^9S(F*@YH5Q>LQR*0OZ_QM(DDE8#+E"3QWL#<5WQA[,]Q MQA^QR,8*!->]/=NC9^4-1)3'E\Q[: AC5@OT 2V+"."># M!1-X'@ $%O6VP#>8-V*0?8#X5P *C/B9.>,$>[T)YT7AA!81\#Z;>C[BQ@IY M[I0"5\\"CF_;QQ>>82X;0/5,F3KP!\1UB\5_X^ M&"5P0B*3BJL8F+SDPR(+T1=PO/+<-,0/:@_XB@!$B&/Y22D8IZ6!8(L2TE:$ MQ#SC H WF[Y9/OPV_M=L2QHNW MIO-'X]!/L8P R#=7O@E_B495<>K?$":E$",*A(:<@%E9>@?I=W)N:NYH/. M7X1.:SC(B.::+T(A486$2= G Z,R4"@'I&5H9+:&YCK>C%))%Z)4Z,)K8+B2 M,MGL-.NV8-E'GY9<#E8!XR)U.82_"ZX%8S@ />F*%GUR;)=OG=%6:M\ MJPI@03D$K3C=_QPVHW/\>%E%P/Q@GH +>RZHKDX[O3+EDEVKK%-$JXXNSCVG M4=&!"Y\)7"[2O?[7SY=0\3-I()/ZM3VI.K77D7SE'W^&%WHL= MBA%JSO&3_1^O\!7IM<5>F/>S6K+NWR/+[R;2DWEF]/L7.Q@!7\[\C"1!&+A<6^5/4BKO60U)?07]/@W M;P8VS2,K8=L+)6-^0[+VP8H]+:ZVL5H$3U#/,_V3QEK"#1"]DL_ZG;\4__0> M062*Y86GH)3U'^>U)GS4$AEJ/F+L8;3K))XCG L6SF[IQ?"P:,C+)LY? KCZ ME_TR>^%O 1-SRMD&;\AWJIPA$3T_?NK<+H4Y>5-A@^'H1YQVB^'Q.V'Q8F\. M:C)+:(B<<&O?+$QF46Z$9;A'SS*&<#;W&(*9Y\%ZN^@Y/&ZW1<5Z$E?)TVOT M(1WUY-=*G1M7^_1DR-F:H+AM;$230QGVQ_N7Q$C!S%$5HL]$+\\+&W'<0 MLM&S"T-_BIV.[\ITY@>SB*TLP!6;,!\?&82PT>"WH'\#.UA/H&4*AP5*/FU-)7"R+B)#'05@@>R(S(_:^)L370HR,5@#&:\Q48!;;8)1]*EMW4 MPS*5_8P.U$M>C7I'\VU!C:PA8>7,K)Z-\8C.$ -82@GDN8/U?M;["_BNA%9# MQ4D4'#+FDW2 =<;TFDE:,)KU)-7QI$-;8QYGDS3.6H\HJG&*&A'&(W0O]G]E MA%6U7(?OH+,@KGH4ADYR:/'C -?CCAT0%RS>+".. M:==OWDF\^ZR4+VKV_A/+8E0*A6D-#^^%F. M-?HS7\5 M>2 \:DMJX])6CNHK^V4'_+ "5LKG2OY\ ^?KO= DQK#1CUBL1;25/^ 9?EQC M*/]]"RUB28_!C[ET[OX!J\+?G)#!'7TX+NP M'[X!18 *5Q: #923Y20#=_9R/O;"\^B16<(=;-A.5EU+(;;G$AX *RR BO/I MKM]Y;M$@6$SJ=S_5X;/$%'28@EXT!>[M%^4;136Q@C)_PI)=Z'X5Y]W+7<>O MHMBC^[28=E3?C$NAP%?-5;I VHOPD M%I:$C[7!,OBGEEU9]RAHW7V';H8?UKNHW^9="L7[\SQ I#(E.KS941$I^-FZ M&^O^*QI_GN#@D(C-AVNMV;GJ6#ENFE#-MH'YS$&YSS&(&>[^H C;(EH M(L;F@3L\BH&EO#B),#/@I$?/][TWD&G!9KO>(%=:II+K_GY[$^U\]V)D/^8# MP\VDLK@P8?,H%!=MY3*$20(U, .;$VY*(2 M9PA_$OX2Y#8 MC-(Q;A+SBG0U;C]RG"#B-]"H*^X#=UPKF&O6"PI4!9&!+1#4W-3:^CE@YQ," MVU40\XK,W"#1SJ'\2)SH<(]:K+L&RYM#=+2:/!:.4BV$OFDM M3%?0;'?*3Y'V>3E_W<]H4)7AAX76"@W5:D(8F>_P%*F/0XW6L)N;#YFTY<.% M99[#DL=][%QD:GZWP"S,.G:=NRNGP$)Y/M&-K+:NGHN27 #$(9@58= I8Z2A M/V^TU&IE253GN!/VO59+Z,2@D;N6P'NQR'+. M,=8;-6GJH45?E#11<60%)Q)UF%M&'X>]F;65C8'UVWX[US%-WNB:O-%G<[JF M0M\PU$=>&DMG^XJ#IK_-G/>,E)PXI%$<\58YG9FO3R(E3<%@Y,RCKJ^8_.9Q MYA"LS1DR ,,-Y;VB]3/B1"KKA(F&6 ?0"!>[03(PXL7*C-Y<3CY/II.7R7I? MZ1R&$1;%-.ZN*.3UILB4RR\8]+16QB+*&\3?KS6(/U;[@/L>;9=3?5T$OS%( M1_ ;@W0$_^<_[F]NK^_OE:N[[Y]O;B\?;NYN[P\;K"^&F3%X_> A_-D+?>V" MBN%[KOWK#,3EJ,'&ZYVK7,Z>9D&H8+1!>DM8! Y'+1 7,1G>0B^';1JD$%=[ M_Q][[]Z<.++LBWZ5"LZ>O=P1-@,23_>Z1'C<[AFOTVWW;7MFQ_UKAXP*H]5" M8O2PV^O3W\RJT@,02#(""E$[SIG5YB&JLO*7F97/9=*1LT;R$HMK)G^B[C:B M1A5\R!U0P)K-0?>+85\4; */725AJ\8SC4IRI]3P JS$MC%O?P[LQFKR>7HC MKIF7;+&D"Y27-@U8&!7S@;&@&[0:_3F/M%:2T.L#B,9!B%F-_">PJGL"9HD; MQ8L=(#Q:3@"Y, "4P\8-IB1-$YMVL.>Q(9A@"<]H )^G)J-,M$CBAQ.P)>-* M[X6MK&2B[:1V\21KXKKK:^)D+F];+U.U3)FJ'URFKM"_K0%1OJ6+9](018-_ M]>H;%0C8[\I[ZJW) (MT[P8?C,B"6[E6=EJ-42_+UT)F>5E-:9DHFE^ 6)I: MV 4(C6G[;6G,I217&'9N$EP3V3H(GM"SN(,8:"/QICXVH-3AI?%X $ESCO,X MS >+C?-5ES-Z%NNP4KJI=-^'/)[+L/<> CJ_2J# O1]14>>M(W@S*;)O9_$E MQM$V\67$2G->,]4LHV@.H--C: >C\] M-O>&ZH!5N5J!\@LYPQ&AB<>')5REI S+SEJJ,6+VRG;WY;7U2TO43N3"2@LB M UB5SA=D)M9JC5%B,"<)RS2[XE_#7WI LXQ=.J]=DZ7$LR\]NG.P5P:M[CEI M1,0G*>K[S09[BH7"\\X*H"XF-Q<@K(*2] V80+.F9 M^4Y3I55 BN57HR?POACAG/N& -)P4G@3=K"$"ZC'>-),M^)I+C6Q$4)"K'?S M.4=%F0O"(RYW864)B(;D !9_+'7[GF$/GSEK$C1F%3%LP#VOZXW$5_(KT2_D M+"\U:/ZT7O-S<,[&MQ/K@U_ M*B!B9B&B"Y;&<)"1EKAL>XD6=-CJ:4+&\-0E.I0W-M=LLL %I]#.>G#9Z0PW M%<*>H5:/=A/K[U]C-,3KN)]\\\ XX(OXGEY# MUDZ'C5$W*Y,PVNER==6&%)TM\K;Z.:G$V<('-XA]TM+B(*H(?\O8;!?S0#=Y M(5@;!SQ##&_S'KCP%G8M8+RP-YX[T66"&N#\N>4Z8HHE@L*ZF:,W:X MOF&]D+FY!)B)9?:UZWV[>G@@3ZP=*Z\Q%5D.W8R6DK'M(P%5RR44=-O9)%_, M(AG'O[HDVY/ 742YK/M+)(A2CXF/+3HO<<B2A$P='GX2#=:7\"X[ V/1DQ?-;L(^Y/*+Z$U\QWV#I[3TJ0 M?XFWC.<E:QO.$JQ[JN2.F49KS_P%TC_Y'@O[6]9'&NT'[ON/C/ KQTQUK('W MX"?,1XS6KN8L8.N;Y1!5M[.:LR";?(VOK1/7MEEI+1'QZ'"& >3_4#_C'K$H MH8+D+AD;V@NMT(7/=,GQN=QRRN $QI*6")S^A\O*G06IH.32=,@X:"LH$ 6" MV9@3=*D;1O_X:%H^J):W2\MA%&5?^K@8!,4?6!IQPGZ/OYU$4ILM'DT5 MD]?$+XNWF_#6KZNOX]2XCI;Y5JO9+OGZ0--+?6/=HOK-07M0R9K:S7:[O_$; M]1I>OFX^:)X]4/5X[S+4J]LTJZPMUF<>U3:>M'6I MUN8]3KMM;FH!_;'-1Z MS;_,YIF'@CZP=TD6->E;'F]AM[?&6WB>UW&:\4F MA$16Q%+1;+O#8JI5JM<]?#]%:'V.DS="#.8N4[JRU9V"5_(Z!-1@7M!"::2* M.*J(8_6>F=6T'#:Y(C\Q1S#IVHE7/2R6S!C8I3RKLL+HFX>9M&)Z)L8^YGP, M0:JZ2=W_CANTT1%_PSXH\(F;Z)2S *S#15+;/C92\^ND3'SWN^N:F)2O(I6' M@VMT!EF(PGZW[0J"&DHI[HTW;IV+N>>RX7[8XX)UKD7]*'I+H>Q4RG&':,L9 M<5JEC=4 C3;5QA2M-N9==FN_K?C=OXE+_@(7_'U=Y/ M_O3I>C\2INBMG4Y4,[4;U3C!1NGZG]OEIT[!+N#->W;C75?VP&$\6^Q,[UQG MG.>6'C1&+>66/B*T?EFM655VP [3D?9D"*1>B7OU?1(=5!^-GZFWLU \;(RT M7D89G,IRDA#!T;&2P/B9+D%7NO< ,-Z%\BV,VWZK,>JW,F)*Q7%;<\TK=7;B M'0V6VTH<4A6?;C[_CL =Q:XR00Z'GX7H=D6I_Z7.5&EJN5/_E9(^1.I_7]LV M]5\IU]JF_F_0N05ELFBRE)'ENX4BEDX$%D\FK9@Z,?>)KD2_XI:]V[J+NRL7@UY?V#Q"-:1D$V)CV=<9!T; MKAQ6$"UZI[-$%ZMO3FMD7:]N(^OTS)%U'?DZ@&KI1-UHP+2?ZJ;\#Q;FH#. M D#(]7Z *$%\8%+^3QPLC@VPWQP*A!/-0J/.RT\@%^@+O,@>+<;,L$F02^V; MFX3$*V"#H7P?6)(WJT\]\+__ST!K]S_ZY$^'#0I^P+;;/O'I<]RV&"2LXX*2 MI&8XYA/L62MRXR?"&W!!UW86-S.2L]ABHJ%&.*4I'LRV-%D''XHC/J-!._%W MTI.6Q*@G[*".UO,$)#B./_XW[VOMBP$:*/M,RX\F8V&[?C[,3#R$K\$@GN4# M#%A+9OB8)U2 1X/0$T.;HJ?P-T.?/RU>VIKY$&OI4':*4K^7-KKTS3;7HM_G M:Z)%;IUYF/AY4G.1^AV<=-GLKDY&6G?"M]^^_[_V8+MPL(,,!QX<[#4?<"LZIOOA&!.A M)R$.:4>)DD8SQUAK><]%.<./ @')GQ !$2-VQZG!96)(+SXCM=QH MX@".XS)\,-J0=82UAZ<&TCX2SG"$+N:CB:[K0D9R"IRGG\E-+-A;B#/:0B^: MSA /]6*KY]WR!2VCEI Q,? )RY1)YJD$:/<]<\'S',)Z7#1KQ?P,P:+)T+&H MPW,UW6^<;3X[^+[/@KQ_R4D.1&:*QU[>)!:(TZ_4W3@-#.3@SK=3GX M?%X$?"S$:=&O;FB;B'"+YX.DV"EMOXL#0>'!_\54XRTW=F,RS;2C?,#L!@L8AP;RHOZ$E[46EI?#"8D_S+0X, _;D(LQQ+O#T I_SEG MXS[2F%M@+WPVW 2I9[_Q]J%KB!&)0"'F9BY<.5%RPFW)8^,($TL>1!CB&64C M+*!HC_@.L_..\,;(C:*EL2%,_J3Q+97YJ!' Z?%Q.OBOTPVE/LQU-#57TQ.R=>?'H H<>_@^?I M6>SR&3>6C3@^?ZGX3/.5C?;\ KS@CRUD:+\6 ^K[F>SPKVORE9HH9_D\^=WL ME%_VT&JT)F\?I<'"?31Z5CO/&#^;S P "8)ON&'@X^A7*QK^R1AFF8+DK)&\ MU/BP.--DR[%T_<'>7(HXZ:V=E5R4S#?+\LHWBXX""^=LE.\V \'>U>A>X;)@._XK_O)?1@PMQ-KFOH'\$P6C; Y8V;4-STMK-BL,)^K)>Y$^AF0 MS0-&D ]R3GYCI\E',-07QG0!@L:79NBAZR_9WQ!KGY?]IP0_LS(.^/T#R"H[ MQ4U]- >L']CZ09)K6Z@>>KR8+^%\L159?_2*(,W+[YO<52K6DS>Y:]!F30>. M9')7DUS!PR9@DONKXZ_?*< 6*/2':Z/._<;NI9EBBTU]2LB'&0#=%;DE1D,Q M)^[**#=FFT90,RW_*?2$6R-1YO]@M(*G+8S^KG0JV:#\".KB4\D&V,M"3263 M<"I9_23JBE6,CFI8A!6I*JP8BJ36EEU2MK?+E;#$8<8'9"NU-9^VC),^"E[Q,A_0)K41JO M9F$=7)3MQX??S?;AU[('SND,]E"SL&2T/K:7(RTF25D;;+D-K^'2&;F\ /63'6:HF?:E,K(6HKG=UP MNJ:>O) M/+MAB"FVO8P&8"J:?@S1]*IF-ZC\,SE]G.^8W3#LJE2U^FAJE:IV MS*EJPYY*53M>Y2I]JIJ:W;!3ZL@MUR1-:' S9" M0'6:5YWF.;OI>^PT/QPV1MWNID:H=>DT/UAM+C]4S>7W8-"N;RZ?& ?'T%P^ MM=I]-I>O]L:#L+>Z^G#0TB=#LS,9=";#KM%O==M:NZ-U-=WL&JW_[78;&5PE M[F<7Z."XU/KS1>_3!;YRH*;UPR:_&Z_[[^;>L\LN2NP?PMI\?P)CPW91@?N/ M\/G?P)C_$4G.-NQH9;@6OHC/@[,TYG@\7D@;H\]7M]_)7U=?_KPA7V^N'O[\ M?O/UYN[Q864.X3HT%Z=[UJEGMZ^+5IJU 4W2\6"IOBX6FK 39K\*H/(+%VL; M&FL?CXZI]<)5!)HQK+L\D]/8@A\;=2%6A7L&+)&DM3<:)J +/";W^4>$ZGZB MP2M*BIGA_8 'S0WT?5A C6"I!3K3>%80M]>ST/[S,TS6=!\];,;MQ&9K^H;N M4>SN'-!G>"CU5WOF57F'U'L'.^,OJ%(Y:-OLGJ9]_']#%T5H1' \9Y^WHF;] M??GKHFLUBP..$^\#O)9R/JR_>>>UD/PH'WDT01YVKP 3U06.P6:IL*B_.<76 MD>J]S0BWV!!/,_W$ 7,^[@(N_BCDMY*",+BCSIY-L+X)? MO'-4WV/7\]PGUV,J^NDM8C%0V88:L;FC%K&#.K6(%>HR4XOJDFI1N%Z)VSK> MJ:A_GJ6=A LV[4J9&6_P)_/MH?JR)J S6>(J B_N )OZPM0"8Q^N2F_L2@?W M[6GZ!]G7,J93Q-^*' 3<@[3TJ;2+&#[#[E=P!!X-^"+]Q"67?^+JYJN76)R@7>MYP7X";A MAXL_/#?>N&Z-$ ?OP)5@(2+"G4M/J(K0U/.YMX'YQ5Y<^X7=>CVX=P;I 1OL M- S/8Y?BM*O37T?Q9SXBP1;NJI_,%['@R35#*KC=PH$6KA=<('+@R)61,YLB_B5TG0+Y5N1[Y& M@XI OK);W%_\P!&OWRFZ")&/?T.D%MMUJZEM)E>I"__#>$K-T*;WD_C4A1M_ M(6LPVL6]$Z^9+?D1^27+0: M>P*DE>PYK>&3B179PB6)\LQ2)YV&-G?T1R?- M9')>%_@EVPTM-4ZD_?9_'PZ;_5:_;/OW3K_9T:MIVMYN-[5VKZ).\EVUJ ,L M2LM^JV"K?"G2;8=YCEBX<_&5F3B%A=V2+GG@!#Z%LYJ6AQP5R/G;L'-^B]W/ MW@<%]BX\$*1=8ELY+:^.]>/]'=LSS?A;W7JW(W>]=76_=>*].!4.Y< MVNS4U,HJIQ0M%2T5+>6C944%9"RQO,\]^')(_ WCGC!!#BZU>._=I@BI;J4C M65N4FY_+N0Z[!94C) $.G,1ITM=KTG%10J#44^CM1&A/K)S4O_D,]-Q,B7335 M6 *, HD"B?P@*=(P8#>65:\QTL_;G5:S+0E2*G*;'+ MF7(*(Z=35"Q5/KO> \B4!TP[8 D&^=581^> MRMTJ)RJ[$WE2Q[W&J#^0YL*N.*=:SCE .*.MPAFU9BJM MM<-P1GL@E3C:0\Z$U$,6%GM=/F._22?N8VP\4V?\EF4>*L?A*F@JB^1D@&:( M=RIIKE3J-EXMY^PP7*-AN$;O;)_]KUA'2M8Y0+1"4]&*FC/5#J,5FH9=_#K; MY\SNQSMX^"G6LGY*N56S ^^S&?58AZ.Y,:>>\J?F"IL#Q+>TZN);RH$A)5/M M,+ZEXL<(+ZCJ?A.S9EJA_$=K2>7/%(9F5GL\A7X P<]V"H9 MLPQN#A#=TJJ+;BGWAHQ,U=YA=$L;-$9:LZ\8IY:,L-T$FP46MR3 >1^ALS & T=_O#NP?AJ7I]SF:9S0"1(^O]Q9 MUS@WU FN'//.Y4-$G2 3(>W&J-_L2G)U4K?NO?82*\XXQ?6UKBE73KV9*L<_ MN!.F4O&*FC-5CG]P*Q77D4G%G5B/JMN4]3>EMLE&EYET0ME8:?]3&AT&Z-V1]_>=:ZNUE(R3([]E\[]XZ517\:*81TKFR;7)"H@7 M32KQLJVCK=#\A+)3RNHV7*'T_NN$F;S"#8:4*B8M=-@,J\Y@L+T7^QUC]0YQ M7U: 4X K;0-7"#@L<3GO:]65C2O 2<5W"G!57"D* B[G;E%=[8_"FL*:1!NO M] 96H7+K-4:= VW>=_6XYI9_)*5\LX\FR-R?"%MARZAQTH+3I MAD\VKX5CP2G3H-2M MJHY9- H0]05$X?CV B R&!\+D#MUZA2JN+Z^7%\X9O]>-5#'ZFD%B/H"HG > M0HX:Z+:D4@.JR^9ANVP>RVWP&CX!R\;^\U@F;\$]GQ='V04\A"J/*?=>]5OH MPP_X_K4[>[(<1MJ$Y-=IBD?RY:V,NNVJ/+F:\U?.-677_*6*ZVO.7SD7@G?Q M5P8?Z8V1OGUNB^(A*7DHQX:NBHZJI4O;0@R J;ND%LF M,74K3V*2P,^B^*FXX5 M1<$]A2J%*HDV7ND%XAVH:C=&@\H<>@I44O&6 E45-ZQW@$IKC'1]^VFO^T#5 MO@=75.B?]SDS!(T1NWWAAU^\.F)DE M4Q4\*2AL@$*G,B@4#TSV.C7,+E(@J2](11'1M(*:9*F$IK[4X>]5MRR:-]9S0=21 M2Q[M(0-KV>:3BC'^!$8 &_ A, )XZ+,+:W,PPD ,QR3&,W7&;UD&HG(=KJ(F M;S;H+D1Q'0/6BJE23)4W_W(;4=QKC/HM:;J *,ZIEG,.$,GHJTA&S9EJAY&, M_D J<:1B\KN)R1]^@;)^2KFJL^335Q!(8VMNV,I/7490'R!NV*^\]Y7R"TG% M5/H.XX8#[._4["G&J27C'"!J-E!1LYHSU0ZC9@--)FFD+.K#I@&E(*=;89M MS#2J;OZ9%',O%*(4HJHTPIK FT<8KO4,5Q)H3SBY,E\T'PD=E @X+%L]['?TXE-LI3/!(C>3:I@UB MO4>Y[+FGH2*F(J8BYOZ)>6(I;AO"GUN'^J7;K.IS73J:FS(-2MVJZI@'HP!1 M7T 4CE O "*#\3&;IRM-CW?%]8KKJXBZOU<-U+%_@0)$?0%1.),@3PT,I%(# MJN!)]5Z0BG!URR*^#Z;44_G#[[]Q,@*FA.JV43V5\U=S?LJYL%7+3[! Q4_U MYJ>&]3*-)Q30'R$7F/[X<7EH?Z#^%.W5>C=\"T M6XV!JV"J8*I@6O R^@Z8]AHCK;M]3>R!8=^J(@42OYBO$$! F#]5])D6,,"Z7>_EE6PS6UATN]I%/_ MG7K1:N;&,[UX\JCQX\*8P&(O#?O5>//QM%)[FEG.Q1(-UVU_9GC/\&E!.)P) M)%Y!?AIL/##^WR4&B ,)K=:%GD'IB!VT9G>7C;S9$R^M YV7(#XUX8_)3=_ MA]8+0!F;%N+,H;AMYP7<>"]\>(>D^AJN9=XUWG 5_]';KXW#F('8J+(BA2 M7ZCX-%^*A>1#448,5G53]O?'Z\;5G_,'KLXI/<=FEB +QQ;\Z-P .IR3Q4%6 MR$FP-B"QDSO4ZIR]/,OH,T^>WDA@_ !I#EL/7%1A/NS6XYC#7;!_P4Z> @/. M%'[3P3\LS+^:&%[PQRN'W@2]>D(9-1IOE5TGH4_@),_0##Y86P((,STQ^ M <[(I#:LE+,%?A5DQQ3_=&>4KY^=R 4_.6,^]UQC/,7-X1&]3JWQE!@V; XH M8DW@M( :EC,/$74>A0W@4A!VYX1:Z Z9@7^)1.%H\E\ S3'$N3Y[[ U2G28'5/X-RFN$WR9E';1"[PJ&D!QP #/P;_G=NO,4G;=*)$=H!O.S^FX[Y2<6< M/;7\P/48VYI&8' F<-G.$V*([2QQ- J,.652 \CCT1>+OO*M 2DL,^;UZ)2! MNZ8FF!-^61J *@=-X!G^T R>#9B'?Z?^>^0BU[\_FOXQR";D06-:S*" %] 5@=OP#1(&+@MQ9THZS, @!SDR%B>47/3G^.IX3Q3=NO%>RC7#V//]?V+^-/^JS%/ M?0)0 EL"^V3UN?3GG-U[D:^O0(VG%II>'G(S"&87=/Q_.$OC:I\,0!AH%G]* M@:V- %\$6"38.!<&PJL!UB U\(=,( @*8_8(7(< 3-'?3#/C MLE\BNRIKRP XR^=?$3A-C,3$F 553!'_'M=,#B@]O;%[H_/2(CK M!;LVJ[SZ&.FQ>??40Y,]8A_!+?\ "(WA%L;=&$R7N?8+1[&@U>(=P/ \9!V& M/N"?;\+ZA*>B%P@_ @)D\2N6GWY<.!<@9;\;Z49D7 \10A.!9+A6L."P(C ME($B !E0?H R/T3;'E8>X,>8!3:G8S#R\TJ_E%A=MOSR$H M9Q?L1G9; $$@P.AOV*^=\ 8#9BPM '41ALV49!%21%PI##0YG_@3W@@_'_BX M:?EC1"]N'N_!$]M]!=EAV&\H)ES\WE=T'I)KP[-=O!O@RN-KT3F_"P'-N12+ M5KQPUPF=-5;]ZIWEK/V!G4BT+":H4#^8W 9G\DELC]N]['J17OTJ< [#Y6?( MG7@ S$A?ZY]UPMD3]58GK"RD+.C+'MK?\&Q!) -VGD!9XB,3F;(@4B*)\O:5 MLPMBY!:)'KMQ+[24'[??&&7-@?P%R5]Z#YW#[ $+*MK-_NHF/I)7 .P=,S^ M7?I5Q9[]PVR!Y7EF[*%:[AP<9G-:8S1H-8?9[*E_6!+:D<>(^VT6 M.5)K:5T\5JVE:QM) Q\+DP*]X49;.N9K9W_*/I*X3W3FDPHL^,-WP]G8O3,>^=[^@"16?@;WAK^C-EQ[!C M^X[NOS%\BU'H$7[F-]L=_T@=(6A "D<[QSUX(3U<>"CW+CYQ;3">F-\3]^># M:3N#2QI>W/#<^#6-7<(7V>0+VK=$7W-G3]NHZ>_A5="+B"ONI&?P;-BM?WV@Z94L MJM_L]^BNU:9D>R'2=WZ3;B(045^HF.*)BC1V^=HU^K9T]8+ID^I MMJRGU):UDS,A/+9T4Y>/_X%;U8I5ZR^:M?ZB$1S?8=BSRM3&M"MO]*7:)TO% MK@JGA7":,Y!]1SC-P&-O%ZGU"HQR\*0"8R$PY@RRWQ\8^\<#QGKU.<_FHBL1 M0E:3/C>A)Z>N^KWH60.>;Z$WGAI^9ANU=AN'/FX_&5=USY"2T7+*?W?':"6N M-ZJ/5*V9<$=F^WMDG=:22=;MVU%W"$81R67OLP9.9-[]GJV!!QH$-L_^*R.F MM78-^PPK-CR8K?!>-M04&]:9#?=K+;R7"2OO5J5<"P78*/VC\)#QA?7S8FJ9 M)G4NV:ET&J/KK'2;^#"41V*M\,]I0%,Q[GXW+.>+Z_NWHF+\UKDQ/$SQ+P?# MZ@)CZN:X)ZYP/@+^=4#^S.##'J:6K[J@/RCV.W+VZQ\%^_4E M8;^3FN1P"MZ;5(;5 YT'(L6JQ5*L.I6%UDXZ2%S?"/% D@BQ5DV J]1!'ENJ MAH)@+2$XE 6"K/9RM71/05!!L-X0[!XFN7@5@GJK,1H<@1849G6T@HCRO,9O MJ[*.8C/5"]:&'.]O%2SNJE.-C"J74N52JEQJ0[F4ILJE5.9W48M&EC(,O=T8 M:;VJ!Y&H,@PY>%*!L1 892G#T'&>7F?W5WP%1@5&:<&XHSS.\F#4&Z-.ZS@T MHXH9RK3 @P9(:YB2IJN4M/=G7W17$I)ES+[0NVNN(2K[Y]CY;R4G4DK^ZV%X M>[7=H6*_8V>_H\A]U/L@_H89C4M5]IE4QE7-LL_T=UYBLBRU*M!)S:L@ M>A%_;G$LQZ>;[[=_73W>_G5#;N\>'K__^?7F[O&!7-U](G_3>U $. L;UI^.9N!)N>&CR7Q0-C8]F0V:FLE)/,O_ MP>8066RD76H\IW@K-57%)$_4=E^;)*)\/$839_OY@2$&02_.5C=QX(FW,*W> MP"'<;K T'E2,&L69TG/*Y\:;?.9G>N^F"Y_$ 9],@O-!ZWQ.;WJX(A]Z[QG( M"VQ .#PQF@(X#SW0&9M&]:9$G,A^W^M$E^&PV6_URPYTZ?>:>GM8S4"75K/5 M*3?R9/WK7;V:X2G#9J^EAJ?P30V/,P4\EAM<9)=)!I?B\(KMLO#@FS+9/7(? M[$*0@-D%667J[R5!L2H<(6%7'U,?,J^?M7)2"!K6$$$+D^0.6B5S"*_1Y^4! M]F"^O1J>F5B(\=C[;=J[U=2S6%?W8"^G@C>YY"U>!1=#>4XXNS#=X$(\*=/] MAV-+S[7VL+(JW2/PUBM@R+2WRS,8N=L8Z3@HMQP;[T:,%\R_K/WY MYA3ME#K?WD'.5_K$QP+AP#7.[O;FX(Z,+O)/>1YQRWEQ;7AW[%'3"KB#VQ)# MWE^P1P4;&XX\1KVYX04@E*=L0+Q))T9H!TU";@-B^>QSPB']#Y_,X=H) CQP MX;I"QV% B1^.IPN__&H%4_)LNT^PHL6U64'(1]$'4^'_CCS=3]2V8%G,D?\4 M+?K5]8+I&RQDP2<.6_9\:V)AK4M0(#1@S%SG.;U3B__,S'*L&($EX%GB],\Q& +_!KXSR=,;^TQJS87P M<82H6@D\38I?UEED:;S)SEF*4J7Y;IQ4;V4'KV IGCLC9\8',@D#_-;8\*=D M8KNO\,N"T>"L&/A8;&LL]@&_[?A<08@U@H0WX(=L%\1\^N?FU,$]XS_&^"Q8 MESN&]]E#D7OFP(L_08<%U'XK&3#^:L 7P]D7ZCP'T_L)GIIPA%R+!5S#?C[# M=C"$O)BABA5OEV;H@3PP?>JD-&&_,4*TOE'#6Y;UY,RD6,G J +,').+3/$' M_ _GY.SI SL(1!2(2^H'$4XB$D7'[X=/OF5:AH>R8^G!2]\63V>4/AM_6.4@ MX'(79(_X.B#9QZ"=+?)V,GX@*>>+'KY6&)5A5R:#,9B) <;%7YSR*/YRA-6= M3&"Y3!:DF(H\ Z4X9]G _'25'3V*J^=R$$1,1%RQ>?;%U.[3]$G@@.^XV%$( MU\UD%A!E$CIC(7A3'SOSJ \B##0J0 M-)+N"G1&ONKT,$(]=I\=%A$'?DGQHM 6W@NKRF*UHB,5;UQ?YNGG9X=$HB[AKG-VF.R-OT,@SN3M/$M+K)S;V 9F MXM8G-Q!7I!_+THA91G"@#\J0X'88-_ DE-0[<]B!RUYZG5J D6Q&6M3DC'_C M'X*%IBK \?LIY #39VHI 7#D10X6Q8REF)%)*+Q2B/L"$>O%Q;'#$EDXAOGO M4! >3_Z5W;.>:)J=S&6^F2PSP;*5XF,(T&0)/V"=! 9<5)B>LZV_0RZ.!?/B M\0K5R];(#8&%/@&$I:!RDP^U(QA5#K-0A1QENA._G"4[4](5^0GN6_![_UG9 MD?M"^04&P!9=L%+0%8M=@5,1?./5* '.:O:4C4CA2S?&[":(! T\:@3QLM/B M/T.SL8PO_FNP='CLRM#&U)B#\9*#V"^="&R3$7H7DDM+*VAJB.C'SV2D4 M ++ABT^PFV27S1MR+KJ-KT4.$!_A(Q-=16NW:K-K! MT6353EP;T,RD'TOS!&WJ"Q.)LKL0UU< _92LBC)?F7LHPWCW%VR(PI<"LI ' M9_IMMJC*Y8A&6Y"60^K[YKJ'@]#R@[]Z=XV8MLI)0O MCTK1TK*@_+DL7ZW,/D,S(7*FNR,\RW;:+9,V:#?-("Z=?((+T5=.N#+WJ MEJ^?M46YI4JY3->5=LKK,EVY=9*5X=IMXR#'K>M3Y.DXJ_B]OOR^TK[Y'?R. M8TUZS;8D#"]]IO?1-L(]%BOJ?>4Z>S#5C\^0VL* 4@6/A;=8)X52N!1L@T+! M(M^VJO!5#'\,#%^X-FX#PW> X?5F1Q*&5Q94S>\1"/SCOC)7''@XP?ORU7CLA9B>@U56 M[.YL9^A!=8%6]XFJ(A I.ROS4M%GM^BJ!MRJ6[3B>AGB$'E12WD+I!;@AU^@(HD$GSKYRH"L MR, !W4KJ^^+[*LM:95D?V-FITD\+;U%N@[&9D_VNYM:Y[2E+=="Y9^T/L8]3BK3K&N/T5L=-OO/' M>.;7VM]9&1AZG UX>%\U[+.SOATT&@R,5W@C,MZ2U:UEVYUNKUVV[8XV;&K# M :>E:97UI.M4,JVPW!YJ$B])*/FKWBY+Q](9-7=O<56C_:QHT!X/- M@U3%U39Z,Y)H'2X3Y&T1LZL.0+7?VS8()[[6H(.\C68^1T+V,3H M79\PH_?.#0@W*(GEL%=XL]C$9&(O+O9#VD#)#20Z!HYZ]W32-?I DUT?5#S0 MN,Y[6L>_M9(*#.VQ0,#[$WM%"82#:-?E2(H2+_7=4ZYXR9X+*+UXN0-)DA8N MW[AO)VZ+7)5\625/-2#3AK*#K$C;3[XRDXY=WJ+_DL]0@$\MM6\D!5LW'A4/ M,A7'^"KB1-7%BE2['8"7-3:60OP7=$*GAI-NW/ZEU=\8]YRTI6BI:*EHJ6BI:*EH> M=\U4Y8FJ*EVLONEB@Z+I8C@1A0U$N9\L=9W*S!+359M:A8&Z88"Q>PP$YD^* M4OW>2N50=F3+H50(40BI#"&92?2]KM((BM\/MK>S73+\G1OP:/DWN 6-WVYP MJ#+\QB=JANP?F7CH85')*AX^*"A(P"YUAL*.D)"$.>Z?8),LP/CH?J=!Z#D8 M"REE(/65@:104D>4K+]&\X 8UR-7SP9VJTD@E0F206.D-5N2 *1>P;L*9C^4 MV7C=X%[WAG+#'7G-AFHV@0)![4!0E=NL7UWIL4*(0HAL",ETF_7;2B4HAJ\G MP^>[S4KH!DWI!@65.D*E2K]:7U!:.]T]0E M,=K5M58!H0H@Q#R_$>02CI^>]X?;)M[KN"@X""1$D@<^M_QQS \-K8-:U8Z/C949I)"2!T1LOE&73I&-FB! M6=5J=B5!B9H'6+-/'770<]M6C)_H6'1B;+-.C+H*A*I@@B*7(I4V# M3F,T;'943TT%A7K(_NL*:_\'764A*934$245UOX/>HU1K]F7!"#U"HBIGIHJ ME7$#W-L[\IMA 8B>812J?%YI&$6!H#0(*O.;#53&NT)(;1&2[3<;*I6@&+Z> M#%]E3\VAZK>LH%)+J%3I5QNV%4H42NJ(D@K]:D--*I.K7MEH^^ZIN6U]PK%_ M_UAS,(^4W.JX%+E.KGI(M5%4!MQN J,;VR@.,:6LV]0DL=/4348!H0H@5-5& M<=A1=WV%D#HC9$T;Q6%7Z07%]?5+-=ZJC>*PMVVZL8*#@H-$2N"ZHC:*P[XR MDQ1"ZHB0BMLH#@>-45>N26._!L:33>%_3>ME%"WL+IS!;L>K?R_\N436]C(9 M'\934*?V NUN@48>?-T)_-^!8%_@5G;K/ 1 ,GSM?O+9<@QG;!GV-^HQ >2, MZ2/\QF^V._Z1(N2P02C0=PX_!\^CP "P_HAB,\-[MIP+OM/+ 3"0>"5PY^Q/ M1B/+,>$G+S6MV070[YUM-63;QRD%.6O;[BL<)&%'X9.Y1WU8&0G@33AGL$R( M.P&&33H).2:!8[A(O024?L9'6 E]"< 'P&GY(.18P*-42KBKGV*W"6([N/3 MW3GEC0E]]O1"WQF[,UCJ%-["%5@._$W)F>40()2-C_IP&;,TXZZU1]1;/")^ M'HP:,0A<#W:+ +"-N4\OHW]\C#I)6@ZC+OO2Q\6GP^.60< 8@+_]\=4R@RF* MD6:+BQ+A5!:_+-YNPEN_KK[>U9KM=B_SK5:S7?+UKI[](^N^L6Y1P^:@UU%K M.M8U];6-3\H)?,@9W\B.61>.@FT,=FGMQI*8$,!'I0:%J,/-"Y2TJ"J)ZY$SU)N5X0QK=<&(,&2%3O M/Y^\7T=G-TRAX&>^N1X*_ ]94;5HI[&RXA)97H8K1M%J^ UL#\]]%;RWS'JH MOXZ<[QZG'J7D*WQNZI,;T/TF8YT'.@]$G^+6^28:9A#GI.EY!Z^4(:?"8#;/ M%%1\.0D11?,F:L-^6DOK%$DT*;+A4R):D3;LIT@7Q4Q;,U.]R-XU.9#*Q MW5?FFWAG)FI%W30K84>UN.->7+V2P+=-&-PVU;0,U>H6'CF^3BPEX^G:D4J#GI(&+>G0Z%7@T "9?!N+Y.T4:J:_OL-SPK!TFV,].USIA5B%&+VH&@&R*ME MV\"6-G"9Q]YP7/Q%PR9&G)G]W_]GH/AVW%HV.*B=__50J;E:YV"+8<%MJL7^W$B;"E$'IX; M'C8I@ -]3!V-V(I/?#JS+@S'">%4+/P\X)_,C3=>I+3F8>3)P&HFI UAE:W) M5SWD)OBL9:]PCO'L45[\U%S$$NX%B6;!*MAF"J$K!Y4"&1VMV/)=.PS6?V6=X-BW -"T)<*F_CN-\Z'GQC.] M>/*H\>/"F,!B+PW[U7CS45ZF"\PLYV*)ANNVGU>M"L=-O=O1!);5KO6:WM;EVK=)ZNHP;141+P!LM]2D9]U=P M3;U.N=/;_9KZS:[657RP;YKKNJH;Y9M:*2*H1T'H%Y??7)E)7[ ZE!L$9:H/ MI&"$2FK)VMT:%I,4JO79^)6-^P MB^7?5% N\V[;Y61.Y3;RUO">,^?$H4&5!>EUIQ_O&($=A,2]ES4.4J14 J(F MIU)60%1Q.+4F:!F)L:9]1;> 051-ZX9B^-CMP^J5I)P=XWUT@S@6%OMF^:WS M'8[7LMT/"X.K;LD I?=?HTR!G%((U,;WD]]=U_2O'/.!>B_6F/H/KFUF12/; M[<9(ZVE;59>6/8P#-;/=@8M4 ;/FP*P0EY$]QIV1-S_GJ KN:&:.0!M'!W:: M>D5-G3$>%)H6FRDS'7F.D=S-JB"3$ M5+UJXM>E?T2IK\Q_.C$LC[S@A!K1).*R2)SCP".\*PE@2;*74__^:9YE1>$= MKG>'&2(GG8=_,5Q-_Y:TR^C[I,]^>ZSLEF-E[1=3S^^?YEE69.>LESXR"1M6 M_F02*Z"SXC%B51-^Y/<8;9#GKYL:SC.]=?YT/ I[^P\UHVKO>X>SS"UPS*T3 M3W!D+[9+C#75VM6--96GC<)>W'D*?D,ILTH6PV>15EX!%7<;*AL' MK[,(R-JBW"*@G 3(:8N\"?@+8&?I%S$'E5.;>F5JI(?X49NJ+F94&RP? 3%=A1F'F># SS&E\O!?,]&J(&67G*?P5P=\6 M&2"5X:^Z%!!Y\*$Y[/.>!5 M(=8+=:CODX#ZK$O3F3%S8>%PTEMYB^LF!XXO3%%I]N2FP0&)W_M&\!=^$$PN M!XLP06[X]!/E_WME_COD\W;\*QS%P.;IE-"N=4Q74;%WA= *$BSE0*A>Q^P8 MA:KZHBHG!U,25*FD%X6J8T)53IJF)*C2:H@J94TJA%:0R2D)0JO+6I$'H0I5 M]4752J[G_E"5@9Y.8]1J#B1!3KT:G!?JM3,V_"F9V.[K5JUV5(,$]7UUEA(U MNSBI5COEKAJJ.93Z_FF?Y4E5O"0C19]QI.B9S>:)>G1L&[YO3:PHTFPD$\B) MRR8#C=-&,,'O$E24F1S I4J*LOZG)*8BI$70EO7QUSEQ6(Z@NBG!J9PX!()2 K$!T1B/** M9G9K_PT:([U=V9@C"9"B[#^%N@I*90ZCNJK+[I4'D I$]071%AFY.P-1I[H$ M7+D*;23!1*' KT-QDOP+Y4%Z-6A%-]ZH,!?5]=98299O()&^*EQ&KTN&327H=YI10)8FMJ08!ZZX\GX&C MKI)L@?OKVT=7C)P$OIKA:W,W I=88M;>?'2L/)A6.ZHNCG!(J*?6>*JA2&#LFC.445$F)L>I: M_I":MZ:Z688GCS/">+>>"__IE=[79(/L] M_O;'5\L,II?#87/0U?'@A#-2_#!_M]V$,_UU]?5.O]EM#3/?:C7;F:^O>U2O MV6WKI9ZT_O6NKN5]8P=J6ZK]%5Q3KUON]':_IGY3'Y;];<4'V]*\V]G\I)PP MQ3'%/K/E?[*IE'G"A:X0HRCU?=>V3!*M<<.NN13?S[X'A;;]Q>5Q?6(X)DE: M,*)"):Y'SKZP+HS?Z=A]=G".'X'7;U?[*AX#(Q0C2 X?M+O+?!"X\V-G@L>I M1RGY"I^;^N3&,:GYSR?OU]$#G0=T]D0]HK?.B=;2]"*Q_R)4R;PIUY*T=_!* M:^\G]K->2(:]=G(M:'F\E*@+M20%6<1%'K4[G% M!5$_$$V#S['M1DD6S3N+6M./]:=A&6/NG'H&F_ZK2*D$1&U.I:R J.)P:DW0 M,A)CC4'4+6 0Y3!^I?C8[-WKA.;X@NPRL14MS'J;=]= M14%*04JBC9>R''/JTTM:CKW&J*_UFQUE.2K+40%S&UV7@\M2EF._,=*U[>=> M'PDR%9H4FDJBZ1V6XP!N8ZVF?@R8.L%Y Q/#\LB+88=4S1HXR%Y._?NG>98G M-6N@ZL'RJB6)^KXZ2S5H(%/8L+%8)K$".E,-94ZH>BRGI?+UU'">Z:WSI^-1 MV-M_J)E4D7&6N06.N74^@SW\%YK#[,5VJ8++ZH80RE-PN1?OG8+?T<,O+Z]B M]_#KU;&Q@(+,,4&F9/.9%5_;FN8S[P9/!DC:6 ^M.M(H;,BM3G*:&.]#G6@U M5"?*FE/P*P*_G.Z<^X"?&C>C('-,UEQ[I='F'JPYS'35FMW#FW.5QC-D=S$F M78=\DNJ8;_@LA,HKF^+1"F4#W'66 5E;E%L&E!,!*]U$BR-_ >TLKR+FH')Z MLUN9WMP T1JG$"K\R;2W!A@GE>(H&K?2GV,[-*E))IX[$S4=U@MUJ.^3@/JLQ=*9 M,7-AX7#46[F$ZR8(CB\846DR)*OBNG9G.S65@"24(#I]^HOQ_K\Q_AW[ 9,35)*#>H_&SC'KMUW% A8JP*X16D"\I"4+K MF .C4%5?5!6I7MX1JC+0HX.)W-042L9\?F,(S[/;#;?TZ-CV_!]:V)% MP6-C/ YGHA*^/;JF(ZL M0%1?$.64MAP&1"JG6('HF$"44P>S4_-OT&J,NGJS51^D*/M/H:Z"ZI>#J*Y! M=?FZ\@!2@:B^(-HBQW9W(*HNI5:NTAE),%$HS.M0'.S^0GE(7@T^D=QE7\_O MG^99GE3XY=K#N$D<4JS]X34#E]APN-FO#R85CNJ+HYR"*2GUGBJ?4A@[(HQI M.>534F*LN@Z]\F!,V98*KT7PFI/,>U#;LM\8=56[#(6C8\!13GZNE'JONO3= MBC!V@@7&0/2+U,@8564L=_2@GM\_S;-45<8L[*PB/Z=CI>040"162M('.GD- M;(Y2YD5UA0WRF/#J6JV 5@1H.442E0)MJ.;<*W <$SAR:AD*@",#!.W&J-V1 MIE660H!"P 8$Y!0B5*L>ZMBS6]EA"FA%@%8XU:T*H-4Q1TV!H[[@*)Q75L8. MPX2P8;,M"0*8C^_7P'BR*?RO:;V,HH7=A3/8RWCT3W@Q6@9[KN68U DN-:W9 M!13PSU^+@@M8P&@X;X3^G+,@0S U F*&'I 1_DV) M XLEP2NU7RB9P1.G/K$"\FK9=M('[(T$+J&&Y\"7?&*0_RK#6'E#S[,J*3&, M]3W5A>Q_K&!J.8]LE5_9(C.9K=L8=3)XC0!I;5PF:W+&79Z!_8;[M;^.1+C]I,WGQ\M,)]^U MPV#]5U+R8PRKI-Z!X*KI2V1-_1>7BWQN=?7AH*5/AF9G,NA,AEVCW^JVM79' MZVJZV35:_]N#JZ_XTM2+MC WGNG%DT>-'Q<&5B5?&O:K\>:C3$P18F8Y%TN$ M7T>SF>$]PZ<%M>%8/XI7 G=^N?F45\Y:2/4+M TNM7YD, B>NYHDK_EY!_+NB,57FWI#@M?VR[?NC1^PG"&##,4/*=,H!?NW[@/TP-C_YF M^-3\9KRQ;(!'>.)OMCO^D9)O/2Y; 6;4O JB%_$7*4C#.;*R%]+&Z.'Q_OK_ M7OQV]7#SB5S??_UV<_=P]7A[?P''GZ#7W+Y M"631N[],6"FU_$, J[YXPAVSMIS1EIG*=WQ*/,YHJ,2-5\,S0!;=DQ\?;#_MX,/4H)89C$C )8KN!.JA,'^@\H+,G M>+#>.B=:2^NP#\(_=/)J@/F CX'3>/7)&2A>H9O]#Y=K>3$E63B5F0&7"'S0 MX1X:BK8Q]^EE](^/T=W>J?7' Z'F6^UFNW,U]<]"L20KO5*/6K]ZUT]^T?4HG:Y*%W?^*B< MY(-CRFC*OMG%FQH6V10WP_:SK4'!/"V4>/SN06Y0T#&UMR#L"J1I;71>'BEI M[E %E*#,,?!ZL9WGL'K*Q\9U%&HP=%O ?<0R2;2\HSILU.=5;3@O=:M.1-.W M%0XUI8MBIJV9J5YITFLZY< 5#?.C?<.FQ5,4Q48+GWW=(A:E]U^G<$9.>:]P M"% SVU]PP^_.F6[F06/4VSZD4?9P)&V J04.!2 MX))HX^7 E1,Q?3>X]%8+SMDT953FKL%NC#GN%?9-*J=HJM>39VS MV>*!VO#B\SEYI@[U#/NEB5F8>_^_4IX8WGC*CS:0OU';G;!K'5A9; MT:D]QXZ$G$*7+9#0:XP&E?GG)' 2*+9)L4U."<@6;--OC"JPUQ3;2,DVNPJU MZ:T!W \'M1SPK?A&[^PJBJ2WAEA-(8V:RK'7JNRW5:]/5=F3J\\+6F2V>1_= MP+#A1S?G\V_CJMPNY''<\F9G7H5VJS'2JVM-*T58K2*7PRGSV\Z\$>TV:+?J MBJH5O]6#WW:6-M#6L!*RW>PJAE,,EV*XG3F9VGIC-*S.W2I7)/T(?;&\VS@) MC)_DB3IT8@4GYGP]J]#.+%2N_&C\_(U3&KN_%X4-1K>:K174?%!^DJ-FJ!Q# MBQO8]605!QUW!R58PKND*/ZK-&K!!RE?)49 MOLISXE!6N >VXSO-=M&J0P?2F&Z(C3^BS:VUZVN=O%TQ=>060GOW[][1X'X" MDBA3U@R8WZUB/^^V)RAI)U"%7H7>O7O+-Z(78\*=RG(_%7H5>A5Z*XT];$*O MUFJ,AIT,YY9"KT*O0J\$@9R-Z&TW1@-M^\+CPZ/W_1W$B_<^EJ:SZ%60=//D M)Q6U]#SG;4"9#\"C,\/"UN"+'H QMNQ)M1X%$KU0'_]@3@/BSO%C_CE\Q@^ M<,D[R*KP^LSP?M! .!?6?0BK ZCP+HEWYJ$WGL*76,]2?CVK?&!^.&3 M/_8L]JM1'U2##*V@;WA<01)0; 8%D_] CF +TMG[B M $(-K+_ U?W#AQ/X.[1\*P R\UV1.>N>VR0$^\QS1J+FA0'?-)YIBBW6?9/ M[Y1K^KLSNO)&P)]=3[R$GVLO3/L #(TOS=!CO6Y3Q-<;(UU?E@&B(VZ3D/(@ M/P+AT-9 .-P[Y*OQ1OII@2#:"+.Q)_V//@?DU+5!& /8YG,/V,IDGX1C=4Q6 MSX,(1G2#G&!_H[,PXU%?7.?Y(J#>C+!^Q^0V[E.L6!X(/3ES('^/% ML&S6H1C;)6.K90/6FFJVO&8]Y.F-K)5!_/=74ZAS#.\US; ]SW">&;E_>UMI M/I6*B[O@39>>T]=Q^6"LYU-1[EX3/!!//FW.3]D M0?[W8".G2E\";/19?O6Z88[+T$ >/=,_$-@CZ!A.463#5S9$1IA"2'1!LQEH M,3"*@#F9*9C/P<$4+B7/4_*9/GFAX;T1K8U*$-!;2VW/K@*?4A.#"K3\7S ' M8M*69,U=Z;9[?O/X'5?EWSK<]OO=<_VLJ4(X%VN4E?L:3Q5:N,X0 T3ABC&\ M$):Z0/R2YW0_PBB7G&:WHC- M?,.]Q ?72AWD>,:)9C:8(N%\*?S)Q*<,-XLAQ^*8?3 M&%,OP.E[D0<(!3!?#IX M[[])ELEK#G,LG_%T*+(B652-,U@:6;RLXNCC%)7 M1^Z#@#T'H>>0:(@%]>G7!8J5.ZLSA4LVF,5V\4<-;\4/-DZ=&3C=.^3?"5D0FGCM; M+W3X&:R"9"%@<'OWN0H"\&O"#1M324V< /D[9\4K'PB"SAX D88O.?4K-$+ M+44+N$.O7KQ^P5,NO<.!G#MD^;.KMN@OT3T_8-]=Q8Y ]>H%9>,M9/_C,+/' M\*'4(TSLD628GE_HTG2$41>4@2FE!H=81&[C:+642 Q]E-X&F\L#,M'P;)?X M%ILIRC2O:U(["@N$/BP>W@JLN4U!"L[# '[;L]#7P'P4\7,9C\T]]\EXLFS0 M9WPD0V#YD[=(62P+=>[]][B]ORY68(!HGXD+5.CS>,SBCRX2)-BQ,HL'UEG. MV [Q0P;Q+/_'Q02G0%DX$@35G8?VQR:7RSKILF!DZ)49&;%U<)70\SLL^S.L M^E8L^CNL.5NV]+'8(TNV;+PLK=OB4,8MPE5>S_ C_<*"D"B6P2BPWT2C6$?, M3(;3?W$1-XSCC^',(Q7S5[SL]22!2[*>U1%1_F,OL=0TX>+VT9\:(C7N2?]%8WO!3X M?F%B]@4QZX<834;$=-9$EQ2O')17=!EY!6LALD)21^?/*'AJ422+F-:+96+2 M^IM%;;/$W;6>S-E:DX2STW#B)W$&G#W3I0H3ZR;;7N-T9WKT!6^ MK_C;A_7MSU54':<1W[0!U[]9:'_,<^+'+LI^ 3O%E-BCJQ;N R MN_Q*)$5U,2FJO7U+I2KZI];-4:$8?]^^NS*,WV;9@%),AZL;XY=4=O4U;_;H MA"O#^AJP?BNC4%1Q1)U<;64X0F?"<+4U6_V];:RUPQG6S?DKW>)KXGS)SD%G M%FD&^SWEL]]3&?9[! )G=]%"HJ=XL-,8=9/@0-Q)[Z3]9NN.;K6 X*!'U\6C MT_9S=,>F&]8=8799^<&.L(='N-+#3AWAIB/,UM\'.\(^'F%[XQ&>@F_J%37K*,[8'9W>^NAJO(,Q%*X MJC^NMNSXM0=<#9E7N[VN6Z#"E02\IW"UT5TH(ZYZ/%JD2Q$N4KA2N"J&*UUZ M7+5Y%+:JXHL]#+C OY'.EL.;42ST-A!GUM'X",NYZ[,V0)=1S[6D!\$OBQTI M1 >#5O(5X\EW[3!8_Y65@K$#];!(E=-Q@J7^._42-\@SO7CRJ/'CPIC 8B\- M^]5X\Y'HZ=X0EG.Q1,-UVU]L_8!E;*G&$IO[7NV@3TD\FP&;<'P3,SB^V893 MIFE)3UMI6K+$;-%'M6'O0BM'CX_U:WJ"GIXHIA)=3Q1'4\.FOC8D;#& MN*WIC\Z?H3J>5&')TOKLRC(]M'SH91?Z* M\55_BR-TPI5A?>QOH?@T.&*/KK8R'-%A&?=Y'%%';]L)=SSI2%6PW\=1 MY8G#5W4\V71T7;F.KK?'HSLVW;#N"'MR'6%?'6'I(^S+=82#_",\!=_4^#VL]Z;&& :1NL[6JPZIV)IX !$Y>M?2E9W<-5,NPV9)% MM:SI3;+8BV3Y1AC736?UP<#.!+A;JZL/!RU],C0[DT%G,NP:_5:WK;4[6E?3 MS:[1^E],@%]M9R!V=(%HN]3Z2STF+O"5G;/D2O46:S'1UIK\D-+_):1DSP_L MY3%U;9-Z_LW?H16\W;D!_63Y8]OU0R^K@\= YXP.!P+<%D0OXK,7&WM<75_? M?+GY?O5X\XD\_''U_89\O_GVY_?K/ZX>;M9>Z]]/_ZS37]-:A"]WM=.,#)U# M/O&.'EC0R!IX8)'>.>O*@5+"<-X(JR-DS3H"EQB /)MZK+\'?,34]U+6.!"?-J8SVT0#]@V M)%GY.;&I[Q.#F,"<('J"9EE>OTI(Q>3J]WCC?A:;=[+8O+/*YEFM7OQP-C,\ M.'4_WIP?[0Z.)'T@9R:V0/%\=MCL!+&%"P'.LE'(GQ/ZV%W'I^1Z#L=4Q -12,%&?I6&%-=2\12"C04W?[QAR-7PXR =?KR(DZQ]+^!QG\0!_LUSGSUC M=A4&4Q?=UB:WI]MQS+"7&.-QE7LU_CNT/&IF,ED/F.PT6*PRW7=J@KM&LGM]"LEP M8PK)AI"F\ (RBPQ=(LE/9*2!]!NC0:O9Z4C?_4\BJ5XWP;ZNQC.; ^GK)N9C MUW8Q1\9/7C>O?&!#O+[ 9>%^$MWTN;&161M^-"LB:#2G43)UE;/%Z)L2HI MVCMQ%0[;C5&[6X&K,!N'.U.X&T!0R*8K"H@CXIIUEIM6J>4VQ'J4YM9N"'G8 M1ZNV?WBJ_&VD]O%J4J#=8:57JUAU47#JB\#OI5AI0RK8H:5O@?W M50_47J_97YWB=!ADG$)'LZOP.?2#]RL1U52C\!:/5RJL2H/.;EQ4_<:H6V$V MFP0QH3)AQU.PI+K56E(#G/HG1:-]U8M+RU@GH7L\O_,*#+[8.>DDN;[&5W5UG78:@^6 M.VSA*P=JA?6_A?YOL?'1:KNXMOW6]V6&BOFSHV:8RE"5EM]\;_^[C< M58J @"4&R- I-4,;.X/%U:+8/8HU^OI$QQ2%/-'ZY^PNWB3D*F =JF =8SOT M<159/:L6NY'-C#?B\;I)@N3%Q1MVU,G*]=@'GK#-&+>I2>"2.;R4^NS8\*?X M2?&=,R,@;N@14"A,PG]HKIXJ(04[QFT^Y'4= \6CI&D*MW+"/GFE'L7N;Z@N M@:K8S0T./7AUX;#G!FIB @K5\;F6]"_)6?L#9Q?6ODT48;.CM$3#$%,T#,'7 MQ5F\PC/A=#$IR\3G1\9^?/&/*< M=3\[TU(K].C,@(4YS\1@)D&TV+A9'>\T-P>C=&65!I(#.V4R P8-!8*G^)-S MWV)#.O?56=J+PQ\HJ&*_)8^&W46\LB,N8$^\M +0HN,"?'&5@ BM<^!5L[7N?&5?%6=N&3#Y '7K7?SDDX1_K&4NB$>D(RR$7>R#5 MF&_@H"05P %^9BF1K-\C_ &B"9LR/AFVX0 :_"FE@=\DCYM1#?\_M ,!5U U MLQDU+908< JA "I'FQL&?@#'B3@47PY]?E1@[(U#F\D9^"/(B:@0984H( MC-1S4%0]&;XU9GQB6G:(2Z&&AVCWDT:'?!N1GC$I=E$$PL"/3PVNJ)91[J^' M^0+$9S0@@.SE9I-CSX+?L)CT()1U0R5CV_!]:P*?8&2!%3/UYU'X#(@M)H4= M-UB5Q :LV+->X&LO>!9^X(7(^TRX<75-J#7]U^_WCY^O;E[?"!7=Y_(]?W=X^W= M[S=WU[X'G\7:K_S)P MD_@,EWU\9G@_0)*2%PO'#<(OLKZY:!+'?5P_@P" JRZLSO/">4"^,8?$&)YW M!?;&V7__GX&FM3Y^OOYVQ?[9_O@!+.RT1,,6NDY@>$ ]%"$@9)ALH^3AYIHM M!?_])^P97GX(8!4^&.U@VC$NQE7\*_0#UFU7_-:G^W]%/T6,)Q"Y[ DS(P!* M10\$C3;!/WD?8+P:P)-#D.ISU"F@.@@!VC_0>2!N!W S6#P%8>S#(1";LD=/ M/'<6+QQ6.IFPI_+6OD)4XUN6ST0EFE.@<;@R *I3!T3FF-].N)G8+&^1'XLE M?[] W,&Y8/,K%]TG0'K'?6',@")D=3S0(#P$,P M1,PD'A0SE.5D\:,%>LT"=K^&"UL0MY2.7V;W3%@BMBT&A4N?8YY(/;[=_RB9 MW?=P]>WVYH[HY$\;[(J#VGV 4S3)@/P3[)4-3UXZO#D!AX-V'W6C+D P@!@*.Z \'$A)M#R\<5'#,)&$>!'YBY80?@X^G/. M5.7'M!7DN.*2YI,IV']@UU,'+2)0C.;JPEZL9]=S0]]&HVXBY !LA=H3SF7P M&=N*Q'B-90'2Y2;TW#DU4(V @>(SI\L9'I2 8?)R@D0_K>B =BNZ;1ZK(CBZ M2")8Z-2):(VN?E1L'BA08#$@1R1XR)D!(N9B[,[?P.;] "*(=H9/>8+["'U!M0O+R%BR'\Y!6 5D2@T[F+ZAY3ZG M ;OF+OW@V'!0GZ39>X&KZ9)!(*33W,5MX-7(@N>@E'*8OVEB.7")PM=1>W$W MRT[-=?$]P1,=K=E'7Q7@BVWVTJ,VNSTD#=!_6;361/OT5O(5XPENAW"=6ON5 MK#[NAV!]K;M$V-1_IUYB#3_3BR!BV9(NW,N[#P#W6N(/F88QJ-! MEL8XQ,;'/ SX_=:GX]#CQC2[, L[CF'7!M&4V"?IQRR9(JFWA%G@@[J!)[.? M<"=P":>>7\H0N:;H&+ 7#))K8']XW[&,FKGF MW(%L$[;(<\+<*,USQ%O 7 MW1D20ZSF1E;JN)* %(@ON$N_ 8W.HU?9.;]:/N4!*W\.K,J. ^B/TW>YJ> \89S(@7,UZH]\(,'6![C[G'\8DX#YEZ-L;3 MG' "XC-$CSB\ ?84>\\\9U[%V%MY3I[>TAQ_3EY=[P?P])BRGZ' WRZ;&29X M#GA;_ /-(M=^P:7"-FSD1!:#B<@D;#B&4T_882 JV6RAYU! ^%QHNV?\!71+ M6V;T+4;/9_>%>@[^/AI::3O,7S!POPCZ)4X2/+'H58 &'H=IH?0'4'&=@=BE M/PDC$SP=7P-1@;_C^R'E9,;EPL7VWQ01Z2)9WP"K0MV@M#E/3@QH&0;,-V%; M,XL?&G=Z3(SHV,:6-PYGZ,06=C4UQE/&0K@PP\,H)I-2H "M&?_VOT&P^2@3 MN#N*O$XM^ [[(@,@\.,3 !"8]5SXPB<30#O[!73-)ZYIX+(F^6HXQK.(XKJ4 M.U.$->Y/;P4 M(T.?OFVG+&0,/3"3\UP$$QA)%AF'A74GMOL*4O,/]Q56Z9V+B5/,2A5AAK5) M2 )9RUE("Z7JMW>?4UE(7V#OB6OW[1I/PG\$RMQ.>+]D\QKW_P=L_^JKV/P5 MW_LMNPKGD3C@#=)D^=3(2WSHMK3$"(V(E,XF)%9#@^3PNZA5WBYSG',QW&?Q>7" *0(265 A#_0"2B#!M$D_D6 M?=S&TE?9E:A?$F);P)WH"F[HUO"[QT& M*,(C7ETPKQ?X!^7!/!'UMO6#"HV'$H![S]$08J%'U'1,7AN.$+FH>3BOA?PK MZ'T44E6L#WXW=/#:L;J-DQ/""T4'V]O#%4F#W'A%N)'+Q&7 9O1 MBYHL#IL8"<:B,C=X70683J\,UPG-9B % ^QN#\GX!X"F=HL@5^>_0YRF&AY^ZND\+OA@=_W30V8SE^.1WC/B=H6+\@%?;/ZCY M3/TE.UAFRA7Q(TE%<"0U4OKJQ;!LU- 78%E=^'#!);?,-;_(M?*?P,%(*?NA M?T.K,XD+R[K,:XRM[I'?Y%,K;/@@UQO)!8+]S2X17-VD+Q+LE?1E8JN)>G+: M%=GUO'&IHMX^SQS4D+=9U06_'EWPS\IU#.HM-W[Q80?PKQ6_39+IY-^PLI], M[R^.)&MW,N9*K%2;5W8>DK:$47BJ!Y[*P:F_N8]2013U&Z/6]HTH%9 4D"3: M>$G%M#*8=3O%- #%U,EH2:;TDH+3*^QQ)(#,0J/7H\7HM=G-O/26RQG@3RQ2@2L MX%YHBY'GR:MG2_]R6JJ_,N-R#;#NQ]9OC,S?EZG,7WXT?EX%@6<]A2S6_NA^ M,[",(!-];4"?WEQMR%D0C+6<0>)5LU 7;J+_]E'"Y!K^P MW^WS['29+^-7HHXYN4E@H3?VD3)2Z;1NQH7$7HZ U[]-^[87C44,+4/G,U#] MRAU;/+- M-5Z0';$5ALJVU_F*MZ3DK9P[2!4LE:X8G5@_J7GQ'^JYF:PVQ(3X@=;6/BIV M.Q)V*Z49\^XJNY%@\*NC7L;M=^^*445,6&:J:%TOXB.!\1-;-V%3=J)B(EM? M53;7SO[\AMU37"<+.EFS'CM:&^\HJQ7\*AIR['R4%PZIF(^TQFBHHFHUY*.\ M:$C%?*0K>51//LJ+AE3,1RPBHOBH;GR4&PVIF(VZ(([:S=[A^>@4BMJ^&MYX M&E6T=2I+ACOIQ,S:9F7J_6K3,C6L9>NTML)ZJ<,XMA1G!:,C@5$Y%'6K*&'3 M^BQS8!4[%=>P*0 I $FGAZJMJ=8&8')6XLY6*)*$GQ2*"J!HI91Z.Q0-&R.] M.50@4B Z'1!IU59]ZEBHIF]7*[-S%*F8ZYHJ-1%^%<5JJDKMW1>DE5IG16H5 M]**1P!VFV*G$?6-'[-0'=LHJ)U+\)!T_;7GKV&N5FHY1L>T[92C>DI*W]E!/ M6[Q*35=5:D?';B6[8QY",W9:(,$J"::HD,F.RM3.1)T:ADL<.K&"DXR.5'MK MJ3@AN]-&_Y$$^=C*?[3?ZTK5?(0ADJV2K!0?26E*%FXI6C$_Z=E^;14IJ0-3 M[;*6MOC%I-.I[&*B^$Q*)9@71:E89F$D9:L<2;EB*%('3OX5.I3H+57:IO(X M"RB?F.D9XTX5*5M"D!'!Z"2 M>JC:$NO.@'53V";[2Z%(+GY2*"J HI42Z^U0Q(:QK8;"%8@4B&H+HDZU&.IB M:9O6VNE(PV.,TYY>^5KJ^'0X(],-GVQ:4)#(AZER>FE_2=M=5ME654%2P3,[ M H]VO;BOI%E4M.*_2C[$R6U9>82E?=Z*!^7DP7(LN+_:WJZ.34NY6'E!5GRLF9I71ST+H]L][?].6T/3OO?QM"*D#30F)UL9O]]&]F5ND"")", "'7 MB3T]&'2IRGHR*^\U9IZL6I,IFKFVH%'>VOM\.9I]JEK+TH(KE*,I,YTE&Y7- M1GG;,N=DHT'C9ECM1&?)1)*)RF:BEU,M%% ?1@3R<(U MR42OC8GZY1I% RQU/+H=>L)1 ;#"2/ATR&SXW'RX<% M8[7UA<^NHP_O3,M?V/KRVG)(QM%-[\33.3/3"];8G-['?W[W;)G!['HT:G4[ M/70D"Y>H>#'_M=,"F?G3YO>:VE*':N9/[58G\_MMC^IT6OU1M]"CMG_?TWIE M#:K;SO[IK(.J)*4J.JC^SD?MB0)4T]D_R%1ILL,HQ2;%I<]IIC7,-:M?70_^ M=$B<\DPY8TE_/'KP4)LRZ>CO6_.OT _F,('M50N;--BS3UP4J?YP/ :C^"\S ME=]TRU% J_T',Z>LE<^V +*O?/$ M)%(YG6C%OF!T6;#Q>X^9UJLES*,;Z#879TEU%OU-P7A.H71$GK[Y?;U2ZS7$ MMC\P0X2V.Q3:5DNSG5^['Z?.KAQM5&X[O &F#G>&912\Y%Z/2W.*2GZZ*'XJ MQDY[BEYRY%%";R')29*3*C3Q@CM3WNJ7G#R%S6IZ1^T7+ME)LE-E-Z8] MU?0YF:B+.2,#N2])1JH1(Q4+?N>MG\O)47A@3:][T)$UIV G6H\U,&>F/K .H-@R6$X%J@*DC,NA61U#M#Y:< MIE/G<"@[==8;9WM,F%/A;"1Q5F><;9HNI]DC1VU,**A9S*72@9:/NF?,HI(Y M37:#E7V/=FX_Y7;@&U&QG.S!)]GHTMFH&!=MM.![$?.HN%<>[*20_%,M)+U. M_BFX#95;LSW2&C<]]:B5<9*+)!=5;12_%,#_BFT"PU+MH6H M#JY7QL&=1V\"^[I#NEE%<*+Z301Y91'HW;CJ=@\ZDD5[L M2JHX>VK^R\30H'&C:95Q74L@E0NDT]7FCH;R[.'ZXNATM;DCJH#;/")*XNCR M<;3W7-C28-1K8QE"$Y;! M]&1(T5'2LW+[K4Q0B(+XBX& M5.7:+F6#"4,E!^7\2AQ54CCM"Y*D?U4KQE+IP,H_0XIT,5' ?*K7BH-?!7I=9 MQS?(;4ART25Q43$F*J/XNM>ALK>CGT\J^4?R3\5VH=P]&7,RDBA[J[0Q=(80 M[NLK;4LMGP9K9+KAV&8Y!A08F9W9T^'7!RB/I7;.4NP*5=+PP6 M@^">=@!E(@\#P,/2T@DD_.H OSWI^&7"CTZ;VPRT2/2]7O0=JU X?SBY4WHX M62+S\I%Y.JFHMNG;8PEM/6]P/C1990 QJ5_K_I,O'*-EI+3TE4J_9/56O7#T;Z 3\DX&N!Q M!;+'Y@7@J-S S6FJL519]5=SG!VS2+D SF35W\7AK$Q3I>1=46LW;K*"+K+H M[P@X>&"+@,W'S).5?S+7-=^F4VZRJX:5?]U11O52A9)=9)P,5VX?4IU<5(R)2BE MUV3EG^2?NO!/H5VHLUDZ>]@N1*5_61I=A;8AX1>)1B"HIU$4M4S/6X[[&K'(3^3KC /WP- H/"PGI(2.FXC%/X5SD%1&JL3UYN>QAP]) MQ_U3^0N"X;HJ3]1>N+Z%#[SVF U/?F+OGBTSF$7J0.I&SL+7[>06?0QR(0RV MWY*2"@8#R>>=7BJK."9UL)8&D?IW%HNBA3YE5V./Z=^N] D,]EJWG_6ECRN2 MFM/</*81J$\=%8[>Z56FSJ?,.P M'!-@<:VJK;-DT1 V'F=,F;BV[3X##RK$=,K"(47H:\LO?)[JI3A'&17WEB. L^UL;;F[?56 M<96"#<<(7Z%8)I%4A4';^L)GU]&'=Z;E+VQ]>6TY]&JZZ=TJ*)%SU[04 B7_ M.6'J5ILSMHCEB#>+GUOPTT^;WVO=5F^@9OX$ZEGF]]L>U6]IO7ZA)VW_OJ=E MOZ/HF'JMP:#HNU_GF/IJKV)CTM26-MP]J&P5O=/=H:-7,VHYR+31LAT+\:1& M#<5SG]?#]SLFR%6;TTQQF&N&CS./,>4C7#?SE3O89$U2,5;"M5OGK^V,+YU_W,L!_EFN'M9,(,U!%_1_R# MEOL>U#%T]I#B"'^8F$TNF"& +^<,M5]WHGQ>,&^M4]%V0*B=(P"B_*9.^6CV M@06Z9?O"(-A0M#=4V3,,DM/09(;+U^@ZA(7T\*K&S:8=0*:!Z^#*[BD72#DZ MMCD(,WR$U9;\:EOM[F+Q(A/>YQVJ$]$VXCO>$UA9LAQ4,HY=D47Y=+B]Y*I:LQ4>_I?OX"IAMG];"132:9Z+4R5 MIR:[&%.-,,WLZ,G.DJDD4U66J?(4J!=BJFX;F:JLED959ZHB][_4.J\<:_'D M 5C[X)7?^'-7S)9MM.X:1]T.H0L MLZXF1O;8(44PHDJ,U!,C>]3J(ABA;H85*+27&"D9(WNTQ"(8Z=80(T=L,W<. M<'S!7%==('4 M+[IO&9GB"/M72A>0Y+)7S&5[C(0RN*Q?9IMKR665 IODLC+,K#*X#(]\.W[5 MO.0RR665Y;(]AFH97#9$+MOL+E9/+JMK#AT 3/6P:@M-5IQ_GSUG//_3;<< MYDW/>NW[P>?*;ZYK^K6,^ M,._),IC_ &(V4[R.P%089/3"+_N(O%,*V!T^1,E=DKNRN&NC$WCL,%F:L#ED'G<-- [U,9-3WL] MBF%=@\NXZFAZ^[# A>+)4?\>6'NVG4;RJL.N*C.HGRN'YG)/9SS07"Z6:)W_ M])R>)@_ZK#>4\IS25"AGO]=MW'1+BQQ)N%0++AO6SL%PZ4FXU!PX2>0%< M,/LCZR2$R\=+S:)BEU#86\ P/P!3?/4IO+G\1Q;,7/CEB8GN(IF&[9 .L3]X@Y*PK1EL]VC.YX;MB$Z8.K@IB(1MS6"[1X,_,VS[[<9-?_3Z MI&W-_/B/;J#;RIB0W>LUS@M68N8R ')58O8[Z,79+,HH?#!4E0QRB9&\ MVG8^C*B-&[6,HY0E1BJ&D5RJ;3Z,:(V;H<1(#3&22X_,AY$N6=B;(8.+!DG- MO+_'*OLO)X7L=15Q%9Y_M05/J3IN"452N8"^ S786KZSDJS@! M:B1\M?8^3R$/&Z^DB@(?9DK9$38:/D(7HS.6>973QDARU$5S5#'GN];)6459 MA+<&[>P^?(6]\)*M)%M59.8%V6JCI6P9;-7!*/EF'IYD*\E6KX2M-GK(EL%6 M*C:KV2PFJ!];U36B'*UVY8J(:I^[L=\BRYV[,=#0(#M$:7)7F>O_WR:[A*+D(%KI*+4(&K:!%^"G#_BC.M84O" MG=%R0NK%=!-M4I_".8A"(Y4X?O/SV,.'I!.UX1_:Y:R>-AJVMOO?&-9-W21&*&3\%0KT:W4027G+,9D37%_A-T>7Z(-U MB:ZB1._T6MP;EOY747Y>HRQLW=[==/]Y]^>U"^W'U5'OYQ^_5N8ZDV MEJ8PE;/6> TAJ9%?;1F[VEAY??IEJMKJG6!--W9I6E-2T!0F%D59,$_Q<5D4 MRX=YS!=AP$QEO%1@[!82#/-'HE "?!W,F,*?S\PK'=0/?TN&7R@+FZ" .Z">L$UL1\PEH7 *_E]306&!]HY $+WHGLLQP>VH-(1 M9>KICE@Y'!XHYH"M94OYDCD.>L(3J.AXZPR(JHP9 M'S$%E9[=T(8W,!A+8%U%5&TI:W4K&])T"QMTACM9+G67 '!7;0V <=XM7-_" M)U][#)8%AO#NV3*#611G2-THC(1V5:+> -KO9BJVVU6]:$]_FCZT0T[5#A4%.Z2# =#*93-[ X MAU*!81T>_",+(K+$%##%%++%E/?"08+6QG4>4.4H&GLYVHX5BI.#.\W@#JU/ M2T=V!]S9L*Y[?;BO#%#US"1_G-L^=1ZYE=#NZ\5D15-27%6LMF'Y?MVR/ MK"E6.U^C2+I&[] C1N[)]PQ??7$]_.(V"#QK' 8\E^.3Z^#[/->&84ZC,M+, M5 X-#\%12SM.I (5(9)KZLHU!Y_>5QK7=(%KM&Y&UW[)-95!EN2:.!1S#JY) MG[CNA/,KTPVNQ#@R60I;BC?;O4YIQU]*II),=32F.OA$SM*VHG[C9CCL5V8K M*LF-65 E<3 1)+:IBB57UM[I9Y"DZFX;2SA+X70RWB\'N MX/)@F>"1S1D>.BSYX1^)JTY0X-:Z&);62E+BJ%*Z*-04Z J[P4..,2GB) MJ\O&U8:^>6)[%7-!%H7/:2CTKID M'@]FTG>:UFU-RX^+,5/:[2OSEAY-)?V0(F_"0)]8\'GRJ']?M1*_L@5&*1(# ML:BL[X'UV!RT!X=W'I7NB0H"KY"2>A#P,K#5;]QTAZ6=>"6!525@%5)+3RK1 M!B31M.[AW=HE\"H(O$*::-D2#6-#W2QOZWF0)5VNGY*^&8?Z5H]H^UU^LE#. MR=='S.S1V%=Z]17?HS 6V&P/2C@.]!(\+)*S)&?E-DG6.&N#>?KM-C#/L+P4 M;\DZ%0&19)T#C:Z#-J5^&R.0/; M:RBV_U,T.E1N1:-#JK OK:I^K5MVE2K#Y=".,C193<\;GFYT$-UL_7E(1EN= M/)N<,@6]#I'@$G+K4XC]ISY/N/CZG!!YV_D _;;6N.F-!AGI[1=;R2](,GO=K7]BZS HK7^$3[;@W6.;6_"OT ^Q4G\DW=!+KP4YSF1-132"]1/%[ M(9"&6'!VL"=+ JF:0'J) OA"((VPTEI*I)H"Z26*X,N U,&(\.$F:063LBY< M(3RR/_!U5..4Z2G+C0\]HI/:^'T;?^P;Z4ZCB[)5/4G2GZ1V>*/C)%KT:A M1,D4=6>*SM&9@OJ:#PYNO2:90C+%J9AB<'2FH*;LW8,;Q5U.B+=*D/A08K^W M&N;!EF17[.Y5LY]%1HV;;JLG\ZKKC*%+;J)RWRVI0(O%413P5T68/ MQ5.'Y%-987V)IRKBJ8@B>"B>5)1/:E7VNQ.7@8PJEO+'ZW]9.GY*(?6BFOGK M[+I1;/+U$QN[U>0H*A_=O5H:EA8)6-WRQ5 F'4JVN"RV*"'I<"];4#.6@60+R187PQ8EI!WN M8PNM38F'5C7@%O).O\IT.%M\%_3 M>KJ)YO0IG,/*&#<_PY?1#-*&=F<(_,K7_N;GL8?/$K.FIVRY2U7QE('38T9% MS#S0:5+N@H(_3<5C?@ S1.N M,8-KX!Y%GTX]-M4#A@=7%6P0W-6ZNUL$WSJ!98KC$!Z8$7I68#'_[KMAAR8S M>6!RO@@#'V[M>F35& !;!PZDJ/P=/8<*W"TZ73; MN(]N9A_$LS'<^1S^(PZ0F+B>$LP8_+_'F (_!#-?80!54WE@BX!A(V9%:S<5 MM:UVB1+P02/H+)B!H[>7S9=1:$\'_.-1J-.X&;0V(QV'K?>>#M?'FPUV^<\X M6B*>S=I"PV-?OL[/S&/I,T>:RC@,^+>.&RB6PZ<#'^A=1C(E% GF5D\@C(T_">W= VE9G^Q.!7ALL46%<135N*<@L; ;Y*MW&H MA1=P>)(%+'C@?5?;=;+3VA(',WV32AXS& P9UF1"Q+Q]^ J"&I@=SP"")?&- MT/?YDGUR071W5.59]Q6?!8$-7\-'6+D,B)2PZ(77>'6#19J(. &][9"-&NEM M];31L*U-1F9W,NQ.1CU]T.YUU$Y7[:F:V=/;_Q[T&QF[N]! KE!QOE8'BU5W M_!5^<_HN[+3==_HM#I3TOTK$&D*_V33HLK)_'O7O&):Q73_TV"-<_HL->D * MJ%W.412TN0VB+_%Q#&"]P"7Q0M:XN?_T_O/'.^7Q]O^[>]C0M HK4%GKN0:+ MU!!Q-%F#!!%:277M$1@#I8KN+/_F"Q;!TZ L6A(ET+\K'JA;OJ('H)Z!*$8M M%K4R(ZLV@K/L5KGHT*$+.WWGVH;%$ TI!LE7&$]6AE@LW(#8R8KT2/7:W+Q^ MW+T'9P^U?]2A8MFMS."H(T53M).A MS_U8ALX#>@5R(0S?8VCFB$TNX45D0-BK@F?B:JI[8YU.RW/]!"4.*%]H(;BPP+<@QX@=+MF!O5?J-MR<#\+ ]99\?4&/43L_KJT4$.5-YVV^>3>5-^I;Y5?Q=!S" M>]VVX%;'TA%O<#,HO_B]R0!V[H*T,R"W&1OD;[2W7,PDE.>$9_.%[2Z9.!-0 M6.RHA3'')[YI98+J5-BI)J(?,V D-%E%WTOC<]*3UK>2-%T!74Z=!#CKAUV> MS+VG-?K >_!IJ];ZE<$##,NV>!:1BV(AA/? J.Z^XVA95"_/S/>I\;]W_6Q[ M>T11Q=W>@T)3VO"#G'I*/4K-W^$0*<])5(@P&V?5G9PPG2WZZ\--=/(Y M@;'34?.L]CF%7)Z=O)HRD-3C,U(..:^2E-G0J\NQ]JMJM]\#UWL.*'M?0:%S M0%U\8-Z393#E3>/^ZT/C+0'%!3[S4-O 75$/@YG+W8H*NL= RS8M4%$\5 5! M(9TRVB[9=Q@R:IK*$^BB;N@K2] >Z:=@Q5^ 2LP$! ?HI$#M#Z&']\ E&*P) MN5Z9ND&9Z\O(60B*KKMP48WDZK@>'QHNG(P&N>G&P**@.'F6;J/[%;7T)^;Y MY"$FA9X;2_'[Q&WDW=/C6R/7G^NLC1_@$MH!32RE,) !83DZR$2X%V0C-PR$ MG19-!L-53XPB5/ 8UX8WPC,>K6 &&COHW&O$7Z+B3C8&D9FK,C;J MY/1F/@./[DR\J/0T7=@OJ>?@2 ( %@SNSYEELQ5ZSW28C&%X6)&%(C<:&M![ MS&R+/0D8S%TT4ZQOZ"4@.P6=KC2O_X06_)382GP]D3AVO 290^-+C=3%)>*_ MP@8S!K $2[["8)=&"X3F3HQ#TH;I"H]-;$8AP=CQZU!<5L?ODB5"4RHVY7X- M/80\SFD3?3:^D+9'DVN,,W@YE 3G=ESW611J'()R\4\PT+; M%!!#(5]\@KY8, 0G0B-T#.8%NK!= =Z6 !30T&-/%GN&8?\GU#T8A'#(<-QS M+SAR,8+1,$*/$T#GN"W@E!9"HJOR+.YH#-<>@ZD#7M\]6V8PB^+[J1M%8+R= MW**/@=9AL/V65 3<8"B+SB0+,:-GA4"I?V=>XD.?@N4*?/7M2I_ 8*]U^UE? M^AB@3\T)&/)JC8;;I@]V^A2N%H0;PI7B&TPAV!T/V.M%5K.]R!H?P7G(O' # M6&7DMXB1+>$8T>.P&'DF@'DHT :0MO6%3^;8!!G%M@PRU;CK@^\UMC6W>"@' M;DLVA803E?%R1;98^'R'3=W $O(Z=HVM7V7A/FU-X*U1J,@!4EB^'S+A\<#/ M($18])O-II9OZ]P/Y+%I:$=#@VD:Z)BR]>>\BL4%9F_#AGQ>SZ /MW MZJ=.4QAB*&E!^?/]E)B'O1Z3:OCFDWC@<-?Q?1=$-PH^VCZV24Z,$Q8R?K3= M(=8_'!S3U &2F&#Y_"+1 M,K:77P!5:(QFTJ'7N-'4G=D)9:]2>6/OP][5:[A9NY;C MRV&@LU :0G&WV\LX]Q'P^R>"]1Z0;01QH$>$>#+)/@#(:'O3L4[ V"\9_! ' MKV6$S;9A!O185.>%+F\V!6]'$9)EI&0&6R+!40BXI7S4'="AR!R)S0>NIIKP M<$1*:NUI,W;0D+$)DF :Z7; E5X+E4600:DL#-CYGZQHJR!=?-T@3%D4PD) MH;5EXVC5V_*/Y?AW9E#J"PSCUGPB3>:+8.3;V'9\\[__,U35]KO;+[?TJ?/N M+1I4:KLS7 DK_@$ 1S=8$(?1'D"0_!=L%?P\=<'R=OB"D/\.Z,W= FJ[/4+' MK1M.9Z@-M($YX-J4_X G<2$,P=QJ;@H=89@*"SMTR.XUMU[7)/8"Z#Z$H' # MC\"8O= (0HQ\_0/&%-#H'_%VT/UF#(V^6Q?36#E[#A* MWHB>^=/C[;^^-MYRL!J"X)Z[)!33R#CC<1\'9D%A C".VE7NOSZL6/=(KPFW M2\F&M4SA;$ =>8'C%:Z5A'4Y;?\FE% OB5QFABLW ,'=/K"?H\$+5(&UQQT" M1F+;[K-_K9C<60,@�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�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�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�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

    A\O";M^3!=LN+CQ++A&CZO\K;"_M.UBH&9&QZ_OT&"L#\E/ MCN27IRUI>[2QW=DD0O.-X*2,2Q;W ZS1I1>3AI9 W@->4J??'.&(58&[:(YV MGA&_)VXV)5=3HLY__W!5Y@R 8N08VBJOV,D\8RQ._^]D(_WO*W]GE2Y+LLAY M6@VH/<#1*C:=LN#](A)&)Q&)57TK,_A:LS]>-RO99E&T.V;>AQ4'3AR'[G6" M7T#W-.*_-Z&_M&Y"YHW_X0/?))I@COZ<$H!EF3AN0DJG)E=RWW _8/GQE..@ MUC*!!#Q$!T:_O'2/U+B1]G:V;5_.]?D5[&K4AWN_:<7K__%P<#\BQPE[&F!P MJP)>^S;5Y]WH28\=3$B,KM]ZUWT'YS1/KR^C"0@\&:LDGHZ_L;3)5\B[?'3%GRAS MN M31N/> !1R]?3\:_QFMTM=:T9=0EUQ=\_<09-,>;D5_W;HWE.4$!KHS4ZQZ>DEX7[,EN M/?!V9*TH(R.OP'?7XQEM>F+7^0ENQ:BJ#&PPY9'OZ/DF2L/=3(64" FH/*[![+/+I^6P? MI"!3D",OSFH%,!Q9^?YB56 Z)5PSJ0>VW7@EQ>4CT;\6<7SC:?#8VWG9%"^6 M5D-+?M$OC8ST9X>A%3"1+F&D$JCZ#):($N9H B-QOZ>OC+P$W4_@QLG7^2&/ MR-;G0QFN6!G\=?&9"EI>DS?5,0/;,'"_X^JKI32< Y[I&%^Y*L388=?K:'%V M-#T;=?Z(,1^H#GC3!'O@H!:.P5?)I<831;$I%#$>P5)\H3 M2"KA18&4E1X'/?T.:UJGUOF$]8<ZX.JZ,\.<'7'.T2H][:/5_V(V$F[ MH7?-P']_:*!/WIT3N-J]'R4)-04\O/"@RPR ^62O&B"<+_L[69] AJQ'=4 PMXL"(/WGF-V M@?R$=:^DEREN)[R?+S%GK52[?MW,L/I,]J%IRW[P0KTG-:">5]C7!$ ;5F*U MNXHIU=J=C[OS@G2S&X+]%=]'Z5[.OOPD9QARYY]3D$>9,<9?!+CAZ$4T>T_- MRX.%R N'G49R57O/VX$W;4::4&XN=-;SEY>_KR/7SY;[J["FSS6:2?S5ZJI^ MY=+#3'+L";75/P-L)RX!*FTICDA<]@"C2KR6N7)Y-ME3@0KITW*GSR);LVQ6 M\KEW(1=CA(AG==:@.T&,/F&T(N^:UM/]]L5Z[?L]-6BH=:U\]W9H/(+0XYIG MVJDR+B9XN-\BV\ZS?[A)1Q]3\&+=U>,/J]%B/V^PTZGA\\HVSH%#G58*0;*" M6BZW*C#(++L7B M]2@LOC#V5>R+7(A.:T^S=S;+/1YN^TH8E1!>P=W*[+;4! M3$H5RH03,-;5%^K+'A:Q>KSCXL-,[4?A5B6<\K6XVW=R(=RZWB=V>< /=_/5 MKZV5?[RC?=8U<+C(>MO/2*.>(UC)K[>>6HGG+19X/'TQZQ$:EM M9"!*>^HI,_(-_#Y6PN0%$XJQ% $=W2>\3&SQDYPC@6%&!](/Y&>)2 B>*-8) MZUZ0!FKN-^ZST"/7B"ZM6Q8$MM.)=_)]\H"3K6G-GVA\+KKO!_BS>U>-^?Y( M,F'4:;HO6P9-B.BRN$$"+M7$HR30VY&(48Y)-6C-.X,%&;9<&BH 5Z."G8" DCNZD MKA:80":)N'V;0AV<=/[ 4#O\_IPU:^+^UU2-EJ'GPZ$6=K].L?%6W'T\JP1C MXH\["B/]P0N4&OFET ]:& >F34+(*_?*$@D56W/#1$AQ:+$_$4\@Q7OM!C*2 M>C;N4?R2#!I5#?Q8UU.BGLX.^?O7"6OGBNPYS:HPS"BY(B6X(\92*H>"28<% MK( F:\=!>V#;YP#N[FF83X;4@%W3N-:NM?Q;-YJ[[66)Z*GV'LW6"Z.?R@=, MME[JI/.<#)W;[66^$=NE@KC@S*1K4W]D4()@W6M8@:>-852138B$6W?>LP]3 M'ZL]?0L/GH>OAE9\=<8,Y?A]"XGM4D/P4ZKSM5* Q3=$R_N^)H1B]V/29U+' MM!^^+G]0^E=)W26G;*,$_MK*(B@+#8I35E(BL4KAXK$HR3IF9DDZCJO; ,Q7 MNA4-XIPTQ_HU;]V+'>!)ZRK;G7-^*^':M1%0_TX%4YXKC 7@W=-8$4MSCL9' M.D>=AI%%N!WS^PM@M;Y0E+H'-;RAT(WYVFZ4 %T.FGES_GWQFEFO(ZBUEH'V M@1'15!>.-)O\LB?(H#L/+ACQ&"[-N0R8Q=-_5ZA>9[/-&1FQ'B=#H+.H$;6! M; >&DLG[&V78]Y(; TQMBDOW)B2]2SZ'!SGE>I9/OBU3"[-]M:)M M4?1:D:N0XF&-T,*$+E&D6@B?&^= 2(*:DJ5\G;!NAVFX#KK6/4'CE7UTL=N5 M;!L9;ZT8F(:%.]5 ',=1S!6;9LT7)'-DZQNEHI_>>7S_M34T]\G&!BUXH3W1 M?-J)Q]X,F"NQ'5# EBM4Q.SIL]09_[T)$>3Q*<4.Z; *Q+,?#*GNP1UCN?%C M'\Z^I1$S^SXE\"ED0[3P#H[T8;99D<8-058T8/O)FM B!P=27?_LO=9^YK%% M9WMS# ]K*53\0DJ !J%D;Z";1A%/^ R,/CJ#M%C?7E=GN&,!^G;_EQ]S_'[! M82-N$%"95<[3E&*DYM9+25A*#;VJFCMF#NW&QUMJ@4>B:?S,@@@%XR6D&XDH M?K-0+['FUC97MS;W8^,>;[KM)J_^U$RWN&WW%0Y88Z"HH4ALLR!C%MAK(.<0 M]@+$4@5*V/N"A?&^7PT.:IN0B1%Y MSF[0GKEC\70G$% >+(MFJ Y00(8X7TR]1&S=J<15=]NS'A#._:N7T>5MEBV(XGV+O M_8.6-I!R""=BXR'Z!ND3B0KC2+DM\*'+ ?+21 MF9E"25F-"MZ>,!F?FE=S=S0/WIC2&ZI;P2XPW;:PE=HW)9]L2Y_V8XMS9]K@ M/<,Z5"R]$PC>A#@!BVG7&IKB>I7N?FO+RP]\>3E X]KI:BF^X/?UMT6+W6*5 MK$>\@9,$J.)GP/0^ *<^!/TO3%1UA @9.8HS84CF4,;8.RA*.-! M;TK&]J :X_8C6\+-*C$G5F[2TR\RH".[4BBJ\3 MS^\/G(:1*S='B=CJ=NUG0GOFK6:M&Q*:.^G/>)S1Y\*X MT8%&]<.*^=D[ J>Y'&JRUR&)U7*?[MLK;O@E:/P=%:>^"APHWKJ%G:EAA.=08D*3] M!BJ R^#_H69@*=M@7G+3&Q;PDS-'2_]1!5?A:((N3 LBKA>?B((R)>O%6>K5 MWSYZ;F!1\VR+B:#'S=6AZ0S%;_OXC5AAT\9H:=1(UPZF>%*3_;U999+@4H.; ME]N@1N8-XI1A=>7AW7$3+MUHP ,KA;AGL]& O^+N"?=H;.)9;'^$YJF6EHN: M G:*P8X./VU:5R-4^U!QH YE,<92:>GV#>PNI-CS;W(7/!2_-HP:OZW:&_77 MZP+A4Z]%9"\IJA\^=U1XF)G_!A\+EXP(I8HGPP21.M6D9.<]T97@7>+WJPH: M\:0#1D$"3T3)/A\%"?!F=(K%,5^>T5'G#BA=6FCUEQU'&C';-HKM$\0+=,M^ M]H^%_5+X+/+=J>Z)TI\AUD%PF>=4B!L86""4:,LRX-F,=N0!,(1'JU31W3^8 M@ND=BK2:E 7AQI:DWB[HI+[8>]'\!IYM-2P:;GK$__6A1\=MOG5F%-N,.Z*4 M6=G&?0K($\)(3].KZ MRC?[W,ZQ>J RT?Q$N"7MS3O"O?&H(?0.0IUWZBGV% M] '5*>)R<_Y2\F,OF6:)52$+[U($&ATL;GH?@7P)'8N!Z>+)]0VH#\0:CH1R M'UZ"IX>PF7%K,!IHAJ=PH9.-LL!(_/-1QFJT14"SDVGCS6>QZL(.N_>:1LSK M[A=HW7;ITH83>(0Y3EYCB%'XF8)D>&^&>E\7U,PA:!>^Q$MO,N-]ZFN/D[<* M,F^5-1O9O'_]G9FMJNIRSP,@)2$=2^9 E]ZV[7G/RQ;+H9P/]4P'KZL(*>L!W-L/GT%EV$C*RFQW9J_ M!,)W',JW"2%8X[U'9G)8K(U6!DH5HHZHA;[ 2'9J5?\PB MB2;S/YXJ-F?/WE6>O>'7G%N:X:J(FFH-JAXD'?-$$SSP00;Q:,"NW3$9VCBA M)MW.#,IG.*,D Z#*WL"ZYXV4%[-SM?G]6;,'*HW^W#YA$?J@0MI1JM6KSNS[ M=.\F9*:'%07.'QAA/B>;Q5EX?4M.Y>[C<;\2JZ?74D69.&'/MZIIS>:%4Y.6 M\DBC*CSHB(2:&;66)U8[+/^' ;[2;1,6IH @Q-KH8+6\J"%ZB;D&Z2ZO*[ M>]4<)T#V"8/::?A]_=[;$*F?@9%&V;CMEQ13;B#S,+>SY;^+$UW(CAQI'58' M* OHL%R9-3W:&]B;%J&5@<05^G(E>. P4B_JV7>Y!EO-#M9'C4-ZC6NLM?\Q M^1RQ3PK)#6O$'NC=W_.G_+=M#=./I8_6&A^/%]['7F%_I.I>E^/%K7.K#YMM MGQ[&8IB0."WBYJ.#*KU+BHK#]RG5*/[P_UCM&RO]Z/QA?KX?B\X*7M2U<5WD M6"VU^NT]IC,]#+FK)][/.._H("\(3(/R=HIU=^78_RZQLP'Z<7_V_5ZS_PP2 MP.9)<[J3G=B/8SHNYMLGQCOJW+^Y_8G8_5(ACCMMZ1-K#L7>3>GIW[^:_^'U MP_QM^]G_Z/(W[A/Z8W/AC^ZB:&/3??T/[ZI)2T=TRVR,6!CJJO+UP+/M SN: M-8I'\2@>Q4,4,_^_"0!02P,$% @ @X)F608\R!?X^@ 32X! !( !E M=RTR,#(T,#DS,%]G."YJ<&?LNV=44U'8)AH$Z4CO2$2JTI2J4H*B(B)&4*E" M5$ Z$1&($A*D=P0%%(6H5 6D@U(2Z2(B35H0TQ2E22(:CJ;=XS&2)T^Z7@2PK>##W(9_('P?D!V'?5' M7@V !$# QL=;A-A#=O#]:_^N._XU ?Y_UYT" OP"@CL%!?^C"XD(@UU(4%!8 M3%A$]%\#[\3%1,7_/?CW)O]IZ(Z=_/P[184$A43_AQOO#41:>,<1_E_\?'LA M.Z3Y^*7Y> ,0*+C&G?^Q/#[(?VY\._@%=@H*@/"LJZ7!':®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�"F'%L#(&?1$>HL8RBOZ&3MW-6/:!JX*W4?0+@/ MMII::0=EF]?F._@<8#XRSC&I)!"K<$G*Y$O@804)/E%M,.RHWV%H"[*:Z(!> M"0>;059-*0W@K/^-!*,K.,:G+T9*.24R ]Q":+FDH3/Z4:6RQS(*&K\2.O]T M7NX->T.WD6S?(6@5:PTLPQ]D"&X'9 6C0S>.BI9+<%%I8J,+:%TTJB%%Q6/U M62#;D?97]X=WA-;]':0'/3< W[4K :=^G$;@J:*!!D(E2"*U*O/3#"/4@L,= MT F442^6_H:$@;V0/M3\6(.C'63> &1N/+2W4&9R7TT%'QF17"J-KI5$STEZ MP,7%,B=.6X?.DXT66&7D;*9DX#$G+P"@"AIH $?7TBDWQ?'+TL!ST3G^TW25 MT[L3!-S8_QL14J\"YYX3B&6<&D8'Q(>,N^-/_57^V+ M(J.!E7 V_OAI>9(_+%9-7$["$N/==0-)KRZ7[V?+_X!EY_GDF,O=0DX$Y18WP0Z"&G"%MCW8YXYS2WTBR4F-HA>: M.(4.)2B571#>)%7]H/I_JGAVA-6.53S/T7$+T/UAG8"+,@)/Q"O!B*39$\>C M)YYZ, 99HZKZR/F_1!7/LX#P["J>9VBE'90=KA8F,O2@7$1*Y8)20*CC&,NJ^,&@'LW M5WK3L40FK7R9 &P"*Y.BR]&/YH0!I( ;;'90&Z@;"?FKV^0ZP-Q?A\T!<6V^ MA.3@@W>*1,HXD0*],@_1D)RXE %D$*SV'?;_QS8?CE, M--J1XOC]Q=';MT>'%Q\.WIZ>G9P>G5W\Q\%O9T?=^>S!^]>'^(.#X_=OCR^. M?SNX.#YY?_3OIT?OSX_.=SZ[WON--0ZGZ[)=Z?3Y8 MQLTU0[C?QRAM-[DRE\0)@B^:@$X!Y8P':WSU*]O/(G#O/JNSQ>+.*U8!+S.X MK)4Q!%)&?YQ917QPEH"RP><8I."UW8?-E Q<'-D;5AYT7=U?#P-N_HOYK@N'W_,!"I MH<]'H;&C<(?M]?8.TG(^FXXC>J+7APF)E62K)B+:;@8>H!U-D5AP.2;##5CZ MM/>S\;FM:'Q7-U&7?G(]Y.O@XQRZ*/@"YI]'R=+@I)2$ M<4!7+%M<#D9;PE3 :-4EX=*/>[S_\#6-N1D[JG+6DUP;,#/7UT#?S.9OX:.? MG,-RN;J(NAB9Q#Q7E!,=%,K(L41\])&X,K"R6V&A=IOW)\AIS-#L!Z7:XF\ M2;=;^"T3W66@!8QR] $IQE407?'>#.[B7.!63 -0]-]DU+5;9#U!SK#I]IZ0 M5$O\.R/I*\S#K)95FL,7/TYGL^]^4FIT1EZXS%A&H1CY_[/W9MM-)DF[\!7% MOW(>#H&BJMF+ A90_:U]Y!4Y@78;B99LJOBN_H^4Y1'9UI"OWI2A#V@;4U8, M3V1$9,; 0!G.(3A3H$BC, F'7K8>2'J7AG$OLHH2V<$H+SR%RI%C& MDO,)A '@7(M8DC')MPX -B9N[T+*5;/7VW+/1R[W]URD$T8$+2F5@%3=L?(A M08A,@A"^)%F$E\TW:FU!WK@Q]C!H^J'"7LRQOOJ*3 M=(130F%1LCJ!K5!"$018H3G]1-NO%AX+"0]MR]M1+!S"K=VIW M1+:Z8DM24:)A/"2L0N+5Y0LR3A(9I;!"QLA:7R?=2TQ'9]F^*I\-(?\.@/22 M8J;9]YP_9(KX:S7%ZGZ5@LTB4F9 ?Y9:X%[W?M<-X%$)E[Q-6K>&T3VDC NB M1HJ>M9=Z!^!YP,*N$QKK3='*:RC.$B=,*D"+!H03PL007'&M9\)M0M?(#2SC MN[W=--0=ZC[C_!-ENC9RZW6J'0LB@'+1 0:7("=G)3I#67/KH'X='=UZO!VU M_2"<=A!];_"Y;7#UAJU6Y+TYKZ?QV_)NMEA6%"Y>GDZ^3*;UGYV@YG6)8AUB M@W4"N4[$+4M@2D'CM;&Q;%3CL7\6O2'%XQYTAX7DL.H\#O#6K]_G&J+0/^$G MDB6*5&2 8FLYM1>)0@J*6FSMY0[>Y<*;SP;2NOTWO:W5Q]> MO'WS\=6;OU[^5BMAE_6N'][@O%9:?\L[W^!N^'M;W.7NPD*C6]WUU>F$G=O5 M[-=+KIA!2A=JSN B*,2ZYE(Z2D:2EA4ZKOFUTI8D]M_"?!%M%QL]3YY,3VDR M=),C1=M"@S4E.Q=RT+'UM)N?8@S4D(@>:^#3-ECI('BXQ>&+4UPL)F42+Q!0 M+\2XD,R'R,%GY!3(U\:3@A'JOG"7C/71MQZ:\PA)3[WE> <8S8;3:=\075V[ M66=9S,10]/76-B<+7H0,T3%O@Y<"0^MX]E&B1C]9VT%@6&Y+6+=AV <2/<&NN MG0Y -[PCN9C=YH(/7D@(EB?R(YX!\OJ5BS$:965N7I=W&,Z>^H"'_<. #A'6 M@=UMQ> ;_'+9IA*-T:6^#'NM+2CZ%CR3NG[+DHTR)M?:D'8D]:D'R-NC[J$ M9B (C-L<\F).4HYUT=3\TCU*QM$972^UC2#BZ\ISE0IPAM*+Z!TO=V+D-=T@ M/_[>CB*/H30Y:R76D;M07\S.I_2;2+)GWZLL+@I>A/6I;AI+(5#4I)0D.TH& M-!Y4B0KC+H HHX^.6OE9N,E'H'@Q@2-UR.[O\YG0RM@7+_V/,#%[,M7G'Z_[ #.F+3F'!RO(UY+HB.=F0)2B5HG98@9]ZB3 M>^1#QH/'0!J=#2+>#D+]0XZ&*G3*&VLC:#)64"PJP!3)5+5U4:64C6U]3][; MA-LC'O%U#,GV;ECKP QO3Z9I1.1G)%&9""3Q;K;7$*@*!*L,@Q-%%'A(Y5>S6EZZI<0 M^\%[7 ATA/U'^/YK6O#;;%ZCR-K"7XN5KIJ<2J)038+5YJ\B1 M)@YJE'\FWQ?BBU'P_2ZP2DWV?S%Y<_N;3S$^6#4J@C9!\D*'06 M@DO+.:!2.*O)KX6F*+^/DHT0KG\A_'#J[B B?Q9CO2E;O,\Q3[Y5@Z5HC)R1 ME2P) X[7QYM$?U JP<$R+#YJ+,:W#KW7$K(19,W/"MEV.CR>8_8AS_+LRVQ^ MMEJ>>Y(Q<1F+ 6]J=["/6!M!!9@B#-=<&K3R8,'%3_0IA\W7$O13@R/U&D4L[,8*8O+49 %\!3 VSI]UR94LGCA0FL_ M^D0[C3@783GI+24500E9)^=+!!N"BR'Q*+UI+,E?G49[(GJL3J-ML-)!"/Y8 M2T) GB-: 3'7;EKGR'75DG%KL10K$:7/[0^17YU&6\%HRTZC;73:-T17A14Y M&<,3'0E19E&+<32X6#O #:=$6+"@XZ!/DL?7:;05!+;N--I&'WT ;*->%A-0 MYT 1O$P4P:LZ^,E94U=C\(P\)9[= %V73Z'3:"M [-AIM(UV.@#=@2KR%:*H MJQC!U&G"2K,"R%P [O/TVFT3QC0(<(ZL+M=FQ.X2*DD9VKN M49L3I .O,G&=21%%Q!+N7NG]ZC3J!76-.HVV@4!WG4:ZQ,@LR8H%'RAW9G5+ MJG7 HJN#.H1.[$X]_Q/N--I*DP]V&FTCU@Y.OT/>P%L*Q I%99!,E+6]/-8< M@R(_'H1)3$BF6L_?ZZWX^HA+E(XA_M@-:QV8X1:O3._SMTQ_<2*"2DJAA5 4 MI3@BX&N"B8G-72A-;SS/<@]ZFGH0='_%YX."[HTS]9 M+-[-9V5R5FO43Z2P3DD6R:H3!V4L!_2Y@/="VXQ>IF%3S*VH?>KQS\&!OP\: M=L?][ Q/#UA"]2&?TB_X]$>>TE^<+E7U93*=U/?=.JCU9K7N/!58#O)5 MD:3@4\B@;= JL9@8>WS/_8Y MS]_,IO, M>N_AL=Y0\<<5TZ^^N&1X&:K$#Q3;[XN*HXGO+^W^BN&5Q5_P73M#C-!)^NS!N9K.VU# )%!U= M;MMW^2A%&X'=_:Q@'U/]?9S\/W*YP5B!WY8;9-[5J5!OSU==UL]SFS/RF:O:>R738T/ MI"?FJJZ'XA##D1^ #M'\WYV,R2?CU,CPVA9F[I M$,VOSQ:+?+; :;IL^IWDR[+T#WC:>F_>AI\V7.OK+NR.U/FJ".7"X'("?:AW MJ:%NU-&0LU1**^US.DRCQM%WOFIGN+6.\K/E8*A0.RY=SF B)\325_8(!Z@> M8>?K-H@>J_-U&ZST$2\]O(R+&>>DEI"DJQ7F3D*HDP&%#%%&P22SKPR,TT%@-#%D5%UVS"(DAEHXSH1#=CB0]M!_ MTA0"6W>^;J.//@"V46]EM"X$CL2,DYEB>(N (B>2G',F9IFX'J R[2ETOFX% MB!T[7[?13@>@.U"'6-:JUH=2(JPQ@O)I^=*0()+)1Y<-9B..+G3]>3I?]PD# M.D18!W:W%8,WFN6"EY*3HP2#=(ZI1&F']S[57OYDI(C*AD%CC%^=K[NCKE'G MZS80Z*[SU5B60X@)7*GNT5IRE&@X&%&$9SM>M-/E@Y^LV8NW@]#OD M';RPO+ 2'-@H*.AS+ ,F(<%KF8(Q/$MV?.M]7_]60^>"RF=MLC,H/=RNQ#] MU .3'>&X1Y?@_M@X+F.X'+/]9G:6ZSO!ZQE.[\S<-BD+S)B )2YK8)C!T9=0 MBHW%,9UM&K%Q]G$&GGI>>W C:8R9X^HZN>9S\>)\7A%PXAUJICD).WL%*@M+ M8J?8-43N98KD\$5I7GK\(QU//7[:#^>'5_5Q.8)7TV_$X&S^_9)55"6&$C4P M81V9L!40G/>@$Z5ASFE="A_OV+]+[L_30WN@0WXO/!S-D?YNGK_B)*W:"2Y9 M%3P&GG4 +NL46VL8!,,D6!^*$NB-9TW[!]=2\?.TR Y_G.^OYN,ZS)?N:\7F M17W=B632>R41,I,,E+827)UN*!F7)5OF11PQBO^1X)^G:_9 !_J>F.C "ZH M?ENVR>V /<^ P A0YBIBTD4$3_A/U&'ZL$N M1IN Y+@LX[<5A1_QG]7=02G(R?%EH%R)3@&E#7CI&&CN?3&Z>(EZ/(/X@=[- M[.#7*_"A('%<\+^38& 5@-J-#(Y0S\:M(!Y!YHW M,X.?]I%X%&@ 59Y!J(W MLX.?]GEY'' (<4[?WQC;4L\ZT(G@%&1TB++G68A9C7H MWN0=Z=[,)GZ].1\:(D?ZG+"&:QU\T;84\$76P566#@/+0Q4[TZ8P%6+3_1./ M$;09XG_:I^81M=^!*[C!P4ZO[(%Y&ZU6D$GTH$0($+(PP 133*6(V;0.B_8D M>3-S^.E?E@\)C..94'Z?]=_(C +ZD)R/H+*U=32UA<"5!LZXR98)X>ZNH!OH M^-\V'_[UACP*!HXF\/F+E#8_PTD=C_MNMIA<=(=?,UU$5L2@!1-,W69I=B&E*Y4N M9J4.'/C]=/;WHO%T[^T_>+A!WWL*8:29WUYB"-9X0(O+,?,.4# '.5.HCMXE MS0=H@WV*,[^=-)(5&8#I>OWEE $G.'U;3.362FU,ZW5U!V)M])%=@R%ZK)G? MVV"E@]#H%H=KA@-GP5-D.H+5@9)^XSB$PAAPIXH*WCL6?LW\'AM&6\[\WD:G M?4-T-<)/2H9>) 51>Q=175 =E[ZC,KCR'^V UK1U.;\ELF^N+D M E0DL2^S^=GD?Z^>GG#Q^439E(WT'ICPM4;?U9GLB<3@$S,A%F;0/7JJ-R7I MJ41:TE#5RHG3,7DK-/# '2A.@:53P@%3.E+.Y3AB;(GD-33\/..VAX?ROBIN MAN6VE5"OWOS[Y8>/?[Y\\_'#A_@YI_/3/"O5;!=GRWJ?"05FX>Q#CN?S9='8 MSI5/NWY0BTJG)DPVJFRZ\;'U0U=S',^^7W_Z50F(B"(BTBG)!,N@3.#D\TVA MA-1IS96W*.QMH3>X5-B4NGUO9RX5\;9\G&.UNAL?,4W+>MS5#RY&%USDZ%DY M$T0Q8(.,M2DI@Y.2@S/646I0(MK06"0[$3IV9C@(QNY>>@ROP@YN$7^?3,EM M3?#TU91$=KX,SY=5!8IKRY,'80RQ88L&E\CC6(699<:M:MX]?P\IXV+M ""8 MM==(!\ BJ4P7],E53!_R_-LDDHS>EC7<+3[2KURL_]'E8L\H9 RU15-29J@* MS^#)]T()DD(@9[*/K<_%EO2/"^$F@)IUHMT.D/TMBU98VSPS M>9"@<:\QNT%>.Z5U@,!E!/TS?/NJ[+(T2%G'2@I@69TF6>\2 MG$0)*7@4R4K+L'7_W8,$C;N6KQO\M5-:!PC\\WQ*@OR*I\]GTW3-@^%,UYHT MPQPH%SPXG3/$E)*V,L?,6]^1KJ-CW#UXW>!M;Q5U +-M+[2N'Z$XUXH.[5I: MZ:L]25N;/C*HZ.J" :%<:8W%G8D=-S$Y_*7A8;3: 7QKL]#'V9]X5KE;>^,? MC W<4JX5Z_@&XPH$3=&OX#IBYEY&W]I5/T;3<=U@[PB-V8!ZZAAW)\B82H4[ MBFZ-I.,_&0A>)PB*)6.E"\ZT'K)T'RWCXJRMQC>$TU;B[V#.^[U"BO'\R_EI MG4KRUW2>X^S3=/*_.?UK=EH-\X\:N.3"?4 M@*%0E,QS3A&'DZ!C"0)C,D&W M;EG=G=IQ_>\H4&RLPH[/O(HOP#K-GRH-@\+U=YS,_XVGY_F$6:=89!J\K$-G M)$= 15D@RQ$INK:8?3H0*J^(&OXV)"XBN%ZTQ'-F,Q@;),5CLK4*)&IKW/.C9_,]F2QG%3EM88>02" M317603+S"'_7(<8?V-@@UR,9I+(PZ+TLT('_=0'1>Z ZBV_P/V7J9KN'S-= @E9%80BJKC+%PI M%#MY2V&T%]88%M&WGB[2A/!QLZ!.\;R[:KM(B>Z7ZFT!G!A1+*5T@BQ52E", M%?"8- BG9/'U8J+Y(N5-:1LW03HP+ILHZ)AZL6KP@]-TE1(^V+@4OK^839=" M/\?3R[RR;5>UJU J4J:NZA> 034A9ZMHNV]I3 M'JX![+[+C_JQJ[^])8LD,@NY@%;%T2'B.,FBSE9$KJT/TBG=^@#>CL*C:?G: M!E6;WE@U4%H'\6WE[FSVY3'N;N:E[V>G]-L^74KDBG,44J40.*0:WBLM(WA& MDN8^.V&]LJZT3MK:4=_G.VD+C*V!\P@*/QJHOR&?MV+XX]_Y]%O^DWSEY]L" M.6&,:71TGC@*\NMYDL!'%R#YE&-(2>?2NJ^G'?7C0WT,_.UD!LW!<#1FL.+Z M_V:U%*+$L$EZ\ 9;;E%XU$-\7K6 MBO[Q2Q*.QA0& $0GQO"XX_V?R=GGV?G9!^+_-%\E3'B6W^2S%SB??Z_O5%]F MYW65LBPYNZH(.@- 92/!A[JWBF%2 556*8\2LV_.P_BE#YT8Q6C Z, P;M\8 MW);&+>$_*_2ASTY/9W_744>_S^8OB-C)V;)<) =*L# A,,\H[8I6@.-8@.=D M-68GF6I='=Z"[O'++SHP@(,#H(/'R\V,_NJ2[3ZQ^VRLH!/N4!5SVU$^?N)[:,SM!/NF #@:V-^;WUSS'9E@LNX*3XDE4,); MP, L)'*S,DC,F8T#_,=I/X:3O0/H-P;!T8#_WCSFFN_"?!24P8 .F83/_ZK^[P2NNZFM@[SRX8J>-;E-,L;XR!!QO"0=[^!U5 3A D.) M6$QH/86N.1.]-B"TP-RN !\$ $=D 9N\!%\T;(3$$&U,Y)$814;U\6.)C(,0H[(1#9[(;X0@9*D"6$82(,>E%81G-*6 MCC EL<28T/F1C&0+-GIM]^G93(9"R1$9RKV)]NU2"A&8-SQ1XK341F(2D()9 M,,B58J(.%#M0R C0XMX]&NURP4=]I88'5O[W(.O>=2 Z5P M@J,SB86A>X^:M"F/T(/4 [J;ZO>(+G >O1:S'&6M%H7D!>5JFIR95Y:#X3YG M2N-(QJWO&UO1?B3!SB&SXJ;J[O"8WOF%6&>+3F0Z1G*H0\8+\1WI6W0N<^-] MBO*PK:/'4B0P#O+:9KR[P>"(X+_!*[&S1"&Z,8+".\X(\URFS=5&YTX#":TBN.,^L5<$?%N+]S\CH!L [ MJK%9.GJ 21IK)M?DQCH($N[;H>I2D-$I M#2K56"=R#L&A!F>8P1R-#,UWHG2Y)KFYRC=?/+TER)O!:@AER)OH]T.D/WP(DI9G_ -B1&S)M'Z M',#KDL$*'IAREJ7FZP#VWQYZ'"N2M\+)5MM#MU':S@BDSPRS ^P/C3;RN-P_ M:6H'J4<)%.*0\Z'$4C*&Q:OF14A[[@\]CKW)^^"OE<(Z./\>7D5IA2*Z70%> MXQ^5ZPVQY!ZDS4I;C";RUKM[]M\?>AS;D_?!7SNE=7'^K5U/2?Q'LA<)#HLD M+FH!:J"O3&*:%YZRY:U=[\X;1(]C8_(^B-M;15T [7JCQ_VWKJ^OMGA$763T M,M;&\6I'BD[RK"7(S*QBG@>I6]_$;$7@N,YXZ,QY.%UUX'4?%EZ=?#R9GL_. M%^NO:E_GQ>+C9YQR<5',<)**8H&L$4K,ICX->$!34IVY+8+/,;0?PMN6@UXV MC3:'VE8WC(/J_$KVU=UBB? M!=/)M7[\;\O!N"G?L9C!7GH_>M=PE_N[AX FVP^Q%(@Z5[T4RHAS\6#0:DI; MM%'8>F'#H R-FY0>JTWL@XHC< WKA7"2T/+,1;7\Y7C+6&=!93H7>#0FJ(28 M#IL;K*=S(TCKIP[I!CKLH!-I%Q[O&F?D)BN'DM!50KTZ(&Y=,<"(Y\"S5B(= M]LC>B.R-4&Q^3A3OH^%]C]^/AR]KO%-R%V?3Q>QTDBHUSTJ9G$[HJT7;FL6M M/G*P@L3=&3]\M2'SPG"7,_@81&W^"8","^#!.\=\<*YY8'BX:L.+W_MG/OL\ M2]>?>O5 \($4GNO?O,]?9_.JG>40^!O[ 5,I4FL'1CH'JD@/P0<)E#U(9QU# M:UKW]N])\M%4*6Z#N[MG[R'5VD%FN)[=Q8D5T7NG,Z2"",J+ ,XR"UE*EY)Q MAC.B[J!PV B*V^FF XC=(/W9Z>G;L\_Y9L'\];A(BS(&EH"8DJ!L M*'6'DH18@G:")8RN]07S9I0=S9C#?8Z] 934 ?3NBNKW;V\F+\[G5>XDR#>S M:;SXALPT9^$7]^'K\%Y] M8)7VWQ+[!N=S^G7?/[GH>)'>$FQ[& BB%P;PD/(15 [1%8\]$Z'=Q(\M,79_.>-0*AS102_F9S<87'\K\./?YOP& MO^1E]UIVR3 7%8ABR87$+ !]X72NF_H6RW@Q&W5]$R$W8$K?74-T7QI[*5$< M##ZS$70Y,F;OXV-5,,^]5K8H"T[7JS%)IH[:D?B,RF@IO-CP=> 15#Y,Q3BX M.RP*9H.H9$1PY;]/WN2__\3Y?Y:V^,_%NM%5VT2B= Y-J<_W=9 +,@3WY,JG% M/!,,DU,Z^5_,OGS%Z??5Z>Q=0AT\@R#K7;B)=-PCF5SA,N3@M-:J]13I!PGJ M!U2[:'LVE.@[P-&V1_KKJQ(V83)&5\?V<[!UZ$G@0* S)E%H5I/,=J9 MV%[Z& [E-@^CU0[@NSXY>OOWE#[A\^3KNSR/5=.?\HDQMNC (RAGJCB5!,\* MB5.GS#U:E[EL#->-B3NNZXT=P;)1^_0VI)#M!X^M9F&45!DTWKV3?# M<-)+HV+G=M$:$\=I&6M/AQ<7/4,7NQ>K'%12.0M-1X(,#%1@'EQ*I*FHG1 1 M ]X-7+KQ&'=YZ:7GL7/K:(^+X[2/>TZ)'R014TZ2<0NZ%MZK:!)X7R/,8H-" M'F.6_7J/G6SD !V5G=O($-AH9B6#5OWKV_/7+5V\^OGQ/?TU_^^KC MJY3"J-74U(9):W*YX$%RZD5("Q M6B#,-(.@"#C6R62DEP&%?%B>&WQ*N_OC^S[IXC:3J9)*JKM9K*#< I. X*R M')5'GW)1S?L9-R1MG,NWU@"X_P:XG5Y&+AAZ<:.9^4I6]260R9B2R\NJ?9*3 MS@FP> TL\UA$+E*KC0;E/E(J=-_G]W)[VU#1L\92[Q YEP^!)D26&,G!)TFA M0IWB%U2"R'(N/-@4-AM4&?28&Z8A7/FO %%S=P<0+.JY+:!U>;4WD."]1!P=A*S6-[C// M*UM?:]',56$Q\L?/[N4=ES,O[K*T,KB0N77.\UIJ10:7HJ^3K^KB3F:\ MC(YC;E'7OS%!8[K&?74^&UH!XY93_)G3).+I;_G;).;;57;":9,1(V@56;U* M\^!T"!"$-XPE$M&N*H#L34](]OQ;BY5H^5[LE1 %C;1T* M1D;J+1:P/CN&G+%@XT[^\MZ/[+85;BL5/^PWV\B[/QS]2<1\)K[D#WPQGYRT MEI&T7.4K)$ ;$+0UR#PS]/^[X>C>CQSOUN!P.&HC[PXNKNH0ASN[<2D2T-YD M!=&Y>L'"(WC!ZFY<:4-6@0O;^F;J1RIZ*85K'TXUDGQWV+EA:%'DG GZ8*2D ME#@J]( M7)/%8C:O%[#Y\OATR!$Y^5U=V_Q09W I&HC6:14*]\651]W5(Q_2$R9V5>)L M$(EV<*C466;YO^O>0TDL=ZG"NJ84.^H32RM2(_YR3)$L0M?K5902'LD LQ%26HCC3NMOZ7F)& M+D9IH>K'X;.#W/L#T.4>7[2>8R196$%,*,E)-,Y!]$I%2B50VM8E]6L)Z0XX MNRCY8>CL(/$.8+/^E?GU5;&SS,*9;!4DCHH$%"E9#(:#CZP4"F,H$VW=V/P( M2;V4C0_GTEKJI .(7=3/GR@>DTQ%0A2BD'5(!R%'2B988IARPI):!T47GSSN MV=-4F;.])=L!'BY'FY"MG' 3@C1* _UAB70*_;T0'AQ7/A:'V?O6LUUO?/RX M51]#(F-7&8^;<+^>X73Q/L<\^58%L_@3_YE\.?_R.D]K'\X+_(J1)'12DI39 ME@"NSIQ3T4=P*G*(67N6@D[Q;I''FKQ[L\\:]Z5T"(0,(^8.CI5ZC7"#JS_F MRT6@C N1)*M-#K4TDVOPGC,01#]RIBQQU/A\64?'N#?$0QXT>TM]W!-GM4QI M^NF:A6?I&_W5LC;F[71I*B?"<)4"&8$0V8#*3$+0P8'.Q@BC@BN:/7K@;/11 MX][7#'3>M!=R!\?-LD/T'7Y?#H#Y.'L6_WL^F>?GYPN2%H5EBUI!94I&#<6X M6#, XJ?6_EK++>6<]+ULO5/J,9K&39V&/(:::J.',4\W5A+]^\VKE8=>_F5. MMZ_.3R0S%@,&*#R+B]GUSGL2HPBR+A"./#[^:K[MIVX$)7M,4!I:]/VAZC8S M;\_/%F>X# %/4NTD+SE3'LD\J"0,(!8'Q(X61I-4(^X$J7L_ IS9" M[\ !KEN==N(8=Y;"/#I7,];)IX*.62V@""]+9B:G//0(ETK'1FCRQX2F9E+O M[QAZ^[4JYLII7UAL8\Y,@$1-TA3:@.<:P1J,A4AE[NX2 MPEWAM>?I=507VH?5R[@ O)>'U80G5P+/I7E']&+V)4RF%TB?IN7+ZA(MB^4!K$ M).+_OTOJG4PHK8>H%(+B0D"HE_RL!962<+QD;%XNL 5YO3H[G7WZ M_G[RZ3,Q=W'J!QE#<:Q 6,XU3#Q!B%&!YLQ8KBU/S9N8'B&I6]CM#X3 M)#>^]>JRC0@;UPL?$G;M]=0!^/[,N#B?+XM>7TV_GE\WL"K*E',6%H2AF(4D M)<$%%)37Y.)E81Q%Z^NK^VCI933< 0*])NKH%%8K$U0%N8YZ:7@2E(T1?$B) M(H^"5FOK==QH%N&>P.HA5FNC[0T@M(/H.P31;Y-%K$^C[_%J.(=$+EDM=G7D M\VN;80843D&T@;/@*7[UK7MI'J>J/U#MHO]'8+6G,CJ UYKC_/I1O]19LU8* M2*H44$4@N&(#E%JP[ZP+[4

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

    3V=YYI)V"8TQA)%;'.N&>7(,$^0 M4=$$'B&&U*7C[JT"5<^DZHD'+Q..BX'2 ,->Z+"\+6QE M\AV23,EA:3BSMH><]6["M; /'D6$_;?# U!IBV[7$SN:#A<@A?^YG\Y#O*56 M+F&CHV#(I02V(UPC&V"A!Y.&X#%/@?;(M2V2-;\['D*+S>0KA5%;S/L9IF?V M(B[B[+V=?OUI./[CEQANX^1(M$C3G6$B2PP8C@HS;UASO9P MA[R/B-6SDT_+Q>*HM45*4.NWT23:84[Y^3CZ'A>3;:7U2C^NN:+"(8!J,8WL41_&&66S-.7VT% MF.FDK'7YD:#\GE:$&$P(CPPVX.T(84VT_;&R@X35DYM/R\G2F+7%R&T' X_W M\@2'@&UT2!.1>]!S@W1N]4FBUL0'332K='+W:QL9T2<[:ND5NC9R%"_??SR; MS28#=S_+YKH>+YP2V!ORNVI_?AD/\]52OAJXH5Y0161$CN1K*9G;8TB8\5$' MG@SEN5UH:5YV%Z_Y^.8(IKRD94^@-;!8SE.4\BTEC+@XG+A)%CLM@D;)8'! MDJ7(!>Q1$"1:#MX'+9X2^UJ*RNSJ"_!71\M'6?]@_GR;-^BYFMG)K B++OW@ M74SCG);F<^K;( W\'*SIXL=@LG7FO*&.8AUM=G,=Q&#&Y#-5B6%Z.NP=MUKZ MTC<:!XI:>0,^$1]/@6,#B]Y+[7X"@Y^-_>#]_22KLVA?M4-C[XP3)H"*(??Y MA>T$] 134VY\9,D[6_K&Y'BI*\?;)R+QB='=G\]FP>=1O,WN2YD%>*M;_N?G M\62.\AI=R0T/.!!",(K2YJZ'VB.7.X4J&XUEDH;H2X<_1XA;.3X_U4)\(CR/ M)>]UGXZHB$(ZYO-C<-S!KN+!%:*2H*B,I(0H+WWIKD0'.J*]%1)4=$3WL?Z1 MCNCYZ.DJ6"]-<9ZH.7WLT%D0;F8KGZY7-3GSIYUS>PYK0X5QD<4SG# L^/U1A/ NYUS'L$HY2 ME*12@1+L/2^]N!XE< MY&P=Q9Y=[VA]L#49:796=9UP%:Z4T+"&"#46<8P96 MQAATY8H$RFGY>_5CY*W+T!/2JA"A]\;X#?-YF>BE/4E$:YO?IY.(>PK::N)0 MH(81AJ,-KO2CJ,=)_#8YO3^S"E'Z )C?,*F7U\/<*1^TQA!@&M@,'6R&UAF) M7 !EO7,VA%8\B18R\T[)K4*T/@#H!FB]/9W;6 ;;G%5(BGGZEPC(><=1P$9% M*9.UO'3>Z/'%%+U=,-3S'LJAU #EUJ=W6R=,2OG\1!,%T0+-;0$E1SY&;;#4 M1%O22Z3YAJHK]@*Z4W7%/E9O@#H=4ZF5M(82Q9"W^6:"F82L" $ISXV#F1:$ M*GWO]!;2W0M0X+#4]GWP:",!:<\T:2YT3#C7QBL,:[L-H&!P$6PH"%5"VM1' M@[2WD]S>*_.*(]0:!3NF1#,>L2$".0:>+NG](OQ&T1IZTRF%NM*X-1$DAPX,H]95&?? M[6"X2*G);&.5C*ST; M(K:U<]VNXN3[P"^>(+D12FX7'@?#T4! M#_M#G'X:C,83B$0_CL!-@#@1;/!\E$6@^BG.OHZ?A)+3&V("Y_DA.HXQA5 U M1:1M?D:1*&69%=R8TKRD9LH\"D^-WZ)EDZD5C^]4E< *F"YU]EDZ7/S[YKS M^9?YH_"/";W9H/>+\<=I[D;94?@P&-Z#Q<_M9 3S>+IJ/7]P/G39SY=(>>[1 M(*6RFE]\ZR%'U?@H%ZX1-;DQ,S8IO4Y_/KLQPWX[%@;)1'/YS0\"8VL#1YA MG)^TD?E!7WKR>;!;[KKGQZVROC#>;X+C-SA::ZC,;=PB[*(D&J2CEX@D;B*# M313;TKU\=DM5]_BX57[NA=7A[!OG1T/*LR\_,K)0"D+A!YU6]<+/Y]Z7^"UO M/ _3#CN;-)<)!9-?-Y::P[2+'GD(:6%7L<2XTGDVQ82O>_[< I=/A7P#"^XS M<]](X4)TCB"MC44KN[Q;AWJ'8Y ROF/^+@]FNV MQ'>8);=Q\6;8ZIG/R_O9=&9'V2U?&NSQW:;Y^>&#_6A0V&'8)[SG KP4YY%F MR2,5K0@^<"FI+,R[,I)7SICMXZ2A J0-K(-=M5[<>R=&=9 0.6KL16[#GANR M@VOM7!#24F*,*9W5M9> =0\):C#H0!+O#V<3&;=KU5N:\Y6.CQ<\-TI)'"7L M+N"B:,0I!N?$.(F4"8&&:*,TI??W T6MN["VRN#"$+>[[FY2]";(9$1P!EPK MXG.)AH>I2@5*43,E=3#!E4YIW%/$ND(O> M1P.#!(U$R,<+#C-D6<"(A/P>T,=2C$O)UH9I"F%*-(*%?2*^T4.\6NV]9N6XY>QUN]0[YB>0^S/#.P;WE P@*/@UNH8E>2,B=)M2PJKT);35Y+.-;%N8/7= M8-J;:+&2C"2DN7&(V\B0D;!?,0HJ<*YQ8*6S+S:(TI9#6))Z)6Q?S"GLMW;C MPD[RM/E>KASCU8A]5%AL%[OOH@G*4G Q ;>$Y3G<4,C CHD8USHZ)JPMWNVJ MKZ*)5:G*93J#A31DHH-5KZ*_GPQF@S@]_S,G'\>P<"D>BEDNTTN!%HU6+ XX M^N@1=DR#93P#W\(JY&&>,,*(,;9TL%I6@[;A+M]'[R8Z72W7BE"*BA8;?PB OPN+BS/C<"HDA( MHZ/U-J7'A^T+L6FC,)4?F.V32V4 :(!)1^X OSX^1LX"YD$+I&R^OLQG#II9 MBC1EPI,HO4BE^X66DKTN3_\ZON1A9'C[DV#Q,N -BR90P@D2.*?J29J0HRXA MG_NH:)ZLH8W-@(7@+6[Y?7.N+/$/($ QUI<]N: M,4J,W(>#+8>I=9YR)"EVB'O)86_W"06JO(P>1UV\.^$6 M<8HUJUW1*+C;-\LBY9Q&KJJ12E'YK:)$N+)#H$[9VHQ%H@$[G*44_>_+,RY]?["RN;=3C8+%6RBF$ MM3.($Z\03 ^.-#%)6^,2*%TH/]H&RB\?;9G>>($Y\T0AH65" MG!J%= 07V"E)A::.!5*:GAM$J9MEVA_A2EB^@=7P0_3YW@Z6^0T*?9Q^@;\? MC\!]^?%Y/)WFB70CO<-2\PA^BV*(^ZAAR<<,_E-[)ZSG+I9V]PX2M&Z14G_D MZQ^U!JBY0;7KKW;VC_'],'R\^V;][,%16;HH-]Y[KKB02 8,=E5*("=T0%XZ M;,#4*1;OPG&8I'4;RIU\92R)6T5VQC]N5EU#SL)W._+Q\V3@Z _EG-,,AXV>'C(WPWT4;O#:S6^:H6<0%_X]I0H:F-O M-PQ%-.C$8?UV.-P SHTLGD\47V29?(C?QM,!A-37XT\PCW-TO7I'X7($_V!E MGD&65? U;Z!LI*0."X8P\3B7,#O0+%\K*:9]\DS*V%NRS$[INIUDX[=#R)X! M:C1=[>K\YT_G%]^>47GMC^W8_E7RXN1:4U ?L@$''Y7$I2B/Q5,B@HXV4D M/,3B!1H'B%FYO+($=S97%O<#5L7=>3J9W63>0S8G!9%HI6!" MH.153KPP&FDA#?+4V4 2!'TOCV76TPT^\81J\%^/--O\]5:*='L"?%S4^LWQ M9YD/I(*WN3$A"II%Q,%/1ETIDU2 MZ>X46P5JI2:PWZVK/#8M$&TA^ZK*5[G(KOXWRR=S<+BMC+-=310.CV/M\"D<1%YP@K9A% M7HF@,,RG1%\$IFM.2S<.WT1$=0A:X\*FJPO_^?UD_"T^ESX(;8CRN524!L0- MXR!]8 @SPQE6++J7Z8UK@%\S<.4]I 3DQYJK+MC_;;_9T7/AP4V*+&"!!,U= M:9Q6R'AAP)E/!KQXRT*4.[%^/6[=Q+\B4!]IK+I(?\EW*^D?X\DPO%B9.%-1 M.(JBD; \:>P06 C1)I'A7,1B8B>$0NDM)1QTL9FG X"Z(\+FCR=BBSZGZ?5<@I M*^_OI[/Q79PL>H_DNX]Y"M<\N?2&L.0YXQ8)@G,+?"7R>P\,R61-)."$I\=7 MW,NR:A\QZQ+O.%ZL)UEO(#7Q3L'NIQC>19B\C\5Q<2S5Z1^T*:9> M"[7'#5.]WM3\,LP*&Z3_;3 ,C\[,G!.8/3\$@K:- S#,)3F%4GI=^2ZZE;#-/HK,"_%YF M X9 W3@$D;L!H:55@B0-_NC?V68%N%,BVVP?L)K+%II?*"KE?/""(,PC15P' MCPR&+2LFCJ/!Q(9N;TS\AV2;[07X[FRS?:S?'']6W:=(-.#W:,1$SGUGN?M4 MM<#<$UBBJOS2(E"%FU M141I(:3QCN#2O=S>3K;97AAWS#;;Q^ -\.:3A;$&=OC@HL(ZG"VTU(:Y)%)@ M!O$PGU9$Y5Z)! S& D0LQ@I7^GQ^NT1UCHIZ8U%!\S= IO?C">SEH-+%^,4- M.0-3R/R^3:*1@(MH-3)&PH9N".>&$.)9Z1O%C<+4N4;LC4)EC-X >SJ=PTKF M&#;2(LLT TLICK3S$1&CL.78B:!*'X@7NYIN*@WV$)^Z-Z0:8-^K^S"FJ"", M>F1M3MCC3B+G:4+!&Y)8/EC4?U]-[X?RKJOI?4S>Q)7@(?>>4C-,-&SG"A.P MF&:PUOO\\(QBL)U[3E,JW87O[5].[\6, I?3^X#4P.)5X]I%!/@_[<%$#L)N M;L%.#H(ST8N:6Z?T]>YRJ,8_WF7O7N19].1S8$X-K#0/[])O$P/*GV>C--@ MMK+BZDSJ>OP8X/*N;0'!6^A3 M_7;H?GJN-+%:YY[=4S#TLF7?],9KXI0D"K$$'B.W0B"C14*.<>EDRJ_6ELX& M?2E#;6_ZY$1X=49U!"9-]%3/]1^3>S^[GX#=WG^UDUO0@AN]2F M7#VJ#&*"0 RG\_OG/+ M9G@/'?=FV72#L/1QSB83"S^=6Q6F&OSQX[*;XV7:\$\>&I&2&^&32-Z1>8L^ MQ$T42"N+85(Z)J0A1A:_C3Z1:G5+'.M/AQ89U,34^@DB@L'MZ/T]?#V_^ 7* M3\'8H-7/=C#*R"RBAOFI(Y5):Z91/M*!$%3FEDF1(.UUM)($Z6CI%S3V$*_N MTP3U*=X7DDU$31?CT?CY\A\0$2S>?,3A73P"A%LHX^,ALA@2,DQ9Q'$R2%LMD0K,.NRQC[9T*GN/ZK3P5-;;.?-JA5>'3['QS ZK M5.^<9SV_30;3^ ]PO)[<-/52J+/S:WW7Y.RG;M_E-R%I*I3R".=7XC@W&CGE M"?)86F>LA3\7KS_IO?QF=8L_G_1@P,G(#E>W[ODT\-?QZ/;7P7?8&Z?3"/OE M/"_)\!@"5@E9C+.#SS$RRL^?529<6):\*1TB'B=Q6TDZ!S%J&HS:G%E'RJPC+-UP0#?DU2R/%\>"$L00:#C^.LM"Q&&7CJ M] KA+DYM$J!>"48A8,>EK5R1*CX?>4U^W/QV=>.5(CSXB+RR"7$%UG"<.Q1\ MB$($EZC:MN=-H_^OV_'W_WLYXH(:R_]X9,;C]RK2H QHXZ,L6'EY6+2*7*;H M4\Z]24(A&PVH33$!]E.2GVQ(ED@G=;>ZXQTKPM-OUJN@*8O^4;9L8-[_]^<; M@HT7UB3DO0R@M@0#>*"NDMPD8Q039%L1YW[S_K\_URM\Z6?>[VG!9CIOKO@J M/+?&482UE(AK8Y"E)E<*BB!LY)&&%PFTVUMNUNRU61[DHTU6>9G_/!F'>S^[ MG%S%R?>!CW-G1SCI)582$6_S$D7 !BH:Q*(*-L&21;N54^Y8[M=]NY4*I9/& M$T>#T :)LEV6&JPJ!D.P3N=#THAEK@Q5,+D8([D'$B/$BFAUI]2C;DQZ+4 ] M'_)X3%\3Y$@#U]U9YA>1\/=?(PQWEH^!_.]V^#U^B=^&ULS9Q0[3Y-)A-(" ?A>O)P-]/ MOPW"]=<(N_@@KDK1,NRZ.I^]4/J\@5P5$C'2F'>2IAQM)I_\@PVR')V)\7SPUZW2^,_\O^\'T\$9/_.(GQX0[ 4T(Q1S0_EL6=,\C%7&U/O3), M&LI-Z:[[.X6JRZ4BT'>@T^$XU#U:^#@:C;_G$/C=8/PIAAP6_SJXRT]K+H-A MHHGU%%S )$C*F?0&V0C.F51:&.FL Y5VGBWL^DI['#D"SW$_QFU@ 7JY,,,_ M6UP,)*HQD;EO)F?@NU."G \*;$0U,Y(XQ3NE7!WA[BQ%J7P!5WKC*F'P-GFS M>BC2&:^U34@G8A&7,H K",;1QFJ:(B56E.YOM5&8MIR>@Z#>39\#[-X>@9:K MIU/$,R4EHI'DQ\UR0U<.ZD0;,?:,*15[)D\+NU;Q\,MR@AU MSFG$G ]=$S(&LN0TT0:@3ELO,4K03;(4OEDN^<=ZS"3-T"=S_;'LKYTZ0JN MG,0X_7F2>YIARY((X*MQD3N9Y=(/G6(.)8R)E++$9&F?9Y=,3:U#!R(_[A&& M!FC5O8/#0SN&&YXPPTH*% 4U$'PP4-%AADP,&%;WD()EA9EV@)A->=YER-%Q*OZW(\/D?%/=C#YW0[O([G!T=!<30SA<.Z-&HA &H/B M,4D(9*/AU):^ARLA=U,[;V^,[1?.-TWASW'B,^2W\<8: NI%A;P(^;83C*YA M'B,K>(+Y:[#O5HAX$@H_REVW(5)C%#X0SOJ7R<_J3*(/B^'/\L7M]> .MIL/ M@ZD?CJ?WDQ?S;MU=\MKBE3SH@I(^/#)Q_1?VO&0^6/@C[YCA4S>+K]S-/_$8 M4!UJCLTC'GJ\_F3 3Z-O@SSH-:C]#O[R7T7$?#UJE1!@)Q8/9^)=+%+S0N2I M?//>*87Q>C%F%9_Y,+366Z,1K#[#9V>3NU'X:6AOBR#U?,0JGN)!.*VU1",H MY1G_?C0-DW(PO1BRBCMT\.KWVA:- /7+^(]'^^K@+H:?QA-PHK]!5'?T=-LV;I5N@7M!U\$J+4R\Z7MPD^/U^$'-8G6#5@-H0TV'WA'5W8NU7:5.$\ MB3Y$K'HQOIX,+_,F>D2F >*=WWT;CG_$>#4#)^WR6]9MYU)^"'LV?Z=N;D2? MZ([W-'4#=)C+=O8-/N\7?=Z_#&Z_SJ979U^N>J'%[N_5S5XX(3TZF[X!FH U M[O+U'TC<"RU>CU\W)>"$--AHVH-A'Y8I Y_.)@,_BV$NVF^CP6SZY>JW7M#? M_JVZ-^LG9$(GD]=A1?SCYI.=_"O.YFJN$W0=,=;4'W4;I>K3.Z> ?%][5D-] MY<. 1A?C47SMT70%OO- 5=^\.1'V^UJU[E;PS(_M/UC8@P?%3\&KAPDMX+[Q MI.4CT!74*7]ROAJX"^:F-.;'GYV_L$OM<]HLXF^C,!G^N+V*_GXRF WB].QN M=CQN:T?M%,_C^JAM,TD+D)W_.?&?P0TH,+\>A^H$3@-I:*^4;P&1GV&YGWVP ML\><[..A63-F)XP:2#[;;([*8#V?V3\^_6LVI]+[KZ/;S_ZX96_'T)V@JYN/ MULTXK>9>GT_F22(]Y5V_'KU(SO4.H0OD6^>W.;_'R8_+].I;K\AP$.\[?>"( M*;L<=?69XS,RU@Y8[3)Y'WR>3M9M9JF\R.9#BN6K1GD/.#HS8]UXU?#::O=Q M)R/\1^?,].*== 7E[VR9O[-E]L+F8CRZB.,2H#P?J5YVV39;CW35PM47M4,^@BYEJ+WFWM[.E4D>?-CT?JEK5SZ%HK3=%97Q6 M HWL\,=T,"V3T+YQT&H50$?ZWAO-4QF]J]F_/D_\Y>1Z.CF?S@:+U[M+ED9V M^D"U\J!#4=W';)41OKR?P1H_FO=C+[>4;AZU6KW0H5CN-% [&^#%>/;/^+!3 MQU*U>UT^4*U\J,!FN=-LE1'^"08=C^)*TQ(7HAN&K%9&="B*VTW3%FX?[N/U M^/S/?+$?0<]1&D\6SYH=N]CN\YUJE]V%$.YBQ 9A_WTP'L[-?)E^&=_%]XO7 M=7^U?_2!_=:/U;LX+\F +O9LD :@\;_O[7"0!GXI_;7]\UT#HC7VI?^T+HS^CO9X/O\3TL$[?C MR8^C4T?6CU@/II?V'G=4OO9!\G#X4KS'9^*/.D#>-G"][*NM4(SWLTMEZ#[' M<0&<'D>IF5.RV];C+8K73_(!D2Z*P/%RK'H-CR/QX^='L]'JI9&M6UVK%6V-@##X8-89:;&R^'J;>MKS3WNHGMM M4&YO9_.JI=%T]+N%R7MU?W>W.+>:SD;7;OC3>'+V;>B&_YR4P&SOK]7TU#8A M-BY@O@9@SS*#BM.K[_[]=%8(W;6#UO3L.H*XS1BU@Y_2.!V,43\3;9?UQ]U, MT0A*GR>3XD"]'+/>?#H JPT&J7U*]^_9C[,_)F&:12P U;KQZCVKT6G9VV*" M5L#IV1W9YSOUSO&VP+0.S3?C@SQ3[/Q//[P%#^K+M\DLO%:A] SM]KEZ19I[ M8KZW!2M#_\_)^2C\E-M=7*8')7Z>C++@[[]/PC\G^2X]C&[/1N&WT??I+!0@ MP,$?;6/J[X?ON)RQ*W,EAU@R?Y?J^84EJ''P>9M9Q4YFUZFI1J7:<[@!S4* ML^/@CU8K\RR^AAQD[-IIS"O!%_*.PNM]<['P_30,<]W>CT=A^F$"?RC%G$(B M5"LL+<.CLD!49M6'[R%,+R>7LZ^3!AW)]&9>;:[M'K+8&'8=G97K77S!@G/T_&]]\^3J?W!1'=-FXUW_?0 M=72WC6JOJ%]SH_[P(&@I%+>-6\WC/'1UW6VCZG-Q?#V>V6&)\KV78U7KDG+P MG%MKB_H(G?G9O1T.?WRV@U (J'5#5NN'6RQ3.Z1ZC4&.65=W&:IZGL_]8/8C/VVR,"6$-W?S]]@^ M#!(($T';4NCN^:EZ?4(.A/LP4]8.&U\L,[]/YYO(_*6WK^,A6/G+K%0DN=^G MZK48.?CL[A!3-H?_19Q]'/GQ7:$S]$X?J-=II!C6F\W6',*O#IG[0GK+ASHA MWM39T0%FK(S\FN4G:[X\_"H#>M=O=,*[I=.G/8W7W"2_G'V-DY[G]_IO=(*Z MI8.K/8U7>U9;=S^TDU\'TUG!J^[-HW:"LZ7CK)T&J@W@ZY7EV).0#4-VRE9H MZ3!KNVFJG_RO%O_R .X:NQ.2+1UE=31614A7CY$_..Z_CJ?;\K4.>>7]^=B= M0&SE &NK>:I[.R\\[V.GW]H!.\'5T@'4-K/4[E";':JL42' UHW7":^6#HRV M&*6%(_XBKYH]':@30"V=\JPS0W4G9'QTJN1JC$YXM'0&\T+Y-M*\CX9CWWQ5 MVM(Q28-IJN/1S^"X+ 7[$*=^,IA?PQ3*4]T]?"<06SH Z6ZRZOM2&&2Y[)!C M^OU1NU+7S[M&[X1L2VUL;34?O1FF62XB*Y1]O&+-334!+IR([C%,] M@^"Q^JM&X87UU_Z3 MFDVA-QMVW$'+@ZT_/-+P[^)D9"?AO__K_XR_#VZ_#NRHH_DW_L.:39V[@+!+ MXTI0Y /-V61X'2=WT\MT/0FPQI:):+<,6PVK_?SDW8:I[BUGJ4J\7OI\I&H] M)/:-8]:HWPHDUX/9T2'FLZ&J-8,X$)1G!JB,RI?[8238"9(]^S#^-HOAIZ&] M/0J>36-6:_2P'TX[3%+_2JL/S+8,6ZVSPWZP[39,$PO@7*Y<"&9G)1;!9\-5 MZ^IPR$*XSA -+8;7D[O1K.Q:^&3(:OT<#E\*7QNDK96P$&";1ZW6RN&H=; Y MV%8!P^1N,+(%5\*7(];KWG#(:KC!'DU@=?[GM\&D)%0O!JS7F^$0I-9;HPF@ M/MPO!"L T<-0]3HM' +.2PLT 3P6P0IV>WMV??[6!X=(W/EG'K]4HX M!+"MMGD;*1&?Q\.!!P4^3\:^QY2(9Y_I(25BLQK%4R*>?NH51PKD1JP?_ZB+ MP^7PX>G0I6+OW:,WDCZQ%;?GMXT=[57]0GB=G!?CV5+4,N?]W;_2R/'_D3AO ML5__*_KR+_+_.#N-_\__]?\#4$L#!!0 ( (."9EE"\C%5(0@ +$J 4 M 97@M,S$Q,3!X<7$S,C R-"YH=&WM6FUO&[D1_MY?P3KHQ0$D6:^V)3L& M%%GIJ0CLJ^QKVGXIN+M=+MQ4 \:O--N'!\WNMW3?S4.T!7BOH^Q\T2\/TAE5IT( M&K_7;M9..KD]F\G(3GJ->OU/!T[TXCQ6F<5X&OW]5Z]F4QG7=] 7*&M5VCN% MKO*-5;E[M.+!5GDB[[*>\_G ZU[T#U6B=.]-W?T[HY9JS%.9S'MO;V4J#+L2 M,S96*<_>5@S/3-4(+6,O:.2_!8S&(.YQYGTZ@9Y$9F+A8Z-)7@T?)C*0]H/Z6:M1:ZS[M>+1BL$A0B#T;V7QY>?^^/*&?1I]'-X,1L.KP?"&#:['/UV/ M^[>CZZN]=V P'-^./HX&SMH;]M//XYN?^U>W[/9Z[TV_&0[(Z!(M]2:[_KCW M-M_^.&0W_?&'_M7PIGK]]T_#?[#^X!:6>R^:]7ISPX=GU_D+5O@^H&M_C6]O M-7Y481^$SKB.V%]J[)]JBC;)LPH+A;8RGC,[X>"JSNG9K_;,$Z_,(F"RUVS6 M.K^9LXW:PHGO/_I9SJ,(*;B:B-CVCFD._'(8L0F?"J;%5(H9$K6=2,-^*;C& M D[F>)\K;9G*V$>E4]^E4:_^E:F8#:,9 F?8)QD+$TJ1A;!VH#1Z<"M5AKAU M7T/!?! M& R9N/(.8Y! *#7*.8@YI!0(K6:SB0PGS!3TL>P_$UJ42LB!5)H$=1^5D#-I M)W#0Y")T!I+>'*:I"&Y.T2UBP7QU&EX+"EN_*Q0*%LL,<2;(+.-: 00ACF:] MTBZS&-SB* /?PZ2(H!/860EB!;B3Q$>KMA964%;V9AS(:UKP5R M[7V$W.U:?-Z:$DYEP4 4H>)8XO'0O'-A&S&NA0,( BZ#1% @F0 J@T2:"?4@ ML10,22Q)SY$T8:),@7[$G5HE'BFY5J&(\-JP0P C$D":C_[P(9SP[$ZP/FAI M7"3"E+FRQ:N-SJ'PIC0ZD7_RCY*JY,S#E 9A1& KZ/5H(H->-EJ\-EJ,T"E'\HE6%1H*0%U3:1PA0DID3@\5V4LJ7:5C+1+N %AFVB5^*B55 M4Z,$K<(6HQ(9N=,>4P1&1I)K20Y(7P^X!)&1IL)0CG;KUKB$[NA3&0&#+.B: M.N6H0&58))Q8'VXY(Y:Y'CU\Y;!:\.!;($@0Q(S^(OI*(MYO; =[A.U6>TG0 MZPC?F>,V@+X[.^Z,=ZR1J8P(QMRHC%,NX 9+@ I2PC:V,PN< ?F2!S*1=DY5 MP;9A:=4Y2#JT^06S)KI2T+J4\U ZE!?8(QG$@JJ8,%0Z<@:XTO9.9"A.$H > M+2*GU40B*-L]L+'J9.X(_Q5#.]PC:'O:'DYY4CANHXB+.$:Q*:>(E=E2-*(H MV8&E_>/V"M*A%QW!L,;7J8$J[/-C[Y)'^*.TH"(\_O+6B06+\MXM2.'G8+&S MIP%>*P"C/0*@Y]9+'^%-I-"FOJP&7).51Q!/YRE=,R#< ^=X NK./.[G5SU^QJW/GEM%B6526 M9$70%F:2FN%V)H- D4GW&B))&QR MW0\!8Y"O(7+'7RJY%^M-_%)(F.Q66)&%[J#BW?^W:=\UWWM4]A,4<2@J):!' M>V;:@KN#;EGF[\=-TTSP>TK(OJAS*=F5H^XL=7'<]"+XE?L;?W:QA>MXA(Y& M/%+=%JB6Y2N$@3I4F15?#Q@4 Z9(@1!,DG.C3"5;C^1>?:[?OWU4'RD]UB"6 M"D @'!$"1NX@O,1;Q>=(F4U5,A64*#-^5Y[GZY([19HG:B[0.ILHSY9\#&Y$;W%ES/P>9[P>4]F;JI\*BY"QY'-MILZ]1: MG<:SK?7:\VW_56NC=MIJ?G.UK=I)Z_3;:VW7CD^Z.ZD]VX?BJ/[YTUR2N_S;Z\X^C_M6:SSNNQ#IS M]>9*T?_ -*>Q)RVF M(MS!V,%$BI@-'T18T*D1N_;[J"?7&1\1=.12[@NO1CVY19DKXWYT[?F?#Z9B MXU[E$A0NI=>777@ 9!3V^2[/73-[]I)F^>FOC!ZYJZK_ 5!+ P04 " "# M@F99#&R>"QT( #2*@ % &5X+3,Q,C$P>'%Q,S(P,C0N:'1M[5IM4QLY M$OY^OT)'ZC:DRC9^@\2&4$6,J:.*@QQV-K>?MN09#5:A&BOU2H[U5&1BLRQR CN M1,P**[,;]C46]I95JZ543^'1_%+'A\E.G,8SZ!_ M^!K4K"OCY@;Z1MHYG78_0%?YQNG";KG_2.MM.F^J?M_ MA]1237@JU:S[=BA38=FEF+)KG?+L;<7RS%:M,#()@E;^6\!H#.(?I\&G]]"C M9";F/C::Y%7_;BQ'TOWTIG%0/VPU:LU5OY8\6C(X0@B$V7ER-C;H]>)^GGX] MN3X=L(OSL_Z@=]Z_[/4'K'=U_?GJ^F1X?G6Y]0[T^M?#\[/SGK=VP#Y_N1Y\ M.;D<5-HA@$_M48U^4$FF%1<(XF)]KXYC.V)DV:>C2J%?_R73"^O&4F]BR M"YD(&TF11;"YIPUZ<"=UANAU7D/TFML5O4_<(DZ(2#ICMYF>*A'?B$H(7!FN M6&/\3(.T03V7&>/9C!69,X6 ^:!QGM$AA)RE>#*2*Y;P"*\,TZETS.D@MR:0 M"039@?Q#Q&"@35L.E81F-F"_I8 M])\*(THEY$ JK0)/),HYE6X,!VTN(F\@Z^1*F+H!&J6PER)NQRQ1>FKG$#7B1EIG. ;B M]#+8#2LK2TBSDYEC92VA;H1_G2:!4PDAL=B1BO+=L% M)&(!C(6X]^^B,<]N!#M!*KHNE+!E96SQ:F-_5P13&OMQ> J/DCAQ%@!*@S!* M6DNX#3@B@YXW6K(R6H+1R..'D(8$%?KO9%0K <*>5(H<3JPD !4M=$6I\0(24RKX?H M]2*5+J=C(Q3W,"QK[ )%E3)54Z-$6H4M5BL9^W,A6XRLC"4WDAR0@0GX I&1 MIL)2=?:KU_I2[M.GM@(&.:1KZI2#=.,>M07SS[+@QTK$Z)C(F '.K,TZU@%N MGT@HH1J;ESG"@'G)1U))-R,^\-BPM-X\&#W.PE)9$5TBL;[DW)4.Y05V1!91 M(/X21=K$W@!/9V]$!EJB '>TB)S6$8F J@=(8[W)W"?\5PSJ:(M '=)V?\)5 MX;,:15PD"6BFG"!6]A&Z"%*R07X.CX]S1X]>=$1NM8&ACG3AGAY[DPK"[Z4% MT>_DV]LE-IH3>[\@19B#^3Z>!GBM (RW"(!E5@T17D<*;>1+-NA;'@#Q&5F4 MZK^.HL(0$I:*[8J^5%N'-W2>"RTV@HKR;(CMK@DG@#%RV@.YTDQLN(0_<:## MB*RXM^5=L&3,[3T;H6SH82]B7R:\]V4*GS$E;X4JCQ\>R%>^8T)^ ,BW!M#[ MV[6'"R3X=^SD_,ED/%\*E46"HGRY#,U%KB*(/8.$K%%K0 C#39!+;&$3;[[+J"+A&LIH>,O$>SY&A._%1(F^U559)$_EGCW M_ZW9B];X$P7*!@HI 3K:(=.&VQ]BR[):WV^.IH+?4OD-%,X78$\^_6GI_%CI M6< K]S'AI.*1S,9C=+3B/K$] M*2K$(8> .GK(3J;U'Z;9$"&Y@>[T99.!X] M>GOUE7W[]DLG*.")04JI 3"IT# R!]UEWBKA(HHLXE6$T%E,>,WY8F]*;.F M2'.E9P*MT[$.>9*OH!GH^TZ&4/L6)@@!-!&(K?.;J[)Y!#0*4\4D*YY;T9U_ M.40FSQ6?=67FI\IW.EP%&*%G0A4!#*+\+=F#*30O+G74ZN%BAS/X'\]'+IMK MOFG/Q>MM[5JKWGFRM5YK/-GV7[5V:O7VP0]7VZQU.JT?KK75J37WFQNIW?/3 M&Z884;0YSS[NM';F'4I\=YOY'6NLWHLAR#\,9(CARV<"CY13+*[5 ELZ_R?W MZQ++-QUA!1]4_-6K5^;>I]EK#-I/;]KO#ZW_#-QXT+L:#OT=B(N+_C]6O-UP M#=:9)S6;S-"/%2VSO2\&.6:2SH/9? J?&10H6;ZL]])A6;V)\L0=H3_ **^Q M*QTF(=K S/D-"\%^QG:)?38@HT2U*JPWEB)A9_>U_"ILJ![<=[Q'U9ZOP,^\ M!?7@FF6NK?^MM1M^-9B(M8N7"Z#X"E]?=.$CH*5P3W=YQKW%E<]PIW3/WV7] M#U!+ P04 " "#@F99W.( HOT$ Z%@ $P &5X+3,R,3!X<7$S,C R M-"YH=&WM6&UOVS80_KY?<7.P-@4L1[)E)Y'= (ZBK!XR.[6<9MN7@1:IF*@D MJA2=Q/OU.U*2\U:WZ8JVZ= @$"0?[_C< M3/]V&JB*PTN=0JT2]K*1\LQ:,#V_Y[9;N]U<]:\X50O/L>U?&F;HP2 6F<+Y M).J7KZ69M;&-(VY-I-BULDC"+S+/N-LHE6IQ)!(AO2W;_/6UQ(I)RI.5]WS& M4U; F%W!5*0D>]XL2%98!9,\+@<6_!^&>!&Z^;PJW=E%.PG/6.V>T]8.!=<+ M/N?JV1;RTN^T'P,W0NZ9_%9XC\Z'TZ,03D;'0>B/@K$?A.!/IJ>3Z7 VFHR? MO -^,)V-CD>^00NG9]/P;#B>P6SRY)$[>W#6"EM^"\+ U^C+I'$Z7;OYY,$/ M0Q@>34YGP=%WQ?D=IO?M'DR.8?8J@' X/1R.@]":_'$2_ E#?X:2XJM^42(WGX84GE$DQ&N[ICE^<5K<]](RRB 26<8B MQ44&5UPM0"T8O%X2B;%*5C!EN9 *1 P!O2*2%G#"8U9$G&41PO"%1#DQVMM: M\]E6Q^W[(LU)MC+O+P!%QT*F59+;UFN(A333Y A:4&#(!(60Y8JELT84L6DJN.,Y/,@K!=;0@V05#,&G*BT)CP7\]DN+R" LF&>*_ M@5?Z5*)KPA5KPB&3&3H'O[7@+W&)_'"2-<%?<(9^7^-TBE\RF,0QCYC49&A; ME9=- R*,,-IPV(*S)&%IH Z>2%5S'N[9ZS#.219PDM=4FX$/Q&.WE M2UDL"2:#$G#3*TQ[T&P0*G*]ZM\>%I81O$GO"F-(Y)QDK+ FUPE;P3 RH=29 MW40Y01*Z>_W_GL@YH12W'E;"8N5U>O=2V_UV>;WMO*B]^OK3WZ7%Z;8ZKB9B MAO&HRBE>)EA;$290HK-XG=F2O5MRR?2FK-"!*FZ'U>EL$ZPF"4YWF[Y81_BF M&-:%4(79V>^X&.#]OL[0_V.0VT\SR#S#!I>631&[JR*H2O%7$Z\Z PC7[37' MOJ"#W=1BDB2 :H@&VP(*LELZ%I$Q:2'5"\H)Y]4N?\B)/R,KCF2',*/7OII@^"ESJ M7A>1I-H:F(0JQ=4I87^_M=?MZ(."0I"*UA-79XB6.4/L*/I0UNVU''=WH]AN M.1ME'S+K.JU>">BC9G<,Y!(V$E-@$%XV.HU:H4HTL;@T:S+TRM5XG2X5!Y_O7LHI3=@WN-#_)4E9 N,!P+A4@XA=KE3R01C=P^4G]M&M^W M?=K0=+X -&/1XPJIB!X!=L.N[MX-Q(\Z_I[<>U#'H3^9S'-D4$L! A0#% @ @X)F69#931IB.P +6X" !, M ( !WN@! &5W+3(P,C0P.3,P7V-A;"YX;6Q02P$"% ,4 " "#@F99 M*6^?D0:, ND 8 $P @ %Q) ( 97DH !I; 2 M " 2#J"0!E=RTR,#(T,#DS,%]G.2YJ<&=02P$"% ,4 M" "#@F99K]87JM*" 0!XZ0X $P @ '*- H 97N0 ,GB"@ 3 M " &UL4$L! A0#% @ @X)F M64+R,54A" L2H !0 ( !>)P, &5X+3,Q,3$P>'%Q,S(P M,C0N:'1M4$L! A0#% @ @X)F60QLG@L=" TBH !0 M ( !RZ0, &5X+3,Q,C$P>'%Q,S(P,C0N:'1M4$L! A0#% @ @X)F6=SB M *+]! .A8 !, ( !&JT, &5X+3,R,3!X<7$S,C R-"YH 8=&U02P4& !0 % %!0 2+(, end XML 111 ew-20240930_htm.xml IDEA: XBRL DOCUMENT 0001099800 2024-01-01 2024-09-30 0001099800 2024-10-31 0001099800 2024-09-30 0001099800 2023-12-31 0001099800 2024-07-01 2024-09-30 0001099800 2023-07-01 2023-09-30 0001099800 2023-01-01 2023-09-30 0001099800 2022-12-31 0001099800 2023-09-30 0001099800 us-gaap:CommonStockMember 2023-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001099800 us-gaap:RetainedEarningsMember 2023-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001099800 us-gaap:ParentMember 2023-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-12-31 0001099800 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001099800 us-gaap:ParentMember 2024-01-01 2024-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001099800 2024-01-01 2024-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001099800 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001099800 us-gaap:CommonStockMember 2024-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2024-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001099800 us-gaap:RetainedEarningsMember 2024-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001099800 us-gaap:ParentMember 2024-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2024-03-31 0001099800 2024-03-31 0001099800 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001099800 us-gaap:ParentMember 2024-04-01 2024-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001099800 2024-04-01 2024-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001099800 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001099800 us-gaap:CommonStockMember 2024-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2024-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001099800 us-gaap:RetainedEarningsMember 2024-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001099800 us-gaap:ParentMember 2024-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2024-06-30 0001099800 2024-06-30 0001099800 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001099800 us-gaap:ParentMember 2024-07-01 2024-09-30 0001099800 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001099800 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001099800 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001099800 us-gaap:CommonStockMember 2024-09-30 0001099800 us-gaap:TreasuryStockCommonMember 2024-09-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001099800 us-gaap:RetainedEarningsMember 2024-09-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001099800 us-gaap:ParentMember 2024-09-30 0001099800 us-gaap:NoncontrollingInterestMember 2024-09-30 0001099800 us-gaap:CommonStockMember 2022-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2022-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001099800 us-gaap:ParentMember 2022-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001099800 us-gaap:ParentMember 2023-01-01 2023-03-31 0001099800 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001099800 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001099800 us-gaap:CommonStockMember 2023-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001099800 us-gaap:RetainedEarningsMember 2023-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001099800 us-gaap:ParentMember 2023-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-03-31 0001099800 2023-03-31 0001099800 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001099800 us-gaap:ParentMember 2023-04-01 2023-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001099800 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001099800 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001099800 us-gaap:CommonStockMember 2023-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001099800 us-gaap:RetainedEarningsMember 2023-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001099800 us-gaap:ParentMember 2023-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-06-30 0001099800 2023-06-30 0001099800 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001099800 us-gaap:ParentMember 2023-07-01 2023-09-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001099800 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001099800 us-gaap:CommonStockMember 2023-09-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-09-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001099800 us-gaap:RetainedEarningsMember 2023-09-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001099800 us-gaap:ParentMember 2023-09-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-09-30 0001099800 us-gaap:SegmentDiscontinuedOperationsMember 2024-01-01 2024-09-30 0001099800 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-09-30 0001099800 us-gaap:SegmentContinuingOperationsMember 2024-09-30 0001099800 us-gaap:SegmentContinuingOperationsMember 2023-12-31 0001099800 us-gaap:SegmentDiscontinuedOperationsMember 2024-09-30 0001099800 us-gaap:SegmentDiscontinuedOperationsMember 2023-12-31 0001099800 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-03-01 2023-03-31 0001099800 ew:MedtronicIncMember 2023-04-30 0001099800 ew:MedtronicIncMember 2023-04-01 2023-04-30 0001099800 2024-09-01 2024-09-30 0001099800 us-gaap:EmployeeSeveranceMember 2024-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-06-03 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-09-03 2024-09-03 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-06-03 2024-06-03 0001099800 ew:BectonDickinsonAndCompanyMember 2024-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-07-01 2024-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-01-01 2024-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2023-07-01 2023-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2023-01-01 2023-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2024-09-30 0001099800 us-gaap:DiscontinuedOperationsHeldforsaleMember ew:CriticalCareMember 2023-12-31 0001099800 us-gaap:BankTimeDepositsMember 2024-09-30 0001099800 us-gaap:BankTimeDepositsMember 2023-12-31 0001099800 us-gaap:CommercialPaperMember 2024-09-30 0001099800 us-gaap:CommercialPaperMember 2023-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2024-09-30 0001099800 us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2024-09-30 0001099800 us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0001099800 us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:MunicipalBondsMember 2024-09-30 0001099800 us-gaap:MunicipalBondsMember 2023-12-31 0001099800 ew:NewMarketsTaxCreditMember us-gaap:LimitedLiabilityCompanyMember 2024-09-30 0001099800 us-gaap:LimitedLiabilityCompanyMember 2024-01-01 2024-09-30 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-09-30 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-06-01 2022-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2024-09-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember us-gaap:SubsequentEventMember 2024-10-01 2024-10-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2019-01-01 2019-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyApril2021InvestmentMember 2021-04-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyApril2021InvestmentMember 2024-09-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyApril2021InvestmentMember 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMarch2023InvestmentMember 2023-03-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMarch2023InvestmentMember 2023-03-01 2024-09-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMarch2023InvestmentMember ew:ConvertiblePromissoryNoteMember 2023-03-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMarch2023InvestmentMember 2024-09-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMarch2023InvestmentMember 2023-12-31 0001099800 ew:EndotronixIncMember 2024-08-18 2024-08-18 0001099800 ew:EndotronixIncMember 2024-08-18 0001099800 ew:EndotronixIncMember 2024-08-19 2024-08-19 0001099800 ew:EndotronixIncMember 2024-07-01 2024-09-30 0001099800 ew:EndotronixIncMember 2024-08-19 0001099800 ew:EndotronixIncMember 2024-09-30 0001099800 ew:EndotronixIncMember 2024-01-01 2024-09-30 0001099800 ew:EndotronixIncMember us-gaap:InProcessResearchAndDevelopmentMember 2024-08-19 0001099800 ew:EndotronixIncMember us-gaap:DevelopedTechnologyRightsMember 2024-08-19 0001099800 ew:EndotronixIncMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MeasurementInputDiscountRateMember 2024-08-19 0001099800 ew:EndotronixIncMember us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MeasurementInputDiscountRateMember 2024-08-19 0001099800 ew:JCMedicalInc.Member 2024-07-22 2024-07-22 0001099800 ew:JCMedicalInc.Member 2024-07-22 0001099800 ew:JCMedicalInc.Member 2024-01-01 2024-09-30 0001099800 ew:JCMedicalInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2024-07-22 0001099800 ew:JCMedicalInc.Member us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MeasurementInputDiscountRateMember 2024-07-22 0001099800 ew:JCMedicalInc.Member 2024-08-19 0001099800 us-gaap:FairValueInputsLevel2Member 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-09-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 srt:MinimumMember us-gaap:MeasurementInputDiscountRateMember 2024-09-30 0001099800 srt:MaximumMember us-gaap:MeasurementInputDiscountRateMember 2024-09-30 0001099800 srt:WeightedAverageMember us-gaap:MeasurementInputDiscountRateMember 2024-09-30 0001099800 srt:MinimumMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2024-09-30 0001099800 srt:MaximumMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2024-09-30 0001099800 srt:WeightedAverageMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2024-09-30 0001099800 ew:MeasurementInputRevenueVolatilityMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2024-01-01 2024-09-30 0001099800 us-gaap:OtherLiabilitiesMember 2024-01-01 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-01-01 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-09-30 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2024-09-30 0001099800 us-gaap:CurrencySwapMember 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember 2023-12-31 0001099800 us-gaap:CurrencySwapMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-07-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-07-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:InterestIncomeMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:InterestIncomeMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2024-07-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-07-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2024-01-01 2024-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestIncomeMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-07-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestIncomeMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:InterestIncomeMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:InterestIncomeMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-07-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-07-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-01-01 2023-09-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestIncomeMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-07-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:InterestIncomeMember 2023-01-01 2023-09-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-09-30 0001099800 us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001099800 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001099800 us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001099800 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-09-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2024-07-01 2024-09-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-09-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001099800 us-gaap:CommonStockMember ew:LongTermStockIncentiveCompensationProgramMember 2024-05-07 2024-05-07 0001099800 us-gaap:CommonStockMember ew:LongTermStockIncentiveCompensationProgramMember 2024-05-07 0001099800 us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2024-05-07 2024-05-07 0001099800 us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2024-05-07 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2024-01-01 2024-09-30 0001099800 srt:MinimumMember ew:MarketBasedRestrictedStockUnitsMember 2024-01-01 2024-09-30 0001099800 srt:MaximumMember ew:MarketBasedRestrictedStockUnitsMember 2024-01-01 2024-09-30 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2023-01-01 2023-09-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2024-07-01 2024-09-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-07-01 2023-09-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2024-01-01 2024-09-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-01-01 2023-09-30 0001099800 us-gaap:EmployeeStockMember 2024-07-01 2024-09-30 0001099800 us-gaap:EmployeeStockMember 2023-07-01 2023-09-30 0001099800 us-gaap:EmployeeStockMember 2024-01-01 2024-09-30 0001099800 us-gaap:EmployeeStockMember 2023-01-01 2023-09-30 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-28 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-01 2023-02-28 0001099800 ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member 2023-03-01 2023-03-31 0001099800 ew:InitialDeliveryOfSharesSettledApril2024Member 2024-04-30 0001099800 ew:InitialDeliveryOfSharesSettledApril2024Member 2024-04-01 2024-04-30 0001099800 ew:April2024StockRepurchaseProgramSharesSoldInMay2024Member 2024-05-01 2024-05-31 0001099800 ew:InitialDeliveryOfSharesSettledApril2024Member 2024-08-31 0001099800 ew:InitialDeliveryOfSharesSettledApril2024Member 2024-08-01 2024-08-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-04-01 2024-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-04-01 2024-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-04-01 2024-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-04-01 2024-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2024-09-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-07-01 2024-09-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-09-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-09-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-09-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2023-09-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-07-01 2023-09-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-09-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-07-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-07-01 2023-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-09-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-09-30 0001099800 us-gaap:StockCompensationPlanMember 2024-07-01 2024-09-30 0001099800 us-gaap:StockCompensationPlanMember 2023-07-01 2023-09-30 0001099800 us-gaap:StockCompensationPlanMember 2024-01-01 2024-09-30 0001099800 us-gaap:StockCompensationPlanMember 2023-01-01 2023-09-30 0001099800 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0001099800 2020-12-31 0001099800 2021-01-01 2021-12-31 0001099800 2022-11-01 2022-11-30 0001099800 2024-03-01 2024-03-31 0001099800 us-gaap:IsraelTaxAuthorityMember 2024-01-01 2024-03-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2023-01-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2023-01-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2023-01-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2023-01-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0001099800 us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0001099800 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2024-07-01 2024-09-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2023-07-01 2023-09-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-09-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-09-30 0001099800 us-gaap:CorporateNonSegmentMember 2024-07-01 2024-09-30 0001099800 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0001099800 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-09-30 0001099800 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0001099800 country:US 2024-07-01 2024-09-30 0001099800 country:US 2023-07-01 2023-09-30 0001099800 country:US 2024-01-01 2024-09-30 0001099800 country:US 2023-01-01 2023-09-30 0001099800 srt:EuropeMember 2024-07-01 2024-09-30 0001099800 srt:EuropeMember 2023-07-01 2023-09-30 0001099800 srt:EuropeMember 2024-01-01 2024-09-30 0001099800 srt:EuropeMember 2023-01-01 2023-09-30 0001099800 country:JP 2024-07-01 2024-09-30 0001099800 country:JP 2023-07-01 2023-09-30 0001099800 country:JP 2024-01-01 2024-09-30 0001099800 country:JP 2023-01-01 2023-09-30 0001099800 ew:RestOfWorldMember 2024-07-01 2024-09-30 0001099800 ew:RestOfWorldMember 2023-07-01 2023-09-30 0001099800 ew:RestOfWorldMember 2024-01-01 2024-09-30 0001099800 ew:RestOfWorldMember 2023-01-01 2023-09-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2024-07-01 2024-09-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2023-07-01 2023-09-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2024-01-01 2024-09-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2023-01-01 2023-09-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2024-07-01 2024-09-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2023-07-01 2023-09-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2024-01-01 2024-09-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2023-01-01 2023-09-30 0001099800 ew:SurgicalHeartValveTherapyMember 2024-07-01 2024-09-30 0001099800 ew:SurgicalHeartValveTherapyMember 2023-07-01 2023-09-30 0001099800 ew:SurgicalHeartValveTherapyMember 2024-01-01 2024-09-30 0001099800 ew:SurgicalHeartValveTherapyMember 2023-01-01 2023-09-30 0001099800 ew:InnovalveBioMedicalLimitedMember us-gaap:SubsequentEventMember 2024-10-01 2024-10-31 0001099800 ew:InnovalveBioMedicalLimitedMember us-gaap:SubsequentEventMember 2024-10-31 0001099800 ew:InnovalveBioMedicalLimitedMember 2024-07-01 2024-07-31 0001099800 ew:InnovalveBioMedicalLimitedMember 2024-07-31 0001099800 ew:ScottB.UllemMember 2024-01-01 2024-09-30 0001099800 ew:ScottB.UllemMember 2024-07-01 2024-09-30 0001099800 ew:ScottB.UllemMember 2024-09-30 0001099800 ew:BernardJ.ZovighianMember 2024-01-01 2024-09-30 0001099800 ew:BernardJ.ZovighianMember 2024-07-01 2024-09-30 0001099800 ew:BernardJ.ZovighianMember 2024-09-30 shares iso4217:USD iso4217:USD shares ew:employee pure iso4217:EUR ew:lawsuit ew:agreement 0001099800 --12-31 2024 Q3 false http://fasb.org/us-gaap/2024#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 http://fasb.org/us-gaap/2024#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://www.edwards.com/20240930#AccruedAndOtherLiabilitiesCurrent http://www.edwards.com/20240930#AccruedAndOtherLiabilitiesCurrent P151D 10-Q true 2024-09-30 false 1-15525 EDWARDS LIFESCIENCES CORPORATION DE 36-4316614 One Edwards Way Irvine CA 92614 949 250-2500 Common Stock, par value $1.00 per share EW NYSE Yes Yes Large Accelerated Filer false false false 589800000 3676400000 1132300000 769700000 500500000 12600000 8200000 716000000.0 771500000 95500000 56600000 1104200000 903500000 114900000 128800000 231000000.0 224900000 20000000.0 317600000 6727700000 4035700000 319600000 583900000 1675700000 1591000000 104400000 84400000 1605300000 1145100000 956100000 399400000 888400000 749400000 683500000 463200000 10500000 311100000 12971200000 9363200000 172800000 186600000 1745300000 856400000 24200000 22900000 1800000 129500000 1944100000 1195400000 597500000 597000000.0 1100000 80600000 85000000.0 65200000 345600000 335000000.0 63900000 94200000 322600000 251300000 0 25100000 3359800000 2643800000 0.01 0.01 50000000.0 50000000.0 0 0 0 0 1.00 1.00 1050000000 1050000000 654300000 650500000 589800000 601100000 654300000 650500000 2452100000 2274400000 12781400000 8992400000 -252500000 -242800000 64500000 49400000 6089700000 5024500000 9545600000 6650000000 65800000 69400000 9611400000 6719400000 12971200000 9363200000 1354400000 1243400000 4053700000 3743600000 262900000 250600000 825300000 727400000 1091500000 992800000 3228400000 3016200000 421400000 381900000 1297300000 1165900000 253400000 242800000 781900000 720800000 10800000 2200000 27800000 193600000 0 0 0 -26200000 32900000 0 32900000 0 -22400000 0 -22400000 0 350600000 365900000 1066100000 962100000 24300000 15100000 56300000 32800000 27900000 6600000 35600000 10300000 402800000 387600000 1158000000 1005200000 40700000 52700000 107000000.0 118300000 362100000 334900000 1051000000 886900000 2707300000 48800000 2734400000 142800000 3069400000 383700000 3785400000 1029700000 -1400000 -1200000 -3600000 -2800000 3070800000 384900000 3789000000 1032500000 0.61 0.55 1.76 1.47 4.53 0.08 4.55 0.23 5.14 0.63 6.31 1.70 0.61 0.55 1.75 1.46 4.52 0.08 4.54 0.23 5.13 0.63 6.29 1.69 597200000 607000000.0 600300000 607200000 598100000 609500000 602200000 610200000 3069400000 383700000 3785400000 1029700000 4300000 -23400000 -20800000 -31100000 -42700000 18200000 -8900000 6300000 0 0 -200000 -100000 6100000 10600000 19800000 29500000 -32300000 5400000 -9700000 4800000 3037100000 389100000 3775700000 1034500000 -1400000 -1200000 -3600000 -2800000 3038500000 390300000 3779300000 1037300000 3785400000 1029700000 112600000 108200000 21600000 20700000 130600000 108900000 3337400000 0 0 -26200000 224900000 180700000 24600000 0 -2700000 -8800000 -15300000 123000000.0 204900000 189700000 92600000 112600000 301800000 106300000 -27400000 63700000 -24300000 -26000000.0 -6200000 111900000 10300000 14800000 669800000 759200000 202600000 164700000 36300000 23500000 50400000 91500000 518800000 8400000 539100000 486900000 25400000 13300000 3927400000 0 763600000 141200000 16200000 15000000.0 28000000.0 47500000 36400000 5100000 2889600000 159700000 1059300000 431200000 100000000.0 0 150900000 136700000 -3200000 -3300000 -1011600000 -297800000 -12400000 20200000 2535400000 641300000 1148000000 772600000 3683400000 1413900000 650500000 650500000 49400000 -5024500000 2274400000 8992400000 -242800000 6650000000 69400000 6719400000 351900000 351900000 -900000 351000000.0 9500000 9500000 9500000 1300000 1300000 60800000 62100000 62100000 44600000 44600000 44600000 200000 200000 200000 651800000 651800000 49400000 -5024700000 2379800000 9344300000 -233300000 7117900000 68500000 7186400000 366300000 366300000 -1300000 365000000.0 13100000 13100000 13100000 1700000 1700000 52600000 54300000 54300000 43900000 43900000 43900000 1800000 158100000 158100000 158100000 653500000 653500000 51200000 -5182800000 2476300000 9710600000 -220200000 7437400000 67200000 7504600000 3070800000 3070800000 -1400000 3069400000 -32300000 -32300000 -32300000 800000 800000 33700000 34500000 34500000 42100000 42100000 42100000 13300000 906900000 100000000.0 1006900000 1006900000 654300000 654300000 64500000 -6089700000 2452100000 12781400000 -252500000 9545600000 65800000 9611400000 646300000 646300000 38000000.0 -4144000000 1969300000 7590000000 -254900000 5806700000 0 5806700000 340500000 340500000 340500000 -500000 -500000 -500000 800000 800000 41100000 41900000 41900000 38900000 38900000 38900000 3100000 249500000 249500000 249500000 84000000.0 84000000.0 647100000 647100000 41100000 -4393500000 2049300000 7930500000 -255400000 5978000000 84000000.0 6062000000 307100000 307100000 -1600000 305500000 -100000 -100000 -100000 2000000.0 2000000.0 58800000 60800000 60800000 37400000 37400000 37400000 100000 7500000 7500000 7500000 -11600000 -11600000 649100000 649100000 41200000 -4401000000 2145500000 8237600000 -255500000 6375700000 70800000 6446500000 384900000 384900000 -1200000 383700000 5400000 5400000 5400000 800000 800000 33200000 34000000.0 34000000.0 32600000 32600000 32600000 2200000 175100000 175100000 175100000 649900000 649900000 43400000 -4576100000 2211300000 8622500000 -250100000 6657500000 69600000 6727100000 BASIS OF PRESENTATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2024, the Company sold its Critical Care product group ("Critical Care"). The historical results of Critical Care are reflected as discontinued operations in the Company's consolidated condensed financial statements for all periods presented. In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the historical results of a small non-core product group that the Company plans to sell are also included in discontinued operations. Unless otherwise indicated, the information in the notes to the consolidated condensed financial statements refer only to Edwards Lifesciences' continuing operations. For more information, see Note 5.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued an amendment to the accounting guidance on income statement presentation to require disclosure, in the notes to the financial statements, of disaggregated information about certain costs and expenses, including purchases of inventory, employee compensation, and depreciation and amortization included in each relevant expense caption within continuing operations. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to allow the legal process to proceed. The Company is currently evaluating the disclosure impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2024, the Company sold its Critical Care product group ("Critical Care"). The historical results of Critical Care are reflected as discontinued operations in the Company's consolidated condensed financial statements for all periods presented. In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the historical results of a small non-core product group that the Company plans to sell are also included in discontinued operations. Unless otherwise indicated, the information in the notes to the consolidated condensed financial statements refer only to Edwards Lifesciences' continuing operations. For more information, see Note 5.</span></div> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued an amendment to the accounting guidance on income statement presentation to require disclosure, in the notes to the financial statements, of disaggregated information about certain costs and expenses, including purchases of inventory, employee compensation, and depreciation and amortization included in each relevant expense caption within continuing operations. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the SEC issued final climate-related disclosure rules that will require disclosure of material climate-related risks and material direct greenhouse gas emissions from operations owned or controlled (Scope 1) and/or material indirect greenhouse gas emissions from purchased energy consumed in owned or controlled operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. Subsequent to issuance, the rules became the subject of litigation, and the SEC has issued a stay </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to allow the legal process to proceed. The Company is currently evaluating the disclosure impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is currently evaluating the impact the guidance will have on its consolidated financial statements.</span></div> OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2024 and December 31, 2023, $187.8 million and $164.6 million, respectively, of the Company's finished products inventories were held on consignment. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable (Note 16)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 16)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Includes cash paid for income taxes from discontinued operations of $29.7 million and $22.7 million for the nine months ended September 30, 2024 and 2023, respectively.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,683.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 248800000 196300000 244400000 195800000 611000000.0 511400000 1104200000 903500000 187800000 164600000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable (Note 16)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable contract liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 293700000 0 132900000 155100000 117500000 161300000 103700000 109900000 21800000 23400000 13900000 13500000 683500000 463200000 312100000 316400000 715100000 52700000 83700000 53800000 79000000.0 71600000 140000000.0 123500000 24300000 15200000 14500000 13700000 29500000 28900000 75100000 69100000 16200000 16900000 62200000 8500000 39600000 6400000 66000000.0 0 88000000.0 79700000 1745300000 856400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 16)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Includes cash paid for income taxes from discontinued operations of $29.7 million and $22.7 million for the nine months ended September 30, 2024 and 2023, respectively.</span></div> 633800000 219100000 21000000.0 19100000 38900000 19900000 22900000 32500000 29700000 22700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,683.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,680.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,683.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> 3676400000 1132300000 3200000 3300000 900000 700000 3680500000 1136300000 2900000 11700000 2900000 11700000 3683400000 1148000000 INTELLECTUAL PROPERTY AGREEMENT AND CERTAIN LITIGATION EXPENSES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalties tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Certain Litigation Expenses</span> in April 2023 related to products currently in development. P15Y 300000000 300000000 37000000 124000000 139000000 RESTRUCTURING EXPENSES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, the Company recorded an expense of $32.9 million related primarily to severance expenses associated with a global workforce realignment impacting approximately 360 employees. As of September 30, 2024, the Company's remaining severance obligations of $30.6 million are expected to be substantially paid within the next 12 months.</span></div> 32900000 360 30600000 DISCONTINUED OPERATIONS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2024, the Company entered into a definitive agreement to sell its Critical Care product group ("Critical Care") to Becton, Dickinson and Company ("BD"). In addition, as a next step in the Company's disposal plan to exit businesses that are not focused on implantable medical innovations for structural heart disease, the Company has committed to a plan to sell a non-core product group, with the sale expected to occur within the next 12 months. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Care and the aforementioned non-core product group (collectively, the "discontinued product groups") were historically reported in each of the Company's segments (United States, Europe, Japan, and Rest of World). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded that the Critical Care product group met the criteria to be classified as held-for-sale in June 2024 and that the non-core product group met the criteria to be classified as held-for-sale in September 2024. The Company determined that, when considered together, the conditions for discontinued operations presentation had been met with respect to the discontinued product groups. A component of an entity is reported in discontinued operations after meeting the criteria for held-for-sale classification if the disposition represents a strategic shift that has (or will have) a major effect on the entity's operations and financial results. The Company analyzed the quantitative and qualitative factors relevant to the discontinued product groups, including their significance to the Company’s overall net income and total assets, and determined that those </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conditions for discontinued operations presentation had been met. As such, the historical financial condition and results of the discontinued product groups have been reflected as discontinued operations in the Company's consolidated condensed financial statements. The assets and liabilities associated with discontinued product groups are classified as assets and liabilities of discontinued operations in the Company's consolidated condensed balance sheets. Prior period amounts have been adjusted to reflect the discontinued operations presentation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2024, Critical Care was sold for $4.2 billion, which is subject to a further working capital adjustment, resulting in a gain of $3.3 billion which was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of Critical Care, the Company entered into a Transition Services Agreement ("TSA") to provide certain support services for up to 36 months from the closing date of the sale (with certain extension rights as provided therein). These support services may be in the areas of accounting, information technology, human resources, quality assurance, regulatory affairs, customer support, and global supply chain, among others. In connection with the TSA, the Company recognized an unfavorable contract liability of $115.1 million, which will be recognized over the TSA term. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards and BD entered into other agreements to provide a framework for the ongoing activities between the Company and BD after the sale and until the end of the TSA including, but not limited to, interim operating model agreements to support the commercial operations until full transfer of all regulatory licenses to BD and completion of services under the TSA agreement, a manufacturing and supply agreement, and a quality agreement. Under these agreements, the Company will continue to provide certain services to BD during the term of these agreements including serving as an undisclosed selling and purchasing agent for the Critical Care business on behalf of BD for a period of up to 36 months. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, the Company had a receivable of approximately $24.6 million from BD related to the services under the agreements. The Company recorded income from the TSA of $7.6 million during the three and nine months ended September 30, 2024, which is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's consolidated condensed statements of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Income from Discontinued Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> are as follows (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,338.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,337.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,333.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separation costs related primarily to consulting, legal, tax, and other professional advisory services associated with the sale of Critical Care. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Details of assets and liabilities of discontinued operations are as follows (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current assets of discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current liabilities of discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cash flows attributable to the Company's discontinued operations are included in the Company's consolidated condensed statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4200000000 3300000000 P36M 115100000 P36M 24600000 7600000 7600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Income from Discontinued Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> are as follows (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,338.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,337.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,333.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Details of assets and liabilities of discontinued operations are as follows (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets of discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current assets of discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities of discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current liabilities of discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cash flows attributable to the Company's discontinued operations are included in the Company's consolidated condensed statements of cash flows. Significant non-cash operating and investing activities attributable to discontinued operations consisted of the following (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 177200000 237500000 708400000 727100000 65400000 99800000 265100000 295500000 111800000 137700000 443300000 431600000 40900000 57700000 163200000 178700000 21400000 27500000 81300000 81000000.0 81500000 0 202500000 0 -32000000.0 52500000 -3700000 171900000 -3338900000 800000 -3337500000 700000 3306900000 51700000 3333800000 171200000 599600000 2900000 599400000 28400000 2707300000 48800000 2734400000 142800000 2900000 11700000 0 3600000 0 5200000 17100000 264700000 0 18000000.0 0 14400000 20000000.0 317600000 3100000 158400000 0 9600000 7400000 108400000 0 29000000.0 0 5200000 0 500000 10500000 311100000 0 14800000 1800000 112700000 0 2000000.0 1800000 129500000 0 7800000 0 4300000 0 13000000.0 0 25100000 12100000 16200000 16700000 11600000 17000000.0 13200000 16400000 21000000.0 INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of September 30, 2024, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage-backed and asset-backed securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024 and December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The unrealized losses on the debt securities were largely due to changes in interest rates, not credit quality, and as of September 30, 2024, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities. These investments are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets, and are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable equity securities consist of investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $0.5 million and a downward adjustment of $2.4 million during the nine months ended September 30, 2024 based on observable price changes. As of September 30, 2024, the Company had recorded cumulative upward adjustments of $9.3 million based on observable price changes, and cumulative downward adjustments of $5.5 million due to impairments and observable price changes. </span></div>During the three and nine months ended September 30, 2024, the gross realized gains or losses from sales of available-for-sale investments were not material. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 50500000 0 0 50500000 64500000 0 0 64500000 17600000 0 0 17600000 0 0 0 0 112900000 0 0 112900000 0 0 0 0 185200000 100000 1200000 184100000 72700000 100000 2800000 70000000.0 80200000 0 1600000 78600000 192100000 0 7800000 184300000 502200000 100000 4000000.0 498300000 658500000 0 16700000 641800000 2800000 0 100000 2700000 2800000 0 200000 2600000 900900000 200000 6900000 894200000 926100000 100000 27500000 898700000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of September 30, 2024, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage-backed and asset-backed securities.</span></div> 50500000 50500000 721100000 719200000 0 0 81400000 79200000 0 0 98400000 95800000 50500000 50500000 900900000 894200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024 and December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 34000000.0 1200000 34000000.0 1200000 3600000 100000 65300000 1500000 68900000 1600000 0 0 193000000.0 4000000.0 193000000.0 4000000.0 0 0 2700000 100000 2700000 100000 3600000 100000 295000000.0 6800000 298600000 6900000 0 0 67100000 2800000 67100000 2800000 10200000 1800000 172700000 6000000.0 182900000 7800000 25000000.0 100000 601300000 16600000 626300000 16700000 0 0 2600000 200000 2600000 200000 35200000 1900000 843700000 25600000 878900000 27500000 These investments are recorded in <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets, and are as follows:</span><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 32300000 33600000 7400000 0 104900000 87600000 144600000 121200000 0.39 P7Y 500000 2400000 9300000 5500000 INVESTMENTS IN VARIABLE INTEREST ENTITIES <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a VIE. The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. The total assets and liabilities of the Company's consolidated VIE was $258.1 million and $26.7 million, respectively, as of September 30, 2024, and were $272.1 million and $31.5 million, respectively, as of December 31, 2023. The assets of the VIE can only be used to settle obligations of the VIE and general creditors have no recourse to the Company. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $42.5 million had been advanced as of September 30, 2024. The remaining $5.0 million was advanced in October 2024. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The option and the note receivable are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a promissory note agreement, a preferred stock purchase agreement, and an option agreement with a privately-held medical device company (the "Investee"). The secured promissory note provides for borrowings up to $45.0 million. At both September 30, 2024 and December 31, 2023, the Company had advanced $30.0 million under the promissory note (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As of September 30, 2024 and December 31, 2023, the Company had invested $42.8 million and $39.3 million, respectively, in the Investee's preferred equity securities (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and had paid $20.9 million and $13.1 million, respectively, for an option to acquire the Investee (included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Pursuant to the agreements, the Company may be required to invest up to an additional $3.0 million in the Investee's preferred equity securities and up to an additional $6.6 million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to acquire that medical device company, of which $30.0 million had been paid as of September 30, 2024. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. In addition, as of September 30, 2024 and December 31, 2023, the Company had invested $3.5 million and $3.3 million, respectively, in the medical device company's preferred equity securities. The option and the note are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets, and the equity investment is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In July 2024, the Company exercised its option to acquire the medical device company and the transaction closed in October 2024. For more information, see Note 18. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 6.</span></div> 258100000 26700000 272100000 31500000 47500000 42500000 5000000 35000000 45000000 30000000 30000000 42800000 39300000 20900000 13100000 3000000 6600000 45000000 30000000 5000000 3500000 3300000 BUSINESS COMBINATIONS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Endotronix, Inc.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 19, 2024, the Company acquired all the remaining outstanding shares of Endotronix, Inc. ("Endotronix"). Endotronix is a developer of an implantable sensor for management of heart failure patients. The acquisition was completed primarily to expand the Company's structural heart portfolio into a new therapeutic area to address the large unmet needs of patients suffering from heart failure. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the acquisition date, the Company had previously paid $60.0 million for an option to acquire Endotronix, which was historically recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> using the measurement alternative for fair value, and had an existing preferred stock investment in Endotronix of $10.0 million, which represented an ownership interest in Endotronix of approximately 7% (collectively, the "previously held equity interest"). In July 2024, the Company exercised its option to acquire the remaining equity interest in Endotronix which was accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations." Accordingly, the Company allocated the purchase price of the acquired company to the net tangible assets and intangible assets acquired based upon their preliminary estimated fair values. The Company remeasured the previously held equity interest to its fair value, as of the date of acquisition. The Company considered multiple factors in determining the fair value of the previously held equity interest, including, (i) the price negotiated with the selling shareholders for the remaining 93% interest in Endotronix and (ii) an income approach valuation model. As a result of the remeasurement of the previously held equity interest, the Company recognized a gain of $24.6 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the third quarter of 2024. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The purchase consideration for the acquisition of Endotronix was $798.8 million, which consisted of cash consideration of $649.1 million (net of cash acquired of $1.2 million), the fair value of the Company's previously held equity interest of $94.6 million, and the settlement of pre-existing relationships of $53.1 million. In addition, the Company agreed to pay an additional $2.0 million in a pre-specified milestone-driven payment that is dependent on the receipt of CE Mark approval for the CorPASS before June 30, 2025. The Company recognized a $2.0 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payment will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Endotronix, the Company placed $35.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement and for purchase price adjustments. Acquisition-related costs of $5.6 million were recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the nine months ended September 30, 2024. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid at closing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of pre-existing relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of previously held equity interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes Endotronix's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. The fair value of the developed technology was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the developed technology was 15.5%. The fair value of the IPR&amp;D was also determined using the income approach. IPR&amp;D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The discount rate used to determine the fair value of the IPR&amp;D was 18.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $47.1 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2027 and in Japan and Europe in 2028. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for Endotronix have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of Endotronix are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JC Medical, Inc.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2024, the Company acquired all the outstanding shares of JC Medical, Inc. ("JC Medical") for purchase consideration of $116.3 million, net of cash acquired. In addition, the Company agreed to pay up to an additional $200.0 million in pre-specified milestone-driven payments over the next 12 years. The Company recognized a $1.8 million contingent consideration liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments will be remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company placed $12.0 million of the cash consideration paid at closing into escrow to satisfy any claims for indemnification made in accordance with the merger agreement. Any funds remaining 15 months after the acquisition date will be disbursed to JC Medical's former shareholders. Acquisition-related costs of $1.6 million were recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the nine months ended September 30, 2024.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JC Medical, Inc. is a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart disease. The acquisition was completed primarily to expand the Company's TAVR portfolio to enable the treatment of patients with aortic regurgitation. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid at closing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price allocation is preliminary and subject to revision for a one-year measurement period following the date of acquisition as additional information about the fair value of individual assets and liabilities becomes available. The preliminary measurement of intangible assets, goodwill, and deferred income taxes are subject to change. A change in the estimated fair value of the net assets acquired will change the amount of the purchase price allocable to goodwill.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes JC Medical's assembled workforce and expected synergies the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. IPR&amp;D has been capitalized at fair value as an intangible asset with an indefinite life and will be assessed for impairment in subsequent periods. The fair value of the IPR&amp;D was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The discount rate used to determine the fair value of the IPR&amp;D was 15.0%. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $55.8 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in the United States in 2028 and Europe in 2029. Upon completion of development, the underlying research and development asset will be amortized over its estimated useful life. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for JC Medical have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of JC Medical are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div> 60000000.0 10000000.0 0.07 0.93 24600000 798800000 649100000 1200000 94600000 53100000 2000000.0 2000000 35000000.0 5600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid at closing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of pre-existing relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of previously held equity interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of consideration transferred and the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid at closing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> 650300000 53100000 94600000 2000000.0 800000000.0 1200000 798800000 7700000 12600000 412000000.0 69000000.0 385000000.0 9900000 700000 26300000 70600000 800000000.0 1200000 798800000 0.155 0.180 47100000 116300000 200000000.0 P12Y 1800000 12000000.0 P15M 1600000 114800000 1800000 116600000 300000 116300000 300000 300000 46900000 86600000 1000000.0 16500000 116600000 300000 116300000 0.150 55800000 FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of September 30, 2024, the fair value of the notes payable, based on Level 2 inputs, was $600.0 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments in unconsolidated entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,488.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,213.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, commercial paper, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service. </span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross-currency swap contracts to manage foreign currency exposures. All derivative instruments are recognized on the balance sheet at their fair value, which was measured using quoted foreign exchange rates, interest rates, yield curves, and cross-currency swap basis rates. The estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ranging from 0.0% to 11.7%; with a weighted average of 5.6%), (2) the probability of milestone achievement (ranging from 60% to 100%; with a weighted average of 80.9%), (3) the projected payment dates (ranging from 2025 to 2032; with a weighted average of 2029), and (4) the volatility of future revenue (27%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1124">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1134">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 600000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments in unconsolidated entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,488.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,213.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2287800000 852300000 0 3140100000 0 17600000 0 17600000 0 498300000 0 498300000 0 78600000 0 78600000 49300000 134800000 0 184100000 0 112900000 0 112900000 0 2700000 0 2700000 7500000 0 0 7500000 143900000 0 0 143900000 0 27600000 0 27600000 2488500000 1724800000 0 4213300000 0 24300000 0 24300000 0 0 3800000 3800000 0 0 5000000.0 5000000.0 0 24300000 8800000 33100000 579200000 0 0 579200000 0 641800000 0 641800000 0 184300000 0 184300000 0 70000000.0 0 70000000.0 0 2600000 0 2600000 125800000 0 0 125800000 0 39500000 0 39500000 705000000.0 938200000 0 1643200000 0 15200000 0 15200000 0 0 10300000 10300000 0 15200000 10300000 25500000 0.000 0.117 0.056 0.60 1 0.809 0.27 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1124">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1134">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 10300000 10300000 3800000 0 3800000 0 0 0 0 -5300000 -5300000 3800000 5000000.0 8800000 26200000 14000000.0 40200000 -26200000 -3700000 -29900000 0 10300000 10300000 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross-currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately one year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings and offsets the loss or gain on the underlying hedged item. The Company reports in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1149"><span style="-sec-ix-hidden:f-1150">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1155"><span style="-sec-ix-hidden:f-1156">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross-currency swap contracts have an expiration date of June 15, 2028. At the maturity of the cross-currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative instruments on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2024</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts presented in the consolidated condensed statements of operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing (amortized)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated other comprehensive loss into income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of non-designated hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts presented in the consolidated condensed statements of operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing (amortized)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated other comprehensive loss into income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of non-designated hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $4.1 million gain currently recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 2219800000 1460300000 300000000.0 300000000.0 P1Y <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1149"><span style="-sec-ix-hidden:f-1150">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1155"><span style="-sec-ix-hidden:f-1156">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5800000 16100000 21800000 23400000 21200000 15200000 3100000 0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5800000 0 5800000 3800000 0 2000000.0 21800000 0 21800000 0 0 21800000 24300000 0 24300000 3800000 0 20500000 16100000 0 16100000 9400000 0 6700000 23400000 0 23400000 0 0 23400000 15200000 0 15200000 9400000 0 5800000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivative<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -40900000 33500000 17000000.0 60400000 -8700000 3800000 -1600000 -5200000 257200000 300000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative instruments on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2024</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts presented in the consolidated condensed statements of operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing (amortized)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated other comprehensive loss into income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of non-designated hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest income, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other non-operating income, net</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts presented in the consolidated condensed statements of operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing (amortized)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated other comprehensive loss into income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The effects of non-designated hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 262900000 24300000 27900000 825300000 56300000 35600000 0 0 0 0 0 -4000000.0 0 0 0 0 0 4000000.0 0 0 0 0 0 800000 17000000.0 0 0 31900000 0 0 0 1600000 0 0 5100000 0 0 0 -29600000 0 0 3700000 250600000 15100000 6600000 727400000 32800000 10300000 0 0 -3600000 0 0 -12500000 0 0 3600000 0 0 12500000 0 0 1200000 0 0 3600000 9300000 0 0 53000000.0 0 0 0 1700000 0 0 5200000 0 0 0 14600000 0 0 19100000 4100000 STOCK-BASED COMPENSATION <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2024 and 2023 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2024, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $289.7 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 33 months. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 7, 2024, the Company’s stockholders approved the amendment and restatement of the Company’s Long-term Stock Incentive Compensation Program (the “Long-term Stock Program”) to (1) increase the total number of shares of the Company’s common stock available for issuance under the Long-term Stock Program by 6.9 million shares to a new total share limit of 334.5 million shares, (2) increase the total number of shares of the Company’s common stock available for issuance as restricted stock and restricted stock unit awards under the Long-term Stock Program by 2.0 million shares to a new limit on the total number of shares available for these types of awards of 35.6 million shares, and (3) extend the term within which new awards may be granted under the Long-term Stock Program through February 21, 2034.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2024, the Company granted 1.5 million stock options at a weighted-average</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise price per share of $85.94, and 1.9 million restricted stock units at a weighted-average grant-date fair value per share of $85.09. During the nine months ended September 30, 2024, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $97.66. The market-based restricted stock units granted during the nine months ended September 30, 2024 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2024 and 2023 included a risk-free interest rate of 4.5% and 3.6%, respectively, and an expected volatility rate of 32.4% and 32.6%, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2024 and 2023 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 6100000 4700000 20800000 16300000 20400000 17200000 62400000 57300000 8700000 7200000 28300000 23700000 35200000 29100000 111500000 97300000 6000000.0 4700000 17500000 14500000 29200000 24400000 94000000.0 82800000 289700000 P33M 6900000 334500000 2000000 35600000 1500000 85.94 1900000 85.09 100000 97.66 P3Y 0 1.75 0.045 0.036 0.324 0.326 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.042 0.043 0.045 0.034 0 0 0 0 0.310 0.327 0.309 0.328 P5Y6M P5Y2M12D P5Y3M18D P5Y1M6D 32.15 31.16 31.30 31.02 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.053 0.053 0.052 0.046 0 0 0 0 0.295 0.348 0.335 0.315 P0Y7M6D P0Y7M6D P0Y7M6D P0Y7M6D 16.51 18.53 25.01 19.03 ACCELERATED SHARE REPURCHASE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024 and 2023, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     The ASR agreement has a scheduled settlement date of December 27, 2024. At the conclusion of the ASR agreement, the Company may receive additional shares or may be required to pay additional cash or shares (at our election). </span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently, upon settlement, will be transferred to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.</span></div> The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div>(a)     The ASR agreement has a scheduled settlement date of December 27, 2024. At the conclusion of the ASR agreement, the Company may receive additional shares or may be required to pay additional cash or shares (at our election). 200000000.0 2000000.0 80.44 0.80 2500000 79.28 150000000.0 1400000 85.95 0.80 1700000 86.72 500000000.0 5800000 68.93 0.80 COMMITMENTS AND CONTINGENCIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2021, the Company initiated an internal review and investigation into whether certain business activities in Japan and other markets violated provisions of the Foreign Corrupt Practices Act (“FCPA”). The Company voluntarily notified the SEC and the United States Department of Justice (“DOJ”) about the matter and thereafter provided status updates. In September 2024, the Company received a letter from the SEC Staff stating that the SEC is not recommending an enforcement action.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (“Edwards”) in the United States District Court for the District of Delaware alleging that Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company is vigorously defending itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission (the “Commission”) is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is cooperating with the Commission and believes its business practices support healthy competition. The Company cannot predict the outcome of the investigation or the potential impact on our financial statements.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 14, 2024, a purported stockholder of the Company filed a putative securities class action complaint against the Company and certain of the Company’s executive officers in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Patel v. Edwards Lifesciences Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, et al., No. 24-cv-02221. The complaint alleges violations of various securities laws based on alleged false or misleading statements regarding the Company’s business prospects. The complaint seeks damages, interest, costs and other fees. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to defend against the lawsuit vigorously.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the “Lawsuits”). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div>The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million. 1 1000000 ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.385%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) on hedges</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div> -214500000 700000 -24800000 -4200000 -242800000 -23300000 43400000 7000000.0 400000 27500000 1700000 7200000 -2500000 0 6400000 1100000 9300000 1100000 100000 11600000 -240600000 27600000 -16400000 -3900000 -233300000 3400000 21800000 4200000 -100000 29300000 1800000 12500000 -1000000.0 0 13300000 600000 2400000 -100000 0 2900000 -239600000 34500000 -11100000 -4000000.0 -220200000 3800000 -41000000.0 6800000 0 -30400000 1600000 17000000.0 800000 19400000 -2100000 -15300000 -100000 0 -17500000 -235300000 -8200000 -5000000.0 -4000000.0 -252500000 -218800000 23800000 -65600000 5700000 -254900000 4900000 6700000 9000000.0 -100000 20500000 1700000 29800000 -4000000.0 0 27500000 -600000 -5900000 0 0 -6500000 -215000000.0 6600000 -52600000 5600000 -255400000 -11300000 33500000 2100000 200000 24500000 1800000 25200000 -3800000 0 23200000 -1600000 3000000.0 0 0 1400000 -226500000 11900000 -46700000 5800000 -255500000 -20700000 38600000 9400000 0 27300000 1700000 14100000 -1200000 0 14600000 1000000.0 6300000 0 0 7300000 -249900000 30100000 -36100000 5800000 -250100000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.385%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) on hedges</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1600000 1700000 5100000 5200000 500000 500000 1300000 1300000 1100000 1200000 3800000 3900000 -17000000.0 -9300000 -31900000 -53000000.0 0 4800000 4800000 16100000 17000000.0 14100000 36700000 69100000 4200000 2900000 8900000 14800000 12800000 11200000 27800000 54300000 800000 -1200000 -2700000 -9000000.0 200000 -400000 -700000 -2300000 600000 -800000 -2000000.0 -6700000 EARNINGS PER SHARE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income for Earnings Per Share Calculations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to Edwards Lifesciences Corporation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Shares:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.29 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 10.4 million and 6.5 million common shares for the three months ended September 30, 2024 and 2023, respectively, and 7.8 million and 6.1 million shares for the nine months ended September 30, 2024 and 2023, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive. Additionally, 1.9 million shares that would have been received if the ASR agreement discussed in Note 12 was settled as of September 30, 2024 were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income for Earnings Per Share Calculations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to Edwards Lifesciences Corporation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Shares:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.29 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 362100000 334900000 1051000000 886900000 -1400000 -1200000 -3600000 -2800000 363500000 336100000 1054600000 889700000 2707300000 48800000 2734400000 142800000 3070800000 384900000 3789000000 1032500000 597200000 607000000.0 600300000 607200000 900000 2500000 1900000 3000000.0 598100000 609500000 602200000 610200000 0.61 0.55 1.76 1.47 4.53 0.08 4.55 0.23 5.14 0.63 6.31 1.70 0.61 0.55 1.75 1.46 4.52 0.08 4.54 0.23 5.13 0.63 6.29 1.69 10400000 6500000 7800000 6100000 1900000 INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates attributable to continuing operations were 10.1% and 13.6% for the three months ended September 30, 2024 and 2023, respectively and 9.2% and 11.8% for the nine months ended September 30, 2024 and 2023, respectively. The decrease in the effective rate between the nine months ended September 30, 2024 and 2023 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to an increase in tax benefits from foreign earnings taxed at lower rates and favorable global income tax audit settlements. In addition, the effective rates for the nine months ended September 30, 2024 and 2023 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation attributable to continuing operations of $0.6 million and $1.8 million for the three months ended September 30, 2024 and 2023, respectively, and $10.1 million and $12.8 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits, the Company may receive proposed audit adjustments that could be material. An adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each taxing authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, the gross liability recorded for income taxes associated with uncertain tax positions was $656.5 million and $583.9 million, respectively. The Company estimates that these liabilities would be reduced by $326.1 million and $250.7 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $330.4 million and $333.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The APA renewal between Singapore and Japan covering tax years 2020 through 2026 is pending.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years. The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for the 2015 through 2017 period of approximately $250 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2024 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS of $75 million in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. In March 2024, the Company made an additional deposit with the IRS of $305 million to further mitigate interest on potential tax liabilities and interest thereon while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2024 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September 30, 2024. The Company has considered this information, as well as information regarding the NOD and other proceedings described above in its evaluation </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Company received a notice of assessment from the Israel Tax Authority (“ITA”) wherein the ITA claimed that the Company owes approximately $110 million of tax excluding interest and penalties in connection with a claimed 2017 transfer of intellectual property. The Company maintains that it did not transfer intellectual property outside of Israel and intends to vigorously defend that position through administrative proceedings including a formal appeal of the assessment that was filed during the third quarter of 2024. If necessary, the Company will defend that position through judicial proceedings. There can be no assurance that this matter will be resolved in the Company's favor and an adverse outcome could have a material effect on the Company's consolidated financial statements.</span></div> 0.101 0.136 0.092 0.118 -600000 -1800000 -10100000 -12800000 656500000 583900000 326100000 250700000 330400000 333200000 3 250000000 269300000 75000000 305000000 110000000 SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,068.0 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,732.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504.0 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,328.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,068.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,732.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,328.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,396.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,068.0 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,732.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504.0 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,328.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,068.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,732.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,504.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,328.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,396.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring expenses (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and certain litigation expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 804600000 735900000 2393100000 2203600000 315100000 282700000 968400000 878000000.0 85800000 84900000 265600000 251500000 153200000 136100000 440900000 399000000.0 1358700000 1239600000 4068000000 3732100000 551200000 498400000 1619200000 1510200000 177300000 156100000 540300000 489200000 54400000 53700000 159800000 158500000 67200000 59500000 184700000 170600000 850100000 767700000 2504000000 2328500000 1358700000 1239600000 4068000000 3732100000 -4300000 3800000 -14300000 11500000 1354400000 1243400000 4053700000 3743600000 850100000 767700000 2504000000 2328500000 468700000 410100000 1396500000 1259400000 32900000 0 32900000 0 10800000 2200000 27800000 193600000 0 0 0 -26200000 12900000 10500000 19300000 60400000 350600000 365900000 1066100000 962100000 52200000 21700000 91900000 43100000 402800000 387600000 1158000000 1005200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,743.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 804600000 735900000 2393100000 2203600000 319800000 286500000 978000000.0 877700000 81400000 85800000 253900000 266400000 148600000 135200000 428700000 395900000 1354400000 1243400000 4053700000 3743600000 1023300000 960900000 3069800000 2900400000 91100000 52400000 247000000.0 141600000 240000000.0 230100000 736900000 701600000 1354400000 1243400000 4053700000 3743600000 SUBSEQUENT EVENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In October 2024, the Company acquired all the remaining outstanding shares of Innovalve Bio Medical Limited ("Innovalve") for an aggregate cash purchase price of $300.0 million, subject to certain adjustments, plus an additional $25.0 million upon achievement of a certain regulatory milestone. Innovalve is a developer of a transcatheter mitral valve replacement system. </span></div>Prior to the acquisition date, the Company had previously paid $30.0 million for an option to acquire Innovalve, which the Company exercised in July 2024, and had an existing preferred stock investment in Innovalve of $3.5 million, which represented approximately a 4% interest in Innovalve (collectively, the "previously held interest"). The acquisition of the remaining equity interest in Innovalve is expected to be accounted for as a step acquisition in accordance with Accounting Standards Codification Topic 805, "Business Combinations." 300000000.0 25000000.0 30000000.0 3500000 0.04 false false <div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 19, 2024, Scott B. Ullem, Corporate Vice President, Chief Financial Officer, entered into a Plan providing for the potential sale of 56,250 shares of the Company’s stock commencing December 9, 2024. Mr. Ullem's Plan terminates on the earlier of May 9, 2025 or the date all shares are sold.</span></div> August 19, 2024 Scott B. Ullem Corporate Vice President, Chief Financial Officer true 56250 May 9, 2025 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on September 23, 2024, Bernard J. Zovighian, Chief Executive Officer and Director, terminated a Plan that had provided for the potential sale of 25,147 shares of the Company’s stock commencing May 20, 2024. Following the termination date, no remaining shares can be sold pursuant to the Plan.</span> September 23, 2024 Bernard J. Zovighian Chief Executive Officer and Director true 25147

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